[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

TW201219451A - Liquid crystal aligning agent, liquid crystal alignment film, and liquid crystal display element - Google Patents

Liquid crystal aligning agent, liquid crystal alignment film, and liquid crystal display element Download PDF

Info

Publication number
TW201219451A
TW201219451A TW100126353A TW100126353A TW201219451A TW 201219451 A TW201219451 A TW 201219451A TW 100126353 A TW100126353 A TW 100126353A TW 100126353 A TW100126353 A TW 100126353A TW 201219451 A TW201219451 A TW 201219451A
Authority
TW
Taiwan
Prior art keywords
ring
liquid crystal
single bond
group
carbon number
Prior art date
Application number
TW100126353A
Other languages
Chinese (zh)
Other versions
TWI522391B (en
Inventor
Kazuyoshi Hosaka
Kohei Goto
Noritoshi Miki
Masaaki Katayama
Koji Sonoyama
Original Assignee
Nissan Chemical Ind Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nissan Chemical Ind Ltd filed Critical Nissan Chemical Ind Ltd
Publication of TW201219451A publication Critical patent/TW201219451A/en
Application granted granted Critical
Publication of TWI522391B publication Critical patent/TWI522391B/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G73/00—Macromolecular compounds obtained by reactions forming a linkage containing nitrogen with or without oxygen or carbon in the main chain of the macromolecule, not provided for in groups C08G12/00 - C08G71/00
    • C08G73/06—Polycondensates having nitrogen-containing heterocyclic rings in the main chain of the macromolecule
    • C08G73/10—Polyimides; Polyester-imides; Polyamide-imides; Polyamide acids or similar polyimide precursors
    • C08G73/1042—Copolyimides derived from at least two different tetracarboxylic compounds or two different diamino compounds
    • C—CHEMISTRY; METALLURGY
    • C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K19/00—Liquid crystal materials
    • C09K19/52—Liquid crystal materials characterised by components which are not liquid crystals, e.g. additives with special physical aspect: solvents, solid particles
    • C09K19/54—Additives having no specific mesophase characterised by their chemical composition
    • C09K19/56—Aligning agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Materials Engineering (AREA)
  • Liquid Crystal (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)

Abstract

Disclosed is a liquid crystal aligning agent which contains at least one kind of polymer that is selected from the group consisting of polyimides and polyimide precursors that are obtained by causing a diamine component that contains a diamine compound represented by formula (1) and a diamine compound represented by formula (2) to react with a tetracarboxylic acid dianhydride component. (In formula (1), X1 represents -O-, -CO-, -NH-, -CONH-, -NHCO-, -CH2O-, -OCO- or the like; X2 represents an alkyl group having 1-5 carbon atoms or a non-aromatic heterocyclic ring containing a nitrogen atom; X3 represents a five-membered or six-membered aromatic heterocyclic ring containing two nitrogen atoms which may be substituted by an alkyl group having 1-5 carbon atoms; and n represents an integer of 1-4. In formula (2), Y1 represents a single bond, -(CH2)a- (wherein a represents an integer of 1-15), -O-, -CH2O-, -COO- or OCO-; Y2 represents a single bond or (CH2)b- (wherein b represents an integer of 1-15); Y3 represents a single bond, -(CH2)c- (wherein c represents an integer of 1-15), -O-, -CH2O-, -COO- or OCO-; Y4 represents a cyclic group selected from the group consisting of a benzene ring, a cyclohexane ring and heterocyclic rings or a divalent organic group selected from among organic groups having a steroid skeleton and 12-25 carbon atoms; Y5 represents a divalent cyclic group selected from the group consisting of a benzene ring, a cyclohexane ring and heterocyclic rings; n represents an integer of 0-4; Y6 represents an alkyl group having 1-18 carbon atoms, or the like; and m represents an integer of 1-4.)

Description

201219451 六、發明說明： 【發明所屬之技術領域】 本發明爲有關製作液晶配向膜之際所使用 處理劑及使用其之液晶顯示元件之發明》 【先前技術】 目前，液晶顯示元件之液晶配向膜，主要 胺酸等之聚醯亞胺前趨物或可溶性聚醯亞胺之 成分之液晶配向處理劑塗佈、燒焙所得之所謂 之液晶配向膜。 液晶配向膜爲以控制液晶之配向狀態爲目 物品。但是，伴隨液晶顯示元件之高精細化， 顯示元件之反差之降低或降低殘影現象之觀點 之液晶配向膜中，提高電壓保持率或，於施加 際可降低蓄積電荷或儘速緩和因直流電壓所蓄 特性，已逐漸變得更爲重要。 聚醯亞胺系之液晶配向膜中，已知可縮短 所發生之殘影至消失爲止時間的成份，爲使用 胺酸或含醯亞胺基之聚醯胺酸以外，爲含有特 級胺的液晶配向處理劑者（例如，參照專利文i 使用含有作爲原料使用之具有吡啶骨架等之特 溶性聚醯亞胺的液晶配向處理劑所得者（例如 文獻2)等。又，具有高電壓保持率，且可縮短 所發生之殘影至消失爲止之時間的成份，已知 之液晶配向 爲使用聚醯 溶液作爲主 聚醯亞胺系 的所使用之 就抑制液晶 ，於所使用 直流電壓之 積之電荷等 因直流電壓 除含有聚醯 定結構之3 太1),或， 定二胺的可 ，參照專利 因直流電壓 爲使用除含 -5- 201219451 有聚醯胺酸或其醯亞胺化聚合物等以外，尙含有極少量之 由分子內含有1個羧酸基之化合物、分子內含有1個羧酸 酐基之化合物及分子內含有1個3級胺基之化合物所選出 之化合物的液晶配向處理劑（例如，參照專利文獻3)。 [先前技術文獻] [專利文獻] [專利文獻1]日本特開平9-3 1 6200號公報 [專利文獻2]日本特開平1 0- 1 04633號公報 [專利文獻3]日本特開平8-76128號公報 【發明內容】 [發明所欲解決之問題] 近年來，大畫面且具有高精細度之液晶電視以廣泛地 實用化，該些用途中之液晶顯示元件，與目.前爲止以文字 或靜止畫面顯示爲主之顯示器用途相比較時，對於殘影之 要求則更爲嚴苛，而要求可耐長期間在嚴苛使用環境中使 用之特性。因此，所使用之液晶配向膜必須爲較以往具有 更高信賴性之物。因此，液晶配向膜之電特性，即，有關 緩和因電壓保持率及直流電壓而蓄積之電荷的特性，也要 求不僅初期特性必須良好，例如，於長時間暴露於背光之 光線後，也需要可維持良好之特性。該緩和因電壓保持率 及直流電壓而蓄積之電荷的特性大幅降低之情形，因液晶 顯示元件之顯示不良而容易產生電線走火黏結或顯示面走 火黏結等狀態，而無法得到具有高信賴性之液晶顯示元件 -6 - 201219451 本發明爲鑑於上述情事所提出者，而以提出一種除初 期特性以外，即使長時間暴露於光照射下’可抑制電壓保 持率之降低，且可快速地緩和因直流電壓而蓄積之電荷的 液晶配向膜之液晶配向處理劑，此外，可承受嚴苛使用環 境下之長期間的使用之具有高度信賴性之液晶顯示元件之 發明。 [解決問題之手段] 本發明者們，經過深入硏究結果，發現一種含有具有 特定結構之聚醯亞胺前趨物及該聚醯亞胺前趨物經脫水閉 環所得之聚醯亞胺的液晶配向處理劑，就達成上述目的爲 極有效者，因而完成本發明。 即，本發明爲具有以下特徵之發明。 (1) 一種液晶配向處理劑，其特徵爲含有，由含有下述 之式[1]所示之二胺化合物（亦稱爲特定二胺化合物）及下述 之式[2]所示之二胺化合物（亦稱爲特定側鏈型二胺化合物） 之二胺成分與四羧酸二酐成分反應所得之聚醯亞胺前趨物 ，及聚醯亞胺所成群所選出之至少1種之聚合物，[Technical Field] The present invention relates to a treatment agent used in the production of a liquid crystal alignment film and a liquid crystal display element using the same. [Prior Art] Currently, a liquid crystal alignment film of a liquid crystal display element A so-called liquid crystal alignment film obtained by coating and baking a liquid crystal alignment treatment agent of a polyimine precursor such as a major amine acid or a component of a soluble polyimine. The liquid crystal alignment film is intended to control the alignment state of the liquid crystal. However, with the high definition of the liquid crystal display element, the liquid crystal alignment film in which the contrast of the display element is lowered or the phenomenon of image sticking is lowered, the voltage holding ratio is increased or the accumulated electric charge can be lowered or the DC voltage can be alleviated as soon as possible. The stored characteristics have gradually become more important. In a polyimine-based liquid crystal alignment film, it is known that a component which can shorten the time of occurrence of the image sticking to the disappearance is used, and it is a liquid crystal containing a tertiary amine other than an amino acid or a ruthenium group containing a quinone imine group. For example, the use of a liquid crystal alignment treatment agent containing a particularly soluble polyimine such as a pyridine skeleton used as a raw material (for example, Document 2), etc., has a high voltage retention ratio. Further, it is possible to shorten the time of occurrence of the residual image until the disappearance, and the known liquid crystal alignment is to suppress the liquid crystal, the charge of the product of the DC voltage used, etc., using the polyfluorene solution as the main polyimine. Since the DC voltage is different from the polypyrozyl structure, which is 1 to 1), or the diamine is available, the reference patent is based on the DC voltage. In addition to the use of -5 - 201219451, there is polyacrylic acid or its ruthenium imidized polymer. In addition, ruthenium contains a very small amount of a compound selected from a compound containing one carboxylic acid group in the molecule, a compound containing one carboxylic acid anhydride group in the molecule, and a compound having one amino acid group in the molecule. Crystal alignment treating agent (e.g., refer to Patent Document 3). [PRIOR ART DOCUMENT] [Patent Document 1] Japanese Laid-Open Patent Publication No. Hei No. Hei 8- No. Hei No. Hei. [Invention] [Inventors] In recent years, liquid crystal televisions with large screens and high definition have been widely put into practical use. When the still picture display is used as the main display, the requirements for the afterimage are more stringent, and the characteristics that can be used in a severe use environment for a long period of time are required. Therefore, the liquid crystal alignment film to be used must be more reliable than ever. Therefore, the electrical characteristics of the liquid crystal alignment film, that is, the characteristics of the charge accumulated by mitigating the voltage holding ratio and the DC voltage, are required to have good initial characteristics, for example, after exposure to the backlight for a long period of time, Maintain good characteristics. When the characteristics of the electric charge accumulated by the voltage holding ratio and the DC voltage are greatly reduced, the display failure of the liquid crystal display element is likely to cause a state in which the electric wire is ignited or the display surface is ignited and bonded, and a liquid crystal having high reliability cannot be obtained. Display Element-6 - 201219451 The present invention has been proposed in view of the above circumstances, and proposes a reduction in voltage holding ratio even under long-term exposure to light irradiation in addition to initial characteristics, and can quickly alleviate DC voltage The liquid crystal alignment agent of the liquid crystal alignment film which accumulates the charge, and the invention which can withstand the highly reliable liquid crystal display element used in the long-term use environment. [Means for Solving the Problem] The present inventors have found through intensive research that a polyimine precursor having a specific structure and a polyimine obtained by dehydration ring closure of the polyimine precursor are found. The liquid crystal alignment treatment agent is extremely effective in achieving the above object, and thus the present invention has been completed. That is, the present invention is an invention having the following features. (1) A liquid crystal alignment treatment agent comprising a diamine compound (also referred to as a specific diamine compound) represented by the following formula [1] and a formula (2) represented by the following formula [2] At least one selected from the group consisting of a polyamine component obtained by reacting a diamine component of an amine compound (also referred to as a specific side chain type diamine compound) with a tetracarboxylic dianhydride component Polymer,

201219451 (X1 爲，-〇-、-0：〇-、->^-'->^((：113)-、-0：〇]^11-、-仙(：〇-、-CH20-、-OCO-、-CON(CH3)-或 N(CH3)CO-，X2 爲碳數 1〜5之烷基或含有氮原子之非芳香族雜環，χ3爲可被碳 數1〜5之烷基所取代之含有2個氮原子之5員環或6員 環之芳香族雜環）；201219451 (X1 is, -〇-,-0:〇-,->^-'->^((:113)-,-0:〇]^11-,-仙(:〇-, -CH20 -, -OCO-, -CON(CH3)- or N(CH3)CO-, X2 is an alkyl group having 1 to 5 carbon atoms or a non-aromatic heterocyclic ring containing a nitrogen atom, and χ3 is a carbon number of 1 to 5 a 5-membered ring or a 6-membered aromatic heterocyclic ring containing 2 nitrogen atoms substituted by an alkyl group;

(Y1 爲，單鍵、-(CH2)a-(a 爲 1 〜15 之整數）、-0-、-CH20-. 、-C00-或 0C0-，Y2 爲，單鍵或（CH2)b-(b 爲 1 〜15 之 整數），Y3爲，單鍵、-(CH2)c-(c爲1〜15之整數）、-〇-、-CH20-、-C00-或0C0-: Y4爲，由苯環、環己烷環及 雜環所成群所選出之環狀基（該些之環狀基上之任意的氫 原子可被碳數1〜3之烷基、碳數1〜3之烷氧基、碳數1 〜3之含氟烷基、碳數1〜3之含氟烷氧基或氟原子所取代 )，或具有固醇骨架之碳數12〜25之有機基所選出之2價 之有機基，Y5爲，由苯環、環己烷環及雜環所成群所選出 之2價之環狀基（該些之環狀基上之任意的氫原子可被碳 數1〜3之烷基、碳數1〜3之烷氧基、碳數1〜3之含氟 烷基、碳數1〜3之含氟烷氧基或氟原子所取代），η爲0 〜4之整數；Υ6爲碳數1〜18之烷基、碳數1〜18之含氟 烷基、碳數1〜18之烷氧基或碳數1〜18之含氟烷氧基， 201219451 m爲1〜4之整數）。 (2)如上述（1)所記載之液晶配向處理劑，其式[1]中(Y1 is, single bond, -(CH2)a-(a is an integer from 1 to 15), -0-, -CH20-., -C00- or 0C0-, Y2 is, single bond or (CH2)b- (b is an integer from 1 to 15), Y3 is a single bond, -(CH2)c-(c is an integer from 1 to 15), -〇-, -CH20-, -C00- or 0C0-: Y4 is, a cyclic group selected from the group consisting of a benzene ring, a cyclohexane ring, and a heterocyclic ring (any hydrogen atom on the cyclic group may be an alkyl group having 1 to 3 carbon atoms, and a carbon number of 1 to 3) An alkoxy group, a fluorine-containing alkyl group having 1 to 3 carbon atoms, a fluorine-containing alkoxy group having 1 to 3 carbon atoms or a fluorine atom, or an organic group having a sterol skeleton having 12 to 25 carbon atoms selected a divalent organic group, Y5 is a bivalent cyclic group selected from the group consisting of a benzene ring, a cyclohexane ring and a heterocyclic ring (any hydrogen atom on the cyclic group may be carbon number 1 ～3 alkyl group, carbon number 1 to 3 alkoxy group, carbon number 1 to 3 fluorine-containing alkyl group, carbon number 1 to 3 fluorine-containing alkoxy group or fluorine atom substituted), η is 0 to 4 An integer of Υ6 is an alkyl group having 1 to 18 carbon atoms, a fluorine-containing alkyl group having 1 to 18 carbon atoms, an alkoxy group having 1 to 18 carbon atoms or a fluorine-containing alkoxy group having 1 to 18 carbon atoms, 201219451 m 1~4 Integer). (2) The liquid crystal alignment treatment agent according to (1) above, wherein in the formula [1]

X1 爲，0、 或 CH20-。 (3) 如上述（1)或（2)所記載之液晶配向處理劑，其式[1] 中，X2爲哌嗪環。 (4) 如上述（1)〜（3 )中任一項記載之液晶配向處理劑， 其式[1 ]中，X3爲，咪唑環、吡嗪環或嘧啶環。 (5 )如上述（1)〜（4 )中任一項記載之液晶配向處理劑， 其中’ ΒίΙ述聚合物爲使用下述之式[3]所示之四殘酸二軒之 聚合物， [化3]X1 is 0, or CH20-. (3) The liquid crystal alignment treatment agent according to the above (1) or (2), wherein in the formula [1], X2 is a piperazine ring. (4) The liquid crystal alignment treatment agent according to any one of the above (1) to (3), wherein, in the formula [1], X3 is an imidazole ring, a pyrazine ring or a pyrimidine ring. (5) The liquid crystal alignment treatment agent according to any one of the above (1) to (4), wherein the polymer is a polymer of tetrahydrous acid dioxane represented by the following formula [3], [Chemical 3]

(Ζ1爲碳數4〜13之4價之有機基，且含有碳數4~10之 非芳香族環狀烴基）。 (6)如上述（5)所記載之液晶配向處理劑，其中，Ζι爲 下述之式[3a]〜[3j]所示結構之基。 201219451 [化4](Ζ1 is a tetravalent organic group having 4 to 13 carbon atoms and a non-aromatic cyclic hydrocarbon group having 4 to 10 carbon atoms). (6) The liquid crystal alignment treatment agent according to the above (5), wherein Ζι is a group having a structure represented by the following formulas [3a] to [3j]. 201219451 [化4]

z2Z2

文文:ccrcm z3文文:ccrcm z3

(z〜z爲’氫原子 '甲基、氯原子或苯環，其可分別爲 相同或相異皆可；Z6及Z7爲，氫原子或甲基，其可分別 爲相同或相異皆可）。 (7) 如上述（1)〜（6)中任—項記載之液晶配向處理劑， 其中’前述聚合物爲由二胺成分與四羧酸二酐成分反應所 得之聚酿胺酸’及該聚醯胺酸經脫水閉環所得之聚醯亞胺 所成群所選出之至少1種之聚合物。 (8) 如上述（1)〜（6)中任一項記載之液晶配向處理劑， 其中’前述聚合物爲聚醯胺酸經脫水閉環所得之聚醯亞胺 〇 (9) 如上述（1)〜（8)中任一項記載之液晶配向處理劑， 其中，液晶配向處理劑中具有， 具有環氧基、環氧丙烷基、環碳酸醋基或異氰酸醋基(z~z is a 'hydrogen atom' methyl group, a chlorine atom or a benzene ring, which may be the same or different, respectively; Z6 and Z7 are hydrogen atoms or methyl groups, which may be the same or different, respectively. ). (7) The liquid crystal alignment treatment agent according to any one of the above-mentioned items, wherein the polymer is a polyamic acid obtained by reacting a diamine component with a tetracarboxylic dianhydride component and At least one polymer selected from the group consisting of polyamido acids obtained by dehydration ring closure. (8) The liquid crystal alignment treatment agent according to any one of the above-mentioned (1), wherein the polymer is a polyamidimide obtained by dehydration ring closure (9) as described above (1) The liquid crystal alignment treatment agent according to any one of (8), wherein the liquid crystal alignment treatment agent has an epoxy group, an oxypropylene group, a cyclic carbonate group or an isocyanate group.

-10- 201219451 之交聯性化合物、 具有由羥基及烷氧基所成群所選出之至少1種之取代 基的交聯性化合物，或 具有聚合性不飽和鍵結之交聯性化合物。 (1 0)如上述（1)〜（9)中任一項記載之液晶配向處理劑 ，其中，液晶配向處理劑含有有機溶劑，有機溶劑之全體 中含有5〜80質量％之不良溶劑。 (11) 一種液晶配向膜，其特徵爲，使用上述（1)〜（10) 中任一項記載之液晶配向處理劑而得。 (12) —種液晶顯示元件，其特徵爲，具有上述（1 1)所 記載之液晶配向膜。 (13) 如上述（11)所記載之液晶配向膜，其使用於由具 備有電極之一對基板之間具有液晶層者所構成，且於前述 一對基板之間配置含有可經活性能量線及熱之至少一者而 聚合之聚合性化合物的液晶組成物，並經由對前述電極間 施加電壓，使前述聚合性化合物聚合之步驟所製得之液晶 顯示元件。 (1 4) 一種液晶顯示元件’其特徵爲具備上述（丨3 )所記 載之液晶配向膜。 (15)如上述（14)所記載之液晶顯示元件，其爲由具備 有上述（11)或（13)所記載之液晶配向膜與電極之一對基板 間具有液晶層所構成，並經由於前述一對基板之間配置含 有經活性能量線及熱之至少一者而聚合之聚合性化合物的 液晶組成物’並對前述電極間施加電壓，使前述聚合性化 -11- 201219451 合物聚合之步驟所製得之液晶顯示元件。 (1 6)如上述（1 1)所記載之液晶配向膜 具備有電極之一對基板之間具有液晶層者 述一對基板之間配置含有可經活性能量線 而聚合之聚合性基的液晶配向膜，並經由 加電壓，使前述聚合性基聚合之步驟所製 件。 (17) —種液晶顯示元件，其特徵爲， 記載之液晶配向膜。 (18) 如上述（17)所記載之液晶顯示元 具備有電極之一對基板之間具有液晶層所 一對基板之間配置含有可經活性能量線及 聚合之聚合性基的上述（1 1)或（1 3 )所記載 並經由對前述電極間施加電壓，使前述聚 驟所製得。 [發明效果] 使用本發明之液晶配向處理劑時，可 以外，即使長時間暴露於光照射下，可抑 降低，且可快速地緩和因直流電壓而蓄積 膜。此外，可提供一種可承受嚴苛使用環 使用，且具有高度信賴性之液晶顯示元件 [發明之實施形態] ，其爲使用於由 所構成，且於前 及熱之至少一者 對前述電極間施 得之液晶顯示元 具備上述（1 6)所 件’其爲經由對 構成，且於前述 熱之至少一者而 之液晶配向膜， 合性基聚合之步 得到除初期特性 制電壓保持率之 之電荷液晶配向 境下之長期間的 -12- 201219451 <特定二胺化合物> 本發明之特定二胺化合物爲下述式[1]所示。 [化5]-10-201219451 A crosslinkable compound having at least one substituent selected from a group consisting of a hydroxyl group and an alkoxy group, or a crosslinkable compound having a polymerizable unsaturated bond. (10) The liquid crystal alignment treatment agent according to any one of the above aspects, wherein the liquid crystal alignment treatment agent contains an organic solvent, and the organic solvent contains 5 to 80% by mass of a poor solvent. (11) A liquid crystal alignment film obtained by using the liquid crystal alignment treatment agent according to any one of the above (1) to (10). (12) A liquid crystal display device comprising the liquid crystal alignment film according to (1) above. (13) The liquid crystal alignment film according to the above (11), which is configured to have a liquid crystal layer between the pair of substrates, and to include an active energy ray between the pair of substrates And a liquid crystal display device obtained by the step of polymerizing the polymerizable compound by applying a voltage between the electrodes, and a liquid crystal composition of the polymerizable compound polymerized at least one of the heat. (1 4) A liquid crystal display element 'characterized by providing the liquid crystal alignment film described in the above (丨3). (15) The liquid crystal display device according to the above (11), wherein the liquid crystal alignment film and the electrode according to the above (11) or (13) are provided with a liquid crystal layer between the substrates, and A liquid crystal composition containing a polymerizable compound polymerized by at least one of an active energy ray and heat is disposed between the pair of substrates, and a voltage is applied between the electrodes to polymerize the polymerizable -11-201219451 compound. The liquid crystal display element produced in the step. (1) The liquid crystal alignment film according to the above (1), wherein one of the electrodes is provided, and a liquid crystal having a liquid crystal layer between the substrates is disposed between the pair of substrates, and a polymerizable group polymerizable by the active energy ray is disposed. The alignment film is formed by a step of polymerizing the aforementioned polymerizable group by applying a voltage. (17) A liquid crystal display device characterized by the liquid crystal alignment film described. (18) The liquid crystal display element according to the above (17), wherein the one of the electrodes is provided between the pair of substrates having the liquid crystal layer between the substrates, and the polymerizable group capable of undergoing active energy rays and polymerization is disposed (1 1) Or, as described in (1 3), the voltage is applied to the electrodes to prepare the polymerization. [Effect of the Invention] When the liquid crystal alignment agent of the present invention is used, it can be reduced even if it is exposed to light for a long period of time, and the film can be quickly accumulated by the DC voltage. Further, it is possible to provide a liquid crystal display element which can withstand the use of a severe use ring and has high reliability (the embodiment of the invention), which is used for the above, and at least one of the front and the heat is interposed between the electrodes The liquid crystal display element to be applied has the liquid crystal alignment film which is formed by the pair and is at least one of the heats, and the polymerization step is obtained by the polymerization of the initial characteristics. -12-201219451 <Specific diamine compound> The specific diamine compound of the present invention is represented by the following formula [1]. [Chemical 5]

[1] 式 Π]中，X1 爲，-0-、-(：0-、-^111-、->^((：1€3)-、-(：0?^11-、-NHCO-、-CH20-、_0C0-、-CON(CH3)•或 N(CH3)CO-;其 中又以-0-、-COO-、-NH-、-CONH-、-NHCO-、-CON(CH3)-、-CHzO-或oco-，就容易合成二胺化合物等觀點而爲較佳。 特佳爲，_〇-、-CO-、-NH-、-CONH- ' -NHCO-、-CON(CH3)-或 CH2〇-; 式Π]中’ X2爲碳數1〜5之烷基或含有氮原子之非芳 香族雜環。X2爲碳數1〜5之烷基之情形中，該烷基可爲 直鏈狀亦可、分支狀亦可。特別是烷基之碳數以1〜3爲 佳。又’ X2以含有氮原子之非芳香族雜環之情形爲例時， 例如吡咯啶環、哌啶環、吡唑烷環、喹嚀環或咪唑啶環等 。特別是非芳香族雜環爲5員環或6員環者，作爲液晶配 向膜之情形’可得到良好之配向性，而爲較佳。又，非芳 香族雜環含有2個氮原子之情形，其作爲液晶顯示元件之 情形’於液晶配向膜界面中，會吸附液晶中之離子性雜質 ’而期待其可保持液晶顯示元件之良好電特性。 -13- 201219451 由以上之觀點得知’含有氮原子之非芳香族雜環特別 是以哌嗪環爲佳。此外，X2爲X3中之氮原子或與該氮原 子隣接之碳原子鍵結之情形中，於形成液晶顯示元件時， 具有優良之提早緩和因直流電壓所蓄積之殘留電荷的效果 而爲較佳。 式[1]中，X3爲可被碳數1〜5之烷基所取代之含有2 個氮原子之5員環或6員環之芳香族雜環；含有2個氮原 子之5員環或6員環之芳香族雜環之例如’咪唑環、吡唑 環、吡嗪環、嘧啶環或嗒井環等。其中又以咪唑環、吡嗪 環或嘧啶環爲佳。又，X3中之芳香族雜環被烷基所取代之 情形，其烷基之碳數以1〜3爲佳。 式[1]中，η爲1〜4之整數。其中又以1或2之整數 爲佳。 式[1 ]中，X 1、X2、X3及η之較佳組合’係如表1〜 1 4所示內容。[1] In the formula ,], X1 is, -0-, -(:0-, -^111-, ->^((:1€3)-, -(:0?^11-, -NHCO -, -CH20-, _0C0-, -CON(CH3)• or N(CH3)CO-; wherein -0-, -COO-, -NH-, -CONH-, -NHCO-, -CON(CH3) -, -CHzO- or oco-, it is preferred to synthesize a diamine compound, etc. Particularly preferred, _〇-, -CO-, -NH-, -CONH- '-NHCO-, -CON( CH3)- or CH2〇-; wherein X2 is an alkyl group having 1 to 5 carbon atoms or a non-aromatic heterocyclic ring containing a nitrogen atom. In the case where X2 is an alkyl group having 1 to 5 carbon atoms, the alkane The base may be linear or branched, and in particular, the carbon number of the alkyl group is preferably 1 to 3. Further, when X2 is a non-aromatic heterocyclic ring containing a nitrogen atom, for example, pyrrolidine. a ring, a piperidine ring, a pyrazolidine ring, a quinone ring or an imidazolium ring, etc. In particular, a non-aromatic heterocyclic ring is a 5-membered ring or a 6-membered ring, and a good alignment property can be obtained as a liquid crystal alignment film. Further, in the case where the non-aromatic heterocyclic ring contains two nitrogen atoms, it acts as a liquid crystal display element in the liquid crystal alignment film interface, and adsorbs ions in the liquid crystal. It is expected that it can maintain good electrical characteristics of the liquid crystal display element. -13- 201219451 From the above point of view, it is known that a non-aromatic heterocyclic ring containing a nitrogen atom is particularly preferably a piperazine ring. Further, X2 is in X3. In the case where a nitrogen atom or a carbon atom adjacent to the nitrogen atom is bonded, it is preferable to form an effect of preliminarily relaxing the residual charge accumulated by the DC voltage when forming a liquid crystal display element. In the formula [1] X3 is a 5-membered or 6-membered aromatic heterocyclic ring containing 2 nitrogen atoms which may be substituted by an alkyl group having 1 to 5 carbon atoms; a 5-membered ring or a 6-membered ring containing 2 nitrogen atoms The heterocyclic ring is, for example, an 'imidazole ring, a pyrazole ring, a pyrazine ring, a pyrimidine ring or a fluorene ring. Among them, an imidazole ring, a pyrazine ring or a pyrimidine ring is preferred. Further, the aromatic heterocyclic ring in X3 is In the case where the alkyl group is substituted, the carbon number of the alkyl group is preferably from 1 to 3. In the formula [1], η is an integer of from 1 to 4. Among them, an integer of 1 or 2 is preferably used. In the formula [1] The preferred combination of X 1 , X 2 , X 3 and η is as shown in Tables 1 to 14.

-14- . S 201219451 [表1] X1 X2 X3 η 1-1 -0- 碳數1〜3之伸烷基 咪唑環 1 1-2 -0- 碳數卜3之伸烷基 咪唑環 2 1-3 -0- 碳數卜3之伸烷基 吡嗪環 1 1-4 碳數卜3之伸烷基 吡嗪環 2 1-5 -0- 碳數卜3之伸烷基 嘧啶環 1 1-8 -0- 碳數卜3之伸烷基 嘧淀環 2 1-7 -0- 吡咯陡環 咪唑環 1 1-8 吡咯啶環 咪唑環 2 1-9 -0- 吡唂哫環 吡嗪環 1 1-10 毗咯啶環 耻嗪環 2 1-11 -0- 吡咯啶環 嘧陡環 1 1-12 -0- 吡咯啶環 嘧啶環 2 1-13 -0- _旋環 咪唑環 1 t-14 唬呢環 咪哩環 2 1-15 -0- 吡嗪環 1 1-16 -0- 哌啶環 吡嗪環 2 1-17 -0- 哌陡環 嘧陡環 1 1-18 -0- 哌啶環 嘧啶環 2 1-19 -0- 哌嗪環 咪唑環 1 1-20 哌嗪環 咪唑環 2 t-21 岐嗓環 吡嗪環 1 [表2] X1 X2 X3 η t-22 -0- 哌嗪環 吡嗉環 2 1-23 _嗪環 嘧啶環 1 1-24 -0- 哌嗪環 2 1-25 吡唑啶環 咪唑環 1 1-26 -〇 吡唑啶環 咪唑環 2 1-27 -0- 吡唑啶環 吡嗪環 1 1-28 -0- 吡唑啶環 吡嗪環 2 1-29 -0- 吡唑啶環 嘧啶環 1 1-30 -0- 吡唑啶環 嘧啶環 2 1-31 -0- 喹嚀環 咪唑環 1 1-32 -0- 嗳嚀環 咪唑環 2 1-33 -0- 喹嚀環 吡嗪環 1 1-34 -0- 喹嚀環 耻嗪環 2 1-35 -0- 喹嚷環 嘧聢環 1 1-36 喹嚀環 嘧啶環 2 1-37 -0- 咪唑陡環 咪哩環 1 卜38 咪唑啶環 咪唑環 2 1-39 -0- 咪唑啶環 毗嗪環 1 1-40 咪唑賴 吡曉環 2 1-41 咪唑啶環 嘧啶環 1 1-42 咪唑啶環 嘧啶環 2 -15- 201219451 [表3] X1 X2 X3 π t-43 -CO- 碳數1〜3之伸院基 咪唑環 1 1-44 -CO 碳數1〜3之伸烷基 咪唑環 2 1-45 -CO- 碳數1〜3之伸烷基 吡嗪環 1 1-46 -CO- 碳數1〜3之伸烷基 吡嗪環 1 1-47 -CO- 碳數1〜3之伸烷基 嘧啶環 1 1-48 -CO- 碳數1〜3之伸烷基 嘧啶環 2 1-49 -CD- 吡咯啶環 咪唑環 1 1-50 -CO- 吡咯啶環 咪唑環 2 1-51 -CO- 吡咯啶環 吡嗪環 1 1-52 -CO- 吡咯啶環 吡嗪環 2 1-53 -CO 吡咯啶環 嘧啶環 1 1-54 -CO- 吡咯啶環 嘧啶環 1 1-55 -CO- 哌啶環 咪唑環 1 1-56 -CO 哌啶環 咪唑環 2 1-57 -CO- 哌啶環 吡嗪環 1 1-58 -CO- 哌啶環 吡嗪環 2 1-59 -CO- 哌啶環 嘧啶環 1 1-60 -CO- 哌啶環 嘧啶環 2 1-61 -CO- 哌嗪環 咪唑環 1 1-62 -CO- 哌嗪環 咪唑環 2 1-63 -CO- 哌嗪環 吡嗪環 1 [表4] X1 X2 X3 η 1-64 -CO 哌嗪環 吡嗪環 2 t-65 -CO- 哌嗪環 嘧啶環 1 1-66 -CO 哌嗪環 嘧啶環 2 1-67 -CO- 吡唑啶環 咪唑環 1 1-68 -CO- 吡唑啶環 咪唑環 2 1-69 -CO- BH;唑啶環 吡嗪環 1 1-70 -CO- 吡唑啶環 吡嗪環 2 1-71 -CO- 吡唑啶環 嘧啶環 1 1-72 -CO- 吡唑啶環 嘧啶環 2 1-73 -CO- 喹嚀環 咪唑環 1 1-74 -CO- 喹嚀環 咪唑環 2 1-75 -CO- 喹嚀環 吡嗪環 1 1-76 -CO- 喹嚀環 吡嗪環 2 1-77 -CO- 喹嚀環 嘧啶環 1 1-78 -CO- 喹嚀環 嘧啶環 2 1-79 -CO- 咪唑啶環 咪唑環 1 1-80 -CO- 咪唑啶環 咪唑環 2 1-81 -CO- 咪唑啶環 吡嗪環 1 1-82 -CO- 咪唑啶環 吡嗪環 2 1-83 -CO- 咪唑啶環 嘧啶環 1 1-84 -CO- 咪唑啶環 嘧啶環 2 -16- 201219451 [表5] X1 X2 X3 η 1-85 -NH- 碳數1〜3之伸烷基 咪唑環 1 1-86 -NH- 碳數1〜3之伸院基 咪唑環 2 1-87 -NH- 碳數1〜3之伸院基 吡嗪環 1 1-88 -NH- 碳數卜3之伸烷基 吡嗪環 2 1-89 -NH- 碳數1〜3之伸烷基 嘧淀環 1 1-90 -NH- 碳數1〜3之伸烷基 嘧啶環 2 1-91 -NH- 吡咯啶環 咪唑環 1 1-92 -NH- 吡咯啶環 咪哩環 2 1-93 -NH- 吡咯啶環 吡嗪環 1 t-94 -NH- 吡咯啶環 吡嗪環 2 1-95 -NH- 吡咯啶環 嘧啶環 1 1-96 -NH- 吡咯啶環 嘧啶環 2 1-97 -NH- 哌啶環 咪唑環 1 1-98 -NH- 哌啶環 咪唑環 2 1-99 -NH- 哌啶環 吡嗪環 1 1-100 -NH- 岐陡環 吡嗪環 2 1-101 -NH- 哌啶環 嘧啶環 1 1-102 -NH- .哌陡環 嘧啶環 2 1-103 -NH- 哌嗪環 咪唑環 1 1-104 -NH- 哌嗪環 咪唑環 2 1-105 -NH- 哌嗪環 吡嗪環 1 [表6] X1 X2 X3 η 1-106 -NH- 哌嗪環 吡嗪環 2 1-107 -NH- 哌嗪環 嘧啶環 1 1-108 -NH- 哌嗪環 嘧啶環 2 1-109 -NH- 吡唑啶環 咪唑環 1 1-110 -NH- 吡唑啶環 咪唑環 1 1-111 -NH- 吡唑啶環 吡嗪環 1 1-112 -NH- 吡唑啶環 吡嗪環 2 1-113 -NH- 吡唑啶環 嘧啶環 1 1-114 -NH- 吡唑啶環 嘧啶環 2 1-115 -NH- 喹嚀環 咪唑環 1 1-116 -NH- 喹嚀環 咪唑環 1 1-117 -NH- 喹嚀環 吡嗪環 1 1-118 -NH- 唾嚀環 吡嗪環 2 t-119 -NH- 喹嚀環 嘧啶環 1 1-120 -NH- 喹嚀環 喃啶環 2 1-121 -NH- 咪唑啶環 咪唑環 1 1-122 -NH- 咪唑啶環 咪唑環 2 1-123 -NH- 咪唑陡環 吡嗪環 1 1-124 -NH- 咪唑啶環 吡嗪環 2 1-125 -NH- 咪唑啶環 嘧啶環 1 1-126 -NH- 咪唑啶環 嘧陡環 2 -17- 201219451 [表7] XI X2 X3 η 1-127 -CONH- 碳數1〜3之伸烷基 咪唑環 1 1-128 -CONH- 碳數1〜3之伸烷基 咪唑環 1 1-129 -CONH- 碳數1〜3之伸烷基 吡嗪環 \ 1-130 -CONH- 碳數1〜3之伸烷基 吡嗪環 2 1-131 -CONH- 碳數1〜3之伸院基 嘧啶環 1 1-132 -CONH- 碳數1〜3之伸烷基 嘧啶環 2 1-133 -CONH- 吡咯啶環 咪唑環 1 1-134 -CONH- 吡咯啶環 咪唑環 2 1-135 -CONH- 祕啶環 吡嗪環 1 1-136 -CONH- 吡咯啶環 吡嗪環 2 1-137 -CONH- 吡咯啶環 嘧啶環 1 1-138 -CONH- 吡咯啶環 嘧啶環 2 1-139 -CONH- 哌啶環 咪唑環 1 1-140 -CONH- 哌啶環 咪唑環 2 1-141 -CONH- 哌啶環 吡嗪環 1 1-142 -CONH- 哌啶環 吡嗪環 2 1-M3 -CONH- 哌啶環 嘧啶環 1 1-144 -CONH- 哌啶環 嘧啶環 2 1-145 -CONH- 哌嗪環 咪唑環 1 1-146 -CONH- 哌嗪環 咪唑環 2 1-147 -CONH- 哌嗪環' 吡嗪環 1 [表8] Χ1 X2 X3 η 1-148 -CONH- 哌嗪環 吡嗪環 2 1-149 -CONH- 哌嗪環 嘧啶環 1 1-150 -CONH- 哌嗪環 嘧啶環 2 1-151 -CONH- 吡唑啶環 咪唑環 1 1-152 -CONH- 吡唑啶環 咪唑環 2 1-153 -CONH- 吡唑啶環 吡嗪環 1 1-154 -CONH- 吡唑啶環 吡嗪環 2 1-155 -CONH- 吡唑啶環 嘧啶環 1 1-156 -CONH- 吡唑啶環 嘧啶環 2 1-157 -CONH- 喹嚀環 咪唑環 1 1-158 -CONH- 喹嚀環 咪唑環 2 1-159 -CONH- 喹嚀環 吡嗪環 1 1-160 -CONH- 喹嚀環 吡嗪環 2 1-161 -CONH- 喹嚀環 嘧啶環 1 1-162 -CONH- 嗤嚀環 嘧啶環 2 1-163 -OONH- 咪唑啶環 咪唑環 1 1-164 -CONH- 咪唑啶環 咪唑環 2 1-165 -CONH- 咪唑啶環 吡嗪環 1 1-166 -CONH- 咪唑啶環 吡嗪環 2 1-167 -CONH- 咪唑啶環 嘧啶環 1 1-168 -CONH- 咪唑啶環 嘧啶環 2 3 -18- 201219451 [表9] X1 X2 X3 η 1-169 -NHCO- 碳數1〜3之伸烷基 咪唑環 1 1-170 -NHCO- 碳數1〜3之伸烷基 咪唑環 2 1-171 -NHCO- 碳數1〜3之伸烷基 耻嗪環 1 1-172 -NHCO- 碳數卜3之伸烷基 吡嗪環 2 1-173 -NHCO- 碳數卜3之伸烷基 嘧啶環 1 1-174 -NHCO- 碳數卜3之伸烷基 嘧啶環 2 1-175 -NHCO- 吡咯啶環 咪唑環 1 1-176 -NHCO- 吡咯啶環 咪唑環 1 1-177 -NHCO- 吡咯啶環 吡嗪環 1 1-178 •NHCO- 吡咯啶環 吡嗪環 1 1-179 -NHCO- 吡咯啶環 嘧啶環 1 1-180 -NHCO- 吡咯啶環 嘧啶環 2 1-181 -MHCO- 哌啶環 咪唑環 1 1-182 -NHCO- 哌啶環 咪唑環 2 1-183 -NHCO- 哌啶環 吡嗪環 1 1-184 -NHCO- 哌啶環 吡嗪環 2 1-185 -NHCO- 哌陡環 嘧陡環 t 1-186 -NHCO- 哌淀環 嘧啶環 2 1-187 -NHCO- 哌嗪環 咪唑環 1 1-188 -NHCO- 哌嗪環 咪唑環 2 1-189 -NHCO- 哌嗪環 吡嗪環 1 [表 10] X1 X2 X3 η 1-190 -NHCO- 哌嗪環 吡嗪環 2 1-191 -NHCO- 哌嗪環 嘧啶環 1 1-192 -NHCO- 哌嗪環 嘧啶環 2 1-193 -NHCO- 吡唑陡環 咪唑環 1 1-194 -NHCO- 吡唑啶環 咪唑環 2 1-195 -NHCO- 吡唑啶環 吡嗪環 1 1-196 -NHCO- 吡唑啶環 吡嗪環 2 1-197 -NHCO- 吡唑啶環 嘧啶環 1 1-198 -NHCO- 吡唑啶環 嘧啶環 2 1-199 -NHCO- 喹嚀環 咪唑環 1 卜200 -NHCO- 喹障環 咪哩環 2 1-201 -NHCO- 唾嚀環 吡嗪環 1 1-202 -NHCO- 喹嚀環 吡嗪環 2 1-203 -NHCO- 喹嚀環 嘧啶環 1 1-204 -NHCO- 喹嚀環 嘧陡環 2 1-205 -NHCO- 咪唑啶環 咪唑環 1 1-206 -NHCO- 咪唑啶環 咪唑環 2 1-207 -NHCO- 咪唑啶環 吡嗪環 1 1-208 -NHCO- 咪唑啶環 毗嗪環 2 1-209 -NHCO- 咪嗖啶環 嘧啶環 1 1-210 -NHCO- 咪唑啶環 嘧啶環 2 -19- 201219451 [表 11] X1 X2 X3 η 1-211 -CON(CH3)- 碳數卜3之伸烷基 咪唑環 1 1-212 -CON(CH3)- 碳數1〜3之伸烷基 咪唑環 2 1-213 -CON(CH3)- 碳數1〜3之伸烷基 吡嗪環 1 1-214 -CONCCH3)- 碳數1〜3之伸院基 吡嗪環 2 1-215 -CON(CH3)- 碳數1〜3之伸烷基 嘧啶環 1 1-216 -CON(CH3)- 碳數1〜3之伸烷基 嘧啶環 2 1-217 -CON(CH3)- 吡咯啶環 咪唑環. 1 1-218 -CON(CH3)- 吡咯啶環 咪唑環 2 1-219 -CON(CH3)- 吡咯啶環 吡嗪環 1 1-220 -CONCCH3)- 吡咯啶環 吡嗪環 2 1-221 -CON(CH3)- 吡咯啶環 嘧啶環 1 1-222 -CONCCH3)- 吡咯啶環 嘧啶環 2 1-223 -CONCCH3)- 哌啶環 咪唑環 1 1-224 -CONCCH3)- 哌啶環 咪唑環 2 1-225 -CON(CH3)- 哌啶環 吡嗪環 1 1-226 -CON(CH3)- 哌啶環 吡嗪環 2 1-227 -CON(CH3)- 哌啶環 嘧啶環 1 1-228 -CONCCH3)- 哌啶環 嘧啶環 2 1-229 -CON(CH3)- 哌嗪環 咪唑環 1-230 -CON(CH3)- 哌嗪環 咪唑環 2 1-231 -CON(CH3)- 哌嗪環 吡嗪環 1 [表 12] Χ1 X2 X3 η 1-232 -CON(CH3)- 哌嗪環 吡嗪環 2 1-233 -CON(CH3)- 哌嗪環 嘧啶環 1 1-234 -CON(CH3)- 哌嗪環 嘧啶環 2 1-235 -CON(CH3)- 吡唑啶環 咪唑環 1 1-236 -CON(CH3)- 吡唑啶環 咪唑環 2 1-237 -CON(CH3)- 吡唑啶環 吡嗉環 1 1-238 -CON(CH3)- 吡唑啶環 吡嗪環. 2 1-239 -CON(CH3)- 吡唑啶環 嘧啶環 1 1-240 -CON(CH3)- 吡唑啶環 嘧啶環 2 1-241 -CON(CH3)- 喹嚀環 咪唑環 1 1-242 -CON(CH3)- 喹嚀環 咪唑環 2 1-243 -CON(CH3)- 喹嚀環 吡嗪環 1 1-244 -CON(CH3)- 唾嚀環 吡嗪環 2 1-245 -CON(CH3)- 喹嚀環 嘧啶環 1 1-246 -CON(CH3)- 喹嚀環 嘧啶環 2 1-247 -CON(CH3)- 咪唑啶環 咪唑環 1 1-248 -CON(CH3)- 咪唑啶環 咪唑環 2 1-249 -CON(CH3)- 咪唑啶環 吡嗪環 1 1-250 -CON(CH3)- 咪唑啶環 吡嗪環 2 1-251 -CON(CH3)- 咪唑啶環 嘧啶環 1 1-252 -CON(CH3)- 咪唑啶環 嘧啶環 2 -20- 201219451 [表 13] X1 X2 X3 η 卜253 -CH20- 碳數1〜3之伸烷基 咪唑環 1 1-254 -CH20- 碳數1〜3之伸烷基 咪唑環 2 1-255 -CH20- 碳數1〜3之伸院基 吡嗪環 1 1-256 -CH20- 碳數卜3之伸烷基 吡嗪環 2 1-257 -CH20- 碳數卜3之伸烷基 嘧啶環 1 1-258 -CH20- 碳數1〜3之伸烷基 嘧啶環 2 1-259 -CH20- 吡咯陡環 咪哩環 1 1-260 -CH20- 吡咯啶環 咪哗環 2 1-261 -CH20- 吡咯啶環 吡嗪環 1 1-262 -CH20- 吡咯啶環 吡嗪環 2 1-263 -CH20- 吡咯啶環 嘧啶環 \ 1-264 -CH20- 吡咯啶環 嘧啶環 2 卜265 -CH20- 哌陡環 咪唑環 1 1-266 -CH20- 哌啶現 咪唑環 1 1-267 -CH20- 哌啶環 吡嗪環 1 1-268 -CH20- 哌啶環 吡嗪環 2 1-269 -CH20- 峨陡環 嘧啶環 1 1-270 -CH20- 哌啶環 嘧啶環 2 1-271 -CH20- 哌嗪環 咪唑環 1 1-272 -CH20- 哌嗪環 咪唑環 2 1-273 -CH20- 哌嗪環 吡嗪環 1 [表 14] Χ1 Χ2 Χ3 η 1-274 -CH20- 哌嗪環 吡嗪環 2 1-275 -CH20- 哌嗪環 嘧啶環 1 1-276 -CH20- 哌嗪環 嘧啶環 2 1-277 -CH20- 吡唑啶環 咪唑環 1 1-278 -CH20- 吡唑啶環 咪唑環 2 1-279 -CH20- 吡唑啶環 吡嗪環 1 1-280 -CH20- 吡唑陡環 吡嗪環 2 1-281 -CH20- 吡唑啶環 嘧啶環 1 1-282 -CH20- 吡唑啶環 嘧啶環 2 1-283 -CH20- 喹嚀環 咪唑環 1 1-284 -CH20- 喹嚀環 咪唑環 2 1-285 -CH20- 唾嚀環 吡嚷環 1 1-286 -CH20- 喹嚀環 吡嗪環 2 1-287 -CH20- 喹嚀環 嘧啶環 1 1-288 -CH20- 喹嚀環 嘧啶環 2 1-289 -CH20- 咪唑陡環 咪啤環 1 1-290 -CH20- 咪唑啶環 咪唑環 2 1-291 -CH20- 咪唑啶環 吡嗪環 1 1-292 -CH20- 咪唑啶環 吡嗪環 2 1-293 -CH20- 咪唑啶環 嘧啶環 1 1-294 -CH20- 咪唑啶環 嘧啶環 2 201219451 表1〜表Μ所記載之X1、X2、χ3及η之組合中，更 佳之組合爲 ’ 1-1 〜1-6、1-19 〜1-24、1-43 〜1-48、1-61 〜1-66、1-85 〜1-90、1-103 〜1-108、1-127 〜1-132、1-145 〜1-150、1-169 〜1-174、1-187 〜卜 192、"29 〜 1 -234、1 -253〜1 -258或1-276等。特佳之組合爲，、卜3 、1-5 、1-19 、 1-21、 1-23、 1-43 > 1 -45 、 l_ 47 、 1-61 、 1-63 、 1-65 ' 1-85 ' 1-87 ' 1 -89、 1-103 、 1-105 、 1-107 、 1-127 、 1 129、 1-131 、 1-145 、 1-147 ' 1-149 ' 1-169 、1-171 、 1-173 、 1-187、 1-189、 1-191、 1-211、 1-213、 1-215、 1-229、 1-231 、1-233 、 1-253 、 1-255 、 1-257 、 1-271 、 1-273 或 1-275 等。 製造本發明之特定二胺化合物之方法，並未有特別限 定之方法，較佳之方法例如以下之方法等。 本發明之特定二胺化合物爲，合成下述之式[13]所示 之二硝基化合物，隨後將二硝基化合物所具有之硝基還原 ，變換爲胺基而製得。將二硝基化合物還原之方法，並未 有特別限制’通常爲使用鈀-碳、氧化鉛、拉尼鎳、鈾黑 、鍺-氧化鋁、硫化鉑碳等作爲觸媒使用，於乙酸乙酯、 甲苯、四氫呋喃、二噁烷、醇系等之溶劑中，以氫氣體、 聯胺磺酸酯、鹽化氫等進行之方法。 [化6]-14- . . S 201219451 [Table 1] X1 X2 X3 η 1-1 -0- Alkyl imidazole ring with a carbon number of 1 to 3 1 1-2 -0- Alkyl imidazole ring 2 1 -3 -0- Carbon number 3 alkyl alkyl pyrazine ring 1 1-4 carbon number 3 alkyl alkyl pyrazine ring 2 1-5 -0- carbon number 3 alkyl alkyl pyrimidine ring 1 1 -8 -0- Carbon number 3 Alkyl pyrimidine ring 2 1-7 -0- Pyrrole steep ring Imidazole ring 1 1-8 Pyrrolidine ring imidazole ring 2 1-9 -0- Pyridoxine pyrazine Ring 1 1-10 pyrrolidine ring azoazine ring 2 1-11 -0- pyrrolidine cyclopyrimidine 1 1-12 -0- pyrrolidine ring pyrimidine ring 2 1-13 -0- _ Cycloring imidazole ring 1 T-14 唬 环 哩 哩 ring 2 1-15 -0- pyrazine ring 1 1-16 -0- piperidine cyclopyrazine ring 2 1-17 -0- piperazine cyclosalt ring 1 1-18 - 0- piperidine cyclic pyrimidine ring 2 1-19 -0- piperazine cycloimidazole ring 1 1-20 piperazine cycloimidazole ring 2 t-21 anthracycline ring 1 [Table 2] X1 X2 X3 η t-22 -0- piperazine cyclopyridinium ring 2 1-23 azine ring pyrimidine ring 1 1-24 -0- piperazine ring 2 1-25 pyrazolidine ring imidazole ring 1 1-26 -pyrazolidine ring imidazole ring 2 1-27 -0- pyrazole cyclazine ring 1 1-28 -0- pyrazolidine cyclopyridyl Ring 2 1-29 -0- pyrazolidine ring pyrimidine ring 1 1-30 -0- pyrazolidine ring pyrimidine ring 2 1-31 -0- quinacrid ring imidazole ring 1 1-32 -0- anthracene ring imidazole Ring 2 1-33 -0- quinoxaline pyrazine ring 1 1-34 -0- quinacrid ring azoazine ring 2 1-35 -0- quinoxazole cyclopyridyl ring 1 1-36 quinacridine ring 2 1-37 -0- imidazole steep ring oxime ring 1 b 38 imidazolidinium ring imidazole ring 2 1-39 -0- imidazolidinium ring pyridinium ring 1 1-40 imidazolylpyrid ring 2 1-41 imidazolidinium pyrimidine Ring 1 1-42 Imidazolidinylpyrimidine ring 2 -15- 201219451 [Table 3] X1 X2 X3 π t-43 -CO- Carbon number 1 to 3 of the imidazole ring 1 1-44 -CO Carbon number 1~ 3 alkylalkyl imidazole ring 2 1-45 -CO- 1 to 3 carbon alkyl pyrazine ring 1 1-46 -CO- 1 to 3 carbon alkyl pyrazine ring 1 1-47 - CO-alkylalkylpyrimidine ring 1 1-48 -CO- 1 to 3 alkylalkylpyrimidine ring 2 1-49 -CD-pyrrolidine cyclic imidazole ring 1 1-50 -CO- Pyrrolidine cyclic imidazole ring 2 1-51 -CO-pyrrolidine cyclopyrazine ring 1 1-52 -CO-pyrrolidine cyclopyrazine ring 2 1-53 -CO pyrrolidine cyclopyrimidine ring 1 1-54 -CO-pyrrole Pyridine ring 1 1-55 -CO- piperidine cyclic imidazole ring 1 1-56 -CO piperidine cyclic imidazole ring 2 1-57 -CO- piperidine cyclopyrazine ring 1 1-58 -CO- piperidine cyclopyrazine ring 2 1-59 - CO- piperidine cyclic pyrimidine ring 1 1-60 -CO- piperidine cyclopyrimidine ring 2 1-61 -CO- piperazine cycloimidazole ring 1 1-62 -CO- piperazine cycloimidazole ring 2 1-63 -CO- Piperazine Cyclopyrazine Ring 1 [Table 4] X1 X2 X3 η 1-64 -CO Piperazine Cyclopyrazine Ring 2 t-65 -CO- Piperazine Cyclopyrimidine Ring 1 1-66 -CO Piperazine Cyclopyrimidine Ring 2 1-67 -CO-pyrazolidinecycloimidazole ring 1 1-68 -CO-pyrazolidinecycloimidazole ring 2 1-69 -CO- BH;oxazolidinium pyrazine ring 1 1-70 -CO-pyrazolidine Cyclopyrazine ring 2 1-71 -CO-pyrazolidine ring pyrimidine ring 1 1-72 -CO-pyrazolidine ring pyrimidine ring 2 1-73 -CO- quinacrid ring of imidazole ring 1 1-74 -CO- quin Anthracene ring imidazole ring 2 1-75 -CO- quinoxaline pyrazine ring 1 1-76 -CO- quinoxaline pyrazine ring 2 1-77 -CO- quinacridine ring 1 1-78 -CO- quin Anthracycline ring 2 1-79 -CO- Imidazolidinium ring imidazole ring 1 1-80 -CO- Imidazolidinium ring imidazole ring 2 1-81 -CO- Imidazopyridine cyclopyrazine ring 1 1-82 -CO- Imidazopyridine Cyclopyrazine ring 2 1-83 -CO- imidazolidinium ring 1 1-84 -CO- Imidazolidinylpyrimidine ring 2 -16- 201219451 [Table 5] X1 X2 X3 η 1-85 -NH- Alkyl imidazole ring 1 to 86 -NH- 1 to 3 of the imidazole ring 2 1-87 -NH- carbon number 1 to 3 of the extension of the pyrazine ring 1 1-88 -NH- carbon number 3 of the alkyl pyrazine ring 2 1-89 -NH- Alkylpyrimidine ring of 1 to 3 carbon atoms 1 1-90 -NH-alkylpyrimidine ring 2 1-91 -NH-pyrrolidine cyclic imidazole ring 1 1-92 - NH-pyrrolidine cyclomethine ring 2 1-93 -NH-pyrrolidine cyclopyrazine ring 1 t-94 -NH-pyrrolidine cyclopyrazine ring 2 1-95 -NH-pyrrolidinium pyrimidine ring 1 1-96 -NH-pyrrolidine cyclopyrimidine ring 2 1-97 -NH- piperidine cyclic imidazole ring 1 1-98 -NH- piperidine cyclic imidazole ring 2 1-99 -NH- piperidine cyclopyrazine ring 1 1-100 - NH-岐 环 环 吡 pyrazine ring 2 1-101 -NH- piperidine Cyclopyrimidine ring 1 1-102 -NH-. Piperazine ring pyrimidine ring 2 1-103 -NH- piperazine cyclazole ring 1 1-104 - NH-piperazine cyclic imidazole ring 2 1-105 -NH-piperazine cyclopyrazine ring 1 [Table 6] X1 X2 X3 η 1-106 -NH- piperazine cyclopyrazine ring 2 1-107 -NH-piperazine Cycyclic pyrimidine ring 1 1-108 -NH-piperazine cyclopyrimidine ring 2 1-109 - NH-pyrazolidine cyclic imidazole ring 1 1-110 -NH-pyrazolidine cyclic imidazole ring 1 1-111 -NH-pyrazolidine cyclopyrazine ring 1 1-112 -NH-pyrazolidine cyclopyrazine ring 2 1-113 -NH-pyrazolidinium pyrimidine ring 1 1-114 -NH-pyrazolidine ring pyrimidine ring 2 1-115 -NH- quinacrid ring of imidazole ring 1 1-116 -NH- quinacrid ring of imidazole ring 1 1-117 -NH- quinoxaline pyrazine ring 1 1-118 -NH- stilbene ring pyrazine ring 2 t-119 -NH- quinacridine ring 1 1-120 -NH- quinacridone ring 2 1-121 -NH- Imidazolidinium ring imidazole ring 1 1-122 -NH- Imidazolidinium ring imidazole ring 2 1-123 -NH- Imidazole steep ring pyrazine ring 1 1-124 -NH- Imidazopyridine cyclopyrazine ring 2 1-125 -NH- Imidazolidinylpyrimidine ring 1 1-126 -NH- Imidazopyridine cyclopyrimidine 2 -17- 201219451 [Table 7] XI X2 X3 η 1-127 -CONH- Carbon number 1~3 Alkyl imidazole ring 1 1-128 -CONH- Alkyl imidazole ring 1 1-129 -CONH- Alkylpyrazine ring of carbon number 1~3 \ 1-130 -CONH- Carbon Number 1 to 3 of the alkylpyrazine ring 2 1-131 -CONH- carbon number 1 to 3 of the excimer pyrimidine ring 1 1-132 -CONH- carbon number 1 to 3 alkyl pyrimidine ring 2 1- 133 -CONH- pyrrolidine ring Imidazole ring 1 1-134 -CONH-pyrrolidine cyclic imidazole ring 2 1-135 -CONH- pyridine azulazine ring 1 1-136 -CONH- pyrrolidinecyclopyrazine ring 2 1-137 -CONH- pyrrolidine ring Pyrimidine ring 1 1-138 -CONH- pyrrolidinecyclopyrimidine ring 2 1-139 -CONH- piperidine ring imidazole ring 1 1-140 -CONH- piperidine ring imidazole ring 2 1-141 -CONH- piperidine cyclopyrazine Ring 1 1-142 -CONH- piperidine cyclopyrazine ring 2 1-M3 -CONH- piperidinylpyrimidine ring 1 1-144 -CONH- piperidinylpyrimidine ring 2 1-145 -CONH- piperazine ring imidazole ring 1 1-146 -CONH- piperazine cycloimidazole ring 2 1-147 -CONH- piperazine ring 'pyrazine ring 1 [Table 8] Χ1 X2 X3 η 1-148 -CONH- piperazine cyclopyrazine ring 2 1- 149 -CONH- Piperazine Cyclopyrimidine Ring 1 1-150 -CONH- Piperazine Cyclopyrimidine Ring 2 1-151 -CONH- Pyrazolidine Cycloimidazole Ring 1 1-152 -CONH- Pyrazolidine Cycloimidazole Ring 2 1- 153 -CONH- pyrazolidinecyclopyrazine ring 1 1-154 -CONH-pyrazolidine cyclopyrazine ring 2 1-155 -CONH-pyrazolidine ring pyrimidine ring 1 1-156 -CONH-pyrazolidinium Ring 2 1-157 -CONH- quinacrid ring imidazole ring 1 1-158 -CONH- quinacrid ring imidazole ring 2 1-159 -CONH- quinoxaline pyrazine ring 1 1-160 -CONH- quinoxaline pyrazine ring 2 1-161 -CONH- quinoxazolidine ring 1 1-162 -CONH- anthranilidine ring 2 1-163 -OONH- imidazolidinium ring imidazole ring 1 1 -164 -CONH- Imidazolidinium ring imidazole ring 2 1-165 -CONH- Imidazolidinecyclopyrazine ring 1 1-166 -CONH- Imidazolidinecyclopyrazine ring 2 1-167 -CONH- Imidazolidine ring pyrimidine ring 1 1 -168 -CONH- Imidazolidinylpyrimidine ring 2 3 -18- 201219451 [Table 9] X1 X2 X3 η 1-169 -NHCO- Alkyl imidazole ring with a carbon number of 1 to 3 1-170 -NHCO- Carbon number 1 to 3 alkylalkyl imidazole ring 2 1-171 -NHCO- 1 to 3 carbon alkyl thiazide ring 1 1-172 -NHCO- carbon number 3 alkyl alkylpyrazine ring 2 1-173 -NHCO- carbon number 3 alkyl alkyl pyrimidine ring 1 1-174 -NHCO- carbon number 3 alkyl alkyl pyrimidine ring 2 1-175 -NHCO- pyrrolidine cyclic imidazole ring 1 1-176 -NHCO- pyrrole Pyridyl ring imidazole ring 1 1-177 -NHCO-pyrrolidine cyclopyrazine ring 1 1-178 •NHCO-pyrrolidine cyclopyrazine ring 1 1-179 -NHCO- pyrrolidine ring pyrimidine ring 1 1-180 -NHCO- pyrrole Aridazine ring 2 1-181 -MHCO- piperidine ring imidazole ring 1 1-182 -NHCO- piperidine ring imidazole ring 2 1-183 -NHCO- piperidine Cyclopyrazine ring 1 1-184 -NHCO- piperidine cyclopyrazine ring 2 1-185 -NHCO- piperazine cyclopyrimidine t 1-186 -NHCO-piperidinylpyrimidine ring 2 1-187 -NHCO- piperidine Pyrazine imidazole ring 1 1-188 -NHCO- piperazine cycloimidazole ring 2 1-189 -NHCO- piperazine cyclopyrazine ring 1 [Table 10] X1 X2 X3 η 1-190 -NHCO- piperazine cyclopyrazine ring 2 1-191 -NHCO- piperazine cyclopyrimidine ring 1 1-192 -NHCO- piperazine cyclopyrimidine ring 2 1-193 -NHCO- pyrazole steep ring imidazole ring 1 1-194 -NHCO- pyrazolidine ring imidazole ring 2 1-195 -NHCO-pyrazolidinecyclopyrazine ring 1 1-196 -NHCO-pyrazolidine cyclopyrazine ring 2 1-197 -NHCO-pyrazolidine ring pyrimidine ring 1 1-198 -NHCO- pyrazole Aridazine ring 2 1-199 -NHCO- quinacrid ring of imidazole ring 1 200 -NHCO- quinine ring ring of oxime ring 2 1-201 -NHCO- stilbene ring pyrazine ring 1 1-202 -NHCO- quinine Cyclopyrazine ring 2 1-203 -NHCO- quinacridine ring 1 1-204 -NHCO- quinoxacyclopyrimidine 2 1-205 -NHCO- Imidazolidine ring imidazole ring 1 1-206 -NHCO- Imidazopyridine Cyclomidazole ring 2 1-207 -NHCO- Imidazopyridine cyclopyrazine ring 1 1-208 -NHCO- Imidazolidine Cyclopyridazine ring 2 1-209 -NHCO- Irididine cyclopyrimidine Acridine ring 1 1-210 -NHCO- Imidazopyridine ring pyrimidine ring 2 -19- 201219451 [Table 11] X1 X2 X3 η 1-211 -CON(CH3)- Carbon number 3 alkylazimidazole ring 1 1-212 -CON(CH3)-Alkyl imidazole ring of carbon number 1~3 2 1-213 -CON(CH3)-alkylpyrazine ring 1 -214 -CONCCH3) - carbon number 1 〜3的伸院基匹嗪环2 1-215 -CON(CH3)- Alkylpyrimidine ring 1 1-216 -CON(CH3)- Alkylpyrimidine with a carbon number of 1~3 Ring 2 1-217 -CON(CH3)-pyrrolidinecycloimidazole ring. 1 1-218 -CON(CH3)-pyrrolidinecycloimidazole ring 2 1-219 -CON(CH3)-pyrrolidinecyclopyrazine ring 1 1 -220 -CONCCH3)-pyrrolidinecyclopyrazine ring 2 1-221 -CON(CH3)-pyrrolidine cyclopyrimidine ring 1- 1-222 -CONCCH3)-pyrrolidine cyclopyrimidine ring 2 1-223 -CONCCH3)- piperidine Cyclomidazole ring 1 1-224 -CONCCH3)- piperidine cyclic imidazole ring 2 1-225 -CON(CH3)- piperidine cyclopyrazine ring 1 1-226 -CON(CH3)- piperidinylpyrazine ring 2 1 -227 -CON(CH3)-piperidinecyclopyrimidine ring 1 1-228 -CONCCH3)- piperidinylpyrimidine ring 2 1-229 -CON(CH3)-piperazine ring imidazole ring 1-230 -CON(CH3)- Piperazine Cyclomidazole Ring 2 1-231 -CON(CH3 )- Piperazine Cyclopyrazine Ring 1 [Table 12] Χ1 X2 X3 η 1-232 -CON(CH3)- Piperazine Cyclopyrazine Ring 2 1-233 -CON(CH3)- Piperazine Cyclopyrimidine Ring 1 1- 234 -CON(CH3)-piperazinecyclopyrimidine ring 2 1-235 -CON(CH3)-pyrazolidinecycloimidazole ring 1 1-236 -CON(CH3)-pyrazolidinecycloimidazole ring 2 1-237 -CON (CH3)-pyrazolidine cyclopyridinium ring 1- 1-carboxy-CON(CH3)-pyrazolidinecyclopyrazine ring. 2 1-239 -CON(CH3)-pyrazolidinium pyrimidine ring 1 1-240 - CON(CH3)-pyrazolidine ring pyrimidine ring 2 1-241 -CON(CH3)-quinoline ring imidazole ring 1 1-242 -CON(CH3)- quinacrid ring of imidazole ring 2 1-243 -CON(CH3) - quinoxaline pyrazine ring 1 1-244 -CON(CH3)- stilbene ring pyrazine ring 2 1-245 -CON(CH3)- quinoxazolidine ring 1 1-246 -CON(CH3)-quinoline Cycyclic pyrimidine ring 2 1-247 -CON(CH3)-imidazolidinium ring imidazole ring 1 1-248 -CON(CH3)-imidazolidinium ring imidazole ring 2 1-249 -CON(CH3)-imidazolidinium pyrazine ring 1 1-250 -CON(CH3)- Imidazolidinecyclopyrazine ring 2 1-251 -CON(CH3)- Imidazolidine ring pyrimidine ring 1 1-252 -CON(CH3)- Imidazolidine ring pyrimidine ring 2 -20- 201219451 [Table 13] X1 X2 X3 η Bu 253 -CH20- Alkane of 1 to 3 carbon atoms Imidazole ring 1 1-254 -CH20- Alkyl imidazole ring of carbon number 1 to 3 2 1-255 -CH20- Carbonylpyrazine ring 1 1-256 -CH20- Carbon number 3 Alkylpyrazine ring 2 1-257 -CH20- carbon number 3 alkylalkylpyrimidine ring 1 1-258 -CH20- alkyl 1-pyridyl ring 2 1-259 -CH20- pyrrole Steep ring oxime ring 1 1-260 -CH20- pyrrolidine cyclomethine ring 2 1-261 -CH20- pyrrolidine cyclazine ring 1 1-262 -CH20- pyrrolidine cyclazine ring 2 1-263 -CH20 - pyrrolidinecyclopyrimidine ring \ 1-264 -CH20- pyrrolidine cyclopyrimidine ring 2 265 -CH20- piperazine ring imidazole ring 1 1-266 -CH20- piperidine imidazole ring 1 1-267 -CH20- piperidine Cyclopyrazine ring 1 1-268 -CH20- piperidine cyclopyrazine ring 2 1-269 -CH20- 峨spirocycline ring 1 1-270 -CH20- piperidinylpyrimidine ring 2 1-271 -CH20- piperazine Cyclomidazole ring 1 1-272 -CH20- piperazine cycloimidazole ring 2 1-273 -CH20- piperazine cyclopyrazine ring 1 [Table 14] Χ1 Χ2 Χ3 η 1-274 -CH20- piperazine cyclopyrazine ring 2 1-275 -CH20- piperazine cyclopyrimidine ring 1 1-276 -CH20- piperazine cyclopyrimidine ring 2 1-277 -CH20- pyrazolidine cycloimidazole ring 1 1-278 - CH20-pyrazolidine cyclic imidazole ring 2 1-279 -CH20- pyrazolidine cyclopyrazine ring 1 1-280 -CH20- pyrazole steep cyclopyrazine ring 2 1-281 -CH20- pyrazopyridine ring pyrimidine ring 1 1-282 -CH20- pyrazole pyridine ring pyrimidine ring 2 1-283 -CH20- quinacridine ring imidazole ring 1 1-284 -CH20- quinacrid ring of imidazole ring 2 1-285 -CH20- saponin ring pyridinium ring 1 1-286 -CH20- quinoxaline pyrazine ring 2 1-287 -CH20- quinacridine ring 1 1-288 -CH20- quinacridine ring 2 1-289 -CH20- imidazole steep ring 1-290 -CH20- Imidazolidinium ring imidazole ring 2 1-291 -CH20- Imidazolidinecyclopyrazine ring 1 1-292 -CH20- Imidazolidinecyclopyrazine ring 2 1-293 -CH20- Imidazolidine ring pyrimidine ring 1 1-294 -CH20- Imidazolidinylpyrimidine ring 2 201219451 In the combination of X1, X2, χ3 and η described in Table 1 to Table ,, a more preferable combination is '1-1 to 1-6, 1-19 to 1 -24, 1-43 to 1-48, 1-61 to 1-66, 1-85 to 1-90, 1-103 to 1-108, 1-127 to 1-132, 1-145 to 1-150 , 1-169 to 1-174, 1-187 to 192, "29 to 1 -234, 1-253 to 1-258 or 1-276, and the like. The combination of the best is,, 3, 1-5, 1-19, 1-21, 1-23, 1-43 > 1 -45 , l_ 47 , 1-61 , 1-63 , 1-65 ' 1 -85 ' 1-87 ' 1 -89, 1-103 , 1-105 , 1-107 , 1-127 , 1 129 , 1-131 , 1-145 , 1-147 ' 1-149 ' 1-169 , 1-171, 1-173, 1-187, 1-189, 1-191, 1-211, 1-213, 1-215, 1-229, 1-231, 1-233, 1-253, 1- 255, 1-257, 1-271, 1-273 or 1-275, etc. The method for producing the specific diamine compound of the present invention is not particularly limited, and preferred methods are, for example, the following methods. The specific diamine compound of the present invention is obtained by synthesizing a dinitro compound represented by the following formula [13], followed by reduction of a nitro group having a dinitro compound and conversion to an amine group. The method for reducing the dinitro compound is not particularly limited 'usually using palladium-carbon, lead oxide, Raney nickel, uranium black, lanthanum-alumina, sulphide-carbon carbon, etc. as a catalyst, in ethyl acetate Examples of the solvent such as toluene, tetrahydrofuran, dioxane or alcohol are hydrogen gas, hydrazine sulfonate or hydrogenated hydrogen. [Chemical 6]

X3 X2、 [1a] η -22- 201219451 (X1、X2' X3及η，與式[1]之定義爲相同之意義）。 式[1 a]所示之二硝基化合物，可使用對二硝基苯，介 由X1而鍵結-X2-X3之方法等而製得。 例如，X1爲-0-或CHzO-鍵結之情形，可將對應之含 二硝基之鹵素衍生物，與含有X2及X3之羥基衍生物於驗 存在下進行反應之方法，或將含有二硝基之羥基衍生物， 與含有X2及X3之鹵素取代衍生物於鹼存在下進行反應之 方法等。 X1爲-NH-或N(CH3)-鍵結之情形，可將對應之含二硝 基之鹵素衍生物，與含有X2及X3之胺基取代衍生物於鹼 存在下進行反應之方法等。 X1爲-OCO-鍵結之情形，可將對應之含二硝基之羥基 衍生物’與含有X2及X3之酸氯化物體於鹼存在下進行反 應之方法等。 X1爲-CONH-或CON(CH3)-鍵結之情形，可將對應之 含二硝基之酸氯化物體與含有X2及X3之胺基取代體於鹼 存在下進行反應之方法等。 X1爲-NHCO-或N(CH3)CO-鍵結之情形，可將對應之 含二硝基之胺基取代體與含有X2及X3之酸氯化物體於鹼 存在下進行反應之方法等。 含二硝基之鹵素衍生物及含二硝基之羥基衍生物之具 體例如，3,5-二硝基氯苯、2,4-二硝基氯苯、2,4-二硝基氟 苯、3,5-二硝基苯甲酸氯化物、3,5-二硝基苯甲酸、2,4·二 硝基苯甲酸氯化物、2,4-二硝基苯甲酸、3，5'-二硝基苄基 -23- 201219451 氯化物、2,4-二硝基苄基氯化物、3,5-二硝基苄基醇、2,4-二硝基苄基醇、2,4 -二硝基苯胺、3,5 -二硝基苯胺、2,6 -二 硝基苯胺、2,4-二硝基酚、2,5-二硝基酚、2,6-二硝基酚、 2,4 -二硝基苯基乙酸等。於考慮原料之取得、反應等部分 ，可選擇一種或多數種使用。 <特定側鏈型二胺化合物> 本發明之特定側鏈型二胺化合物爲下述之式[2]所示之 二胺化合物。 [化7]X3 X2, [1a] η -22- 201219451 (X1, X2' X3 and η are the same meanings as defined in the formula [1]). The dinitro compound represented by the formula [1 a] can be produced by a method in which p-dinitrobenzene is bonded to X2-X3 via X1. For example, when X1 is -0- or CHzO-bonded, the corresponding dinitro-containing halogen derivative may be reacted with a hydroxyl derivative containing X2 and X3 in the presence of a test, or may contain two A hydroxy derivative of a nitro group, a method of reacting with a halogen-substituted derivative containing X2 and X3 in the presence of a base, and the like. When X1 is -NH- or N(CH3)-bonded, a corresponding halogen derivative containing a dinitro group may be reacted with an amine-substituted derivative containing X2 and X3 in the presence of a base. When X1 is a -OCO-bond, a method of reacting a corresponding dinitro group-containing hydroxy derivative ' with an acid chlorinated object containing X2 and X3 in the presence of a base may be employed. When X1 is a -CONH- or CON(CH3)-bond, a method of reacting a corresponding dinitro acid-containing chlorination object with an amine substituent containing X2 and X3 in the presence of a base may be employed. When X1 is -NHCO- or N(CH3)CO-bonded, a method of reacting a corresponding dinitro group-containing amine substituent with an acid chlorinated object containing X2 and X3 in the presence of a base may be employed. Specific examples of the dinitro-containing halogen derivative and the dinitro-containing hydroxy derivative, for example, 3,5-dinitrochlorobenzene, 2,4-dinitrochlorobenzene, 2,4-dinitrofluorobenzene , 3,5-dinitrobenzoic acid chloride, 3,5-dinitrobenzoic acid, 2,4.dinitrobenzoic acid chloride, 2,4-dinitrobenzoic acid, 3,5'- Dinitrobenzyl-23- 201219451 Chloride, 2,4-dinitrobenzyl chloride, 3,5-dinitrobenzyl alcohol, 2,4-dinitrobenzyl alcohol, 2,4 - Dinitroaniline, 3,5-dinitroaniline, 2,6-dinitroaniline, 2,4-dinitrophenol, 2,5-dinitrophenol, 2,6-dinitrophenol, 2,4-dinitrophenylacetic acid and the like. One or a plurality of types may be selected in consideration of the acquisition, reaction, and the like of the raw materials. <Specific side chain type diamine compound> The specific side chain type diamine compound of the present invention is a diamine compound represented by the following formula [2]. [Chemistry 7]

式[2]中’ Y1爲’單鍵、-(CH2)a-(a爲1〜1 5之整數） 、-0-、-CH20-、-COO-或 OCO-;其中又以單鍵、-(CH2)a- (a 爲1〜15之整數）、-〇-、-CH20-或COO·，以容易合成側 鏈結構之觀點而爲較佳。更佳爲，單鍵、-(CH2)a-(a爲1 〜10 之整數）、-0-、-CH20-或 C00-; 式[2]中’ Y2爲’單鍵或（CH2)b-(b爲1〜15之整數）。 其中又以單鍵或（CH2)b-(b爲1〜10之整數）爲佳。 式[2]中，Y3爲’單鍵、-(CH2)c-(C爲1〜15之整數） 、-〇-、-CH20-' -C00-或 0C0-;其中又以單鍵、-(CH2)c_(c 爲1〜15之整數）、-〇-、-CH20-、-COO-或0C0-，以其容易 201219451 合成而爲較佳。更佳爲，單鍵、-(CH2)e-(c爲 ' -0- ' -CH20- ' -COO-^ 0C0-； 式[2]中，Y4爲，由苯環、環己烷環及 選出之2價之環狀基’該些之環狀基上之任 被碳數1〜3之烷基、碳數1〜3之烷氧基、 含氟烷基、碳數1〜3之含氟烷氧基或氟原 外，Υ4爲有固醇骨架之碳數12〜25之2價 以苯環、環己基環或具有固醇骨架之碳數1 基爲佳。 式[2]中，Υ5爲由苯環、環己基環及雜 出之2價之環狀基，且該些之環狀基上之任 被碳數1〜3之烷基、碳數1〜3之烷氧基、 含氟烷基、碳數1〜3之含氟烷氧基或氟原子 式[2]中，η爲0〜4之整數；較佳爲0〜 式[2]中，Υ6爲碳數1〜18之烷基、碳: 氟烷基、碳數1〜18之烷氧基或碳數1〜18 。其中又以碳數1〜18之烷基、碳數1〜10 碳數1〜18之烷氧基或碳數1〜10之含氟烷 佳爲碳數1〜12之烷基或碳數1〜12之烷氧 數1〜9之烷基或碳數1〜9之烷氧基。 式[2]中，m爲1〜4之整數。較佳爲 式[2]中之 Υ】、Υ2、γ3、Υ4、γ5、Υ6、, 組合，例如表1 5〜4 4所示之內容。 1〜10之整數） 雜環所成群所 意的氫原子可 碳數1〜3之 子所取代，此 之有機基。Υ4 2〜25之有機 環所成群所選 意的氫原子可 碳數1〜3之 '所取代。 2之整數。 敦1〜1 8之含 之含氟烷氧基 之含氟烷基、 氧基爲佳。更 基。最佳爲碳 L整數。 ι及m之較佳 -25- 201219451 [表 15] Y1 Y2 Y3 Y4 Y5 Y6 η m 2-1 單鍵 單鍵 單鍵 苯環 碳數1〜9 之烷基 0 1 2-2 單鍵 單鍵 單鍵 苯環 苯環 碳數1〜9 之烷基 1 1 2-3 單鍵 單鍵 單鍵 苯環 苯環 碳數1〜9 之烷基 2 1 2-4 單鍵 單鍵 單鍵 苯環 碳數1〜9 之烷氧基 0 1 2-5 單鍵 單鍵 單鍵 苯環 苯環 碳數1〜9 之烷氧基 1 2-θ 單鍵 單鍵 單鍵 苯環 苯環 碳數1〜9 之烷氧基 2 1 2-7 單鍵 單鍵 單鍵 苯環 碳數丨〜9 之烷基 0 1 2-8 單鍵 單鍵 單鍵 苯環 環己環 碳數1〜9 之烷基 1 1 2-9 單鍵 單鍵 單鍵 苯環 環己環 碳败1〜9 之烷基 2 1 2-10 單鍵 單鍵 單鍵 苯環 碳數1〜9 之烷氧基 0 1 2-11 單鍵 單鍵 單鍵 苯環 環己環 碳數1〜9 之烷氧基 1 1 2-12 單鍵 單鍵 單鍵 苯環 環己環 碳數1〜9 之烷氬甚 2 1 2-13 單鍵 單鍵 單鍵 環己環 碳數1〜9 之烷基 0 1 2-14 單鍵 單鍵 單鍵 環己環 苯環 碳败1〜9 之烷基 1 1 2-15 單鍵 單鍵 單鍵 環己環 苯環 碳數1〜9 之烷基 2 1 2-16 單鍵 單鍵 單鍵 環己環 碳數1〜9 之烷氣苺 0 1 2-17 單鍵 單鍵 單鍵 環己環 碳數1〜9 之烷氧基 1 1 2-18 單鍵 單鍵 單鍵 環己環 苯環 碳數1〜9 之烷氧基 2 1 2-19 單鍵 單鍵 單鍵 環己環 碳數1〜9 之烷基 0 1 2-20 單鍵 單鍵 單鍵 環己環 環己環 碳赃1〜9 之烷基 1 1 2-21 單鍵 單鍵 單鍵 環己環 環己環 碳數1〜9 之烷基 2 1 201219451 [表 16] Y1 Y2 Y3 Y4 Y5 Y6 η m 2-22 單鍵 單鍵 單鍵 環己環 碳數1〜9 之烷氧基 0 1 2-23 單鍵 單鍵 單鍵 環己環 環己環 碳數1〜9 之烷氧基 1 1 2-24 單鍵 單鍵 單鍵 環己環 環己環 碳數1〜9 之烷氧基 2 1 2-25 單鍵 單鍵 -(CH2)c- 苯環 碳數1〜9 之烷基 0 1 2-26 單鍵 單鍵 -(CH2)c- 苯環 苯環 碳數1〜9 之烷基 1 1 2-27 單鍵 單鍵 -(CH2)c- 苯環 苯環 碳數1〜9 之烷基 2 1 2-28 單鍵 單鍵 -<CH23c- 苯環 碳數1〜9 之烷氧基 0 1 2-29 單鍵 單鍵 -(CH2)c- 苯環 苯環 碳數卜9 之烷氧基 1 1 2-30 單鍵 單鍵 -(CH2)c- 苯環 苯環 碳數卜9 之烷氧基 2 1 2-31 單鍵 單鍵 -(CH2)c- 苯環 .碳數1〜9 之總 0 1 2-32 單鍵 單鍵 -(CH2)c- 苯環 環己環 碳數1〜9 之烷基 1 1 2-33 單鍵 單鍵 -(CH2)c- 苯環 環己環 碳數1〜9 之烷基 2 1 2-34 單鍵 單鍵 -(CH2}c- 賴 碳數卜9 之烷氧基 0 1 2-35 單鍵 單鍵 -<CH2)c- 苯環 環己環 碳數1〜9 之烷氧基 1 1 2-36 單鍵 單鍵 -<CH2)c- 苯環 環己環 碳數1〜9 之烷氣基 2 1 2-37 單鍵 單鍵 -(CH2)c- 環己環 碳數1〜9 之烷基 0 1 2-38 單鍵 單鍵 -(CH2)c- 環己環 賴 碳數1〜9 之烷基 1 1 2-39 單鍵 單鍵 -<CH2)c- 環己環 苯環 碳數卜9 之院基 2 1 2-40 單鍵 單鍵 -<CH2)c- 環己環 碳數1〜9 之烷氧基 0 1 2-41 單鍵 單鍵 -(CH2)c- 環己環 苯環 碳數1〜9 之烷氧基 1 1 2-42 單鍵 單鍵 -(CH2)c- 環己環 賴 碳數1〜9 之烷氧基 2 1 c爲1~10之整數 -27- 201219451 [表 17] Y1 Y2 Y3 Y4 Y5 Y6 η m 2-43 單鍵 單鍵 -(CH2)c- 環己環 碳數1〜9 之烷基 0 1 2-44 單鍵 單鍵 -(CH2)c- 環己環 環己環 碳數1〜9 之烷基 1 1 2-45 單鍵 單鍵 -(CH2)c- 環己環 環己環 碳數1〜9 之烷基 2 1 2-46 單鍵 單鍵 -<CH2}c- 環己環 碳數1〜9 之烷氧基 0 1 2-47 單鍵 單鍵 -(CH2)c- 環己環 環己環 碳救1〜9 之烷氧基 1 1 2-48 單鍵 單鍵 -(CH2}c- 環己環 環己環 碳數卜9 之烷氧基 2 1 2-49 單鍵 單鍵 -0- 苯環 . 碳數1〜9 之烷基 0 1 2-50 單鍵 單鍵 -0- 苯環 苯環 碳數1〜9 之烷基 1 2-51 單鍵 單鍵 -o- 苯環 苯環 碳數1〜9 之院基 2 1 2-52 單鍵 單鍵 -o- 苯環 碳數1〜9 之烷氧基 0 1 2-53 單鍵 單鍵 -0- 苯環 苯環 碳數卜9 之烷氧基 1 1 2-54 單鍵 單鍵 -0- 苯環 苯環 碳數卜9 之烷氧基 2 1 2-55 單鍵 單鍵 -0- 苯環 碳數1〜9 之烷基 0 1 2-56 單鍵 單鍵 -o- 苯環 環己環 碳數1〜9 之烷基 1 1 2-57 單鍵 單鍵 -o- 苯環 環己環 碳數1〜9 之烷基 2 1 2-58 單鍵 單鍵 -0- 苯環 碳數1〜9 之烷氣基 0 1 2-59 單鍵 單鍵 -0- 苯環 環己環 碳數1〜9 之烷氣基 1 1 2-60 單鍵 單鍵 -o- 苯環 環己環 碳數1〜9 之烷氧基 2 1 2-61 單鍵 單鍵 -o- 環己環 碳數1〜9 之烷基 0 1 2-62 單鍵 單鍵 -o- 環己環 苯環 碳數1〜9 之烷基 1 1 2-63 單鍵 單鍵 -0- 環己環 苯環 碳败1〜9 之烷基 2 1 c爲卜10之整數 -28- 201219451 [表 18] Y1 Y2 Y3 Y4 Y5 Y6 η m 2-64 單鍵 單鍵 -0- 環己環 碳數卜9 之烷氧基 0 1 2-65 單鍵 單鍵 -0- 環己環 苯環 碳數卜Θ 之烷氧基 1 2-66 單鍵 單鍵 -0- 環己環 苯環 碳數1〜9 之烷氧基 2 1 2-67 單鍵 單鍵 -0- 環己環 碳數1〜9 之烷基 0 t 2-68 單鍵 單鍵 -0- 環己環 環己環 碳數1〜9 之烷基 1 1 2-69 單鍵 單鍵 -0- 環己環. 環己環 碳數1〜9 之烷基 2 1 2-70 單鍵 單鍵 -0- 環己環 碳數卜9 之烷氧某 0 1 2-71 單鍵 單鍵 -0- 環己環 環己環 碳數卜9 之烷氧基 1 1 2-72 單鍵 單鍵 -0- 環己環 環己環 碳數卜9 之烷氧基 2 1 2-73 單鍵 單鍵 -CH20- 苯環 碳數卜9 之烷基 0 1 2-74 單鍵 單鍵 -CH20- 苯環 苯環 碳數1〜9 之烷基 1 1 2-75 單鍵 單鍵 -CH20- 赖 苯環 碳數卜9 之院基 2 1 2-76 單鍵 單鍵 -CH20- 苯環 碳數1〜9 之烷氧基 0 1 2-77 單鍵 單鍵 -CHZO- 苯環 苯環 碳數1〜9 之烷氧基 1 1 2-78 單鍵 單鍵 -CH20- 苯環 苯環. 碳數1〜9 之烷氧基 2 1 2-79 單鍵 單鍵 -CH20- 苯環 碳數卜9 之院基 0 1 2-80 單鍵 單鍵 -CH20- 苯環 環己環 碳數1〜9 之院基 1 1 2-8ί 單鍵 單鍵 -CH20- 苯環 環己環 碳數1〜9 之烷基 2 1 2-82 單鍵 單鍵 -CH20- 苯環 碳數卜9 之烷氧基 0 1 2-83 單鍵 單鍵 -CH20- 苯環 環己環 碳數卜9 之烷氧基 1 1 2-84 單鍵 單鍵 -CH20- 苯環 環己環 mm-9 之烷氧基 2 1 -29- 201219451 [表 19] Y1 Y2 Y3 Y4 Y5 Y6 η m 2-S5 單鍵 單鍵 -CH20- 環己環 碳败1〜9 之烷基 0 1 2-86 單鍵 單鍵 -CH20- 環己環 苯環 碳數1〜9 之烷基 1 1 2-87 單鍵 單鍵 -CH20- 環己環 苯環 碳數1〜9 之烷基 2 1 2-88 單鍵 單鍵 -CH20- 環己環 碳败1〜9 之烷氣® 0 1 2-89 單鍵 單鍵 -CH20- 環己環 苯環 碳跛1〜9 之烷氣基 1 2-90 單鍵 單鍵 -CH20- 環己環 苯環 碳數1〜9 之烷氣$ 2 1 2-91 單鍵 單鍵 -CH20- 環己環 碳數1〜9 之烷基 0 1 2-92 單鍵 單鍵 -CH20- 環己環 環己環 碳败1〜9 之烷基 1 1 2-93 單鍵 單鍵 -CH20- 環己環 環己環 碳數1〜9 之烷基 2 1 2-94 單鍵 單鍵 -CH20- 環己環 碳数1〜9 之烷氣基 0 1 2-95 單鍵 單鍵 -CH20- 環己環 環己環 碳數卜9 之烷氣基 1 1 2-96 單鍵 單鍵 -CH20- 環己環 環己環 碳数1〜9 之烷氬荘 2 1 2-&7 單鍵 單鍵 -coo- 苯環 碳數1〜9 之烷基 0 1 2-98 單鍵 單鍵 -COO- 苯環 苯環 碳數1〜9 之烷基 1 1 2-99 單鍵 單鍵 -COO- 苯環 苯環 碳數1〜9 之烷基 2 1 2-100 單鍵 單鍵 -COO- 苯環 碳數卜9 之烷氣基 0 1 2-101 單鍵 單鍵 -COO- 苯環 苯環 碳政1〜9 之烷氣基 1 1 2-102 單鍵 單鍵 -coo- 苯環 苯環 碳數卜9 之烷a基 2 1 2-103 單鍵 單鍵 -coo- 苯環 碳數1〜9 之烷基 0 1 2-104 單鍵 單鍵 -coo- 苯環 環己環 碳數1〜9 之烷基 1 1 2-105 單鍵 單鍵 -coo- 苯環 環己環 碳數1〜9 之烷基 2 1 -30- 201219451 [表 20] Y1 Y2 Y3 Y4 Υ5 Υ6 η m 2-106 單鍵 單鍵 -COO- 苯環 碳數卜9 之烷氧基 0 1 2-107 單鍵 單鍵 -COO- 苯環 環己環 碳數1〜9 之烷氧基 1 1 2-108 單鍵 單鍵 -COO- 苯環 環己環 碳數卜9 之烷氧基 2 1 2-109 單鍵 單鍵 -coo- 環己環 碳數卜9 之烷基 0 1 2-110 單鍵 單鍵 -coo- 環己環 苯環 碳數1〜9 之烷基 1 1 2-111 單鍵 單鍵 -coo- 環己環 苯環 碳數1〜9 之烷基 2 1 2-112 單鍵 單鍵 -coo- 環己環 碳數卜9 之烷氧基 0 1 2-113 單鍵 單鍵 -coo- 環己環 苯環 碳數卜9 之烷氧基 1 1 2-114 單鍵 單鍵 -coo- 環己環 苯環 碳數1〜9 之烷氧基 2 1 2-115 單鍵 單鍵 -coo- 環己環 碳數1〜9 之烷基 0 1 2-116 單鍵 單鍵 -coo- 環己環 環己環 碳數1〜9 之烷基 1 1 2-117 單鍵 單鍵 -coo- 環己環 環己環 碳數1〜9 之烷基 2 1 2-118 單鍵 單鍵 -coo- 環己環 碳數1〜9 之烷氧基 0 1 2-119 單鍵 單鍵 -coo- 環己環 環己環 碳數1〜9 之烷氧基 1 1 2-120 單鍵 單鍵 -coo- 環己環 環己環 碳數1〜9 之烷氧基 2 1 2-121 單鍵 單鍵 -OCX)- 苯環 碳數1〜9 之烷基 0 1 2-122 單鍵 單鍵 -0C0- 苯環 碳數1〜9 之烷基 1 1 2-123 單鍵 單鍵 -0C0- 苯環 苯環 碳數1〜9 之烷基 2 1 2-124 單鍵 單鍵 -0C0- 苯環 碳數1〜9 之烷氣基 0 1 2-125 單鍵 單鍵 -OCX)- 苯環 苯環 碳數1〜9 之烷氧基 1 1 2-126 單鍵 單鍵 -oco- 苯環 苯環 碳數1〜9 之烷氧基 2 1 -31 - 201219451 [表 21] Y1 Y2 Υ3 Υ4 Υ5 Υ6 η m 2-127 單鍵 單鍵 -OCO- 苯環 碳數1〜9 之烷基 0 1 2-128 單鍵 單鍵 -OCO- 苯環 環己環 碳败1〜9 1 2-129 單鍵 單鍵 -OCO- 苯環 環己環 碳數卜9 之烷基 2 1 2-130 單鍵 單鍵 -OCO- 苯環 碳败1〜9 之烷氧基 0 1 2-131 單鍵 單鍵 -OCO- 苯環 環己環 碳數1〜9 之烷氣基 1 1 2-132 單鍵 單鍵 -OCO- 苯環 環己環 碳數1〜9 之烷氧基 2 1 2-133 單鍵 單鍵 -OCO- 環己環 碳數1〜9 之烷某 0 1 2-134 單鍵 單鍵 -OCO- 環己環 苯環 碳數1〜9 之烷基 1 1 2-135 單鍵 單鍵 -OCO- 環己環 苯環 碳數1〜9 之烷基 2 1 2-136 單鍵 單鍵 -OCO- 環己環 碳數1〜9 之烷氧基 0 1 2-137 單鍵 單鍵 -OCO- 環己環 苯環 碳數1〜9 之烷氧基 1 1 2-138 單鍵 單鍵 -OCO- 環己環 苯環 碳數1〜9 之烷氧基 2 1 2-139 單鍵 單鍵 -OCO- 環己環 碳數1〜9 之烷基 0 1 2-140 單鍵 單鍵 -OCO- 環己環 環己環 碳數1〜9 之垸基 1 1 2-141 單鍵 單鍵 -OCO- 環己環 環己環 碳數1〜9 之烷基 2 1 2-142 單鍵 單鍵 -OCO- 環己環 ώΜι 〜9 之烷氣基 0 1 2-143 單鍵 單鍵 -OCO- 環己環 環己環 碳數1〜9 之烷氣苌 1 1 2-144 單鍵 單鍵 -OCO- 環己環 環己環 碳數卜9 之烷氧基 2 1 2-145 -(CH2)a- 單鍵 苯環 碳數1〜9 之烷基 0 1 2-146 -(CH2)a- 單鍵 -0- 苯環 苯環 碳數1〜9 之院基 1 1 2-147 -(CH2)a- 單鍵 苯環 苯環 碳數1〜9 之院基 2 1 a爲1~10之整數In the formula [2], 'Y1 is' a single bond, -(CH2)a- (a is an integer of 1 to 15), -0-, -CH20-, -COO- or OCO-; wherein a single bond, -(CH2)a- (a is an integer of 1 to 15), -〇-, -CH20- or COO· is preferable from the viewpoint of easily synthesizing a side chain structure. More preferably, a single bond, -(CH2)a- (a is an integer from 1 to 10), -0-, -CH20- or C00-; in the formula [2], Y2 is a 'single bond or (CH2)b - (b is an integer from 1 to 15). Among them, a single bond or (CH2)b- (b is an integer of 1 to 10) is preferred. In the formula [2], Y3 is 'single bond, -(CH2)c- (C is an integer of 1 to 15), -〇-, -CH20-'-C00- or 0C0-; wherein a single bond, - (CH2)c_(c is an integer of 1 to 15), -〇-, -CH20-, -COO- or 0C0- is preferable because it is easily synthesized in 201219451. More preferably, a single bond, -(CH2)e-(c is '-0-'-CH20-'-COO-^0C0-; wherein, in the formula [2], Y4 is a benzene ring, a cyclohexane ring, and The bivalent cyclic group selected from the group consisting of an alkyl group having 1 to 3 carbon atoms, an alkoxy group having 1 to 3 carbon atoms, a fluorine-containing alkyl group, and a carbon number of 1 to 3 on the cyclic group. In addition to the fluoroalkoxy group or the fluorocarbon, Υ4 is a sterol skeleton having a carbon number of 12 to 25, preferably a benzene ring, a cyclohexyl ring or a carbon number group having a sterol skeleton. In the formula [2], Υ5 is a bivalent cyclic group derived from a benzene ring, a cyclohexyl ring, and a heterocyclic group, and an alkyl group having 1 to 3 carbon atoms or an alkoxy group having 1 to 3 carbon atoms on the cyclic group. Fluorinated alkyl group, fluorine-containing alkoxy group having a carbon number of 1 to 3 or fluorine atom in the formula [2], η is an integer of 0 to 4; preferably 0 to 2, in the formula [2], Υ6 is a carbon number of 1~ 18 alkyl, carbon: fluoroalkyl, alkoxy group having a carbon number of 1 to 18 or a carbon number of 1 to 18. Among them, an alkyl group having a carbon number of 1 to 18, a carbon number of 1 to 10, and a carbon number of 1 to 18 The alkoxy group or the fluorine-containing alkane having a carbon number of 1 to 10 is preferably an alkyl group having 1 to 12 carbon atoms or an alkyl group having 1 to 12 carbon atoms of 1 to 12 or an alkoxy group having 1 to 9 carbon atoms. In the formula [2], m is an integer of 1 to 4. It is a combination of the formula [2], Υ2, γ3, Υ4, γ5, Υ6, and, for example, the contents shown in Tables 1 5 to 4 4. The integers of 1 to 10) The atom may be substituted with a carbon number of 1 to 3, and the organic group. The organic ring of Υ4 2~25 is replaced by a group of selected hydrogen atoms of 1 to 3 carbon atoms. An integer of 2. The fluorine-containing alkoxy group-containing fluorine-containing alkyl group or the oxy group is preferably contained in the group 1 to 18. More basic. The best is the carbon L integer. ι and m preferably -25-19, 201219451 [Table 15] Y1 Y2 Y3 Y4 Y5 Y6 η m 2-1 single bond single bond single bond benzene ring carbon number 1 to 9 alkyl 0 1 2-2 single bond single bond Single bond phenyl ring benzene ring C 1~9 alkyl 1 1 2-3 single bond single bond single bond benzene ring benzene ring carbon number 1 to 9 alkyl 2 1 2-4 single bond single bond single bond benzene ring Alkoxy group having a carbon number of 1 to 9 0 1 2-5 single bond single bond single bond benzene ring benzene ring carbon number 1 to 9 alkoxy group 1 2-theta single bond single bond single bond benzene ring benzene ring carbon number 1 ~9 alkoxy 2 1 2-7 single bond single bond single bond benzene ring carbon number 丨~9 alkyl 0 1 2-8 single bond single bond single bond benzene ring cyclohexane ring number 1 to 9 alkane Base 1 1 2-9 single bond single bond single bond benzene ring cyclohexene ring carbon 1 to 9 alkyl 2 1 2-10 single bond single bond single bond benzene ring carbon number 1 to 9 alkoxy 0 1 2 -11 single bond single bond single bond benzene ring cyclohexene ring number 1 to 9 alkoxy group 1 1 2-12 single bond single bond single bond benzene ring cyclohexane ring number 1~9 alkane argon 2 1 2 -13 single bond single bond single bond ring hexene ring carbon number 1 to 9 alkyl group 0 1 2-14 single bond single bond single bond cyclohexylbenzene ring carbon 1~9 alkyl 1 1 2-15 single bond single bond single bond cyclohexylbenzene ring carbon number 1~9 alkyl 2 1 2-16 single bond single bond single bond ring ring carbon number 1~9 alkane gas raspberry 0 1 2-17 Single bond single bond single bond ring hexene ring carbon number 1 to 9 alkoxy group 1 1 2-18 single bond single bond single bond cyclohexylbenzene ring carbon number 1 to 9 alkoxy 2 1 2-19 single bond Single-bonded single-bonded ring-bonded ring 1 to 9-alkyl group 0 1 2-20 Single-bonded single-bonded single-bonded cyclohexylcyclohexene ring carbon 赃 1 to 9 alkyl 1 1 2-21 One-touch single-button single Alkyl 2 having a carbon number of 1 to 9 in the ring cyclohexylcyclohexene ring 2 1 201219451 [Table 16] Y1 Y2 Y3 Y4 Y5 Y6 Y6 η m 2-22 Single bond single bond single bond ring carbon number 1 to 9 alkoxy Base 0 1 2-23 single bond single bond single bond cyclohexylcyclohexene ring number 1 to 9 alkoxy 1 1 2-24 single bond single bond single bond cyclohexylcyclohexene ring carbon number 1~9 Alkoxy 2 1 2-25 single bond single bond -(CH2)c- alkyl group having 1 to 9 carbon atoms of phenyl ring 0 1 2-26 single bond single bond -(CH2)c- benzene ring benzene ring carbon number 1 ~9 alkyl 1 1 2-27 single bond single bond -(CH2)c- phenyl ring benzene ring carbon number 1~9 alkyl 2 1 2-28 single bond single bond -<CH23c- benzene ring carbon number 1 to 9 Alkoxy 0 1 2-29 single bond single bond -(CH2)c- benzene ring benzene ring carbon number 9 alkoxy group 1 1 2-30 single bond single bond -(CH2)c- benzene ring benzene ring Carbon number 9 alkoxy 2 1 2-31 single bond single bond -(CH2)c- benzene ring. carbon number 1 to 9 total 0 1 2-32 single bond single bond -(CH2)c- benzene ring Alkyl group having 1 to 9 carbon atoms in the cyclohexene ring 1 1 2-33 single bond single bond -(CH2)c-alkyl group having a carbon number of 1 to 9 benzene ring 2 1 2-34 single bond single bond - ( CH2}c- Å carbon number 9 alkoxy 0 1 2-35 single bond single bond-<CH2)c- benzene ring cyclohexene ring number 1 to 9 alkoxy group 1 1 2-36 single bond Single bond-<CH2)c- benzene ring cyclohexene carbon number 1 to 9 alkyl group 2 1 2-37 single bond single bond -(CH2)c- cyclohexene ring number 1 to 9 alkyl group 0 1 2-38 single bond single bond -(CH2)c- cyclohexene cycline 1 to 9 alkyl 1 1 2-39 single bond single bond -<CH2)c- cyclohexylbenzene ring carbon number 9 yard base 2 1 2-40 single button single button -<CH2)c- cyclohexene ring number 1 to 9 alkoxy group 0 1 2-41 single bond single bond -(CH2)c-cyclohexyl ring Alkoxy group having 1 to 9 carbon atoms of benzene ring 1 1 2-42 single bond single bond -(CH2)c- alkane having a carbon number of 1 to 9 Oxygen 2 1 c is an integer from 1 to 10 -27- 201219451 [Table 17] Y1 Y2 Y3 Y4 Y5 Y6 η m 2-43 Single bond single bond -(CH2)c- a cyclohexane ring number 1 to 9 alkane Base 0 1 2-44 single bond single bond -(CH2)c- cyclohexylcyclohexene ring 1 to 9 alkyl 1 1 2-45 single bond single bond -(CH2)c-cyclohexylcyclohexane Alkyl group having 1 to 9 ring carbon atoms 1 1 2-46 Single bond single bond -<CH2}c- Alkoxy group having 1 to 9 ring carbon number 0 1 2-47 Single bond single bond - (CH2) C-cyclohexylcyclohexene ring carbon to rescue 1 to 9 alkoxy 1 1 2-48 single bond single bond -(CH2}c-cyclohexylcyclohexene carbon number a 9 alkoxy 2 1 2- 49 single-button single bond-0-benzene ring. alkyl group with carbon number 1~9 0 1 2-50 single bond single bond-0- phenyl ring benzene ring carbon number 1~9 alkyl 1 2-51 single bond single Key-o- phenyl ring benzene ring carbon number 1~9 of the yard base 2 1 2-52 single bond single bond -o- benzene ring carbon number 1~9 alkoxy 0 1 2-53 single bond single bond-0 - Benzene benzene ring carbon number 9 alkoxy 1 1 2-54 single bond single bond - 0 - benzene ring benzene ring carbon number 9 alkoxy 2 1 2-55 single bond single bond - 0 - benzene Alkyl group having a ring carbon number of 1 to 9 0 1 2-56 single bond single bond -o-benzene ring cyclohexane Number 1 to 9 alkyl 1 1 2-57 single bond single bond -o- phenyl ring cyclohexene carbon number 1 to 9 alkyl 2 1 2-58 single bond single bond-0-benzene ring carbon number 1~ 9 alkane group 0 1 2-59 single bond single bond-0- benzene ring cyclohexene carbon number 1 to 9 alkyl group 1 1 2-60 single bond single bond -o- benzene ring cyclohexene carbon number 1 to 9 alkoxy 2 1 2-61 single bond single bond -o-cyclohexene ring number 1 to 9 alkyl group 0 1 2-62 single bond single bond -o- cyclohexylbenzene ring carbon number 1 ～1 alkyl 1 1 2-63 single bond single bond-0-cyclohexylbenzene ring carbon 1~9 alkyl 2 1 c is the integer of -28 - 201219451 [Table 18] Y1 Y2 Y3 Y4 Y5 Y6 η m 2-64 single bond single bond-0-cyclohexene ring number 9 alkoxy group 0 1 2-65 single bond single bond-0-cyclohexylbenzene ring carbon number alkoxy 1 2-66 single bond single bond-0-cyclohexylbenzene ring carbon number 1 to 9 alkoxy 2 1 2-67 single bond single bond-0-cyclohexene ring carbon number 1~9 alkyl 0 t 2-68 single bond single bond-0-cyclohexylcyclohexene ring carbon number 1~9 alkyl 1 1 2-69 single bond single bond-0-cyclohexyl ring. cyclohexane ring carbon number 1~9 alkane Base 2 1 2-70 single bond single bond-0-cyclohexene ring carbon number 9 alkoxyl 0 1 2-71 single bond single bond-0-cyclohexylcyclohexene ring carbon number 9 alkoxy 1 1 2-72 single bond single bond-0-cyclohexylcyclohexene ring carbon Alkoxy 2 1 2-73 single bond single bond -CH20- phenyl ring carbon number 9 alkyl 0 1 2-74 single bond single bond -CH20- benzene ring benzene ring carbon number 1~9 Alkyl 1 1 2-75 single bond single bond -CH20- phenylene ring carbon number b 9 yard base 2 1 2-76 single bond single bond -CH20- benzene ring carbon number 1~9 alkoxy 0 1 2 -77 single bond single bond-CHZO- benzene ring benzene ring 1 to 9 alkoxy 1 1 2-78 single bond single bond -CH20- phenyl ring benzene ring. alkoxy group 1 to 9 2 1 2-79 One-touch single button-CH20- Benzene ring carbon number 之 9 base 0 1 2-80 Single button single button -CH20- Benzene ring Cyclohexane carbon number 1~9 院 1 1 2 2 单Key single bond -CH20- phenylcyclohexene ring carbon number 1~9 alkyl 2 1 2-82 single bond single bond -CH20- benzene ring carbon number 9 alkoxy 0 1 2-83 single bond single bond -CH20- phenylcyclohexene ring carbon number 9 alkoxy group 1 1 2-84 single bond single bond -CH20- benzene ring cyclohexyl ring mm-9 alkoxy group 2 1 -29- 201219451 [Table 19] Y1 Y2 Y3 Y4 Y5 Y6 η m 2-S5 single bond single bond -CH20- cyclohexene ring carbon 1~9 alkyl 0 1 2-86 single bond single bond -CH20- cyclohexylbenzene ring 1 to 9 alkyl 1 1 2-87 single bond single bond -CH20- cyclohexylbenzene ring carbon number 1~9 alkyl 2 1 2-88 single bond single bond -CH20- cyclohexane ring carbon 1~9 alkane gas 0 1 2-89 single bond single bond-CH20- cyclohexylbenzene ring carbon 跛1~9 alkane group 1 2-90 single bond single bond-CH20- cyclohexene ring benzene ring carbon number 1~9 alkane gas $ 2 1 2-91 single bond single bond -CH20- cyclohexene ring carbon number 1~9 alkyl 0 1 2-92 single bond single bond -CH20- cyclohexylcyclohexene ring carbon 1~9 alkyl 1 1 2-93 single bond single bond -CH20- cyclohexylcyclohexene ring carbon number 1~9 alkyl 2 1 2-94 single bond single bond -CH20- cyclohexane ring carbon number 1~9 alkyl group 0 1 2-95 single bond single bond -CH20- cyclohexylcyclohexene ring carbon number 9 alkane group 1 1 2-96 single bond single bond -CH20- cyclohexane ring cyclohexane carbon number 1~9 alkyl argon荘2 1 2-&7 single bond single bond-coo- phenyl ring carbon number 1~9 alkyl 0 1 2-98 single bond single bond -COO- phenyl ring benzene ring carbon number 1~9 alkyl 1 1 2-99 One-touch single button - COO- phenyl ring benzene ring carbon number 1~9 alkyl 2 1 2-100 single bond single bond -COO- benzene ring carbon number 9 alkane base 0 1 2-101 single bond single bond -COO- benzene ring Benzene ring carbon policy 1 to 9 alkyl group 1 1 2-102 single bond single bond -coo- benzene ring benzene ring carbon number 9 alkane a group 2 1 2-103 single bond single bond -coo- benzene ring carbon Number 1 to 9 alkyl 0 1 2-104 single bond single bond -coo- phenyl ring cyclohexene carbon number 1 to 9 alkyl 1 1 2-105 single bond single bond -coo-benzene ring cyclohexene carbon Number 1 to 9 alkyl 2 1 -30- 201219451 [Table 20] Y1 Y2 Y3 Y4 Υ5 Υ6 η m 2-106 Single bond single bond -COO- phenyl ring carbon number 9 alkoxy group 0 1 2-107 Single-button single bond-COO- benzene ring cyclohexene ring number 1 to 9 alkoxy group 1 1 2-108 single bond single bond -COO- benzene ring cyclohexene carbon number a 9 alkoxy 2 1 2- 109 single-button single-button-coo-cyclohexene ring number 9 alkyl 0 1 2-110 single bond single bond-coo- cyclohexylbenzene ring carbon number 1~9 alkyl 1 1 2-111 single bond Single bond-coo-cyclohexylbenzene ring 1 to 9 alkyl 2 1 2-112 single bond single bond -coo- cyclohexene carbon number 9 alkoxy 0 1 2-113 single bond single bond -coo- Cyclohexene ring carbon number 9 alkoxy group 1 1 2-114 single bond single bond -coo- cyclohexylbenzene ring carbon number 1 to 9 alkoxy 2 1 2-115 single bond single bond -coo- Alkyl group having a carbon number of 1 to 9 in a cyclohexane ring. 1 1 2-116 single bond single bond -coo-cyclohexylcyclohexene ring 1 to 9 alkyl group 1 1 2-117 single bond single bond -coo- ring Alkyl 2 of a cyclohexane ring having 1 to 9 carbon atoms 1 1 2-118 single bond single bond -coo- alkoxy group having 1 to 9 ring carbon number 0 1 2-119 single bond single bond -coo- ring Alkoxy group having 1 to 9 carbon atoms in the cyclohexene ring 1 1 2-120 single bond single bond -coo-cyclohexylcyclohexene ring number 1 to 9 alkoxy group 2 1 2-121 single bond single bond -OCX)- Alkyl group with a benzene ring number of 1 to 9 0 1 2-122 Single bond single bond -0C0- Alkyl group with a benzene ring number of 1 to 9 1 1 2-123 Single bond single bond -0C0- benzene ring Benzene ring carbon number 1 to 9 alkyl 2 1 2-124 single bond single bond -0C0- benzene ring carbon number 1 to 9 alkyl group 0 1 2-125 single bond single bond -OCX)-benzene ring benzene ring Alkoxy group having 1 to 9 carbon atoms 1 1 2-126 Single bond single bond -oco- Alkoxy group having 1 to 9 carbon atoms of benzene ring 2 1 -31 - 201219451 [Table 21] Y1 Y2 Υ3 Υ4 Υ5 Υ6 η m 2-127 Single bond single bond -OCO- phenyl ring carbon number 1~9 alkyl 0 1 2-128 single bond single bond -OCO- benzene ring cyclohexene carbon 1~9 1 2-129 single bond single bond -OCO- Benzene ring cyclohexene carbon number 9 alkyl 2 1 2-130 single bond single bond - OCO- phenyl ring carbon 1 to 9 alkoxy 0 1 2-131 single bond single bond - OCO- benzene ring Alkenyl group having 1 to 9 carbon atoms in the ring 1 1 2-132 single bond single bond - OCO- alkoxy group having 1 to 9 carbon atoms in the benzene ring 2 1 2-133 single bond single bond - OCO-ring Alkyl group having a carbon number of 1 to 9 0 1 2-134 single bond single bond -OCO-cyclohexylbenzene ring 1 to 9 alkyl 1 1 2-135 single bond single bond -OCO-cyclohexyl ring Alkyl group with a benzene ring number of 1 to 9 2 1 2-136 Single bond single bond -OCO- Alkoxy group of a cyclohexene ring number 1 to 9 0 1 2-137 Single bond single bond -OCO-cyclohexylbenzene Alkoxy group having 1 to 9 ring carbon atoms 1 1 2-138 Single bond single bond - OCO-cyclohexylbenzene ring Alkoxy group having 1 to 9 carbon atoms 2 1 2-139 Single bond single bond - OCO-cyclohexane Alkyl group having a ring carbon number of 1 to 9 0 1 2-140 Single bond single bond -OCO-cyclohexylcyclohexene ring 1 to 9 fluorenyl group 1 1 2-141 single bond single bond -OCO-cyclohexyl ring Cyclohexane ring number 1 ~9 alkyl 2 1 2-142 single bond single bond -OCO-cyclohexane ring ι ~9 alkane group 0 1 2-143 single bond single bond -OCO- cyclohexylcyclohexene ring carbon number 1~9 Alkane gas 苌 1 1 2-144 single bond single bond -OCO- cyclohexylcyclohexene ring carbon number 9 alkoxy 2 1 2-145 -(CH2)a- single bond benzene ring carbon number 1~9 Alkyl 0 1 2-146 -(CH2)a- single bond-0- phenyl ring benzene ring carbon number 1~9 院 1 1 2-147 -(CH2)a- single bond benzene ring benzene ring carbon number 1 to 9 yard base 2 1 a is an integer from 1 to 10

-32- 201219451 m22] Y1 Y2 Y3 Y4 Y5 Y6 η m 2-148 -(CH2)a- 單鍵 -0- 苯環 碳數1〜9 之烷氧基 0 1 2-149 -(CH2)a- 單鍵 -0- 苯環 苯環 碳數卜9 之烷氧基 1 1 2-150 -(CH2)a- 單鍵 苯環 苯環 碳數卜9 之焼氧基 2 1 2-151 -(CH2)a- 單鍵 -0- 苯環 碳數卜9 之院基 0 1 2-152 -(CH2)a- 單鍵 -0- 苯環 環己環 碳數1〜9 之烷基 \ 1 2-153 -(CH2)a- 單鍵 -0- 苯環 環己環 碳數1〜9 之烷基 2 1 2-154 -(CH2)a- 單鍵 -0- 苯環 碳數卜9 夕烷氯基 0 1 2-155 -(CH2)a- 單鍵 苯環 環己環 碳數卜9 之烷氧基 1 1 2-156 -(CH2)a- 單鍵 賴 環己環 碳數1〜9 之烷氧基 2 1 2-157 -(CH2)a- 單鍵 環己環 碳數1〜9 之烷基 0 \ 2-158 -(CH2)a- 單鍵 -0- 環己環 苯環 碳數1〜9 之烷基 1 1 2-159 -(CH2)a- 單鍵 -0- 環己環 苯環 碳數1〜9 之院基 2 1 2-160 -(CH2)a- 單鍵 環己環 碳數卜9 之烷氧基 0 1 2-161 -(CH2)a- 單鍵 -0- 環己環 苯環 碳數1〜9 之烷氧基 1 1 2-162 -(CH2)a- 單鍵 環己環 苯環 碳數卜9 之烷氣基 2 1 2-163 -(CH2)a- 單鍵 -0- 環己環 碳數1〜9 之烷基 0 1 2-164 -CCH2)a- 單鍵 -0- 環己環 環己環 碳數1〜9 之烷基 1 1 2-165 -(CH2)a- 單鍵 -0- 環己環 環己環 碳數1〜9 之烷基 2 1 2-166 —(CH2)a- 單鍵 -0- 環己環 碳數1〜9 之烷氧基 0 1 2-167 -(CH2)a- 單鍵 -0- 環己環 環己環 碳數1〜9 之烷氧基 1 1 2-168 -(CH2)a- 單鍵 環己環 環己環 碳數1〜9 之烷氧基 2 1 a爲1~10之整數 -33- 201219451 [表 23] Y1 Y2 Y3 Y4 Y5 Y6 η m 2-169 -(CH2)a- 單鍵 -COO- 苯環 碳败1〜9 之烷基 0 1 2-170 -(CH2)a- 單鍵 -coo- 苯環 苯環 碳數1〜9 之烷基 1 1 2-171 -(CH2)a- 單鍵 -coo- 苯環 苯環 碳數1〜9 之烷基 2 1 2-172 -(CH2)a- 單鍵 -coo- 苯環 碳數1〜9 之烷氧基 0 1 2-173 -(CH2)a- 單鍵 -coo- 苯環 苯環 碳數1〜9 之烷氣基 1 1 2-174 -(CH2)a- 單鍵 -coo- 苯環 苯環 碳數1〜9 之烷氧 2 1 2-175 -(CH2)a- 單鍵 -coo- 苯環 碳數卜9 之烷甚 0 1 2-176 -(CH2)a- 單鍵 -coo- 苯環 環己環 碳數1〜9 之烷基 1 2-177 -(CH2)a- 單鍵 -coo- 苯環 環己環 碳數卜9 之烷基 2 1 2-178 -(CH2)a- 單鍵 -coo- 苯環 碳败1〜9 之烷氣基 0 1 2-179 -(CH2)a- 單鍵 -coo- 苯環 環己環 碳數1〜9 之烷氣基 1 1 2-180 -(CH2)a- 單鍵 -coo- 苯環 環己環 碳數1〜9 之烷氣基 2 1 2-181 -(CH2)a- 單鍵 -coo- 環己環 碳數1〜9 之烷基 0 1 2-182 -(CH2)a- 單鍵 -coo- 環己環 苯環 碳数1〜9 之烷基 1 1 2-183 -(CH2)a- 單鍵 -coo- 環己環 苯環 碳數1〜9 之烷基 2 1 2-184 -(CH2)a- 單鍵 -coo- 環己環 碳败1〜9 之烷氣荘 0 1 2-185 -(CHZ)a- 單鍵 -coo- 環己環 苯環 碳數1〜9 之烷氣芘 1 1 2-186 -(CH2)a- 單鍵 -coo- 環己環 苯環 碳數1〜9 之烷氣基 2 1 2-187 -(CH2)a- 單鍵 -coo- 環己環 碳數1〜9 之烷基 0 1 2-188 -(CH2)a- 單鍵 -coo- 環己環 環己環 碳數卜9 之烷莊 1 1 Ϊ2-189 -(CH2)a- 單鍵 -coo- 環己環 環己環 碳败1〜9 之烷基 2 1 a爲1-10之整數-32- 201219451 m22] Y1 Y2 Y3 Y4 Y5 Y6 η m 2-148 -(CH2)a- Single bond-0- Alkoxy group of benzene ring carbon number 1~9 0 1 2-149 -(CH2)a- Single bond-0-benzene ring benzene ring carbon number 9 alkoxy group 1 1 2-150 -(CH2)a- single bond benzene ring benzene ring carbon number 9 焼 oxy group 2 1 2-151 -(CH2 ) a- single bond-0- phenyl ring carbon number b 9 yard base 0 1 2-152 -(CH2)a- single bond-0- benzene ring cyclohexene ring number 1~9 alkyl group 1 1 2- 153 -(CH2)a- single bond-0- phenylcyclohexene ring 1 to 9 alkyl 2 1 2-154 -(CH2)a- single bond-0-benzene ring carbon number 9 octadecyl chloride Base 0 1 2-155 -(CH2)a- single bond benzene ring cyclohexene carbon number 9 alkoxy 1 1 2-156 -(CH2)a- single bond hexane ring carbon number 1~9 Alkoxy 2 1 2-157 -(CH2)a- A single bond cycloalkyl 1 to 9 alkyl group 0 \ 2-158 -(CH2)a- single bond-0-cyclohexylbenzene ring carbon number 1 to 9 alkyl 1 1 2-159 -(CH2)a- single bond-0-cyclohexylbenzene ring carbon number 1 to 9 of the hospital base 2 1 2-160 -(CH2)a- single bond ring Cyclocarbon number 9 alkoxy 0 1 2-161 -(CH2)a- single bond-0-cyclohexylbenzene ring 1 to 9 alkoxy 1 1 2-162 -(CH2)a- single bond Cyclohexylbenzene ring carbon number 9 alkane group 2 1 2-163 -(CH2)a- single bond-0-cyclohexene ring number 1 to 9 alkyl group 0 1 2-164 -CCH2)a- Single bond-0-cyclohexylcyclohexene ring 1 to 9 alkyl 1 1 2-165 -(CH2)a- single bond-0-cyclohexylcyclohexene ring 1 to 9 alkyl 2 1 2-166 —(CH2)a- Single bond-0- Alkoxy group having 1 to 9 ring carbon groups 0 1 2-167 -(CH2)a- Single bond-0-cyclohexylcyclohexene ring carbon Alkoxy group number 1 to 9 1 1 2-168 -(CH2)a-monocyclic cyclohexylcyclohexyl carbon number 1 to 9 alkoxy group 2 1 a is an integer of 1 to 10 -33 - 201219451 [ Table 23] Y1 Y2 Y3 Y4 Y5 Y6 η m 2-169 -(CH2)a- Single bond-COO- phenyl ring carbon 1~9 alkyl 0 1 2-170 -(CH2)a- single bond-coo - phenyl ring benzene ring 1 to 9 alkyl 1 1 2-171 -(CH2)a- single bond -coo- phenyl ring benzene ring 1 to 9 alkyl 2 1 2-172 -(CH2) A-mono-coo- alkoxy having a benzene ring of 1 to 9 carbon atoms 0 1 2-173 -(CH2)a- single bond-coo- benzene ring benzene ring 1 to 9 alkyl group 1 1 2 -174 -(CH2)a- single bond-coo- benzene ring benzene ring 1 to 9 alkoxy 2 1 2-175 -(CH2)a- single bond-coo- benzene ring carbon number 0 0 1 2-176 -(CH2)a- single bond-coo- phenyl ring cyclohexene alkyl 1 to 9 alkyl 1 2-177 -(CH2)a- single bond-coo- benzene ring cyclohexane Carbon number 2 alkyl 2 1 2-178 -(CH2)a- single bond-coo- benzene ring carbon 1~9 alkane group 0 1 2-179 -(CH2)a- single bond-coo- Benzene cyclohexane ring carbon number 1 to 9 alkyl group 1 1 2-180 -(CH2)a- single bond-coo- benzene ring cyclohexene carbon number 1 to 9 alkyl group 2 1 2-181 - (CH2)a-monobond-coo-cyclohexene ring 1 to 9 alkyl group 0 1 2-182 -(CH2)a- single bond-coo- cyclohexylbenzene ring 1 to 9 alkyl group 1 1 2-183 -(CH2)a- single bond-coo- cyclohexylbenzene ring 1 to 9 alkyl 2 1 2-184 -(CH2)a- single bond-coo- cyclohexene ring carbon 1 to 9 alkane gas 1 0 1 2-185 -(CHZ)a- single bond-coo- cyclohexane ring benzene ring carbon number 1 to 9 alkane gas 芘 1 1 2-186 -(CH2)a- single bond -coo-cyclohexylbenzene ring carbon number 1 to 9 alkyl group 2 1 2-187 -(CH2)a- single bond-coo- cyclohexene ring number 1 to 9 alkyl group 0 1 2-188 - (CH2)a- single bond-coo- cyclohexylcyclohexene carbon number b 9 alkane 1 1 Ϊ2-189 -(CH2)a- single bond-coo- cyclohexylcyclohexene ring carbon defeat 1~9Alkyl 2 1 a is an integer from 1 to 10

-34- 201219451 [表 24] Y1 Y2 Y3 Y4 Y5 Y6 π m 2-190 -(CH2)a- 單鍵 -COO- 環己環 碳數1〜9 之烷氧基 0 1 2-191 -(CH2)a- 單鍵 -COO- 環己環 環己環 碳數卜9 之烷氧基 1 1 2-192 -(CH2)a- 單鍵 -COO- 環己環 環己環 碳數卜9 之烷氧基 2 1 2-193 -(GH2)a- 單鍵 -OCO- 苯環 碳數1〜9 之烷基 0 1 2-194 -(CH2)a- 單鍵 -OCO- 苯環 織 碳數1〜9 之烷基 1 1 2-195 -(CH2)a- 單鍵 -OCO- 苯環 苯環 碳數1〜9 之烷基 2 1 2-196 -(CH2)a- 單鍵 -OCX)- 苯環 碳數1〜9 夕烷氬某 0 1 2-197 -(CH2)a- 單鍵 -0C0- 苯環 苯環 碳數1〜9 之烷氧基 1 1 2-198 -(CH2)a- 單鍵 -0C0- 苯環 苯環 碳數卜9 之烷氧基 2 1 2-199 -(CH2)a- 單鍵 -0C0- 苯環 碳數1〜9 之烷基 0 1 2-200 -(CH2)a- 單鍵 -003- 苯環 環己環 碳數卜9 之烷基 1 1 2-201 -CCH2)a- 單鍵 -0C0- 苯環 環己環 碳數卜9 之烷基 2 1 2-202 -(CH2)a- 單鍵 -OCO- 苯環 碳數1〜9 之院氧基 0 1 2-203 -(CH2)a- 單鍵 -OCO- 苯環 環己環 碳數卜9 之烷氧基 1 1 2-204 -(CH2)a- 單鍵 -0C0- 苯環 環己環 碳數1〜9 夕烷氬某 2 1 2-205 -(CH2)a- 單鍵 -000- 環己環 碳數1〜9 之烷基 0 1 2-206 -CCH2)a- 單鍵 -0C0- 環己環 苯環 碳數1〜9 之烷基 1 1 2-207 -(CH2)a- 單鍵 -0C0- 環己環 苯環 碳數W9 之烷基 2 1 2-208 -(CH2)a- 單鍵 -0C0- 環己環 碳數1〜9 之烷氧基 0 1 2-209 -(C^)a- 單鍵 -0C0- 環己環 苯環 碳數1〜9 之烷氧基 1 1 2-210 -(CH2)a- •單鍵 -0C0- 環己環 苯環 碳數1〜9 之烷氣基 2 1 a爲1~10之整數 -35- 201219451 [表 25] Y1 Y2 Y3 Y4 Y5 Υβ η m 2-211 -(CH2)a- 單鍵 -0C0- 環己環 碳败1〜9 之烷基 0 1 2-212 -(CH2)a- 單鍵 -0C0- 環己環 環己環 碳數1〜9 之烷基 1 2-213 -(CH2)a- 單鍵 -000- 環己環 環己環 碳數1〜9 之烷基 2 1 2-214 -(CH2)a- 單鍵 -OCO- 環己環 碳數1〜9 之烷氣基 0 1 2-215 -(CH2)a- 單鍵 -0C0- 環己環 環己環 碳败1〜9 之烷氣基 1 1 2-216 -(CH2)a- 單鍵 -OCO- 環己環 環己環 碳數卜9 之烷氣基 2 1 2-217 -0- 單鍵 -<CH2)c- 苯環 碳數1〜9 之烷基 0 1 2-218 -0- 單鍵 -(CH2)c- 苯環 苯環 碳數1〜9 之烷基 1 1 2-219 -0- 單鍵 -(CH2)c- 苯環 苯環 碳數1〜9 之烷基 2 1 2-220 -0- 單鍵 -(CH2}c- 苯環 碳數1〜9 之烷氧基 0 1 2-221 -o- 單鍵 -<GH2)c- 苯環 苯環 .碳數1〜9 之烷氣基 1 1 2-222 -0- 單鍵 -(CH2)c- 苯環 苯環 碳數1〜9 之烷氣基 2 1 2-223 -0- 單鍵 -(CH2)c- 苯環 碳數1〜9 之烷基 0 1 2-224 -0- 單鍵 -(CH2)c- 苯環 環己環 碳數1〜9 之焼基 1 1 2-225 -0- 單鍵 -(CH2)c- 苯環 環己環 碳數1〜9 之烷基 2 1 2-226 -o- 單鍵 -(CH2)c- 苯環 碳數1〜9 之烷氣基 0 1 2-227 -0- 單鍵 -(CH2)c- 苯環 環己環 碳數1〜9 之烷氣基 1 1 2-228 -0- 單鍵 <CH2k- 苯環 環己環 碳數1〜9 之烷氧基 2 1 2-229 -0- 單鍵 -(CH2)c- 環己環 碳數1〜9 之烷基 0 1 2-230 -0- 單鍵 -(CH2)c- 環己環 苯環 碳數1〜9 之烷基 1 1 2-231 -o- 單鍵 -(CH2)c- 環己環 苯環 碳數1〜9 之烷基 2 1 c爲1-10之整數-34- 201219451 [Table 24] Y1 Y2 Y3 Y4 Y5 Y6 π m 2-190 -(CH2)a- Single bond-COO- Alkoxy group of cyclohexene ring number 1~9 0 1 2-191 -(CH2 a-monobond-COO-cyclohexylcyclohexene carbon number a 9 alkoxy 1 1 2-192 -(CH2)a- single bond-COO-cyclohexylcyclohexene carbon number Oxygen 2 1 2-193 -(GH2)a- Single bond-OCO- Alkyl group with a carbon number of 1 to 9 Benzene 0 1 2-194 -(CH2)a- Single bond-OCO- Benzene ring carbon number 1 ～9 alkyl 1 1 2-195 -(CH2)a- single bond-OCO- phenyl ring benzene ring alkyl 1 to 9 alkyl 2 1 2-196 -(CH2)a- single bond-OCX)- Benzene ring carbon number 1 to 9 octaphane argon 0 1 2-197 -(CH2)a- single bond-0C0- benzene ring benzene ring alkoxy group 1 to 9 a 2 - 2-198 -(CH2)a - single bond -0C0- benzene ring benzene ring carbon number 9 alkoxy 2 1 2-199 -(CH2)a- single bond-0C0- phenyl ring carbon number 1~9 alkyl 0 1 2-200 - (CH2)a-monobond-003- phenylcyclohexene ring carbon number 9 alkyl 1 1 2-201 -CCH2)a- single bond-0C0- phenylcyclohexene ring carbon number 9 alkyl 2 1 2-202 -(CH2)a- Single bond-OCO- phenyl ring carbon number 1~9 oxime 0 1 2-203 -(CH2)a- single bond-OCO- benzene ring cyclohexene carbon Alkoxy 1 1 2-204 -(CH2)a- single bond-0C0-benzene ring cyclohexene carbon number 1~9 octahexane argon 2 1 2-205 -(CH2)a- single bond- 000-cyclohexene ring carbon number 1 to 9 alkyl group 0 1 2-206 -CCH2)a- single bond-0C0-cyclohexylbenzene ring carbon number 1 to 9 alkyl group 1 1 2-207 -(CH2) A- single bond-0C0-cyclohexylbenzene ring carbon number W9 alkyl 2 1 2-208 -(CH2)a- single bond-0C0-cyclohexene ring number 1~9 alkoxy group 0 1 2- 209 -(C^)a- single bond-0C0-cyclohexylbenzene ring 1 to 9 alkoxy 1 1 2-210 -(CH2)a- • single bond-0C0-cyclohexylbenzene ring carbon Number 1 to 9 of the alkane group 2 1 a is an integer of 1 to 10 -35 - 201219451 [Table 25] Y1 Y2 Y3 Y4 Y5 Υβ η m 2-211 -(CH2)a- Single bond-0C0-cyclohexyl ring Alkyl group with a carbon number of 1 to 9 0 1 2-212 -(CH2)a- single bond-0C0-alkyl group having a carbon number of 1 to 9 of cyclohexylcyclohexyl ring 2-213 -(CH2)a- single bond -000- Cyclohexylcyclohexene ring 1 to 9 alkyl 2 1 2-214 -(CH2)a- single bond-OCO- cyclohexane ring carbon number 1 to 9 alkyl group 0 1 2-215 -(CH2)a- Single bond-0C0- Cyclohexane ring Cyclohexane carbon 1~9 Alkyl group 1 1 2-216 -(CH2)a- Single bond-OCO- Cyclohexyl ring Cyclocarbon number 9 alkane group 2 1 2-217 -0- single bond-<CH2)c- phenyl ring carbon number 1 to 9 alkyl group 0 1 2-218 -0- single bond-(CH2) C- phenyl ring benzene ring alkyl group 1 to 9 carbon 1 1 2-219 -0- single bond -(CH2)c- phenyl ring benzene ring alkyl group 1 to 9 alkyl 2 1 2-220 -0- Single bond-(CH2}c- alkoxy group having a carbon number of 1 to 9 benzene ring 0 1 2-221 -o- single bond-<GH2)c- benzene ring benzene ring. alkane group having a carbon number of 1 to 9 1 1 2-222 -0- single bond-(CH2)c- benzene ring benzene ring carbon number 1 to 9 alkyl group 2 1 2-223 -0- single bond -(CH2)c- benzene ring carbon number 1 ～10的 alkyl 0 1 2-224 -0- single bond-(CH2)c- phenylcyclohexene ring carbon number 1~9 fluorenyl 1 1 2-225 -0- single bond-(CH2)c- Benzene ring cyclohexene carbon number 1 to 9 alkyl 2 1 2-226 -o- single bond -(CH2)c- benzene ring carbon number 1 to 9 alkyl group 0 1 2-227 -0- single bond -(CH2)c- benzene ring cyclohexane carbon number 1 to 9 alkyl group 1 1 2-228 -0- single bond <CH2k- benzene ring cyclohexene carbon number 1 to 9 alkoxy 2 1 2-229 -0- Single bond-(CH2)c- Alkyl group having a carbon number of 1 to 9 of a cyclohexane ring 0 1 2-230 -0- Single bond-(CH2)c- Cyclohexane ring carbon number 1~ 9 alkyl 1 1 2-231 -o- single - (CH2) c- cyclohexyl benzene ring an alkyl group of 1~9 carbon atoms, 2 1 c is an integer of 1-10

-36- 201219451 [表 26] Y1 Y2 Y3 Y4 Y5 Y6 η m 2-232 -0- 單鍵 -(CH2)c- 環己環 碳數1〜9 之烷氧基 0 1 2-233 -0- 單鍵 -(CH2)c- 環己環 苯環 碳數1〜9 之烷氧基 1 1 2-234 -0- 單鍵 -(CH2)c- 環己環 苯環 碳數卜9 之烷氧基 2 1 2-235 -0- 單鍵 -(CH2)c- 環己環 碳數卜9 之院基 0 1 2-236 -0- 單鍵 -(CH2)c- 環己環 環己環 碳數1〜9 之院基 1 1 2-237 -0- 單鍵 -(CH2)c-* 環己環 環己環 碳數卜9 之院基 2 1 2-238 -0- 單鍵 -(CH2)c- 環己環 碳數I〜9 之烷氧基 0 1 2-239 -0- 單鍵 -(CH2)c- 環己環 環己環 碳數1〜9 之院氧基 1 t 2-240 -o- 單鍵 -(CH2)c- 環己環 環己環 碳數1〜9 之烷氧基 2 1 2-241 -0- 單鍵 -CH20- 苯環 碳數1〜9 之烷氧基 0 1 2-242 -0- 單鍵 -CH20- 苯環 苯環 碳數卜9 之烷氧基 1 1 2-243 -0- 單鍵 -CH20- 苯環 苯環 碳數1〜9 之烷氧基 2 1 2-244 -0- 單鍵 -CH20- 苯環 碳數1〜9 之院基 0 1 2-245 -0- 單鍵 -CHZO- 苯環 苯環 碳數卜9 之院基 1 1 2-246 -0- 單鍵 -CH20- 苯環 賴 碳數1〜9 夕烷某 2 1 2-247 -0- 單鍵 -CHZO- 苯環 碳數1〜9 之烷氧基 0 1 2-248 -o- 單鍵 -CH20- 苯環 環己環 碳數1〜9 之烷氧基 1 1 2-249 -0- 單鍵 -CH20- 苯環 環己環 碳數卜9 之烷氧基 2 1 2-250 -0- 單鍵 -CH20- 苯環 碳數1〜9 之院基 0 1 2-251 -0- 單鍵 -CH20- 苯環 環己環 碳數卜9 之烷基 1 1 2-252 -0- 單鍵 -CHZO- 苯環 環己環 碳數1〜9 之院基 2 1 c爲1~10之整數 -37- 201219451 [表 27] Y1 Y2 Υ3 Y4 Y5 Υβ η m 2-253 單鍵 -CH20- 苯環 碳數1〜9 之烷氧S 0 1 2-254 -0- 單鍵 -CH20- 苯環 環己環 碳數1〜9 之烷氧基 1 2-255 -0- 單鍵 -CH20- 苯環 環己環 碳數1〜9 之烷氧基 2 1 2-256 -0- 單鍵 -CH20- 環己環 碳數1〜9 之烷基 0 1 2-257 -0- 單鍵 -CH20- 環己環 苯環 碳數1〜9 之烷基 1 2-258 -0- 單鍵 -CH20- 環己環 苯環 碳數1〜9 之烷基 2 1 2-259 -0- 單鍵 -CH20- 環己環 碳數1〜9 之烷氣茲 0 1 2-260 -0- 單鍵 -CH20- 環己環 苯環 碳數1〜9 之烷氧基 1 2-261 單鍵 -CH20- 環己環 苯環 碳數1〜9 之烷氧基 2 1 2-262 -0- 單鍵 -CH20- 環己環 碳數卜9 之烷基 0 1 2-263 -0- 單鍵 -CH20- 環己環 環己環 碳數1〜9 之烷基 1 1 2-264 -0- 單鍵 -CH20- 環己環 環己環 碳數1〜9 之烷基 2 1 2-265 -0- 單鍵 -CH20- 環己環 碳數1〜9 之烷氣基 0 1 2-266 -0- 單鍵 -CH20- 環己環 環己環 碳數1〜9 之烷氧基 1 1 2-267 -0- 單鍵 -CH20- 環己環 環己環 碳數1〜9 之烷氧基 2 1 2-268 -CH20- 單鍵 -(CH2)c- 苯環 碳數1〜9 之院S 0 1 2-269 -cmo- 單鍵 -(CH2)c- 苯環 苯環 碳數1〜9 之烷基 1 1 2-270 -CH20- 單鍵 -(CH2)c- 苯環 苯環 碳數1〜9 之烷基 2 1 2-271 -CH20- 單鍵 -(CH2)c- 苯環 碳數1〜9 之烷氧基 0 1 2-272 -CH20- 單鍵 -(CH2)c- 郷 苯環 碳數1〜9 之烷氧基 1 1 2-273 -CH20- 單鍵 -(CH2)c- 苯環 苯環 碳數1〜9 之烷氧基 2 1 c爲MO之整數 -38- 201219451 [表 28] Y1 Y2 Υ3 Y4 Y5 Y6 η m 2-274 -CH20- 單鍵 -(CH2)c- 苯環 碳數1〜9 之烷基 0 1 2-275 -CH20- 單鍵 -(CH2)c- 苯環 環己環 碳數1〜9 之烷基 1 1 2-276 -CH20- 單鍵 -(CH23c- 苯環 環己環 碳數1〜9 之焼基 2 1 2-277 -CH20- 單鍵 -(CH2)c- 苯環 碳數卜9 之烷氧基 0 1 2-278 -CH20- 單鍵 -(CH2)c- 苯環 環己環 碳數I〜9 之烷氧基 1 1 2-279 -CH20- 單鍵 -(CH2)c- 苯環 環己環 碳數1〜9 之烷氧基 2 1 2-280 -CH20- 單鍵 -(CH2)c- 環己環 碳數1〜9 之院基 0 1 2-281 -CH20- 單鍵 -(CH2)c- 環己環 苯環 碳數1〜9 之院基 1 1 2-282 -CH20- 單鍵 -<CH2)c- 環己環 賴 碳數卜9 夕掠某 2 1 2-283 -CH20- 單鍵 -(CH2)c- 環己環 碳數卜9 之烷氧基 0 1i 2-284 -CH20- 單鍵 -<GH2}c- 環己環 苯環 碳數1〜9 之烷氧基 1 2-285 -CH20- 單鍵 -(CH2)c- 環己環 苯環 碳數1〜9 之烷氧基 2 2-286 -CH20- 單鍵 -(CH2)c- 環己環 碳數卜9 之院基 0 2-287 -CH20- 單鍵 <CH2h- 環己環 環己環 碳數卜9 之烷基 1 t 2-288 -CH20- 單鍵 -(CH2)c- 環己環 環己環 碳數1〜9 之院基 2 1 2-289 -CH20- 單鍵 -(CH2)c- 環己環 碳數1〜9 之烷氧基 0 1 2-290 -CH20- 單鍵 -(CH2)c- 環己環 環己環 碳數1〜9 夕烷氣某 1 1 2-291 -CH20- 單鍵 -(CH2)c- 環己環 環己環 碳數1〜9 之烷氧基 2 1 2-292 -CH20- 單鍵 -CH20- 苯環 碳數卜9 之烷基 0 1 2-293 -CH20- 單鍵 -CH20- 苯環 苯環 碳數卜9 之烷基 1 1 2-294 -CHZO- 單鍵 -CH20- 苯環 苯環 碳數1〜9 之烷基 2 1 C爲1~10之整數 -39- 201219451 [表 29] Y1 Y2 Y3 Y4 Y5 Y6 η m 2-295 -CH20- 單鍵 -CH20- 苯環 碳數卜9 之烷氣基 0 1 2-296 -CH20- 單鍵 -CH20- 苯環 苯環 碳數1〜9 之烷氣基 1 2-297 -CH20- 單鍵 -CH20- 苯環 苯環 碳數1〜9 之烷氧基 2 1 2-298 -CH20- 單鍵 -CH20- 苯環 碳數1〜9 之院基 0 1 2-299 -CH20- 單鍵 -CH20- 苯環 環己環 碳數1〜9 之烷基 1 2-300 -CH20- 單鍵 -CH20- 苯環 環己環 碳數卜9 之烷基 2 1 2-301 -CH20- 單鍵 -CH20- 苯環 碳败1〜9 之烷氧基 0 1 2-302 -CH20- 單鍵 -CH20- 苯環 環己環 碳數1〜9 之烷氧基 1 1 2-303 -CHZO- 單鍵 -CH20- 苯環 環己環 碳數1〜9 之烷氣基 2 1 2-304 -CH20- 單鍵 -CH20- 環己環 碳數1〜9 之烷基 0 1 2-305 -CH20- 單鍵 -CH20- 環己環 苯環 碳數1〜9 之烷基 1 1 2-306 -CH20- 單鍵 -CH20- 環己環 苯環 碳败1〜9 之烷基 2 1 2-307 -CH20- 單鍵 -CH20- 環己環 碳數1〜9 之烷氣基 0 1 2-308 -CH20- 單鍵 -CH20- 環己環 苯環 碳數1〜9 之烷氣基 1 1 2-309 -CH20- 單鍵 -CH20- 環己環 苯環 碳數1〜9 之烷氧基 2 1 2-310 -CH20- 單鍵 -CH20- 環己環 碳數卜9 之烷基 0 1 2-311 -CH20- 單鍵 甲 GH20- 環己環 環己環 碳數1〜9 之烷基 1 1 2-312 -CH20- 單鍵 -CH20- 環己環 環己環 碳數1〜9 之烷基 2 1 2-313 -CH20- 單鍵 -CH20- 環己環 碳數1〜9 之烷氧基 0 1 2-314 -CH20- 單鍵 -CH20- 環己環 環己環 碳數卜9 之烷氧基 1 1 2-315 -CH20- 單鍵 -CH20- 環己環 環己環 碳數1〜9 之烷氧基 2 1 -40 - 201219451 [表 30] Y1 Y2 Y3 Y4 Y5 Υδ η m 2-316 -coo- 單鍵 <CH2k- 苯環 碳數1〜9 之烷基 0 1 2-317 -coo- 單鍵 -(CH2)c- 苯環 苯環 碳數1〜9 之烷基 1 1 2-318 -coo- 單鍵 -{CH23c- 苯環 苯環 碳數1〜9 之烷基 2 1 2-319 -coo- 單鍵 -<CH2)c- 苯環 碳數1〜9 之烷氧基 0 1 2-320 -coo- 單鍵 -(CH2)c- 苯環 额 碳數卜9 之烷氧基 1 1 2-321 -COO- 單鍵 -<CH2)c- 苯環 苯環 碳數1〜9 之烷氧基 2 1 2-322 -coo- 單鍵 -<CH2)c- 苯環 碳數1〜9 之烷基 0 1 2-323 -coo- 單鍵 -(CH2)c- 苯環 環己環 碳數1〜9 之烷基 1 1 2-324 -coo- 單鍵 -(CH2)c- 苯環 環己環 碳數卜9 之院基 2 1 2-325 -coo- 單鍵 .-<CH2)c- 苯環 碳數1〜9 之烷氧基 0 1 2-326 -coo- 單鍵 -(CH2)c- 苯環 環己環 碳數丨〜9 之烷氧基 1 1 2-327 -coo- 單鍵 -(CH2)c- 苯環 環己環 碳數1〜9 之烷氧基 2 1 2-328 -coo- 單鍵 -(CH2)c- 環己環 碳數1〜9 之烷基 0 1 2-329 -coo- 單鍵 -(CH2)c- 環己環 苯環 碳數卜9 夕烷某 1 1 2-330 -coo- 單鍵 -(CH2)c- 環己環 苯環 碳數1〜9 之烷基 2 1 2-331 -coo- 單鍵 -(CH2)c- 環己環 碳數卜9 之院氧基 0 1 2-332 -coo- 單鍵 -(CH2)c- 環己環 苯環 碳數1〜9 之烷氧基 1 1 2-333 -coo- 單鍵 -(CH2)c- 環己環 苯環 碳數1〜9 之烷氧基 2 1 2-334 -coo- 單鍵 -(CH2)c- 環己環 碳數卜9 之烷基 0 1 2-335 -coo- 單鍵 -(CH2)c- 環己環 環己環 碳數卜9 之烷基 1 1 2-336 -coo- 單鍵 -<CH2)c- 環己環 環己環 碳數1〜9 之烷基 2 1 c爲1~10之整數 -41 - 201219451 [表 31] Y1 Y2 Y3 Y4 Υ5 Υ6 η m 2-337 -COO- 單鍵 -(CH2)c- 環己環 碳數1〜9 之烷氧基 0 1 2-338 -coo- 單鍵 -(CH2)c- 環己環 環己環 碳數卜9 之烷氣基 1 1 2-339 -coo- 單鍵 -(CH2)c- 環己環 環己環 碳败1〜9 之烷氣基 2 1 2-340 -coo- 單鍵 -CH20- 苯環 碳數1〜9 之烷基 0 1 2-341 -000- 單鍵 -CH20- 苯環 苯環 碳數卜9 之烷基 1 2-342 -coo- 單鍵 -CH20- 苯環 苯環 碳败1〜9 之烷基 2 1 2-343 -coo- 單鍵 -CH20- 苯環 碳數卜9 夕烷鈕某 0 1 2-344 -coo- 單鍵 -CH20- 苯環 苯環 碳數1〜9 之烷氧基 1 1 2-345 -coo- 單鍵 -CH20- 苯環 苯環 碳數1〜9 之烷氣基 2 1 2-346 -coo- 單鍵 -CH20- 苯環 碳數1〜9 之烷基 0 1 2-347 -coo- 單鍵 -CH20- 苯環 環己環 碳败1〜9 之烷基 1 1 2-348 -coo- 單鍵 -CH20- 苯環 環己環 碳數1〜9 之烷基 2 1 2-349 -coo- 單鍵 -CH20- 苯環 碳數1〜9 之烷氧基 0 1 2-350 -coo- 單鍵 -CH20- 苯環 環己環 碳數丨〜9 之烷氣基 1 1 2-351 -coo- 單鍵 -CH20- 苯環 環己環 碳數1〜9 之烷a基 2 1 2-352 -coo- 單鍵 -CH20- 環己環 碳數1〜9 之烷基 0 1 2-353 -coo- 單鍵 -CH20- 環己環 苯環 碳數卜9 之烷基 1 1 2-354 -coo- 單鍵 -CH20- 環己環 苯環 碳數1〜9 之烷基 2 1 2-355 -coo- 單鍵 -CH20- 環己環 碳數卜9 之烷氧S 0 1 2-356 -coo- 單鍵 -CH20- 環己環 苯環 碳數1〜9 之烷氣基 1 1 2-357 -coo- 單鍵 -CH20- 環己環 苯環 碳数1〜9 之烷氧基 2 1 c爲1-10之整數-36- 201219451 [Table 26] Y1 Y2 Y3 Y4 Y5 Y6 η m 2-232 -0- Single bond-(CH2)c- Alkoxy group having 1 to 9 ring carbon number 0 1 2-233 -0- Single bond-(CH2)c-cyclohexylbenzene ring 1 to 9 alkoxy 1 1 2-234 -0- single bond-(CH2)c-cyclohexylbenzene ring carbon number 9 alkoxy Base 2 1 2-235 -0- single bond -(CH2)c- cyclohexene carbon number b 9 yard base 0 1 2-236 -0- single bond -(CH2)c- cyclohexylcyclohexene ring carbon Number 1~9 of the yard base 1 1 2-237 -0- single bond-(CH2)c-* cyclohexylcyclohexene carbon number b 9 yard base 2 1 2-238 -0- single bond - (CH2 C-cyclohexene ring number 1 to 9 alkoxy group 0 1 2-239 -0- single bond -(CH2)c- cyclohexylcyclohexene ring number 1 to 9 oxime 1 t 2- 240 -o-mono-bond-(CH2)c-cyclohexylcyclohexene ring alkoxy group 1 to 9 alkoxy 2 1 2-241 -0- single bond-CH20- benzene ring carbon number 1 to 9 alkoxy Base 0 1 2-242 -0- single bond-CH20- phenyl ring benzene ring carbon number 9 alkoxy group 1 1 2-243 -0- single bond -CH20- benzene ring benzene ring carbon number 1~9 alkane Oxygen 2 1 2-244 -0- single bond-CH20- phenyl ring carbon number 1~9 of the yard base 0 1 2-245 -0- single bond -CHZO- benzene ring benzene ring carbon number b 9 1 1 2-246 -0- Single bond-CH20- Benzene ring carbon number 1~9 Oxane 2 1 2-247 -0- Single bond-CHZO- Alkoxy group of 1 to 9 ring carbon number 0 1 2-248 -o- single bond-CH20- benzene ring cyclohexene ring number 1 to 9 alkoxy group 1 1 2-249 -0- single bond -CH20- benzene ring cyclohexane ring number 9 alkoxy Base 2 1 2-250 -0- single bond -CH20- phenyl ring carbon number 1~9 of the yard base 0 1 2-251 -0- single bond -CH20- benzene ring cyclohexene carbon number 9 alkyl 1 1 2-252 -0- single bond-CHZO- phenyl ring cyclohexene ring number 1 to 9 of the yard base 2 1 c is an integer of 1 to 10 -37- 201219451 [Table 27] Y1 Y2 Υ3 Y4 Y5 Υβ η m 2-253 Single bond-CH20- Alkyloxy group with a benzene ring carbon number of 1 to 9 S 0 1 2-254 -0- Single bond-CH20- Alkyloxy group of a benzene ring cyclohexene ring number 1 to 9 2-255 -0- Single bond-CH20- Alkoxy group having a carbon number of 1 to 9 in the benzene ring cyclohexene 2 1 2-256 -0- Single bond -CH20- Alkyl group having a carbon number of 1 to 9 ring 0 1 2- 257 -0- single bond-CH20- cyclohexylbenzene ring 1 to 9 alkyl 1 2-258 -0- single bond -CH20- cyclohexylbenzene ring 1 to 9 alkyl 2 1 2 -259 -0- single bond-CH20- cyclohexane ring carbon number 1~9 alkane gas 0 1 2-260 -0- single bond-CH20-cyclohexylbenzene ring 1 to 9 alkoxy 1 2-261 single bond -CH20- cyclohexylbenzene ring 1 to 9 alkoxy 2 1 2-262 -0- Single bond-CH20- Cyclohexyl carbon number 9 Alkyl group 0 1 2-263 -0- Single bond-CH20- Cyclohexylcyclohexene ring 1 to 9 alkyl 1 1 2-264 -0- Single bond-CH20- Cyclohexylcyclohexene ring 1 to 9 alkyl 2 1 2-265 -0- Single bond-CH20- Cyclohexane ring number 1 to 9 Alkene group 0 1 2 -266 -0- Single bond-CH20- Cyclohexylcyclohexene ring 1 to 9 alkoxy group 1 1 2-267 -0- Single bond-CH20-cyclohexylcyclohexene ring carbon number 1~9 Alkoxy 2 1 2-268 -CH20- single bond -(CH2)c- phenyl ring carbon number 1~9 院S 0 1 2-269 -cmo- single bond-(CH2)c- benzene ring benzene ring carbon Number 1 to 9 alkyl 1 1 2-270 -CH20- single bond -(CH2)c- phenyl ring benzene ring alkyl 1 to 9 alkyl 2 1 2-271 -CH20- single bond -(CH2)c - alkoxy group having 1 to 9 carbon atoms of benzene ring 0 1 2-272 -CH20-monobond-(CH2)c- alkoxy group having 1 to 9 carbon atoms of 1 to 2 ring 2 1 2-273 -CH20- single bond -(CH2)c- phenyl ring benzene ring alkoxy group having a carbon number of 1 to 9 2 1 c is an integer of MO - 38 - 201219451 [Table 28] Y 1 Y2 Υ3 Y4 Y5 Y6 η m 2-274 -CH20- Single bond-(CH2)c- phenyl ring 1 to 9 alkyl group 0 1 2-275 -CH20- single bond-(CH2)c- benzene ring Alkyl group having 1 to 9 carbon atoms in the cyclohexene ring 1 1 2-276 -CH20-monobond-(CH23c- fluorenyl group having 1 to 9 carbon atoms of benzene ring cyclohexene 2 1 2-277 -CH20- single bond - ( CH2)c- phenyl ring carbon number 9 alkoxy group 0 1 2-278 -CH20- single bond -(CH2)c- benzene ring cyclohexene ring number I~9 alkoxy group 1 1 2-279 - CH20- single bond-(CH2)c- benzene ring cyclohexene ring number 1~9 alkoxy 2 1 2-280 -CH20- single bond-(CH2)c- cyclohexene ring number 1~9 Base 0 1 2-281 -CH20- Single bond -(CH2)c-cyclohexylbenzene ring 1 to 9 of the yard base 1 1 2-282 -CH20- single bond-<CH2)c-cyclohexyl ring赖碳数卜 9 夕掠2 1 2-283 -CH20- single bond-(CH2)c- cyclohexene carbon number a 9 alkoxy 0 1i 2-284 -CH20- single bond-<GH2} C-cyclohexylbenzene ring 1 to 9 alkoxy 1 2-285 -CH20- single bond-(CH2)c-cyclohexylbenzene ring 1 to 9 alkoxy 2 2-286 - CH20- single bond-(CH2)c- cyclohexene carbon number b 9 yard base 0 2-287 -CH20- single bond <CH2h-cyclohexyl ring Carbon number 9 alkyl 1 t 2-288 -CH20- single bond -(CH2)c- cyclohexylcyclohexene ring number 1~9 of the yard base 2 1 2-289 -CH20- single bond-(CH2 C-cyclohexene ring number 1 to 9 alkoxy group 0 1 2-290 -CH20- single bond -(CH2)c- cyclohexylcyclohexene ring carbon number 1~9 1987 gas 1 1 2- 291 -CH20-monobond-(CH2)c-cyclohexylcyclohexene ring alkoxy group 1 to 9 alkoxy 2 1 2-292 -CH20- single bond-CH20- phenyl ring carbon number 9 alkyl group 0 1 2-293 -CH20- single bond-CH20- phenyl ring benzene ring carbon number 9 alkyl 1 1 2-294 -CHZO- single bond -CH20- phenyl ring benzene ring carbon number 1~9 alkyl 2 1 C is an integer from 1 to 10 - 39 - 201219451 [Table 29] Y1 Y2 Y3 Y4 Y5 Y6 η m 2-295 -CH20- Single bond-CH20- Benzene ring carbon number 9 Alkene group 0 1 2-296 - CH20- single bond-CH20- phenyl ring benzene ring carbon number 1 to 9 alkyl group 1 2-297 -CH20- single bond-CH20- benzene ring benzene ring alkoxy group 1 to 9 2 1 2-298 -CH20- single bond-CH20- phenyl ring carbon number 1~9 of the yard base 0 1 2-299 -CH20- single bond-CH20- phenyl ring cyclohexene ring number 1~9 alkyl 1 2-300 -CH20 - Single bond-CH20- phenyl ring cyclohexene carbon number 9 alkyl 2 1 2-301 -CH20- Single bond-CH20- Alkoxy group of phenyl ring carbon 1~9 0 2- 2-302 -CH20- Single bond-CH20- Alkoxy group of benzene ring cyclohexene 1 to 9 1 2-303 -CHZO- single bond-CH20- benzene ring cyclohexene carbon number 1 to 9 alkyl group 2 1 2-304 -CH20- single bond -CH20- cyclohexene ring number 1 to 9 alkyl group 0 1 2-305 -CH20- single bond-CH20- cyclohexylbenzene ring 1 to 9 alkyl 1 1 2-306 -CH20- single bond-CH20-cyclohexylbenzene ring carbon 1~9 Alkyl 2 1 2-307 -CH20- single bond -CH20- cyclohexane ring carbon number 1 to 9 alkyl group 0 1 2-308 -CH20- single bond -CH20- cyclohexylbenzene ring carbon number 1~9 Alkyne group 1 1 2-309 -CH20- single bond -CH20- cyclohexylbenzene ring 1 to 9 alkoxy 2 1 2-310 -CH20- single bond -CH20- cyclohexene carbon number 9 alkyl 0 1 2-311 -CH20- single bond GH20- cyclohexyl cyclohexene ring 1 to 9 alkyl 1 1 2-312 -CH20- single bond -CH20- cyclohexylcyclohexyl ring Alkyl group having 1 to 9 carbon atoms 1 1 2-313 -CH20- Single bond-CH20- Alkoxy group having 1 to 9 carbon atoms of cyclohexene ring 0 1 2-314 -CH20- Single bond-CH20-cyclohexyl ring Alkenyl carbon number 9 alkoxy 1 1 2-315 -CH20- single bond-CH20-cyclohexylcyclohexene ring alkoxy group 1 to 9 alkoxy 2 1 -40 - 201219451 [Table 30] Y1 Y2 Y3 Y4 Y5 Υδ η m 2-316 -coo- single bond &lt ;CH2k-alkyl group having 1 to 9 carbon atoms of benzene ring 0 1 2-317 -coo- single bond-(CH2)c-alkyl group having 1 to 9 carbon atoms of phenyl ring benzene ring 1 1 2-318 -coo- single Key-{CH23c- phenyl ring benzene ring alkyl 1 to 9 alkyl 2 1 2-319 -coo- single bond-<CH2)c- benzene ring carbon number 1 to 9 alkoxy 0 1 2-320 -coo- single bond-(CH2)c- phenyl ring carbon number a 9 alkoxy group 1 1 2-321 -COO- single bond-<CH2)c- benzene ring benzene ring carbon number 1~9 Alkyl 2 1 2-322 -coo-mono-bond-<CH2)c-alkyl group having 1 to 9 carbon atoms of phenyl ring 0 1 2-323 -coo- single bond-(CH2)c-benzene ring cyclohexane Alkyl group having 1 to 9 carbon atoms 1 1 2-324 -coo- single bond-(CH2)c- phenylcyclohexene ring carbon number 9 院 2 2 2-325 -coo- single bond.-< CH2)c- alkoxy group having a benzene ring carbon number of 1 to 9 0 1 2-326 -coo- single bond-(CH2)c- benzene ring cyclohexene carbon number 丨~9 alkoxy group 1 1 2-327 -coo- single bond-(CH2)c- benzene ring cyclohexene alkoxy group 1 to 9 2 2 2-328 -coo- single bond-(CH2)c- ring Alkyl group having a ring carbon number of 1 to 9 0 1 2-329 -coo- single bond-(CH2)c-cyclohexylbenzene ring carbon number 9 octanol 1 1 2-330 -coo- single bond-(CH2 C-cyclohexylbenzene ring carbon number 1 to 9 alkyl 2 1 2-331 -coo- single bond-(CH2)c- cyclohexene carbon number b 9 oxime 0 1 2-332 -coo - a single bond -(CH2)c-cyclohexylbenzene ring having a carbon number of 1 to 9 alkoxy 1 1 2-333 -coo- single bond-(CH2)c-cyclohexylbenzene ring carbon number 1 to 9 Alkoxy 2 1 2-334 -coo- single bond -(CH2)c-cyclohexene carbon number 9 alkyl 0 1 2-335 -coo- single bond-(CH2)c-cyclohexylcyclohexane Cyclocarbon number 9 alkyl 1 1 2-336 -coo- single bond-<CH2)c- cyclohexylcyclohexene ring 1 to 9 alkyl 2 1 c is an integer from 1 to 10 -41 - 201219451 [Table 31] Y1 Y2 Y3 Y4 Υ5 Υ6 η m 2-337 -COO- Single bond-(CH2)c- Alkoxy group having 1 to 9 ring carbon number 0 1 2-338 -coo- Single bond -(CH2)c-cyclohexylcyclohexene carbon number 9 alkane group 1 1 2-339 -coo- single bond-(CH2)c- cyclohexane ring cyclohexene carbon 1~9 Base 2 1 2-340 -coo- single bond-CH20- phenyl ring carbon number 1~9 alkyl 0 1 2-341 -000- single bond-CH20- benzene ring benzene Cyclocarbon number 9 alkyl 1 2-342 -coo- single bond-CH20- phenyl ring phenyl ring carbon 1~9 alkyl 2 1 2-343 -coo- single bond-CH20- benzene ring carbon number 9 oxime button 0 1 2-344 -coo- single bond-CH20- phenyl ring benzene ring 1 to 9 alkoxy 1 1 2-345 -coo- single bond-CH20- benzene ring benzene ring carbon number 1 to 9 alkyl group 2 1 2-346 -coo- single bond-CH20- phenyl ring carbon number 1 to 9 alkyl 0 1 2-347 -coo- single bond-CH20- benzene ring cyclohexene carbon 1 to 9 alkyl 1 1 2-348 -coo- single bond-CH20- phenyl ring cyclohexene carbon number 1 to 9 alkyl 2 1 2-349 -coo- single bond-CH20- benzene ring carbon number 1 ~9 alkoxy 0 1 2-350 -coo- single bond-CH20- benzene ring cyclohexene carbon number 9~9 alkyl group 1 1 2-351 -coo- single bond-CH20- benzene ring Alkyl group having a ring carbon number of 1 to 9 2 1 2-352 -coo- Single bond-CH20- Alkyl group having a carbon number of 1 to 9 of a cyclohexane ring 0 1 2-353 -coo- Single bond-CH20-cyclohexyl ring Benzene ring carbon number 9 alkyl 1 1 2-354 -coo- single bond-CH20- cyclohexylbenzene ring carbon number 1 to 9 alkyl 2 1 2-355 -coo- single bond-CH20- cyclohexene Cyclocarbon number 9 alkoxy S 0 1 2-356 -coo- single bond-CH2 0-cyclohexylbenzene ring carbon number 1 to 9 alkyl group 1 1 2-357 -coo- single bond-CH20- cyclohexylbenzene ring carbon number 1 to 9 alkoxy 2 1 c is 1-10 Integer

-42- 201219451 [表 32] Y1 Y2 Y3 Y4 Y5 Y6 η m 2-358 -COO- 單鍵 -CH20- 環己環 碳數1〜9 之烷基 0 1 2-359 -COO- 單鍵 -CH20- 環己環 環己環 碳败卜9 之院基 1 1 2-360 -COO- 單鍵 -CH20- 環己環 環己環 碳數卜9 之烷基 1 1 2-361 -coo- 單鍵 -CH20- 環己環 碳數1〜9 之烷氧基 0 1 2-362 -coo- 單鍵 -CH20- 環己環 環己環 碳數1〜9 之烷氧基 1 1 2-363 -000- 單鍵 -CH20- 環己環 環己環 碳數1〜9 之烷氣基 2 1 2-364 -o- -(CH2)b- -0- 苯環 碳數卜9 之烷基 0 1 2-365 -o- -(CH2)b- -0- 苯環 苯環 碳數1〜9 之烷基 1 1 2-366 -0- -(CH2)b- -0- 苯環 苯環 碳數1〜9 之烷基 2 1 2-367 -0- -(CH2)b- -0- 苯環 碳數卜9 之烷氧基 0 1 2-368 -o- -(CH2)b- -0- 苯環 苯環 碳數卜9 之烷氧基 1 1 2-369 -0- -CCH2)b- -0- 苯環 苯環 碳έα〜9 之烷氧基 2 1 2-370 -0- -CCH23b- -0- 苯環 碳數卜9 之院基 0 1 2-371 -o- -(CH2)b- -o- 苯環 環己環 碳數1〜9 之烷基 1 1 2-372 -0- -<CH2)b- -0- 苯環 環己環 碳數1〜9 之烷基 2 1 2-373 -0- -(CH2)b- -0- 苯環 碳數1〜9 之烷氧基 0 1 2-374 -0- -<CH23b- -0- 苯環 環己環 碳數1〜9 之烷氧基 1 1 2-375 -0- -<CH2)b- -0- 苯環 環己環 碳數1〜9 之烷氣基 2 1 2-376 -0- -(CH2)b- -0- 環己環 碳數卜9 之烷基 0 1 2-377 -0- -(CH2)b- -0- 環己環 苯環 碳數1〜9 之烷基 1 1 2-378 -o- -(CH2)b- -o- 環己環 苯環 碳數卜9 之烷基 2 1 b爲1~10之整數 -43- 201219451 [表 33] Y1 Υ2 Y3 Y4 Y5 Y6 η m Z-379 -0- -(GH2)b- -0- 環己環 碳败1〜9 之烷as 0 1 2-380 -(CH2)b- -0- 環己環 苯環 碳數1〜9 之烷氣基 1 2-381 -ο- -<CH23b- -o- 環己環 苯環 碳數1〜9 之烷氧基 2 1 2-382 -0- -(CH2)b- -0- 環己環 碳數丨〜9 之烷基 0 1 2-383 -0- -(CH2)b- -0- 環己環 環己環 碳胜1〜9 之烷3£ 1 1 2-384 -0- -(GH2)b- -0- 環己環 環己環 碳數1〜9 之烷基 2 1 2-385 -0- -CCH23b- -0- 環己環 碳數1〜9 之烷氣荘 0 1 2-386 -0- <CH2)b- -0- 環己環 環己環 碳數1〜9 之烷氧基 1 1 2-387 -0- -(CH2)b- -0- 環己環 環己環 碳數1〜9 之烷餌基 2 1 2-388 -(CH2)b- -coo- 苯環 碳數1〜9 之烷基 0 1 2-389 -0- -<CH2)b- -coo- 苯環 苯環 碳數1〜9 之烷基 1 1 2-390 -0- -(CH2)b- -coo- 苯環 苯環 碳數1〜9 之烷基 2 1 2-391 -ο- -(CH2)b- -coo- 苯環 碳数丨〜9 之烷氣基 0 1 2-392 -ο- -(CH2)b- -coo- 苯環 苯環 碳數1〜9 之烷氣基 1 1 2-393 -0- -(CH2)b- -coo- 苯環 苯環 碳數1〜9 之烷氣基 2 1 2-394 -0- -(CH2)b- -coo- 苯環 碳跛1〜9 之烷基 0 1 2-395 -ο- -{CH2)b- -coo- 苯環 環己環 碳數1〜9 之烷基 1 1 2-396 -0- -<CH2)b- -coo- 苯環 環己環 碳數卜9 之烷基 2 1 2-397 -0- -<CH2)b- -coo- 苯環 碳數1〜9 之烷織 0 1 2-398 -0- -(CH2)b- -coo- 苯環 環己環 碳數1〜9 之烷as 1 1 2-399 -0- -(CH2)b- -coo- 苯環 環己環 碳數1〜9 之烷氣基 2 1 b爲1~10之整數 -44- 201219451 [表 34] Y1 Υ2 Y3 Y4 Y5 Y6 η m 2-400 -0- -(CH2)b- -COO- 環己環 碳數1〜9 之烷基 0 1 2-401 -0- -(CH2)b- -COO- 環己環 苯環 碳數1〜9 之藏 1 2-402 -0- -(CH2)b- -COO- 環己環 苯環 碳數1〜9 之烷基 2 1 2-403 -0- -CCH2)b- -COO- 環己環 碳數1〜9 之烷氧基 0 1 2-404 -0- -CCH2)b- -COO- 環己環 苯環 碳數1〜9 之烷氧基 1 1 2-405 -0- -(CH2)b- -COO- 環己環 苯環 碳數1〜9 之烷氧基 2 1 2-406 -0- -(CH2)b- -COO- 環己環 碳數卜9 之烷基 0 1 2-407 -0- -(CH2)b- -COO- 環己環 環己環 碳數1〜9 之院基 1 1 2-408 -0- -(CH2)b- -coo- 環己環 環己環 碳數1〜9 之烷基 2 1 2-409 -0- -(CH2)b- -coo- 環己環 碳數卜9 之烷氧基 0 1 2-410 -0- -(CH2)b- -coo- 環己環 環己環 碳數1〜9 之烷氧基 1 1 2-411 -0- -(CH2)b- -coo- 環己環 環己環 碳數1〜9 之烷氧基 2 1 2-412 -0- -CCH2)b- -OCO- 苯環 碳數1〜9 之烷基 0 1 2-413 -0- -(CH2)b- -oco- 苯環 苯環 碳數1〜9 之院基 1 1 2-414 -0- -(CH2)b- -oco- 苯環 雜 碳數1〜9 之烷基 2 1 2-415 -0- -(CH2)b- -oco- 苯環 碳數1〜9 之烷氧基 0 1 2-416 -0- -(CH2)b- -oco- 苯環 苯環 碳數1〜9 之烷氧基 1 1 2-417 -CCH2)b- -000- 鄉 苯環 碳數1〜9 ，之烷氧基 2 1 2-418 -0- -(CH2)b- -000- 苯環 碳數卜9 之烷基 0 1 2-419 -ο- -(CH2)b- -oco- 雜 環己環 碳數1〜9 之院基 1 1 2-420 -0- -(GH2)b- -OGO- 苯環 環己環 碳數1〜9 之烷基 2 1 b爲1~10之整數 -45- 201219451 [表 35] Y1 Υ2 Y3 Y4 Y5 Y6 η m 2-421 -Ο- -(CH2)b- -OCO- 苯環 碳數卜9 之烷氧基 0 1 2-422 -0- -(CH2)b- -oco- 苯環 環己環 碳數1〜9 之烷氧基 1 1 2-423 -0- -(CH2)b- -OCO- 苯環 環己環 碳數1〜9 之烷氧基 2 1 2-424 -0- -(CH2)b- -OCO- 環己環 碳數1〜9 之烷基 0 1 2-425 -<CH2)b- -OCO- 環己環 苯環 碳數1〜9 之院基 1 2-426 -0- -<CH2)b- -000- 環己環 苯環 碳數卜9 夕烷某 2 1 2-427 -0- -(CH2)b- -oco- 環己環 碳數1〜9 之烷氧基 0 1 2-428 -(CH2)b- -OCO- 環己環 苯環 碳數1〜9 之烷氧基 1 2-429 -ο- -(CH2^b- -OCO- 環己環 苯環 碳數1〜9 之烷氧基 2 1 2-430 -Ο- -(CH2)b- -oco- 環己環 碳數卜9 之烷基 0 1 2-431 -ο- -(CH2)b- -oco- 環己環 環己環 碳數卜9 之烷基 1 1 2-432 -ο- -(CH2)b- -oco- 環己環 環己環 碳數卜9 之烷基 2 1 2-433 -0- -CCH2)b- -oco- 環己環 碳數1〜9 之烷氣基 0 1 2-434 -0- -(CH2)b- -oco- 環己環 環己環 碳數卜9 之烷氧基 1 1 2-435 -ο- -<CH2)b- -oco- 環己環 環己環 碳數1〜9 之烷氧基 2 1 2-436 -cmo- -(CH2)b- 單鍵 苯環 碳數卜9 之烷基 0 1 2-437 -CH20- -(CH2)b- 單鍵 苯環 苯環 碳數1〜9 之烷基 1 1 2-438 -CH20- -(CH2)b- 單鍵 苯環 苯環 碳數1〜9 之烷基 2 1 2-439 -CH20- -(CH2)b- 單鍵 苯環 碳數1〜9 之烷氧基 0 1 2-440 -CH20- -<CH2)b- 單鍵 苯環 苯環 碳數卜9 之烷氧基 1 1 2-441 -CH20- -(CH2)b- 單鍵 苯環 苯環 碳數1〜9 之烷氧基 2 1 b爲卜10之整數 -46 - 201219451 [表 36] Y1 Y2 Y3 Y4 Y5 Y6 η m 2-442 -CH20- -<CHZ)b- 單鍵 苯環 碳數1〜9 之烷基 0 1 2-443 -CH20- -(CH2)b- 單鍵 苯環 環己環 碳數卜9 之烷某 1 1 2-444 -CH20- -(CH2)b- 單鍵 苯環 環己環 碳數1〜9 之烷基 2 1 2-445 -CH20- -(CH2)b- 單鍵 苯環 碳數1〜9 之烷氧基 0 1 2-446 -CH20- -(CH2)b- 單鍵 苯環 環己環 碳數1〜9 之烷氧基 1 1 2-447 -CH20- -(CH2)b- 單鍵 苯環 環己環 碳數1〜9 之烷氧基 2 1 2-448 -CH20- -CCH2)b- 單鍵 環己環 碳數卜9 之烷基 0 1 2-449 -CH20- -(CH2)b- 單鍵 環己環 苯環 碳數1〜9 之烷基 1 1 2-450 -CH20- -CCH2)b- 單鍵 環己環 苯環 碳數1〜9 之烷基 2 1 2-451 -CH20- -(CH2)b- 單鍵 環己環 碳數1〜9 之烷氧基 0 1 2-452 -CH20- -(CH2)b- 單鍵 環己環 苯環 碳數1〜9 之烷氧基 1 1 2-453 -CH20- -<CH2)b- 單鍵 環己環 苯環 碳數1〜9 之烷氧基 2 1 2-454 -CH20- -{CH2)b- 單鍵 環己環 碳數1〜9 之烷基 0 1 2-455 -CH20- -(CH2)b- 單鍵 環己環 環己環 碳數1〜9 之烷基 1 1 2-456 -CH20- -(CH2)b- 單鍵 環己環 環己環 碳數卜9 之烷基 2 1 2-457 -CH20- -<CH2}b- 單鍵 環己環 碳數1〜9 之烷氧基 0 1 2-458 -CH20- -(CH2)b- 單鍵 環己環 環己環 碳數1〜9 之烷氧基 1 1 2-459 -CH20- -(CH2)b- 單鍵 環己環 環己環 碳數1〜9 之烷氧基 2 1 2-460 -CH20- -(CH2)b- -0- 苯環 碳數1〜9 之院基 0 1 2-461 -CH20- -(CH2)b- -0- 苯環 苯環 碳數1〜9 之烷基 1 1 2-462 -CH20- -CCH2)b- -0- 苯環 苯環 碳數卜9 之烷某 2 1 b爲1~10之整數 -47- 201219451 [表 37] Y1 Y2 Y3 Y4 Y5 Y8 η m 2-463 -CH20- -(CH2)b- 苯環 碳败1〜9 之烷氧基 0 1 2-464 -CH20- -<CH2)b- -0- 苯環 苯環 碳數1〜9 之烷氧基 1 2-465 -CH20- -(CH2)b- -o- 苯環 苯環 碳數1〜9 之烷氧基 2 1 2-466 -CH20- -(CH2)b- -0- 苯環 碳數卜9 之烷基 0 1 2-467 -CH20- -(CH2)b- -0- 苯環 環己環 碳數1〜9 之烷基 1 1 2-468 -CH20- -(CH2)b- 苯環 環己環 碳數1〜9 之烷基 2 1 2-469 -CH20- -CCH2)b- 苯環 碳數1〜9 之烷氧基 0 1 2-470 -CH20- -(CH2)b- -o- 苯環 環己環 碳败1〜9 之烷氧基 1 1 2-471 -CH20- -(CH2)b- -o- 苯環 環己環 碳數1〜9 之烷氧基 2 1 2-472 -CH20- -(CH2)b- -o- 環己環 碳數卜9 之烷基 0 1 2-473 -CH20- -CCH2)b- -0- 環己環 苯環 碳數1〜9 之烷基 1 1 2-474 -CH20- -CCH2)b- -o- 環己環 苯環 碳數1〜9 之烷某 2 1 2-475 -CH20- -<CM2)b- -o- 環己環 碳數1〜9 之烷氣基 0 1 2-476 -CH20- -<CH2)b- -o- 環己環 苯環 碳败1〜9 之烷氣基 1 1 2-477 -CH20- -CCH2)b- -o- 環己環 苯環 碳數卜9 之烷氧基 2 1 2-478 -CH20- -<CH2)b- -0- 環己環 碳數卜9 之烷基 0 1 2-479 -CH20- -(CH23b- -o- 環己環 環己環 碳數卜9 之烷基 1 1 2-480 -CH20- -(CH2)b- -0- 環己環 環己環 碳數1〜9 之烷基 2 1 2-481 -CH20- -(CH2)b- -o- 環己環 碳數1〜9 之烷氧基 0 1 2-482 -CH20- -<CH2)b- -o- 環己環 環己環 碳數1〜9 之烷氧基 1 1 2-483 -CH20- -(CHZ)b- -o- 環己環 環己環 碳數1〜9 之烷氧基 2 1 b爲1~10之整數-42- 201219451 [Table 32] Y1 Y2 Y3 Y4 Y5 Y6 η m 2-358 -COO- Single bond-CH20- Alkyl group having a carbon number of 1 to 9 of a cyclohexane ring 0 1 2-359 -COO- Single bond-CH20 - Cyclohexylcyclohexene ring carbon sulphide 9 1 1 2-360 -COO- single bond -CH20- cyclohexylcyclohexene ring carbon number 9 alkyl 1 1 2-361 -coo- single bond -CH20- alkoxy group having 1 to 9 carbon atoms of cyclohexene ring 0 1 2-362 -coo- single bond-CH20- alkoxy group having 1 to 9 carbon atoms of cyclohexylcyclohexene ring 1 1 2-363 -000 - single bond -CH20- cyclohexane cyclohexane ring carbon number 1 to 9 alkyl group 2 1 2-364 -o- -(CH2)b- -0- phenyl ring carbon number 9 alkyl 0 1 2 -365 -o- -(CH2)b- -0- phenyl ring benzene ring 1 to 9 alkyl 1 1 2-366 -0- -(CH2)b- -0- benzene ring benzene ring carbon number 1 Alkyl 2 9 2-367 -0- -(CH2)b- -0- phenyl ring carbon number 9 alkoxy 0 1 2-368 -o- -(CH2)b- -0- benzene Cyclophenyl ring carbon number 9 alkoxy 1 1 2-369 -0- -CCH2) b- -0- phenyl ring benzene ring carbon έ α 〜 9 alkoxy 2 1 2-370 -0- -CCH23b- -0- phenyl ring carbon number b 9 yard base 0 1 2-371 -o- -(CH2)b- -o- phenyl ring cyclohexene ring number 1~9 alkyl 1 1 2-372 -0- -<CH2)b- - 0- phenylcyclohexene ring carbon number 1 to 9 alkyl 2 1 2-373 -0- -(CH2)b- -0- benzene ring carbon number 1 to 9 alkoxy group 0 1 2-374 -0 - -<CH23b- -0- alkoxy group having 1 to 9 carbon atoms of benzene ring cyclohexene 1 1 2-375 -0- -<CH2)b- -0- benzene ring cyclohexene carbon number 1~ 9 alkane group 2 1 2-376 -0- -(CH2)b- -0- cyclohexene carbon number 9 alkyl 0 1 2-377 -0- -(CH2)b- -0- ring Alkyl group having 1 to 9 carbon atoms in the benzene ring ring 1 1 2-378 -o- -(CH2)b- -o- Alkyl 2 of the cyclohexylbenzene ring number 2 1 b is an integer of 1 to 10 -43- 201219451 [Table 33] Y1 Υ2 Y3 Y4 Y5 Y6 η m Z-379 -0- -(GH2)b- -0- Cyclohexane ring carbon 1~9 alkane as 0 1 2-380 -(CH2 ) b- -0-cyclohexylbenzene ring carbon number 1 to 9 alkyl group 1 2-381 -ο- -<CH23b- -o- cyclohexylbenzene ring 1 to 9 alkoxy 2 1 2-382 -0- -(CH2)b- -0- Cyclohexene ring carbon number 9~9 alkyl group 0 1 2-383 -0- -(CH2)b- -0- cyclohexylcyclohexyl ring Carbon wins 1 to 9 of alkane 3 £ 1 1 2-384 -0- -(GH2)b- -0- cyclohexylcyclohexene ring 1 to 9 alkyl 2 1 2-385 -0- -CCH23b - -0- Cyclohexane ring number 1 to 9 of alkane gas 荘 0 1 2-386 -0- <CH2)b - -0- alkoxy group having 1 to 9 carbon atoms of cyclohexylcyclohexene ring 1 1 2-387 -0- -(CH2)b- -0- alkane having a carbon number of 1 to 9 Base 2 1 2-388 -(CH2)b- -coo- alkyl group having 1 to 9 carbon atoms of benzene ring 0 1 2-389 -0- -<CH2)b- -coo- phenyl ring benzene ring carbon number 1 ～1 alkyl 1 1 2-390 -0- -(CH2)b- -coo- phenyl ring benzene ring alkyl 1 to 9 alkyl 2 1 2-391 -ο- -(CH2)b- -coo - alkane group of benzene ring carbon number 丨~9 0 1 2-392 -ο- -(CH2)b- -coo- benzene ring benzene ring carbon number 1 to 9 alkyl group 1 1 2-393 -0- -(CH2)b- -coo- phenyl ring benzene ring 1 to 9 carbon group 2 1 2-394 -0- -(CH2)b- -coo- phenyl ring carbon 跛 1~9 alkyl 0 1 2-395 -ο- -{CH2)b- -coo- phenylcyclohexene ring 1 to 9 alkyl 1 1 2-396 -0- -<CH2)b- -coo- phenyl ring Alkyl 2 of a ring carbon number 2 1 2-397 -0- -<CH2)b- -coo- an alkane of a benzene ring having a carbon number of 1 to 9 0 1 2-398 -0- -(CH2)b - -coo- benzene ring cyclohexene carbon number 1 to 9 alkane as 1 1 2-399 -0- -(CH2)b- -coo- benzene ring cyclohexene carbon number 1 to 9 alkyl group 2 1 b is an integer from 1 to 10 - 44 - 201219451 [Table 34] Y1 Υ 2 Y3 Y4 Y5 Y6 η m 2-40 0 -0- -(CH2)b- -COO- alkyl group having 1 to 9 carbon atoms of cyclohexene ring 0 1 2-401 -0- -(CH2)b- -COO- cyclohexylbenzene ring carbon number 1~ 9 藏藏1 2-402 -0- -(CH2)b- -COO- cyclohexylbenzene ring 1 to 9 alkyl 2 1 2-403 -0- -CCH2)b- -COO- cyclohexene Alkoxy group having a ring carbon number of 1 to 9 0 1 2-404 -0- -CCH 2)b- -COO- alkoxy group having a carbon number of 1 to 9 of a cyclohexyl ring 1 1 2-405 -0- - ( CH2)b--COO-cyclohexylbenzene ring 1 to 9 alkoxy 2 1 2-406 -0- -(CH2)b- -COO- cyclohexene carbon number 9 alkyl 0 1 2-407 -0- -(CH2)b- -COO- Cyclohexylcyclohexene ring number 1~9 院 1 1 2-408 -0- -(CH2)b- -coo- Cyclohexane ring Alkyl 2 1 2-409 -0- -(CH2)b- -coo-cyclohexene carbon number 9 alkoxy 0 1 2-410 -0- -(CH2) B--coo- alkoxy group having 1 to 9 carbon atoms of cyclohexylcyclohexene ring 1 1 2-411 -0- -(CH2)b- -coo- alkane having a carbon number of 1 to 9 ring cyclohexene Oxy 2 1 2-412 -0- -CCH 2 ) b - -OCO- alkyl group having 1 to 9 carbon atoms of phenyl ring 0 1 2-413 -0- -(CH2)b- -oco- benzene ring benzene ring carbon Number 1~9 of the yard base 1 1 2-414 -0- -(CH2)b- -oco- benzene ring heterocarbon number 1~9 Alkyl 2 1 2-415 -0- -(CH2)b- -oco- alkoxy group having 1 to 9 carbon atoms of phenyl ring 0 1 2-416 -0- -(CH2)b- -oco- benzene ring benzene Alkoxy group having a ring carbon number of 1 to 9 1 1 2-417 -CCH2)b- -000- phenylene ring carbon number 1 to 9 , alkoxy group 2 1 2-418 -0- -(CH2)b- -000- phenyl ring carbon number 9 alkyl 0 1 2-419 -ο- -(CH2)b- -oco- heterocyclic ring carbon number 1~9 of the yard base 1 1 2-420 -0- - (GH2)b--OGO- phenylcyclohexene ring carbon number 1 to 9 alkyl 2 1 b is an integer from 1 to 10 -45 - 201219451 [Table 35] Y1 Υ2 Y3 Y4 Y5 Y6 η m 2-421 - Ο- -(CH2)b- -OCO- phenyl ring carbon number 9 alkoxy 0 1 2-422 -0- -(CH2)b- -oco- benzene ring cyclohexane carbon number 1~9 Oxyl 1 1 2-423 -0- -(CH2)b- -OCO- alkoxy group having 1 to 9 carbon atoms of benzene ring cyclohexene 2 1 2-424 -0- -(CH2)b- -OCO- Alkyl group having a carbon number of 1 to 9 ring cyclohexene 0 1 2-425 -<CH2)b- -OCO- Cyclohexylbenzene ring having a carbon number of 1 to 9 1 2-426 -0- -<CH2 ) b- -000- cyclohexylbenzene ring carbon number 9 octanol 2 2 2-427 -0- -(CH2)b- -oco- alkoxy group having 1 to 9 ring carbon groups 0 1 2 -428 -(CH2)b- -OCO- cyclohexylbenzene ring carbon number 1~9 Alkoxy 1 2-429 -ο- -(CH2^b- -OCO-cyclohexylbenzene ring 1 to 9 alkoxy 2 1 2-430 -Ο- -(CH2)b- -oco- Alkyl group of cyclohexene ring number 9 0 1 2-431 -ο- -(CH2)b- -oco- alkyl group of cyclohexylcyclohexene ring number 1 1 2-432 -ο- -( CH2)b- -oco- cyclohexylcyclohexene carbon number 2 alkyl 2 1 2-433 -0- -CCH2)b- -oco- cyclohexane ring carbon number 1 to 9 alkyl group 0 1 2-434 -0- -(CH2)b- -oco- Cyclohexylcyclohexene carbon number 9 alkoxy 1 1 2-435 -ο- -<CH2)b- -oco-cyclohexyl ring Alkoxy group having a carbon number of 1 to 9 ring 2 1 2-436 -cmo- -(CH2)b- a single bond benzene ring carbon number 9 alkyl 0 1 2-437 -CH20- -(CH2)b - a single bond phenyl ring benzene ring alkyl group 1 to 9 alkyl 1 1 2-438 -CH20- -(CH2)b- single bond benzene ring benzene ring carbon number 1 to 9 alkyl 2 1 2-439 -CH20 - -(CH2)b- single-bond benzene ring alkoxy group having 1 to 9 carbon atoms 0 1 2-440 -CH20- -<CH2)b- single bond benzene ring benzene ring carbon number 9 alkoxy group 1 1 2-441 -CH20- -(CH2)b- single bond phenyl ring benzene ring alkoxy group 1 to 9 alkoxy 2 1 b is an integer of 10 -46 - 201219451 [Table 36] Y1 Y2 Y3 Y4 Y5 Y6 η m 2- 442 -CH20- -<CHZ)b- a single bond phenyl ring alkyl 1 to 9 alkyl 0 1 2-443 -CH20- -(CH2)b- single bond benzene ring cyclohexene carbon number 9 alkane a certain 1 1 2-444 -CH20- -(CH2)b- single bond phenyl ring cyclohexene carbon number 1 to 9 alkyl 2 1 2-445 -CH20- -(CH2)b- single bond benzene ring carbon number 1 to 9 alkoxy 0 1 2-446 -CH20- -(CH2)b- single bond benzene ring cyclohexene carbon number 1 to 9 alkoxy group 1 1 2-447 -CH20- -(CH2)b - a single bond phenyl ring cyclohexene ring number 1 to 9 alkoxy 2 1 2-448 -CH20- -CCH2)b- a single bond cyclohexyl carbon number 9 alkyl 0 1 2-449 -CH20- -(CH2)b-monoethylcyclohexylbenzene ring 1 to 9 alkyl 1 1 2-450 -CH20- -CCH2)b-monobonded cyclohexylbenzene ring 1 to 9 alkyl 2 1 2-451 -CH20- -(CH2)b- alkoxy group having 1 to 9 carbon atoms of a single bond ring 1 1 2-452 -CH20- -(CH2)b- a single bond cyclohexyl ring carbon number 1 to 9 alkoxy 1 1 2-453 -CH20- -<CH2)b-a single bond cyclohexylbenzene ring alkoxy group having a carbon number of 1 to 9 2 1 2-454 -CH20- -{CH2) B- a single bond cyclohexene ring number 1 to 9 alkyl group 0 1 2-455 -CH20- -(CH2)b- a single bond cyclohexylcyclohexene ring number 1 to 9 alkane Base 1 1 2-456 -CH20- -(CH2)b- single bond cyclohexylcyclohexene carbon number 9 alkyl 2 1 2-457 -CH20- -<CH2}b- single bond cyclohexyl ring Alkoxy group having a carbon number of 1 to 9 0 1 2-458 -CH20- -(CH2)b- alkoxy group having a single bond cyclohexylcyclohexene ring number 1 to 9 1 1 2-459 -CH20- - ( CH2)b- single bond cyclohexylcyclohexene ring alkoxy group 1 to 9 alkoxy 2 1 2-460 -CH20- -(CH2)b- -0- phenyl ring carbon number 1~9 2-461 -CH20- -(CH2)b- -0- phenyl ring benzene ring 1 to 9 alkyl 1 1 2-462 -CH20- -CCH2)b- -0- benzene ring benzene ring carbon number 9 alkane 2 1 b is an integer from 1 to 10 -47- 201219451 [Table 37] Y1 Y2 Y3 Y4 Y5 Y8 η m 2-463 -CH20- -(CH2)b- Benzene ring carbon 1~9 Oxyl 0 1 2-464 -CH20- -<CH2)b- -0- alkoxy 1 to benzene ring benzene ring 1 to 9 2-465 -CH20- -(CH2)b- -o- benzene Alkoxy group having a ring number of benzene ring 1 to 9 2 1 2-466 -CH20- -(CH2)b- -0- phenyl ring carbon number 9 alkyl group 0 1 2-467 -CH20- -(CH2) B- -0- phenylcyclohexene ring 1 to 9 alkyl 1 1 2-468 -CH20- -(CH2)b- phenylcyclohexene ring 1 to 9 alkyl 2 1 2-469 -CH20- -CCH2)b- benzene Alkoxy group having a ring carbon number of 1 to 9 0 1 2-470 -CH20- -(CH2)b- -o- alkoxy group of a benzene ring cyclohexyl ring 1 to 9 1 1 2-471 -CH20- - (CH2)b- -o- alkoxy group having 1 to 9 carbon atoms of benzene ring cyclohexene 2 1 2-472 -CH20- -(CH2)b- -o- alkyl group of cyclohexene carbon number 1 2-473 -CH20- -CCH2)b- -0- cyclohexylbenzene ring 1 to 9 alkyl 1 1 2-474 -CH20- -CCH2)b- -o- cyclohexylbenzene ring carbon Number 1 to 9 alkane 2 1 2-475 -CH20- -<CM2)b- -o- cyclohexane ring carbon number 1 to 9 alkyl group 0 1 2-476 -CH20- -<CH2) B--o-cyclohexylbenzene ring carbon 1 to 9 alkyl group 1 1 2-477 -CH20- -CCH2)b- -o- cyclohexylbenzene ring carbon number 9 alkoxy 2 1 2-478 -CH20- -<CH2)b- -0- Cyclohexylcarbadol 9 Alkyl 0 1 2-479 -CH20- -(CH23b- -o- Cyclohexylcyclohexene Carbon Number 9 alkyl 1 1 2-480 -CH20- -(CH2)b- -0- cyclohexylcyclohexene ring 1 to 9 alkyl 2 1 2-481 -CH20- -(CH2)b- - O- alkoxy having 1 to 9 carbon atoms of cyclohexene ring 0 1 2-482 -CH20- -<CH2)b- -o- alkoxy group having 1 to 9 carbon atoms of cyclohexylcyclohexene ring 1 1 2 -483 -CH20- -(CHZ)b- -o- Cyclohexane ring Ring carbon atoms of 1~9 alkoxy 2 1 b is an integer of from 1 to 10

-48- 201219451 [表 38] Y1 Y2 Y3 Y4 Y5 Υ6 η m 2-484 -CH20- -CCH2)b- -COO- 苯環 碳數1〜9 之烷基 0 1 2-485 -CH20- -(CH2)b- -COO- 苯環 苯環 碳數卜9 之烷基 1 2-486 -CH20- -(CH2)b- -COO- 苯環 苯環 碳數卜9 之烷基 2 1 2-487 -CH20- -(CH2)b- -coo- 苯環 碳數〗〜9 之院氧基 0 1 2-488 -OH20- -(CH2)b- -COO- 苯環 苯環 碳數卜9 之烷氧基 1 2-489 -CH20- -<CH2)b- -COO- 苯環 苯環. 碳數卜9 之烷氧基 2 1 2-490 -CH20- -(CH2)b- -coo- 苯環 碳數1〜9 之院基 0 1 2-491 -CH20- -CCH2)b- -coo- 苯環 環己環 碳數1〜9 之烷基 1 1 2-492 -CH20- -(CH2)b- -coo- 苯環 ira—jib 堪〇堪 碳數卜9 之烷基 2 1 2-493 -CH20- -(CH2)b- -coo- 賴 碳數1〜9 之烷氣某 0 1 2-494 -CH2〇- -<CH2)b- -coo- 苯環 環己環 碳數1〜9 之烷氧基 1 1 2-495 -CH20- .-<CH2)b- -coo- 苯環 環己環 碳數1〜9 之烷氧基 2 1 2-496 -CH20- -CCH2)b- -coo- 環己環 碳數1〜9 之烷基 0 1 2-497 -CH2〇- -(CH2)b- -coo- 環己環 苯環 碳數1〜9 之烷基 1 2-498 -CH2〇- -<CH2)b- -coo- 環己環 苯環 碳數1〜9 之烷基 2 1 2-499 -CH20- -(CH2)b- -coo- 環己環 碳數1〜9 之烷氧基 0 1 2-500 -CH20- -(CH2)b- -coo- 環己環 苯環 碳數1〜9 之烷氧基 1 2-501 -CH20- -(CH2)b- -COO- 環己環 苯環 碳數1〜9 之烷氧基 2 1 2-502 -CH20- -(CH2)b- -coo- 環己環 碳數卜9 之烷基 0 1 2-503 -CH20- -<CH2)b- -coo- 環己環 環己環 碳數卜9 之烷基 1 2-504 -CH20- -(CH2)b- -coo- 環己環 環己環 碳數1〜9 之院基 2 1 b爲1~10之整數 -49- 201219451 [表 39] Y1 Y2 Y3 Y4 Y5 ΥΘ η m 2-505 -CH20- -(CH2)b- -COO- 環己環 碳數卜9 之烷氧基 0 1 2-506 -CH20- -CCH2)b- -COO- 環己環 環己環 碳數1〜9 之烷氧基 1 2-507 -CH20- -(CH2)b- -COO- 環己環 環己環 碳數1〜9 之烷氧基 2 1 2-508 -CH20- -(CH2)b- -oco- 苯環 碳數卜9 之烷S 0 1 2-509 -CH20- -CCH2)b- -OCX)- 苯環 苯環 碳數1〜9 之烷基 1 1 2-510 -CH20- -(CH2)b- -OCO- 苯環 苯環 碳數1〜9 之烷基 2 1 2-511 -CH20- -(CH23b- -oco- 苯環 碳數1〜9 之烷氧基 0 1 2-512 -CH20- -(CH2)b- -oco- 苯環 苯環 碳數1〜9 之烷氣基 1 1 2-513 -CH20- -(CH2)b- -oco- 苯環 苯環 碳败1〜9 之烷氣基 2 1 2-514 -CH20- -(CH2)b- -oco- 苯環 碳數卜9 之院基 0 1 2-515 -CH20- -(CH2)b- -oco- 苯環 環己環 碳數1〜9 之烷基 1 1 2-516 -CH20- -(CH23b- -oco- 苯環 環己環 碳數1〜9 之烷基 2 1 2-517 -CH20- -CCH2)b- -oco- 苯環 碳數1〜9 之烷氣基 0 1 2-518 -CH20- -<CH2)b- -oco- 苯環 環己環 碳數卜9 之烷氣基 1 1 2-519 -CH20- -(CH2)b- -oco- 苯環 環己環 碳数卜9 之烷氧基 2 1 2-520 -CH20- -(CH2)b- -oco- 環己環 碳數1〜9 之烷基 0 1 2-521 -CH20- -(CH2)b- -oco- 環己環 苯環 碳數卜9 之烷基 1 1 2-522 -CH20- -(CH2)b- -oco- 環己環 苯環 碳數卜9 之烷基 2 1 2-523 -CH20- -(CH2)b- -oco- 環己環 碳數1〜9 之烷氣S 0 1 2-524 -CH20- -(CH2)b- -oco- 環己環 苯環 碳败1〜9 之烷氣荘 1 1 2-525 -CH20- -{CH2)b- -oco- 環己環 苯環 碳數1〜9 之烷氣基 2 1 b爲1~10之整數-48- 201219451 [Table 38] Y1 Y2 Y3 Y4 Y5 Υ6 η m 2-484 -CH20- -CCH2)b- -COO- Alkyl group with a benzene ring number of 1 to 9 0 1 2-485 -CH20- -( CH2)b--COO- phenyl ring benzene ring carbon number 9 alkyl 1 2-486 -CH20- -(CH2)b- -COO- phenyl ring benzene ring carbon number 9 alkyl 2 1 2-487 -CH20- -(CH2)b- -coo- phenyl ring carbon number 〜~9 院 oxy 0 1 2-488 -OH20- -(CH2)b- -COO- phenyl ring benzene ring carbon number 9 alkane Oxygen 1 2-489 -CH20- -<CH2)b- -COO- phenyl ring benzene ring. Carbon number 9 alkoxy 2 1 2-490 -CH20- -(CH2)b- -coo- benzene A group of carbon atoms 1 to 9 0 1 2-491 -CH20- -CCH2)b- -coo- phenyl ring cyclohexyl 1 to 9 alkyl 1 1 2-492 -CH20- -(CH2) B- -coo- phenyl ring ira-jib 烷基 碳 carbon number 2 alkyl 2 1 2-493 -CH20- -(CH2)b- -coo- lysing carbon number 1~9 alkane 0 1 2 -494 -CH2〇- -<CH2)b- -coo- alkoxy group having 1 to 9 carbon atoms of phenylcyclohexene ring 1 1 2-495 -CH20- .-<CH2)b- -coo- benzene Alkoxy group having 1 to 9 carbon atoms in the cyclohexene ring 2 1 2-496 -CH20- -CCH 2)b- -coo-alkyl group having 1 to 9 ring carbon groups 0 1 2-497 -CH 2 〇 - - (CH2)b- -coo- ring Alkyl group having a carbon number of 1 to 9 ring: 2-498 -CH2〇- -<CH2)b- -coo- A cycloalkyl ring having 1 to 9 carbon atoms 2 1 2-499 -CH20- -(CH2)b- -coo- alkoxy group having 1 to 9 carbon atoms of cyclohexene ring 0 1 2-500 -CH20- -(CH2)b- -coo- alkane having a carbon number of 1 to 9 Oxyl 1 2-501 -CH20- -(CH2)b- -COO-cyclohexylbenzene ring alkoxy group 1 to 9 2 2 2-502 -CH20- -(CH2)b- -coo- ring Alkyl group of a ring carbon number of 9 0 2 2-503 -CH20- -<CH2)b- -coo- Alkyl group of cyclohexylcyclohexene ring number 9 2-504 -CH20- -(CH2 ) b- -coo- ring of cyclohexylcyclohexane having a carbon number of 1 to 9 2 1 b is an integer of 1 to 10 -49 - 201219451 [Table 39] Y1 Y2 Y3 Y4 Y5 ΥΘ η m 2-505 -CH20 - -(CH2)b- -COO-cyclohexene carbon number 9 alkoxy 0 1 2-506 -CH20- -CCH2)b- -COO- cyclohexane cyclohexane ring carbon number 1~9 Oxyl 1 2-507 -CH20- -(CH2)b- -COO- Cyclohexylcyclohexene Alkoxy 2 1 2-508 -CH20- -(CH2)b- -oco- Benzene ring carbon number 9 alkane S 0 1 2-509 -CH20- -CCH2)b- -OCX)- phenyl ring benzene ring alkyl group 1 to 9 alkyl 1 1 2-510 -CH20- -(CH2) B- -OCO- benzene Alkyl group having 1 to 9 carbon atoms of phenyl ring 1 1 2-511 -CH20- -(CH23b- -oco- alkoxy group having 1 to 9 carbon atoms of benzene ring 0 1 2-512 -CH20- -(CH2)b- -oco- phenyl ring benzene ring carbon number 1 to 9 alkyl group 1 1 2-513 -CH20- -(CH2)b- -oco- benzene ring benzene ring carbon 1~9 alkyl group 2 1 2- 514 -CH20- -(CH2)b- -oco- phenyl ring carbon number 之 9 院 0 0 1- 2- 2- 2- 2- 2- 2- 2- 2- 2- 2- 2- 2- 2- 2- 2- 2- 2- 2- 2- 2- 2- 2- 2- 2- 2- 2- 2- 2- 2- Alkyl 1 1 2-516 -CH20- -(CH23b- -oco- phenylcyclohexene ring 1~9 alkyl 2 1 2-517 -CH20- -CCH2)b- -oco- phenyl ring carbon number 1 to 9 alkyl group 0 1 2-518 -CH20- -<CH2)b- -oco- benzene ring cyclohexene carbon number 9 alkane group 1 1 2-519 -CH20- -(CH2) B- -oco- phenylcyclohexene ring carbon number 9 alkoxy 2 1 2-520 -CH20- -(CH2)b- -oco- cyclohexene ring number 1~9 alkyl 0 1 2- 521 -CH20- -(CH2)b- -oco- cyclohexylbenzene ring carbon number 9 alkyl 1 1 2-522 -CH20- -(CH2)b- -oco- cyclohexylbenzene ring carbon number 9 alkyl 2 1 2-523 -CH20- -(CH2)b- -oco- cyclohexane ring carbon number 1~9 alkane gas S 0 1 2-524 -CH20- -(CH2)b- -oco- Cyclohexylbenzene ring carbon defeat 1~ 9 alkane gas 荘 1 1 2-525 -CH20- -{CH2)b- -oco- cyclohexane ring benzene ring Alkene group having a carbon number of 1 to 9 2 1 b is an integer of 1 to 10

-50- 201219451 K40] Y1 Y2 Y3 Y4 Y5 Y6 η rn 2-526 -CH20- -(CH2)b- -OCO- 環己環 碳數卜9 之烷某 0 1 2-527 -CH20- -(CH2)b- -OCO- 環己環 環己環 碳數1〜9 之烷基 1 2-528 -CH20- -(CH2)b- -OCO- 環己環 環己環 碳數1〜9 之院基 2 2-529 -CH20- -(CH2)b- -OCO- 環己環 碳數1〜9 找氧基 0 2-530 -CH20- -(CH2)b- -OCO- 環己環 環己環 碳數卜9 之烷氣某 1 1 2-531 -CH20- -(CH2)b- -OCO- 環己環 環己環 碳數1〜9 之烷氧基 2 1 2-532 -COO- -(CH2)b- -0- 苯環 碳數1〜9 之烷基 0 1 2-533 -COO- -<CH2)b- Ό- 賴 苯環 碳數1〜9 之烷基 1 1 2-534 -COO- -(CH2)b- -0- 苯環 苯環 碳數卜9 之烷基 2 1 2-535 -COO- -<CH2)b- -0- 苯環 碳數卜9 之烷氧基 0 1 2-536 -COO- -(CH2)b- -*〇* 苯環 苯環 碳數卜9 之烷氧基 1 n 2-537 -COO- -<CH2)b- 苯環 苯環 碳數卜9 之烷氧基 2 1 2-538 -coo- -(CH2)b- 苯環 碳數卜9 之院基 0 t 2-539 -coo- -(CH2)b- 苯環 環己環 碳數1〜9 之烷基 1 1 2-540 -coo- -(CH2)b- 苯環 環己環 碳數1〜9 之惊基 2 1 2-541 -coo- -<CH2)b- -0- 賴 碳數1〜9 之烷氧基 0 1 2-542 -coo- -(CH2)b- -0- 苯環 環己環 碳數1〜9 之烷氧基 1 1 2-543 -coo -(CH2)b- 雜 環己環 碳數1〜9 之烷氧基 2 1 2-544 -coo- -(CH2)b- -0- 環己環 碳數卜9 之烷基 0 1 2-545 -coo- -(CH2)b- -0- 環己環 苯環 碳數1〜9 之烷基 1 1 2-546 -coo -CCH2)b- -0- 環己環 苯環 碳數1〜9 之烷基 2 1 b爲1~10之整數 -51 - 201219451 [表 41] Y1 Y2 Y3 Y4 Y5 Y6 η m 2-547 -COO- -(CH2)b- -0- 環己環 碳數1〜9 之烷氧基 0 1 2-548 -COO- -<CH2)b- -0- 環己環 苯環 碳數1〜9 之烷氧基 1 2-549 -coo- -(CH2)b- -0- 環己環 苯環 碳數1〜9 找氧基 2 1 2-550 -〇〇〇- -{CH2)b- 環己環 碳數1〜9 之烷基 0 1 2-551 -COO- -{CH2)b- -0- 環己環 環己環 碳數卜9 之烷基 1 2-552 -COO- -(CH2)b- -0- 環己環 環己環 碳數卜9 之烷基 2 1 2-553 -COO- -CCH2)b- -0- 環己環 碳數卜9 之烷氣基 0 1 2-554 -COO- -(CH2)b- -0- 環己環 環己環 碳數1〜9 之烷氧基 1 2-555 -coo- -(CH2)b- -0- 環己環 環己環 碳數1〜9 之烷氧基 2 1 2-556 -coo- -(CH2)b- -coo- 苯環 碳數卜9 之烷基 0 1 2-557 -coo- -<CH2)b- -coo- 苯環 苯環 碳數1〜9 之烷基 1 1 2-558 -coo- -CCH2)b- -coo- 苯環 苯環 碳數卜9 之烷基 2 1 2-559 -coo- -(CH2)b- -coo- 苯環 碳數1〜9 之烷氧基 0 1 2-560 -coo- -(CH2)b- -coo- 苯環 苯環 碳數1〜9 之烷氧基 1 1 2-561 -coo- -(CH2)b- -coo- 苯環 苯環 碳數卜9 之烷氣荘 2 1 2-562 -coo- -(CH2)b- -coo- 苯環 碳數I〜9 之烷基 0 1 2-563 -coo- -(CHZ)b- -coo- 苯環 環己環 碳數卜9 之烷基 1 1 2-564 -coo- -(CH2)b- -coo- 苯環 環己環 碳數1〜9 之烷基 2 1 2-565 -coo- -(CH2)b- -coo- 苯環 碳數1〜9 之烷氧基 0 1 2-566 -coo- -(CH2)b- -coo- 苯環 環己環 碳數1〜9 之烷氧基 1 1 2-567 -coo- -(CH2)b- -coo- 苯環 環己環 碳數1〜9 之烷氣基 2 1 b爲1~10之整數-50- 201219451 K40] Y1 Y2 Y3 Y4 Y5 Y6 η rn 2-526 -CH20- -(CH2)b- -OCO- Cyclohexane ring number 9 alkane 0 1 2-527 -CH20- -(CH2 b--OCO-cyclohexylcyclohexene ring 1 to 9 alkyl 1 2-528 -CH20- -(CH2)b- -OCO- cyclohexylcyclohexene ring number 1~9 2 2-529 -CH20- -(CH2)b- -OCO-cyclohexene ring carbon number 1~9 oxyl group 0 2-530 -CH20- -(CH2)b- -OCO- cyclohexylcyclohexene ring carbon Alkane of a certain amount of 1 1 2-531 -CH20- -(CH2)b- -OCO- cyclohexylcyclohexene ring number 1 to 9 alkoxy 2 1 2-532 -COO- -(CH2 ) b- -0-alkyl group having 1 to 9 carbon atoms of benzene ring 0 1 2-533 -COO- -<CH2)b- Ό-alkyl group having 1 to 9 carbon atoms of 1 to 9 ring COO- -(CH2)b- -0- phenyl ring benzene ring carbon number 9 alkyl 2 1 2-535 -COO- -<CH2)b- -0- benzene ring carbon number 9 alkoxy group 0 1 2-536 -COO- -(CH2)b- -*〇* phenyl ring benzene ring carbon number 9 alkoxy group 1 n 2-537 -COO- -<CH2)b- benzene ring benzene ring carbon Alkoxy 2 1 2-538 -coo- -(CH2)b- phenyl ring carbon number 9 院 0 t 2-539 -coo- -(CH2)b- benzene ring cyclohexene carbon Number 1 to 9 of alkyl 1 1 2-540 -coo- -(CH2)b- phenylcyclohexene ring carbon number 1~9 stimulus 2 1 2-541 -coo- -<CH2)b- -0- alkoxy group having a carbon number of 1 to 9 0 1 2-542 -coo- -(CH2)b- -0- alkoxy group having 1 to 9 carbon atoms of benzene ring cyclohexyl 1 1 2-543 -coo -(CH2)b- heterocyclohexene carbon number 1 to 9 alkoxy 2 1 2-544 -coo- -(CH2)b- -0-cyclohexene carbon number 9 alkyl 0 1 2-545 -coo- -(CH2)b- -0 - a cyclohexylbenzene ring having 1 to 9 carbon atoms 1 1 2-546 -coo -CCH2)b- -0- a cyclohexylbenzene ring having 1 to 9 carbon atoms 1 1 b being 1 to 10 Integer-51 - 201219451 [Table 41] Y1 Y2 Y3 Y4 Y5 Y6 η m 2-547 -COO- -(CH2)b- -0- alkoxy group having 1 to 9 ring carbon groups 0 1 2-548 - COO- -<CH2)b- -0- alkoxy group having a carbon number of 1 to 9 in a cyclohexane ring 1 2-549 -coo- -(CH2)b- -0- cyclohexylbenzene ring carbon number 1 ~9 oxy 2 1 2-550 -〇〇〇- -{CH2)b-alkyl group having 1 to 9 ring carbon groups 0 1 2-551 -COO- -{CH2)b- -0- ring Alkyl 1 2-552 -COO- -(CH2)b- -0-cyclohexylcyclohexene carbon number 2 alkyl 2 1 2-553 -COO- - CCH2)b- -0- cyclohexane ring carbon number 0 1 2-554 -COO- -(CH2)b- -0- alkoxy 1 to 555-coo- -(CH2)b- -0- cyclohexylcyclohexylcyclohexane Alkoxy 2 1 2-556 -coo- -(CH2)b- -coo- phenyl ring carbon number 9 alkyl 0 1 2-557 -coo- -< CH2)b- -coo- phenyl ring benzene ring 1 to 9 alkyl 1 1 2-558 -coo- -CCH2)b- -coo- phenyl ring benzene ring carbon number 9 alkyl 2 1 2- 559 -coo- -(CH2)b- -coo- alkoxy group having 1 to 9 carbon atoms of benzene ring 0 1 2-560 -coo- -(CH2)b- -coo- phenyl ring benzene ring carbon number 1~9 Alkoxy 1 1 2-561 -coo- -(CH2)b- -coo- benzene ring benzene ring carbon number 9 alkane gas 荘 2 1 2-562 -coo- -(CH2)b- -coo- Alkyl group having a benzene ring number of carbons I to 9 0 1 2-563 -coo- -(CHZ)b- -coo- phenyl ring cyclohexyl carbon number 9 alkyl 1 1 2-564 -coo- -(CH2 ) b- -coo- phenylcyclohexene ring 1 to 9 alkyl 2 1 2-565 -coo- -(CH2)b- -coo- benzene ring 1 to 9 alkoxy 0 1 2 -566 -coo- -(CH2)b- -coo- alkoxy group having 1 to 9 carbon atoms of phenylcyclohexene ring 1 1 2-567 -coo- -(CH2)b- -coo- phenylcyclohexene ring The alkane group 2 1 b having a carbon number of 1 to 9 is an integer of 1 to 10

-52- 201219451 [表 42] Y1 Y2 Y3 Y4 Y5 Y6 η m 2-568 -COO- -(CH2)b- -COO- 環己環 碳數1〜9 之烷基 0 1 2-569 -COO- -(CH2)b- -COO- 環己環 苯環 碳數1〜9 之烷基 1 1 2-570 -COO- -(CH2)b- -COO- 環己環 苯環 碳數1〜9 之院基 2 1 2-571 -COO- -(CH2)b- -COO- 環己環 碳數1〜9 之烷氧基 0 1 2-572 -coo- -(CH2)b- -coo- 環己環 苯環 碳數卜9 之烷氧基 1 1 2-573 -coo- -(CH2)b- -coo- 環己環 苯環 碳數1〜9 之烷氧基 2 1 2-574 -coo- -CCH2)b- -coo- 環己環 碳數1〜9 之烷基 0 1 2-575 -coo- -(CH2)b- -coo- 環己環 環己環 碳數1〜9 之院基 1 1 2-576 -coo- -(CH2)b- -coo- 環己環 環己環 碳數1〜9 之烷基 2 1 2-577 -coo- -(CH2)b- -coo- 環己環 碳數卜9 之烷氧基 0 1 2-578 -coo- -CCH2)b- -coo- 環己環 環己環 碳數1〜9 之烷氧基 1 1 2-579 -coo- -<CH2)b- -coo- 環己環 環己環 碳數卜9 之烷氧基 2 1 2-580 -000- -CCH2)b- -000- 苯環 碳數1〜9 之烷基 0 1 2-581 -000- -CCH2)b- -OCX)- 苯環 苯環 碳數1〜9 之烷基 1 1 2-582 -coo- -(CH2)b- -oco- 苯環 苯環 碳數卜9 之烷基 2 1 2-583 -coo- -(CH2)b- -oco- 苯環 碳數卜9 之烷氧基 0 1 2-584 -coo- -(CH2)b- -oco- 苯環 苯環 碳數1〜9 之烷氧基 1 1 2-585 -coo- KCH2)b- -oco- 苯環 苯環 碳數卜9 之烷氧基 2 1 2-586 -coo- -(CH2)b- -oco- 苯環 碳數1〜9 之院基 0 1 2-587 -000- -(CH2)b- -oco- 苯環 環己環 碳數1〜9 之烷基 1 \ 2-5B8 -coo- -(CH2}b- -oco- 苯環 環己環 碳數1〜9 之烷某 2 1 b爲1~10之整數 -53- 201219451 [表 43] Y1 Y2 Y3 Y4 Υ5 Υβ π m 2-589 -COO- -CCH2)b- -OCO- 苯環 碳數1〜9 之烷氣基 0 1 2-590 -COO- -(CH2)b- _000- 苯環 環己環 碳數1〜9 之烷氧基 1 2-591 -GOO- -(GH2)b- -OGO- 苯環 環己環 碳數1〜9 之烷氧基 2 1 2-592 -COO- -CCH2)b- -OCO- 環己環 碳數1〜9 之烷基 0 1 2-593 -COO- -(CH23b- -OCO- 環己環 苯環 碳救1〜9 之烷基 1 2-594 -COO- -CCH2)b- -OCO- 環己環 苯環 碳败1〜9 2 1 2-595 -coo- -(CH2)b- -OCO- 環己環 碳數1〜9 之烷氧基 0 1 2-596 -coo- -(CH2)b- -OCO- 環己環 苯環 碳數I〜9 之烷氣基 1 1 2-597 -coo- -CCH2)b- -OCX)- 環己環 苯環 碳数1〜9 之烷氧基 2 1 2-598 -coo- -(CH2)b- -OCO- 環己環 碳败卜9 之烷芘 0 1 2-599 -coo- -CCH2)b- -000- 環己環 環己環 碳数1〜9 之烷基 1 1 2-600 -coo- -(CH2)b- -OCO- 環己環 環己環 碳數1〜9 之烷基 2 1 2-601 -coo- -(CH2)b- -OCO- 環己環 碳赃1〜9 之烷氣基 0 1 2-602 -coo- -(CH2)b- -OCX)- 環己環 環己環 碳數1〜9 之烷氣基 1 1 2-603 -coo- -<CH2)b- -000- 環己環 環己環 碳數1〜9 之烷氧基 2 1 2-604 單鍵 單鍵 單鍵 具有甾醇骨架 之碳败12-25 之有機基 碳數1〜9 之烷基 0 1 2-605 單鍵 單鍵 -(CH2)c- 具有甾醉骨架 之碳數12-25 之有機基 碳數1〜9 之烷基 0 1 2-606 單鍵 單鍵 具有甾醇骨架 之碳數12-25 之有機某 碳數卜9 之院基 0 1 2-607 單鍵 單鍵 甲 CH20- 具有甾醇骨架 之碳數12-25 之有機基 碳败1〜9 之烷氧基 0 1 2-608 單鍵 單鍵 -coo- 具有甾醇骨架 之碳數12-25 之有機《 碳數1〜9 之烷氣基 0 1 2-609 單鍵 單鍵 -OCX)- 具有甾醉骨架 之碳數12~25 之有機基 碳數1〜9 之烷氣基 0 1 b,c各自獨立爲1-10之整數 -54- 201219451 [表 44] Y1 Y2 Y3 Y4 Y5 V6 η m 2-610 單鍵 -(CH2)b- -0- 具有甾醇骨架 之碳數12~25 之有機基 碳數1〜9 之烷基 0 1 2-611 單鍵 -(CH2)b- -COO- 具有甾醇骨架 之碳數12-25 之有機基 碳數1〜9 之烷氧基 0 1 2-612 單鍵 -<CH2)b- -OCO- 具有甾醇骨架 之碳數12-25 之有機基 碳數1〜9 之烷氧基 0 1 2-613 -0- 單鍵 -(CH2)c- 具有甾醇骨架 之碳數12-25 之有機基 碳數卜9 之烷基 0 1 2-614 -0- 單鍵 -CH20- 具有甾醇骨架 之碳數12-25 之有機基 碳數1〜9 之烷氧基 0 1 2-615 -0- -(CH2)b- 具有甾醇骨架 之碳數12~25 之有機基 碳數1〜9 之烷基 0 ί 2-616 -0- -(CH2)b- -COO- 具有甾醇骨架 之碳數丨2_25 之有機基 碳數1〜9 之院氧基 0 1 2-617 -<CH2)b- -OCO- 具有留醇骨架 之碳數12〜25 之有機基 碳數1〜9 之烷氧基 0 1 2-618 -CH20- 單鍵 -(CH23c- 具有甾醇骨架 之碳數12~25 之有機基 碳數卜9 之院基 0 1 2-619 -CH20- -(CH2)b- 單鍵 具有甾醇骨架 之碳數12~25 之有機基 碳數1〜9 之烷氧基 0 1 2-620 -CH20- -(CH2)b- -0- 具有甾醇骨架 之碳數12~25 之有機基 碳數1〜9 之院基 0 1 2-621 -CH20- -(CH2)b- -COO- 具有甾醇骨架 之碳數12-25 之有機基 碳數1〜9 之烷氧基 0 1 2-622 -CH20- -(CH2}b- -OCO- 具有甾醇骨架 之碳败12~25 之有機基 碳數1〜9 之烷氧基 0 1 2-623 -000- 單鍵 單鍵 具有甾醇骨架 之碳數12-25 之有機基 碳數1〜9 之烷基 0 2-624 -COO- 單鍵 -{CH2)c- 具有甾醇骨架 之碳數12-25 之有機基 碳數1〜9 之烷基 0 2-625 -000- -(CH2)b- 單鍵 具有甾醇骨架 之碳數12~25 之有楢某 碳數1〜9 之烷氧基 0 2-626 -COO- -(CH2)b- -0- 具有甾醇骨架 之碳數12-25 之有機基 碳數卜9 之院基 0 2-627 -C00- -(CH2)b- -coo- 具有甾醇骨架 之碳數12-25 之有機基 碳數卜9 之烷氧基 0 1 2-628 -C00- -CCH2)b- -OCO- 具有留醇骨架 之碳數12-25 之有機基 碳數卜9 之烷氧基 0 t b,c各自獨立爲1~10之整數 表 15 〜表 44 所記載之 Υ1、Υ2、Υ3、Υ4、Υ5、Υ6、η 及 m之組合中，更佳之組合爲，2-25〜2-96、2-145〜2-168、 2-217〜2-240、 2-268〜2-315、 2-364〜2-387、 2-436 〜2-483、2-604〜2-628等，特佳之組合爲，2-49〜2-96、 -55- 201219451 2-145〜2-168、 2-217〜2-240 或 2-604〜2-612 等。 更具體而言，例如下述之式[2-1]〜[2_31]所示之結構 之二胺化合物。-52- 201219451 [Table 42] Y1 Y2 Y3 Y4 Y5 Y6 η m 2-568 -COO- -(CH2)b- -COO- Alkyl group having 1 to 9 ring carbon groups 0 1 2-569 -COO- -(CH2)b- -COO-cyclohexylbenzene ring 1 to 9 alkyl 1 1 2-570 -COO- -(CH2)b- -COO- cyclohexylbenzene ring carbon number 1~9 House base 2 1 2-571 -COO- -(CH2)b- -COO- alkoxy group having 1 to 9 ring carbon atoms 0 1 2-572 -coo- -(CH2)b- -coo- ring Cyclophenyl ring carbon number 9 alkoxy group 1 1 2-573 -coo- -(CH2)b- -coo- cyclohexylbenzene ring alkoxy group 1 to 9 alkoxy 2 1 2-574 -coo- -CCH2)b- -coo- Alkyl group having a carbon number of 1 to 9 in a cyclohexene ring. 0 1 2-575 -coo- -(CH2)b- -coo- a ring base having a carbon number of 1 to 9 1 1 2-576 -coo- -(CH2)b- -coo- Cyclohexylcyclohexene ring 1~9 alkyl 2 1 2-577 -coo- -(CH2)b- -coo- ring Cyclocarbon number 9 alkoxy group 0 1 2-578 -coo- -CCH2)b- -coo- cyclohexylcyclohexene ring number 1 to 9 alkoxy group 1 1 2-579 -coo- -&lt ;CH2)b- -coo-cyclohexylcyclohexene carbon number: 9 alkoxy 2 1 2-580 -000- -CCH2)b- -000- phenyl ring carbon number 1 to 9 alkyl 0 1 2-581 -000- -CCH2)b- -OCX)- benzene Alkyl group having a benzene ring number of 1 to 9 1 1 2-582 -coo- -(CH2)b- -oco- phenyl ring benzene ring carbon number 9 alkyl 2 1 2-583 -coo- -(CH2) B- -oco- phenyl ring carbon number 9 alkoxy group 0 1 2-584 -coo- -(CH2)b- -oco- phenyl ring benzene ring alkoxy group 1 to 9 alkoxy 1 1 2-585 -coo- KCH2)b- -oco- phenyl ring benzene ring carbon number 9 alkoxy 2 1 2-586 -coo- -(CH2)b- -oco- phenyl ring carbon number 1~9 1 2-587 -000- -(CH2)b- -oco- phenylcyclohexene ring 1~9 alkyl 1 \ 2-5B8 -coo- -(CH2}b- -oco- phenylcyclohexene Ring with a carbon number of 1 to 9 2 2 b is an integer of 1 to 10 -53 - 201219451 [Table 43] Y1 Y2 Y3 Y4 Υ5 Υβ π m 2-589 -COO- -CCH2)b- -OCO- benzene ring Alkyne group having a carbon number of 1 to 9 0 1 2-590 -COO- -(CH2)b- _000- alkoxy group having a carbon number of 1 to 9 benzene ring 1 2-591 -GOO- -(GH2) B- -OGO- alkoxy group having 1 to 9 carbon atoms of benzene ring cyclohexene 2 1 2-592 -COO- -CCH2)b- -OCO-alkyl group having 1 to 9 carbon atoms of cyclohexene ring 0 1 2- 593 -COO- -(CH23b- -OCO-cyclohexylbenzene ring carbon rescue 1~9 alkyl 1 2-594 -COO- -CCH2) b- -OCO- cyclohexylbenzene ring carbon 1~9 2 1 2-595 -coo- -(CH2)b- -OCO- alkoxy group having 1 to 9 carbon atoms of cyclohexene ring 0 1 2-596 -coo- -(CH2)b- -OCO- alkane having a carbon number of 1 to 9 Gas group 1 1 2-597 -coo- -CCH2)b- -OCX)- alkoxy group having 1 to 9 carbon atoms of cyclohexylbenzene ring 2 1 2-598 -coo- -(CH2)b- -OCO- Cyclohexylcarbazone 9 alkane oxime 0 1 2-599 -coo- -CCH2)b- -000- cyclohexylcyclohexene ring 1 to 9 alkyl 1 1 2-600 -coo- -( CH2)b--OCO-cyclohexylcyclohexene ring 1 to 9 alkyl 2 1 2-601 -coo- -(CH2)b- -OCO- cyclohexane ring carbon 赃 1 to 9 alkyl group 0 1 2-602 -coo- -(CH2)b- -OCX)- alkane group having 1 to 9 carbon atoms of cyclohexylcyclohexene ring 1 1 2-603 -coo- -<CH2)b- -000 - alkoxy group having 1 to 9 carbon atoms in the cyclohexylcyclohexene ring 2 1 2-604 single bond single bond single bond having a decyl alcohol skeleton having a carbon number of 12 to 25 and an alkyl group having 1 to 9 carbon atoms 0 1 2 -605 single bond single bond -(CH2)c- having a carbon number of 12-25 of the intoxicated skeleton, an alkyl group having 1 to 9 carbon atoms 0 1 2-606 single bond single bond having a carbon number of the sterol skeleton 12- 25 Organic Organic Carbon Number 9 Institute Base 0 1 2-607 Single Bond Single Bond CH20- Carbon with Sterol Matrix 12-25 organic radical carbon 1~9 alkoxy 0 1 2-608 single bond single bond -coo- having the sterol skeleton carbon number 12-25 organic "carbon number 1~9 alkyl group 0 1 2-609 One-touch single button - OCX) - The number of carbon atoms with a carbon number of 12 to 25 of the intoxicated skeleton is 1 to 9 and the alkyl group is 0 1 b, and each is independently an integer of 1-10 -54 - 201219451 [Table 44] Y1 Y2 Y3 Y4 Y5 V6 η m 2-610 Single bond -(CH2)b- -0- The alkyl group having a carbon number of 12 to 25 having a sterol skeleton and having an alkyl group of 1 to 9 0 1 2- 611 single bond -(CH2)b- -COO- having a sterol skeleton having 12 to 25 carbon atoms and 1 to 9 alkoxy group 0 1 2-612 single bond - <CH2)b- -OCO- An alkoxy group having a carbon number of 12 to 25 having a sterol skeleton and having a carbon number of 1 to 9 0 1 2-613 -0-a single bond -(CH2)c- an organic carbon having a decyl alcohol skeleton having 12 to 25 carbon atoms Alkyl group 9 1 2-614 -0- single bond -CH20- having a sterol skeleton having a carbon number of 12 to 25 and an alkoxy group having 1 to 9 carbon atoms 0 1 2-615 -0- - ( CH2)b- an alkyl group having a carbon number of 12 to 25 having a sterol skeleton of 1 to 9 ί 2-616 -0- -(CH2)b- -COO- having a sterol skeleton The number of carbons having a carbon number of _2_25 of 1 to 9 is 0. 2-617 -<CH2)b--OCO- having an organic group having a carbon number of 12 to 25 and having a carbon number of 1 to 9 Alkoxy 0 1 2-618 -CH20- single bond-(CH23c- having a decyl alcohol skeleton having an organic number of carbon atoms of 12 to 25, and a hospital base of 0 9 2-619 -CH20- -(CH2)b- a single bond having a decyl alcohol skeleton having a carbon number of 12 to 25 and an alkoxy group having 1 to 9 carbon atoms. 0 1 2-620 -CH20- -(CH2)b- -0- having a sterol skeleton having a carbon number of 12 to 25 Ordinary base carbon number 1 to 9 0 1 2-621 -CH20- -(CH2)b- -COO- having a sterol skeleton having a carbon number of 12 to 25 and an alkoxy group having 1 to 9 carbon atoms 0 1 2-622 -CH20- -(CH2}b- -OCO- having a sterol skeleton, carbonic 12 to 25, an organic alkoxy group having 1 to 9 alkoxy groups 0 1 2-623 -000 - a single bond single bond having a sterol The carbon number of the skeleton is 12-25, the alkyl group having an organic carbon number of 1 to 9 is 0-2-624 -COO- single bond -{CH2)c- having the sterol skeleton, the carbon number of the carbon number 12-25 is 1 to 9 Alkyl 0 2-625 -000- -(CH2)b- single bond having a sterol skeleton having a carbon number of 12 to 25 and having a carbon number of 1 to 9 alkoxy 0 2-626 -COO- -(CH2)b- -0- having a sterol skeleton having an organic number of carbon atoms of 12 to 25, and a base of 0 9 -627 -C00- -(CH2)b- -coo- having a sterol skeleton Carbon number 12-25 organic base carbon number 9 alkoxy group 0 1 2-628 -C00- -CCH2)b- -OCO- organic carbon number having a carbon number 12-25 with a alcohol skeleton The alkoxy groups 0 tb, c are each independently an integer of 1 to 10, and the combination of Υ1, Υ2, Υ3, Υ4, Υ5, Υ6, η, and m described in Table 44, and more preferably, is 2- 25~2-96, 2-145~2-168, 2-217~2-240, 2-268~2-315, 2-364~2-387, 2-436~2-483, 2-604~ 2-628, etc., the most preferable combination is 2-49~2-96, -55-201219451 2-145~2-168, 2-217~2-240 or 2-604~2-612. More specifically, for example, a diamine compound having a structure represented by the following formulas [2-1] to [2_31].

[2-2] [2-1][2-2] [2-1]

(R1 表示-0- ' -OCH2-、-CH20-、-COOCH2-或 CH2OCO-， R2爲碳數1〜22之烷基、烷氧基、含氟烷基或含氟烷氧基 [化9](R1 represents -0-'-OCH2-, -CH20-, -COOCH2- or CH2OCO-, and R2 is an alkyl group having 1 to 22 carbon atoms, an alkoxy group, a fluorine-containing alkyl group or a fluorine-containing alkoxy group. ]

[2 — 4] [2—5] [2 — 6] -56- 201219451 (R3 表示-COO-、-OCO- ' -COOCH2- ' -CH2OCO- ' -ch2o-、-OCH2-或CH2-，R4爲碳數1〜22之烷基、烷氧基、含 氟烷基或含氟烷氧基）。 [化 10][2 - 4] [2-5] [2 - 6] -56- 201219451 (R3 means -COO-, -OCO- ' -COOCH2- ' -CH2OCO- ' -ch2o-, -OCH2- or CH2-, R4 It is an alkyl group having 1 to 22 carbon atoms, an alkoxy group, a fluorine-containing alkyl group or a fluorine-containing alkoxy group). [化10]

(R5 % 7K -COO- > -OCO- ' -COOCH2- ' -CH2〇CO- > -CH20-、-OCH2-、-CH2-或0-，R6爲氟基、氰基、三氟甲烷基、 硝基、偶氮基、甲醯基、乙醯基、丙醯基或羥基）。 [化11(R5 % 7K -COO- > -OCO- ' -COOCH2- ' -CH2〇CO- > -CH20-, -OCH2-, -CH2- or 0-, R6 is fluoro, cyano, trifluoromethane Base, nitro, azo, formamidine, ethyl hydrazino, propyl hydrazide or hydroxy). [11

R7 [2-9] R7 [2-10] (R7爲碳數3〜12之烷基，1,4-伸環己基之順-反異構爲分 別爲反式異構物）。 -57- 201219451 [化 12]R7 [2-9] R7 [2-10] (R7 is an alkyl group having 3 to 12 carbon atoms, and the cis-trans isomer of 1,4-cyclohexylene is a trans isomer). -57- 201219451 [Chem. 12]

[2-11] [2-12] (R爲碳數3以上12以下之垸基’ 1，4 -伸環己基之順·反異 構爲分別爲反式異構物）。 [化 1 3 ][2-11] [2-12] (R is a fluorenyl group having a carbon number of 3 or more and 12 or less, and a cis-trans isomer of a cyclohexylene group is a trans isomer). [化1 3 ]

(A爲氟原子可被取代之碳數3〜20之烷基，A3爲1>4-伸 孩己基或1，4_伸苯基’ a2爲氧原子或COO-* (其中，附有 」之鍵結鍵爲與A3鍵結），A1爲氧原子或COO-*(其中 ’附有「*」之鍵結鍵爲與（CH2)a2)鍵結）。又，a,爲0或 1之整數’ &2爲2〜10之整數，33爲〇或1之整數）。 -58- 201219451(A is an alkyl group having a carbon number of 3 to 20 which may be substituted by a fluorine atom, A3 is 1> 4-extended hexyl or 1,4_phenylene' a2 is an oxygen atom or COO-* (wherein attached) The bonding key is bonded to A3), and A1 is an oxygen atom or COO-* (where the 'bonding key with '*' is bonded to (CH2)a2)). Further, a is an integer of 0 or 1. '&2 is an integer of 2 to 10, and 33 is an integer of 〇 or 1.). -58- 201219451

f化 I4J NH.f I4J NH.

-59- 201219451 [化 15]-59- 201219451 [Chem. 15]

-60- 201219451 [化 16] NH,-60- 201219451 [Chem. 16] NH,

-61 - 201219451 [化 17] NH〇-61 - 201219451 [Chem. 17] NH〇

62- 201219451 [化 18]62- 201219451 [Chem. 18]

上述之式[2-1]〜[2-31]之中’具有特佳結構之二胺化 合物爲式[2-1]〜式[2-6]、式[2-9]〜式[2-13]、式[2-16]、 式[2-19]、式[2-23]、式[2-25]或式[2-29]等。 <其他二胺化合物> 本發明中’於不損本發明效果之限度，特定二胺化合 -63- 201219451 物及特定側鏈型二胺化合物以外該其他之二胺化合物，可 與二胺成分合倂使用。其具體例如以下所列舉者。 p-伸苯二胺、2,3,5,6-四甲基-P-伸苯二胺、2,5-二甲 基-p-伸苯二胺、m-伸苯二胺、2,4-二甲基-m-伸苯二胺、 2,5-二胺基甲苯、2,6-二胺基甲苯、2,5-二胺基酚、2,4-二 胺基酚、3,5-二胺基酚、3,5-二胺基苄基醇、2,4-二胺基苄 基醇、4,6-二胺基間苯二酚、4,4’-二胺基聯苯基、3,3’-二 甲基-4,4’-二胺基聯苯基、3,3’-二甲氧基-4,4’-二胺基聯苯 基、3,3’-二羥基-4,4’-二胺基聯苯基、3,3’-二羧基-4,4’-二 胺基聯苯基、3,3’-二氟-4,4’-聯苯基、3,3’-三氟甲基-4,4’-二胺基聯苯基、3,4’-二胺基聯苯基、3,3’-二胺基聯苯基、 2,2’-二胺基聯苯基、2,3’-二胺基聯苯基、4,4’-二胺基二 苯基甲烷、3,3’-二胺基二苯基甲烷、3，4’-二胺基二苯基甲 烷、2,2’ -二胺基二苯基甲烷、2,3’ -二胺基二苯基甲烷、 4,4’-二胺基二苯基醚、3,3’-二胺基二苯基醚、3,4’-二胺 基二苯基醚、2,2’-二胺基二苯基醚、2,3’-二胺基二苯基醚 、4,4’-磺醯基二苯胺、3,3’-磺醯基二苯胺、雙（4-胺基苯 基）矽烷、雙（3-胺基苯基）矽烷、二甲基-雙（4-胺基苯基）矽 烷、二甲基-雙（3-胺基苯基）矽烷、4,4’-硫代二苯胺、3,3’-硫代二苯胺、4，4 ’ -二胺基二苯基胺、3,3 ’ -二胺基二苯基胺 、3，4’-二胺基二苯基胺、2,2’-二胺基二苯基胺、2,3’ -二 胺基二苯基胺、N -甲基（4,4’-二胺基二苯基）胺、N -甲基 (3,3’-二胺基二苯基）胺、N-甲基（3,4’-二胺基二苯基）胺、 N-甲基（2,2’_二胺基二苯基）胺、N-甲基（2,3’-二胺基二苯 64 - 201219451 基）胺、4,4’-二胺基二苯甲酮、3,3’-二胺基二苯甲酮、 3，4’-二胺基二苯甲酮、1,4 -二胺基萘、2,2’-二胺基二苯甲 酮、2,3’-二胺基二苯甲酮、1，5-二胺基萘、1,6-二胺基萘 、1,7-二胺基萘、1,8-二胺基萘、2,5-二胺基萘、2,6二胺 基萘、2,7-二胺基萘、2,8-二胺基萘、1，2-雙（4-胺基苯基） 乙烷、1，2-雙（3-胺基苯基）乙烷、1,3-雙（4-胺基苯基）丙烷 、1，3-雙（3-胺基苯基）丙烷、1,4-雙（4胺基苯基）丁烷、 1,4-雙（3-胺基苯基）丁烷、雙（3,5-二乙基-4-胺基苯基）甲烷 、1，4-雙（4-胺基苯氧基）苯、1,3-雙（4-胺基苯氧基）苯、 1，4-雙（4-胺基苯基）苯、1,3-雙（4-胺基苯基）苯、1，4-雙（4-胺基苄基）苯、1，3-雙（4-胺基苯氧基）苯、4,4’-[1,4-伸苯雙 (伸甲基）]二苯胺、4,4’-[1，3-伸苯雙（伸甲基）]二苯胺、 3,4’-[1,4-伸苯雙（伸甲基）]二苯胺、3,4’-[1，3-伸苯雙（伸甲 基）]二苯胺、3,3’-[1,4-伸苯雙（伸甲基）]二苯胺、3,3’-[1,3-伸苯雙（伸甲基）]二苯胺、1,4-伸苯雙[(4-胺基苯基）甲 酮]、1，4-伸苯雙[(3-胺基苯基）甲酮]、1，3-伸苯雙[(4-胺基 苯基）甲酮]、1，3-伸苯雙[(3-胺基苯基）甲嗣]、1，4-伸苯雙 (4-胺基苯甲酸酯）、1，4-伸苯雙（3-胺基苯甲酸酯）、1,3-伸 苯雙（4-胺基苯甲酸酯）、1,3-伸苯雙（3-胺基苯甲酸酯）、雙 (4-胺基苯基）對苯二甲酸酯、雙（3-胺基苯基）對苯二甲酸 酯、雙（4-胺基苯基）異苯二甲酸酯、雙（3-胺基苯基）異苯 二甲酸酯、N，N’-(1，4-伸苯）雙（4-胺基苯倂醯胺）、Ν,Ν’-(1,3-伸苯）雙（4-胺基苯倂醯胺）、Ν，Ν’-(1，4-伸苯）雙（3-胺 基苯倂醯胺）、Ν,Ν’-(1，3-伸苯）雙（3-胺基苯倂醯胺）、 -65- 201219451 N，N’-雙（4-胺基苯基）對苯二甲醯胺、N，N’-雙（3-胺基苯基） 對苯二甲醯胺、N，N’-雙（4-胺基苯基）異苯二甲醯胺、 N，N’-雙（3-胺基苯基）異苯二甲醯胺' 9，10_雙（4-胺基苯基） 蒽、4,4’-雙（4-胺基苯氧基）二苯基颯' 2,2’-雙[4-(4-胺基 苯氧基）苯基]丙烷、2,2’-雙[4-(4-胺基苯氧基）苯基]六氟丙 烷、2,2’-雙（4-胺基苯基）六氟丙烷、2,2’-雙（3-胺基苯基） 六氟丙烷、2,2’-雙（3-胺基-4-甲基苯基）六氟丙烷、2,2，-雙 (4 -胺基苯基）丙烷、2，2’-雙（3-胺基苯基）丙烷、2，2’-雙（3-胺基-4-甲基苯基）丙烷、ι，3·雙（4-胺基苯氧基）丙烷、1,3-雙（3-胺基苯氧基）丙烷、I，4-雙（4-胺基苯氧基）丁烷、1,4-雙（3-胺基苯氧基）丁烷、1，5-雙（4-胺基苯氧基）戊烷、1，5-雙（3-胺基苯氧基）戊烷、1,6-雙（4-胺基苯氧基）己烷、1,6-雙（3-胺基苯氧基）己烷、1，7-雙（4-胺基苯氧基）庚烷、1，7-(3-胺基苯氧基）庚烷、1，8_雙（4_胺基苯氧基）辛烷、1，8-雙 (3-胺基苯氧基）辛烷、1，9-雙（4-胺基苯氧基）壬烷、1，9-雙 (3-胺基苯氧基）壬烷、1，10-(4-胺基苯氧基）癸烷、1,10-(3-胺基苯氧基）癸烷、1,11-(4-胺基苯氧基）十一烷、1,11-(3-胺基苯氧基）十一烷、1,12-(4-胺基苯氧基）十二烷、1，12-(3-胺基苯氧基）十二烷、4-(胺基甲基）苯胺、3-(胺基甲基） 苯胺、4-(2-胺基乙基）苯胺、3-(2-胺基乙基苯胺）等之芳香 族二胺化合物；雙（4-胺基環己基）甲烷、雙（4-胺基-3-甲基 環己基）甲烷等之脂環式二胺化合物；1，3-二胺基丙烷、 1，4-二胺基丁烷' 1,5-二胺基戊烷、1，6-二胺基己烷、1，7-二胺基庚烷、1，8-二胺基辛烷、1，9-二胺基壬烷、1,10-二Among the above formulas [2-1] to [2-31], the diamine compound having a particularly preferable structure is a formula [2-1] to a formula [2-6], and a formula [2-9] to a formula [2] -13], formula [2-16], formula [2-19], formula [2-23], formula [2-25] or formula [2-29] and the like. <Other diamine compound> In the present invention, the other diamine compound other than the specific diamine compound-63-201219451 and the specific side chain type diamine compound may be used together with the diamine, without departing from the effects of the present invention. The ingredients are used together. Specifically, for example, those listed below. P-phenylenediamine, 2,3,5,6-tetramethyl-P-phenylenediamine, 2,5-dimethyl-p-phenylenediamine, m-phenylenediamine, 2, 4-dimethyl-m-phenylenediamine, 2,5-diaminotoluene, 2,6-diaminotoluene, 2,5-diaminophenol, 2,4-diaminophenol, 3 , 5-diaminophenol, 3,5-diaminobenzyl alcohol, 2,4-diaminobenzyl alcohol, 4,6-diaminoresorcinol, 4,4'-diamino Biphenyl, 3,3'-dimethyl-4,4'-diaminobiphenyl, 3,3'-dimethoxy-4,4'-diaminobiphenyl, 3,3 '-Dihydroxy-4,4'-diaminobiphenyl, 3,3'-dicarboxy-4,4'-diaminobiphenyl, 3,3'-difluoro-4,4'- Biphenyl, 3,3'-trifluoromethyl-4,4'-diaminobiphenyl, 3,4'-diaminobiphenyl, 3,3'-diaminobiphenyl, 2,2'-diaminobiphenyl, 2,3'-diaminobiphenyl, 4,4'-diaminodiphenylmethane, 3,3'-diaminodiphenylmethane, 3,4'-Diaminodiphenylmethane, 2,2'-diaminodiphenylmethane, 2,3'-diaminodiphenylmethane, 4,4'-diaminodiphenyl Ether, 3,3'-diaminodiphenyl ether, 3,4'-diaminodiphenyl ether, 2,2'- Diaminodiphenyl ether, 2,3'-diaminodiphenyl ether, 4,4'-sulfonyldiphenylamine, 3,3'-sulfonyldiphenylamine, bis(4-aminobenzene) Base) decane, bis(3-aminophenyl)decane, dimethyl-bis(4-aminophenyl)decane, dimethyl-bis(3-aminophenyl)decane, 4,4'- Thiodiphenylamine, 3,3'-thiodiphenylamine, 4,4 '-diaminodiphenylamine, 3,3 '-diaminodiphenylamine, 3,4'-diaminodi Phenylamine, 2,2'-diaminodiphenylamine, 2,3'-diaminodiphenylamine, N-methyl(4,4'-diaminodiphenyl)amine, N -Methyl (3,3'-diaminodiphenyl)amine, N-methyl(3,4'-diaminodiphenyl)amine, N-methyl (2,2'-diamino) Diphenyl)amine, N-methyl (2,3'-diaminodiphenyl 64 - 201219451 yl)amine, 4,4'-diaminobenzophenone, 3,3'-diaminodi Benzophenone, 3,4'-diaminobenzophenone, 1,4-diaminonaphthalene, 2,2'-diaminobenzophenone, 2,3'-diaminobiphenyl Ketone, 1,5-diaminonaphthalene, 1,6-diaminonaphthalene, 1,7-diaminonaphthalene, 1,8-diaminonaphthalene, 2,5-diaminonaphthalene, 2, 6 diaminonaphthalene, 2,7-diaminonaphthalene, 2,8-diaminonaphthalene, 1,2-bis(4-aminophenyl)ethane, 1,2-bis(3-amino group Phenyl)ethane, 1,3-bis(4-aminophenyl)propane, 1,3-bis(3-aminophenyl)propane, 1,4-bis(4-aminophenyl)butane , 1,4-bis(3-aminophenyl)butane, bis(3,5-diethyl-4-aminophenyl)methane, 1,4-bis(4-aminophenoxy) Benzene, 1,3-bis(4-aminophenoxy)benzene, 1,4-bis(4-aminophenyl)benzene, 1,3-bis(4-aminophenyl)benzene, 1, 4-bis(4-aminobenzyl)benzene, 1,3-bis(4-aminophenoxy)benzene, 4,4'-[1,4-phenylenebis(methyl)diphenylamine , 4,4'-[1,3-Benzene bis(methyl)diphenylamine, 3,4'-[1,4-phenylenebis(methyl)diphenylamine, 3,4'- [1,3-Benzene bis(methyl))diphenylamine, 3,3'-[1,4-phenylenebis(methyl)diphenylamine, 3,3'-[1,3-stretch Benzene (methyl)]diphenylamine, 1,4-benzoic bis[(4-aminophenyl)methanone], 1,4-benzoic bis[(3-aminophenyl)methanone] , 1,3-phenylene bis[(4-aminophenyl)methanone], 1,3-phenylene bis[(3-amino) Methyl hydrazine, 1,4-phenylene bis(4-aminobenzoate), 1,4-phenylene bis(3-aminobenzoate), 1,3-phenylene bis ( 4-aminobenzoic acid ester), 1,3-phenylene bis(3-aminobenzoate), bis(4-aminophenyl)terephthalate, bis(3-amino group) Phenyl)terephthalate, bis(4-aminophenyl)isophthalate, bis(3-aminophenyl)isophthalate, N,N'-(1, 4-Benzene) bis(4-aminophenylguanamine), hydrazine, Ν'-(1,3-phenylene) bis(4-aminophenyl phthalamide), hydrazine, Ν'-(1, 4-Benzene) bis(3-aminophenylguanamine), hydrazine, Ν'-(1,3-phenylene) bis(3-aminophenylguanamine), -65- 201219451 N,N' - bis(4-aminophenyl)terephthalamide, N,N'-bis(3-aminophenyl)terephthalamide, N,N'-bis(4-aminobenzene Isophthalamide, N,N'-bis(3-aminophenyl)isophthalamide ' 9,10_bis(4-aminophenyl)anthracene, 4,4'- Bis(4-aminophenoxy)diphenylphosphonium 2,2'-bis[4-(4-aminophenoxy)phenyl]propane, 2,2'-bis[4-(4- Aminophenoxy)phenyl] Hexafluoropropane, 2,2'-bis(4-aminophenyl)hexafluoropropane, 2,2'-bis(3-aminophenyl)hexafluoropropane, 2,2'-bis(3-amine 4-methylphenyl)hexafluoropropane, 2,2,-bis(4-aminophenyl)propane, 2,2'-bis(3-aminophenyl)propane, 2,2'- Bis(3-amino-4-methylphenyl)propane, iota, bis(4-aminophenoxy)propane, 1,3-bis(3-aminophenoxy)propane, I, 4-bis(4-aminophenoxy)butane, 1,4-bis(3-aminophenoxy)butane, 1,5-bis(4-aminophenoxy)pentane, 1 , 5-bis(3-aminophenoxy)pentane, 1,6-bis(4-aminophenoxy)hexane, 1,6-bis(3-aminophenoxy)hexane, 1,7-bis(4-aminophenoxy)heptane, 1,7-(3-aminophenoxy)heptane, 1,8-bis(4-aminophenoxy)octane, 1,8-bis(3-aminophenoxy)octane, 1,9-bis(4-aminophenoxy)decane, 1,9-bis(3-aminophenoxy)decane 1,10-(4-Aminophenoxy)decane, 1,10-(3-aminophenoxy)decane, 1,11-(4-aminophenoxy)undecane, 1,11-(3-Aminophenoxy)undecane, 1,12-(4-Aminophenoxy)dodecane, 1,12-(3-aminophenoxy)dodecane, 4-(aminomethyl)aniline, 3-(aminomethyl) An aromatic diamine compound such as aniline, 4-(2-aminoethyl)aniline or 3-(2-aminoethylaniline); bis(4-aminocyclohexyl)methane, bis(4- An alicyclic diamine compound such as amino-3-methylcyclohexyl)methane; 1,3-diaminopropane, 1,4-diaminobutane ' 1,5-diaminopentane, 1 ,6-diaminohexane, 1,7-diaminoheptane, 1,8-diaminooctane, 1,9-diaminodecane, 1,10-di

-66- S 201219451 胺基癸烷、1,11-二胺基十一烷、1，12-二胺基十二烷等之 脂肪族二胺化合物。 又，於不損本發明效果之限度，亦可使用二胺側鏈具 有烷基或含氟烷基之二胺化合物。 具體而言，例如下述之式[DA1]〜[DA12]所示之二胺 化合物。 [化 19]-66- S 201219451 An aliphatic diamine compound such as an amino decane, 1,11-diaminoundecane or 1,12-diaminododecane. Further, a diamine compound having an alkyl group or a fluorine-containing alkyl group in a diamine side chain can also be used without departing from the effects of the present invention. Specifically, for example, a diamine compound represented by the following formulas [DA1] to [DA12]. [Chem. 19]

[DA1] [DA2] [DA3] [DA4] [〇八5] (A5爲碳數1〜22之烷基或含氟烷基）。 [化 20][DA1] [DA2] [DA3] [DA4] [〇八5] (A5 is an alkyl group having 1 to 22 carbon atoms or a fluorine-containing alkyl group). [Chem. 20]

[DA10] [DA11 ] -67- 201219451 (A6 表示-COO-、-OCO-、-CONH-、-NHCO-、-CH2-、-O-、-CO-或NH-，A7表示碳數1〜22之烷基或含氟烷基）。 [it 21] h2n[DA10] [DA11 ] -67- 201219451 (A6 means -COO-, -OCO-, -CONH-, -NHCO-, -CH2-, -O-, -CO- or NH-, A7 means carbon number 1~ 22 alkyl or fluoroalkyl). [it 21] h2n

[DA12] (P爲1〜10之整數）。 此外，於不損本發明效果之限度，亦可使用下述之式 [DA13]〜[DA20]所示之二胺化合物。 [化 22][DA12] (P is an integer from 1 to 10). Further, the diamine compound represented by the following formulas [DA13] to [DA20] can also be used without departing from the effects of the present invention. [化22]

[DA16] [DA14] [DA15][DA16] [DA14] [DA15]

(m爲0〜3之整數，η爲1〜5之整數）。 此外’於不損本發明效果之限度，亦可使用下述之式 -68- ^4 201219451 [DA21]〜[DA25]所示之分子內具有羧基之二胺化合物。 [化 23] H2(m is an integer of 0 to 3, and η is an integer of 1 to 5). Further, the diamine compound having a carboxyl group in the molecule represented by the following formula -68-^4 201219451 [DA21] to [DA25] can be used as long as the effect of the present invention is not impaired. [Chemical 23] H2

(COOH)rm H2N- 〇α8〇·νη2 (COOH)m2 (COOH)m3(COOH)rm H2N- 〇α8〇·νη2 (COOH)m2 (COOH)m3

(CH2)m4COOH(CH2)m4COOH

NH,NH,

[DA21 ] (CH2)m6CO〇H[DA21 ] (CH2)m6CO〇H

[DA22][DA22]

(mi 爲 1〜4 之整數，A8 爲，單鍵、-(：仏-、-(：2114-、-(：((：113)2- 、-cf2-、-c(cf3)-、-o-、-co-、-nh-、-n(ch3)-、-conh- 、-NHC0-、-CH20-、-0CH2-、-C00-、-0C0-、-C0N(CH3)· 或N(CH3)CO-，m2及m3分別爲0〜4之整數，且爲m2 + m3 爲1〜4之整數。m4及m5分別爲1〜5之整數，A9爲碳數 1〜5之直鏈或分支烷基，m6爲1〜5之整數。A1Q爲，單 鍵、-(1^2-、-€21'14_、_0^(<3143)2_、_€?2-、-〇(〇?3)-、-〇_、-〇〇-、-NH-、-N(CH3)-、-C0NH-、-NHC0-、-CH20-、-0CH2-、-COO-、-0C0-、-CON(CH3)-或 N(CH3)CO-，m7 爲 1〜4 之整數）。 上述其他二胺化合物，可配合作爲液晶配向膜之際的 液晶配向性、電壓保持率、蓄積電荷等之特性，而將1種 類或2種類以上混合使用。 -69 - 201219451 <四羧酸二酐成分> 爲製得本發明之特定聚合物時，以將下述之式[3]所示 々 .__邱份 之四羧酸二酐（亦稱爲特定四羧酸二酐）作爲原料之· α 使用爲佳。 [化 24](mi is an integer from 1 to 4, A8 is a single bond, -(:仏-, -(:2114-, -(:((:113)2-, -cf2-, -c(cf3)-, - O-, -co-, -nh-, -n(ch3)-, -conh-, -NHC0-, -CH20-, -0CH2-, -C00-, -0C0-, -C0N(CH3)· or N (CH3) CO-, m2 and m3 are each an integer of 0 to 4, and m2 + m3 is an integer of 1 to 4. m4 and m5 are integers of 1 to 5, respectively, and A9 is a linear chain having a carbon number of 1 to 5. Or branched alkyl, m6 is an integer from 1 to 5. A1Q is, single bond, -(1^2-, -€21'14_, _0^(<3143)2_, _€?2-, -〇( 〇?3)-, -〇_, -〇〇-, -NH-, -N(CH3)-, -C0NH-, -NHC0-, -CH20-, -0CH2-, -COO-, -0C0-, -CON(CH3)- or N(CH3)CO-, m7 is an integer of 1 to 4.) The other diamine compound may be blended with a liquid crystal alignment film, a voltage holding ratio, an accumulated charge, etc. as a liquid crystal alignment film. In the case of the specific polymer of the present invention, the following formula [3] is used. .__Qiuzhizhi tetracarboxylic dianhydride (also known as specific tetracarboxylic dianhydride) as a raw material It is better to use. [Chem. 24]

η含有碳數4 式[3]中，Ζ1爲碳數4〜13之4價之有機基，旦贪 〜1 0之非芳香族環狀烴基。 攞之基。 具體而言，例如下述之式[3a]〜[3j]所示結稱 [化1 ] ?2 ?4η contains a carbon number of 4 In the formula [3], Ζ1 is a tetravalent organic group having a carbon number of 4 to 13, and a non-aromatic cyclic hydrocarbon group of 10 to 10. The base of 攞. Specifically, for example, the expressions shown in the following formulas [3a] to [3j] [Chemical 1] ? 2 ?

z3 z5 [3a] [3f ] [3b] [3c] [3d] [3β]Z3 z5 [3a] [3f ] [3b] [3c] [3d] [3β]

-70- 201219451 式[3a]中，Z2〜Z5爲由氫原子、甲基、氯原子或苯環 所選出之基，其可分別爲相同或相異皆可’式[3 g]中’ Z6 ，及Z7爲氫原子或甲基，其可分別爲相同或相異皆可。 式[3]中，Z1之特佳結構之基，就聚合反應性或合成 之容易性等觀點，例如式[3 a]、式[3 c]、式[3d]、式[3 e]、 式[3f]或式[3g]。 <其他四羧酸二酐> 本發明中，於無損本發明效果之限度，可使用特定四 羧酸二酐以外之其他之四羧酸二酐（亦稱爲其他四羧酸二 酐）。其他四羧酸二酐，例如以下所示四羧酸之四羧酸二 酐等。 苯均四酸、2,3,6,7-萘四羧酸、ι，2,5,6-萘四羧酸、 1，4,5,8-萘四羧酸、2,3,6,7-蒽四殘酸、1，2,5,6-蒽四羧酸、 3，3’，4,4’ -聯苯基四竣酸、2,3,3’，4-聯苯基四殘酸、雙（3,4· 二錢基苯基）酸、3，3’，4，4’-二苯甲酮四竣酸、雙（3，4_二翔 基本基）楓、雙（3,4 - 一竣基本基）甲院、2,2-雙（3,4 -二殘基 苯基）丙垸、1，1，1，3,3,3-六氟-2,2-雙（3,4_二羧基苯基）丙烷 、雙（3,4 - 一殘基苯基）二甲基砂院、雙（3,4 -二殘基苯基）二 本基砂院、2,3,4,5-啦陡四竣酸、2,6-雙（3 4 -二錢基苯基） 吡啶、3’3’，4,4’-二苯基碾四羧酸、3,4,9，1〇_茈四羧酸或 I，3·二苯基-I，2,3,4·環丁烷四羧酸等。 上述其他四羧酸二酐，可配合其作爲液晶配向膜之際 的液晶配向性、電壓保持率、蓄積電荷等之特性，將丨種 -71 - 201219451 類或2種類以上混合使用亦可。 <特定聚合物> 本發明之特定聚合物爲由聚醯亞胺前趨物及聚醯亞胺 所成群所選出之至少1種之聚合物，聚醯亞胺前趨物爲下 述之式[A]所示之結構。 [化 26]-70- 201219451 In the formula [3a], Z2 to Z5 are groups selected by a hydrogen atom, a methyl group, a chlorine atom or a benzene ring, which may be the same or different, respectively. [3 g] in the 'Z6 And Z7 is a hydrogen atom or a methyl group, which may be the same or different, respectively. In the formula [3], the basis of the particularly preferable structure of Z1 is, for example, the formula [3 a], the formula [3 c], the formula [3d], the formula [3 e], etc., in terms of polymerization reactivity or ease of synthesis. Formula [3f] or formula [3g]. <Other tetracarboxylic dianhydride> In the present invention, other tetracarboxylic dianhydrides other than the specific tetracarboxylic dianhydride (also referred to as other tetracarboxylic dianhydride) may be used without departing from the effects of the present invention. . Other tetracarboxylic dianhydrides are, for example, tetracarboxylic dianhydrides of tetracarboxylic acids shown below. Pyromellitic acid, 2,3,6,7-naphthalenetetracarboxylic acid, iota, 2,5,6-naphthalenetetracarboxylic acid, 1,4,5,8-naphthalenetetracarboxylic acid, 2,3,6, 7-蒽tetraresidic acid, 1,2,5,6-nonanetetracarboxylic acid, 3,3',4,4'-biphenyltetradecanoic acid, 2,3,3',4-biphenyltetra Residual acid, bis(3,4-dixyphenyl) acid, 3,3',4,4'-benzophenone tetradecanoic acid, bis(3,4_difyl basic) maple, double ( 3,4 - a basic base) A, 2,2-bis(3,4-di-resylphenyl)propanoid, 1,1,1,3,3,3-hexafluoro-2,2- Bis(3,4-dicarboxyphenyl)propane, bis(3,4-residylphenyl)dimethyl sand, bis(3,4-di residue phenyl) dibasin sand, 2 , 3,4,5-lathroic acid, 2,6-bis(3 4 -dipicylphenyl)pyridine, 3'3',4,4'-diphenyltricarboxylic acid, 3, 4,9,1〇_茈tetracarboxylic acid or I,3·diphenyl-I, 2,3,4·cyclobutanetetracarboxylic acid, and the like. The above-mentioned other tetracarboxylic dianhydride may be used in combination with the liquid crystal alignment property, the voltage holding ratio, and the accumulated charge when it is used as a liquid crystal alignment film, and may be used in combination of two or more types of the type -71 - 201219451. <Specific polymer> The specific polymer of the present invention is at least one polymer selected from the group consisting of a polyimine precursor and a polyimine, and the polyimine precursor is as follows The structure shown by the formula [A]. [Chem. 26]

(R9爲4價之有機基，R1G爲2價之有機基，A11及A12爲 氫原子或碳數1〜8之烷基，其可分別爲相同或相異皆可 ，η表示正整數）。 本發明之特定聚合物，就由下述之式[Β]所示之二胺 成分與下述之式[C]所示之四羧酸二酐成分與作爲原料而 可以較簡單之方式製得之理由，以使用下述之式[D]所示 之重複單位之結構式所形成之聚醯胺酸或該聚醯胺酸經醯 亞胺化所得之聚醯亞胺爲佳。(R9 is a tetravalent organic group, R1G is a divalent organic group, and A11 and A12 are a hydrogen atom or an alkyl group having 1 to 8 carbon atoms, which may be the same or different, respectively, and η represents a positive integer). The specific polymer of the present invention can be obtained in a relatively simple manner from the diamine component represented by the following formula [Β] and the tetracarboxylic dianhydride component represented by the following formula [C] as a raw material. For the reason, it is preferred to use a polylysine formed by a structural formula of a repeating unit represented by the following formula [D] or a polyimine obtained by ruthenium imidization of the polyglycolic acid.

-72- 201219451 [it 27]-72- 201219451 [it 27]

h2n一 R1-一nh2 [b] (R9及R1()爲與式[A]所定義之內容爲相同之定義）。 [化 28]H2n - R1 - nh2 [b] (R9 and R1() are the same definitions as defined in the formula [A]). [化 28]

(R9、R1()及η爲與式[A]所定義之內容爲相同之定義）。 式[A]及式[D]中，R9及Rie，可分別爲單1種類亦可 ，或將相互不同之R9及R1 ^作爲重複單位，並將相異之多 數種組合所得者亦可。 本發明中，合成特定聚合物之方法並未有特別限定。 通常可由二胺成分與四羧酸二酐成分反應而得。一般而言 ，爲將由四羧酸及其衍生物所成之群所選出之至少1種之 四羧酸成分與，由1種或多數種之二胺化合物所形成之二 胺成分反應，而製得聚醯胺酸。製得聚醯胺酸烷酯中，可 使用將聚醯胺酸之羧基變換爲酯之方法。 此外，欲製得聚醯亞胺時，可使用將前述聚醯胺酸或 -73- 201219451 聚醯胺酸烷酯醯亞胺化以製得聚醯亞胺之方法。 使用本發明之特定聚合物所得之液晶配向膜，於上述 二胺成分中，特定二胺化合物之含有比例越多時，除初期 特性以外，即使受到背光光線長時間曝曬後，亦可快速地 緩和電壓保持率及因直流電壓而蓄積之電荷。又，二胺成 分中，特定側鏈型二胺化合物之含有比例越多時，可增大 液晶之預傾斜角。此時，就提高上述特性之目的中，二胺 成分中之特定側鏈型二胺化合物的含量，以相對於特定二 胺化合物1莫耳，爲〇.〇1〜99莫耳爲佳。較佳爲0.1〜50 莫耳，更佳爲0.5〜20莫耳，最佳爲0.5〜10莫耳。 又，欲製得本發明之特定聚合物，四羧酸二酐成分以 使用特定四羧酸二酐爲佳。此時，四羧酸二酐成分中，以 1莫耳％以上爲特定四羧酸二酐爲佳，較佳爲5莫耳％以上 ’更佳爲10莫耳。/。以上。又，四羧酸二酐成分中，特定四 羧酸二酐亦可爲100莫耳％。 二胺成分與四羧酸二酐成分之反應通常爲於有機溶劑 中進行。此時所使用之有機溶劑，只要可溶解所生成之聚 醯亞胺前趨物之溶劑，並未有特別限定。其具體例如以下 所示。 N，N-二甲基甲醯胺、Ν,Ν-二甲基乙醯胺、N -甲基- 2-吡咯啶酮、Ν-甲基己內醯胺、二甲基亞颯、四甲基尿素、 吡啶、二甲基颯、六甲基亞颯、γ-丁內酯、異丙基醇、甲 氧甲基戊醇、雙戊烯、乙基戊酮、甲基壬基酮、甲基乙基 酮、甲基異戊酮、甲基異丙基酮、甲基溶纖素、乙基溶纖(R9, R1() and η are the same definitions as defined in the formula [A]). In the formula [A] and the formula [D], R9 and Rie may each be a single type, or R9 and R1^ which are different from each other may be used as a repeating unit, and a plurality of different combinations may be obtained. In the present invention, the method of synthesizing a specific polymer is not particularly limited. It is usually obtained by reacting a diamine component with a tetracarboxylic dianhydride component. In general, at least one tetracarboxylic acid component selected from the group consisting of tetracarboxylic acid and a derivative thereof is reacted with a diamine component formed from one or a plurality of diamine compounds. Get polyamic acid. In the preparation of the polyamic acid alkyl ester, a method of converting the carboxyl group of the polyproline to the ester can be used. Further, in order to obtain a polyimine, a method of imidating the aforementioned polyamic acid or -73-201219451 polyalkylenimine oxime to obtain a polyimine may be used. In the liquid crystal alignment film obtained by using the specific polymer of the present invention, in the above diamine component, the more the content ratio of the specific diamine compound is contained, the short-term exposure of the backlight light can be quickly alleviated in addition to the initial characteristics. The voltage holding ratio and the charge accumulated by the DC voltage. Further, in the diamine component, the more the content ratio of the specific side chain type diamine compound, the larger the pretilt angle of the liquid crystal. In this case, in order to enhance the above characteristics, the content of the specific side chain type diamine compound in the diamine component is preferably from 1 to 99 moles per mole of the specific diamine compound. It is preferably 0.1 to 50 m, more preferably 0.5 to 20 m, and most preferably 0.5 to 10 m. Further, in order to obtain a specific polymer of the present invention, the tetracarboxylic dianhydride component is preferably a specific tetracarboxylic dianhydride. In this case, among the tetracarboxylic dianhydride components, 1 mol% or more is preferably a specific tetracarboxylic dianhydride, preferably 5 mol% or more, and more preferably 10 mol. /. the above. Further, among the tetracarboxylic dianhydride components, the specific tetracarboxylic dianhydride may be 100 mol%. The reaction of the diamine component with the tetracarboxylic dianhydride component is usually carried out in an organic solvent. The organic solvent to be used at this time is not particularly limited as long as it can dissolve the solvent of the produced polyimine precursor. The details are as follows, for example. N,N-dimethylformamide, hydrazine, hydrazine-dimethylacetamide, N-methyl-2-pyrrolidone, Ν-methyl caprolactam, dimethyl hydrazine, tetramethyl Base urea, pyridine, dimethyl hydrazine, hexamethylarylene, γ-butyrolactone, isopropyl alcohol, methoxymethylpentanol, dipentene, ethyl pentanone, methyl decyl ketone, A Ethyl ketone, methyl isoamyl ketone, methyl isopropyl ketone, methyl cellosolve, ethyl cellosolve

-74- 201219451 素、甲基賽珞蘇（Cellosolve)乙酸鹽、乙基賽珞蘇（ Cellosolve)乙酸鹽、丁基卡必醇、乙基卡必醇、乙二醇、 乙二醇單乙酸鹽、乙二醇單異丙基醚、乙二醇單丁基醚、 丙二醇、丙二醇單乙酸鹽、丙二醇單甲基醚、丙二醇· tert-丁基醚、二丙二醇單甲基醚、二乙二醇、二乙二醇單 乙酸鹽、二乙二醇二甲基醚、二丙二醇單乙酸鹽單甲基醚 、二丙二醇單甲基醚、二丙二醇單乙基醚、二丙二醇單乙 酸鹽單乙基醚、二丙二醇單丙基醚、二丙二醇單乙酸鹽單 丙基醚、3-甲基-3-甲氧基丁基乙酸鹽、三丙二醇甲基醚、 3_甲基_3_甲氧基丁醇、二異丙基醚、乙基異丁基醚、二異 丁烯、戊基乙酸鹽、丁基丁酯、丁基醚、二異丁基酮、甲 基環己烯、丙基醚、二己基醚、二噁烷、η-己院、η-戊院 、η-辛烷、二乙基醚、環己酮、乙烯碳酸酯、丙烯碳酸酯 、乳酸甲酯、乳酸乙酯、乙酸甲酯、乙酸乙酯、乙酸η-丁 酯、乙酸丙二醇單乙基醚、丙酮酸甲酯、丙酮酸乙酯、3-甲氧基丙酸甲酯、3-乙氧基丙酸甲基乙酯、3-甲氧基丙酸 乙酯、3-乙氧基丙酸、3-甲氧基丙酸、3-甲氧基丙酸丙酯 、3-甲氧基丙酸丁酯、二甘二甲醚或4-羥基-4-甲基-2-戊 酮等。該些可單獨使用或混合使用皆可。此外，即使不會 溶解聚醯亞胺前趨物之溶劑，於不會析出所生成之聚醯亞 胺前趨物之範圍，亦可與上述溶劑混合使用。又，有機溶 劑中之水分會阻礙聚合反應，且會造成所生成之聚醯亞胺 前趨物進行水解之原因，故有機溶劑以使用脫水乾燥者爲 佳。 -75- 201219451 二胺成分與四羧酸二酐成分在有機溶劑中進行反應之 際，例如有將分散或溶解有二胺成分之有機溶劑所得之溶 液進行攪拌中，並將四羧酸二酐成分無處理下，或使其分 散或溶解於有機溶劑後再予添加之方法，相反的，也有使 四羧酸二酐分散或溶解於有機溶劑所得之溶液中添加二胺 成分之方法、將四羧酸二酐成分與二胺成分交互添加之方 法等，可使用該些之任一方法進行即可。又，二胺成分或 四羧酸二酐成分分別使用多數種進行反應之情形，可先於 混合之狀態下進行反應亦可，或個別依序進行反應亦可， 又可將個別反應之低分子量體進行混合反應以作爲特定聚 合物亦可。此時之聚合溫度可選擇-20〜150°C之任意溫度 ，較佳爲·5〜100°C之範圍。又，反應可於任意之濃度下進 行，但濃度過低時，將不易得到高分子量之特定聚合物， 濃度過高時，將會使反應液之黏性過度提昇，而不容易均 勻地攪拌。因此，較佳爲1〜5 0質量％，更佳爲5〜3 0質 量％。反應初期先以高濃度進行，隨後再追加有機溶劑亦 可 0 於製造聚醯亞胺前趨物之聚合反應中，二胺成分之合 計莫耳數與四羧酸二酐成分之合計莫耳數之比以0.8〜1.2 爲佳。其與通常之聚縮合反應相同般，此莫耳比越趨近於 1.0時，將會增大生成之聚醯亞胺前趨物的分子量。 本發明之聚醯亞胺爲前述之聚醯亞胺前趨物經脫水閉 環所得之聚醯亞胺，其適合作爲製造液晶配向膜所使用之 聚合物。-74- 201219451 素,Cellosolve acetate, Cellosolve acetate, butyl carbitol, ethyl carbitol, ethylene glycol, ethylene glycol monoacetate Ethylene glycol monoisopropyl ether, ethylene glycol monobutyl ether, propylene glycol, propylene glycol monoacetate, propylene glycol monomethyl ether, propylene glycol tert-butyl ether, dipropylene glycol monomethyl ether, diethylene glycol , diethylene glycol monoacetate, diethylene glycol dimethyl ether, dipropylene glycol monoacetate monomethyl ether, dipropylene glycol monomethyl ether, dipropylene glycol monoethyl ether, dipropylene glycol monoacetate monoethyl Ether, dipropylene glycol monopropyl ether, dipropylene glycol monoacetate monopropyl ether, 3-methyl-3-methoxybutyl acetate, tripropylene glycol methyl ether, 3-methyl-3-yloxy Butanol, diisopropyl ether, ethyl isobutyl ether, diisobutylene, pentyl acetate, butyl butyl ester, butyl ether, diisobutyl ketone, methyl cyclohexene, propyl ether, two Hexyl ether, dioxane, η-hexan, η-penthouse, η-octane, diethyl ether, cyclohexanone, ethylene carbonate, propylene carbonate, methyl lactate, Ethyl lactate, methyl acetate, ethyl acetate, η-butyl acetate, propylene glycol monoethyl ether, methyl pyruvate, ethyl pyruvate, methyl 3-methoxypropionate, 3-ethoxyl Methyl ethyl propionate, ethyl 3-methoxypropionate, 3-ethoxypropionic acid, 3-methoxypropionic acid, propyl 3-methoxypropionate, 3-methoxypropionic acid Butyl ester, diglyme or 4-hydroxy-4-methyl-2-pentanone. These may be used singly or in combination. Further, even if the solvent of the polyimine precursor is not dissolved, it can be used in combination with the above solvent insofar as it does not precipitate the polyimine precursor formed. Further, the moisture in the organic solvent hinders the polymerization reaction and causes the formation of the polyimine precursor to be hydrolyzed, so that the organic solvent is preferably dried by dehydration. -75- 201219451 When the diamine component and the tetracarboxylic dianhydride component are reacted in an organic solvent, for example, a solution obtained by dispersing or dissolving an organic solvent in which a diamine component is dissolved is stirred, and tetracarboxylic dianhydride is added. a method in which the component is not treated or dispersed or dissolved in an organic solvent, and a method of adding a diamine component to a solution obtained by dispersing or dissolving a tetracarboxylic dianhydride in an organic solvent, or The method of mutually adding a carboxylic dianhydride component and a diamine component can be carried out using any of these methods. Further, when the diamine component or the tetracarboxylic dianhydride component is reacted by a plurality of kinds, the reaction may be carried out before mixing, or the reaction may be carried out in an individual order, and the low molecular weight of the individual reaction may be used. The mixing reaction may be carried out as a specific polymer. The polymerization temperature at this time may be any temperature of from -20 to 150 ° C, preferably from 5 to 100 ° C. Further, the reaction can be carried out at any concentration. However, when the concentration is too low, it is difficult to obtain a specific polymer having a high molecular weight. When the concentration is too high, the viscosity of the reaction liquid is excessively increased, and it is not easy to uniformly stir. Therefore, it is preferably from 1 to 50% by mass, more preferably from 5 to 30,000% by mass. In the initial stage of the reaction, the concentration is firstly carried out at a high concentration, and then the organic solvent may be added. In the polymerization reaction for producing the polyamidiamine precursor, the total number of moles of the diamine component and the total amount of the tetracarboxylic dianhydride component are the number of moles. The ratio is preferably 0.8 to 1.2. It is the same as the usual polycondensation reaction, and the closer the molar ratio is to 1.0, the larger the molecular weight of the resulting polyimine precursor. The polyimine of the present invention is a polyimine obtained by subjecting the aforementioned polyimine precursor to a dehydration ring, which is suitable as a polymer for producing a liquid crystal alignment film.

-76- 201219451 本發明之聚醯亞胺中，醯胺酸基之脫水閉環率（醯亞 胺化率），並非必須爲1 〇〇%，其可配合用途或目的而進行 任意的調整。 使聚醯亞胺前趨物醯亞胺化之方法，例如將聚醯亞胺 前趨物之溶液於無處理下進行加熱使其熱醯亞胺化，或於 聚醯亞胺前趨物之溶液中添加觸媒，使其醯亞胺化等。 使聚醯亞胺前趨物於溶液中進行熱醯亞胺化之情形的 溫度，一般爲100〜400 °c，較佳爲120〜250 °c，醯亞胺化 反應所生成之水，以將其排除於反應系外之方法爲佳。 聚醯亞胺前趨物之觸媒醯亞胺化爲，於聚醯亞胺前趨 物之溶液中，添加鹼性觸媒與酸酐，一般於-20〜25 (TC， 較佳爲於0〜18(TC下進行攪拌之方式進行。鹼性觸媒之量 爲醯胺酸基的0.5〜30莫耳倍，較佳爲2〜20莫耳倍，酸 酐之量爲醯胺酸基的1〜50莫耳倍，較佳爲3〜30莫耳倍 。鹼性觸媒例如，吡啶、三乙基胺、三甲基胺、三丁基胺 、三辛基胺等，其中又以吡啶於反應進行中可維持適度之 鹼性，而爲較佳。 酸酐，例如乙酸酐、偏苯三甲酸酐、苯均四甲酸酐等 ，其中又以使用乙酸酐時，於反應結束後容易進行精製， 而爲較佳。觸媒醯亞胺化之醯亞胺化率，可以調節觸媒量 、反應溫度、反應時間等方式予以控制。 由聚醯亞胺前趨物或聚醯亞胺之反應溶液回收所生成 之聚醯亞胺前趨物或聚醯亞胺之情形，只要將反應溶液投 入溶劑，使其沈澱即可。沈澱所使用之溶劑，例如甲醇、 -77- 201219451 丙酮、己烷、丁基溶纖素、庚烷、甲基乙基酮、甲基異丁 基酮、乙醇、甲苯、苯、水等。過濾回收投入溶劑而沈澱 之聚合物後，於常壓或減壓下，可於常溫或加熱下進行乾 燥。隨後將經沈澱回收之聚合物，以有機溶劑重複進行2 〜20次之再溶解、再沈澱回收之操作，即可降低聚合物中 之雜質。此時所使用之溶劑，例如，醇類、酮類、碳化氫 等，於使用由該些內容所選出之3種類以上之溶劑時，可 更提升精製之效率，而爲較佳。 本發明之特定聚合物之分子量，於考慮所得聚合物被 膜之強度、聚合物被膜形成時之操作性、聚合物被膜之均 句性時，以 GPC(Gel Permeation ChromatographY)法測定 之重量平均分子量爲5,000〜1，000,000爲佳，更佳爲10,000 ~ 150,000 〇 <液晶配向處理劑> 本發明之液晶配向處理劑爲形成液晶配向膜爲目的之 塗佈液，其爲含有特定聚合物及有機溶劑之塗佈液。 本發明之液晶配向處理劑中，聚合物成分可使用全部 爲本發明所使用之特定聚合物亦可，本發明之特定聚合物 再與本發明之液晶配向處理劑以外之其他聚合物混合者亦 可。此時，相對於特定聚合物之本發明之液晶配向處理劑 以外之其他之聚合物的含量爲0.5〜15質量％，較佳爲1 〜1 0質量％。 本發明之液晶配向處理劑以外之其他之聚合物，例如 -78- 201219451 不含特定二胺化合物及特定側鏈型二胺化合物 ，與不含特定四羧酸二酐之四羧酸二酐成分所 胺前趨物，或該聚醯亞胺前趨物所得之聚醯亞 ，例如聚醯亞胺前趨物及聚醯亞胺以外之聚合 言，例如丙烯酸聚合物、甲基丙烯酸聚合物、 聚醯胺等。 本發明之液晶配向處理劑中之有機溶劑， 形成均勻之聚合物被膜之觀點，有機溶劑之含 質量％爲佳。該含量可配合目的液晶配向膜之 之適當變更。此時之有機溶劑，只要可溶解上 物之有機溶劑時，並未有特別限定。更具體 Ν,Ν-二甲基甲醯胺、N，N-二甲基乙醯胺、N-啶酮、N-甲基己內醯胺、2-吡咯啶酮、N-乙基 、N-乙烯基吡咯啶酮、二甲基亞颯、四甲基尿 二甲基颯、六甲基亞颯、γ-丁內酯、1,3-二甲； 酮、乙基戊酮、甲基壬基酮、甲基乙基酮、甲 甲基異丙基酮、環己酮、乙烯碳酸酯、丙烯碳 二甲醚及4-羥基-4-甲基-2-戊酮等。該些可單 合使用皆可。 本發明之液晶配向處理劑，於無損本發明 ，可含有具有環氧基、異氰酸酯基、環氧丙院 酯基之交聯性化合物、具有由羥基或烷氧基所 之至少1種之取代基的交聯性化合物、具有聚 鍵結之交聯性化合物等。 I之二胺成分 :得之聚醯亞 !胺等。此外 _物，具體而 聚苯乙嫌或 就可塗佈而 量以7 0〜9 9 膜厚作適當 述特定聚合 而言，例如 甲基-2 -耻略 -2-吡咯啶酮 素、吡啶、 基-四氫咪哩 基異戊酮、 酸酯、二甘 獨使用或混 效果之限度 基或環碳酸 成群所選出 :合性不飽和 -79- 201219451 具有環氧基或異氰酸酯基之交聯性化合物’例如’雙 酚丙酮縮水甘油醚、酚清漆環氧樹脂、甲酣清漆環氧樹脂 、異氰尿酸三縮水甘油酯、四縮水甘油胺基連苯、四縮水 甘油基二甲苯二胺、四縮水甘油基-1，3-雙（胺基乙基） 環己烷、四苯基縮水甘油醚乙烷、三苯基縮水甘油醚乙院 、雙酚六氟乙醯二縮水甘油醚、1，3-雙（1-(2,3-環氧丙氧基 卜卜三氟甲基^一一-三氟甲基彡苯〜必心雙^^-環氧丙氧基） 八氟聯苯基、三縮水甘油基·ρ-胺基酚、四縮水甘油甲基二 甲苯二胺、2-(4-(2,3-環氧丙氧基）苯基）-2-(4-(1,1-雙（4-(2,3-環氧丙氧基）苯基）乙基）苯基）丙烷、1，3-雙（4-(1-(4-(2，3-環氧丙氧基）苯基）-1-(4-(1-(4-(2,3-環氧丙氧基苯基）-1-甲基乙基）苯基）乙基）苯氧基）-2-丙醇等。 具有環氧丙烷基之交聯性化合物，例如至少具有2個 下述之式[4]所示之環氧丙烷基的交聯性化合物。 [化 29]-76- 201219451 In the polyimine of the present invention, the dehydration ring closure ratio of the valine group is not necessarily 1%, and it can be arbitrarily adjusted depending on the use or purpose. A method for imidating a polyimine precursor hydrazine, for example, heating a solution of a polybendylene precursor to a heat-free imidization without treatment, or a poly-imine precursor A catalyst is added to the solution to imidize the oxime or the like. The temperature at which the polyimine precursor is subjected to thermal imidization in a solution is generally 100 to 400 ° C, preferably 120 to 250 ° C, and the water formed by the hydrazine imidization reaction is It is preferred to exclude it from the reaction system. The catalyst of the polyimine precursor is imidized to a basic catalyst and an acid anhydride in a solution of the polyimine precursor, generally at -20 to 25 (TC, preferably at 0). ~18 (TC is carried out by stirring. The amount of alkaline catalyst is 0.5 to 30 moles of valerine group, preferably 2 to 20 moles, and the amount of anhydride is 1 of amidino group. ~50 moles, preferably 3 to 30 moles. Basic catalysts such as pyridine, triethylamine, trimethylamine, tributylamine, trioctylamine, etc., of which pyridine is It is preferred to maintain a moderate alkalinity during the reaction. An acid anhydride such as acetic anhydride, trimellitic anhydride, benzene tetracarboxylic anhydride, or the like, wherein acetic anhydride is used, and it is easy to refine after the reaction is completed. Preferably, the imidization ratio of the ruthenium imidization can be controlled by adjusting the amount of the catalyst, the reaction temperature, the reaction time, etc. Recycling from the reaction solution of the polyimine precursor or polyimine. In the case of the produced polyimine precursor or polyimine, the reaction solution may be put into a solvent to precipitate it. a solvent such as methanol, -77-201219451 acetone, hexane, butyl cellosolve, heptane, methyl ethyl ketone, methyl isobutyl ketone, ethanol, toluene, benzene, water, etc. The solvent is recovered by filtration. After precipitating the polymer, drying may be carried out at normal temperature or under reduced pressure under normal pressure or under reduced pressure, and then the polymer recovered by precipitation may be repeatedly dissolved in an organic solvent for 2 to 20 times, and then reprecipitated and recovered. The impurities in the polymer can be reduced. The solvent used in this case, for example, an alcohol, a ketone, a hydrocarbon, or the like, can further enhance the purification when using three or more types of solvents selected from the above contents. It is preferable that the molecular weight of the specific polymer of the present invention is GPC (Gel Permeation Chromatograph Y) in consideration of the strength of the obtained polymer film, the workability when the polymer film is formed, and the uniformity of the polymer film. The weight average molecular weight measured by the method is preferably 5,000 to 1,000,000, more preferably 10,000 to 150,000 Å <liquid crystal alignment treatment agent> The liquid crystal alignment treatment agent of the present invention is formed by forming a liquid crystal alignment film. The coating liquid containing a specific polymer and an organic solvent is used as the coating liquid of the liquid crystal alignment treatment agent of the present invention, and the polymer component may be any specific polymer used in the present invention. The specific polymer may be further mixed with a polymer other than the liquid crystal alignment treatment agent of the present invention. At this time, the content of the polymer other than the liquid crystal alignment treatment agent of the present invention relative to the specific polymer is 0.5 to 15 % by mass, preferably 1 to 10% by mass. Other polymers other than the liquid crystal alignment treatment agent of the present invention, for example, -78 to 201219451, do not contain a specific diamine compound and a specific side chain type diamine compound, and do not contain An amine precursor of a tetracarboxylic dianhydride component of a specific tetracarboxylic dianhydride, or a polyfluorene obtained from the polyimine precursor, such as a polyimine precursor and a polyimine For example, an acrylic polymer, a methacrylic polymer, polyamine or the like. The organic solvent in the liquid crystal alignment agent of the present invention is preferably in the form of a uniform polymer film, and the mass % of the organic solvent is preferred. This content can be appropriately changed in accordance with the intended liquid crystal alignment film. The organic solvent at this time is not particularly limited as long as it can dissolve the organic solvent of the above. More specifically, Ν-dimethylformamide, N,N-dimethylacetamide, N- ketone, N-methyl caprolactam, 2-pyrrolidone, N-ethyl, N -vinylpyrrolidone, dimethyl hydrazine, tetramethyl urethane dimethyl hydrazine, hexamethyl hydrazine, γ-butyrolactone, 1,3-dimethyl; ketone, ethyl pentanone, methyl Mercapto ketone, methyl ethyl ketone, methyl isopropyl ketone, cyclohexanone, ethylene carbonate, propylene carbon dimethyl ether and 4-hydroxy-4-methyl-2-pentanone. These can be used alone or in combination. The liquid crystal alignment treatment agent of the present invention may contain a crosslinking compound having an epoxy group, an isocyanate group or a propylene oxide ester group, and a substituent having at least one of a hydroxyl group or an alkoxy group, without detracting from the invention. A crosslinkable compound, a crosslinkable compound having a poly bond, and the like. I diamine component: obtained from polyamines, amines, and the like. In addition, _ matter, specifically polystyrene or susceptibility can be coated and the amount of 70 ~ 9 9 film thickness for the specific polymerization, such as methyl-2 - sylvestre-2-pyrrolidone, pyridine , thiol-tetrahydroindolyl isoamyl ketone, acid ester, di-glycan use or mixed effect limit group or ring carbonic acid group selected: hydrolytic unsaturated -79- 201219451 with epoxy or isocyanate group A combination compound such as 'bisphenol acetone glycidyl ether, phenol varnish epoxy resin, nail varnish epoxy resin, triglycidyl isocyanurate, tetraglycidylaminobenzene, tetraglycidyl xylene diamine , tetraglycidyl-1,3-bis(aminoethyl)cyclohexane, tetraphenyl glycidyl ether ethane, triphenyl glycidyl ether, bisphenol hexafluoroacetic acid diglycidyl ether, 1,3-bis(1-(2,3-epoxypropoxydibufluoromethyl)-monofluoromethylhydrazine-p-bis-^-epoxypropoxy) octafluoro Phenyl, triglycidyl, p-aminophenol, tetraglycidyl methyl xylene diamine, 2-(4-(2,3-epoxypropoxy)phenyl)-2-(4-( 1,1-double (4-(2,3-ring) Propoxy)phenyl)ethyl)phenyl)propane, 1,3-bis(4-(1-(4-(2,3-epoxypropoxy)phenyl)-1-(4-() 1-(4-(2,3-epoxypropoxyphenyl)-1-methylethyl)phenyl)ethyl)phenoxy)-2-propanol, etc. having an oxypropylene group The crosslinking compound is, for example, a crosslinkable compound having at least two propylene oxide groups represented by the following formula [4].

具體而言，例如下述之式[4a]〜[4k]所示之交聯性化 合物。 -80- 201219451Specifically, for example, a crosslinkable compound represented by the following formulas [4a] to [4k]. -80- 201219451

-81 - 201219451 [化 32]-81 - 201219451 [化32]

具有環碳酸酯基之交聯性化合物，例如具有至少2個 下述之式[5]所示之環碳酸酯基之交聯性化合物等。 [化 33]The crosslinkable compound having a cyclic carbonate group, for example, a crosslinkable compound having at least two cyclic carbonate groups represented by the following formula [5]. [化33]

[5] 具體而言，例如下述之式[5-1]〜式[5-37]所示之交聯 性化合物。[5] Specifically, for example, a crosslinkable compound represented by the following formula [5-1] to formula [5-37].

-82- 201219451 [化 3 4]-82- 201219451 [Chem. 3 4]

-83- 201219451 [化 35]-83- 201219451 [化35]

-84- 201219451 [化 36]-84- 201219451 [化36]

-85- 201219451 [化 37]-85- 201219451 [化37]

[5-16] η[5-16] η

C1- -86- 201219451 [化 38]C1- -86- 201219451 [Chem. 38]

-87- 201219451 [it 39]-87- 201219451 [it 39]

[5-23][5-23]

[化 40][40]

[5-31] [5-32] -88- 201219451 [化 41][5-31] [5-32] -88- 201219451 [Chem. 41]

[5-34][5-34]

[5-35][5-35]

(式[5-24]中，η爲1〜5之整數，式[5-25]中，η爲1〜5之 整數，式[5-36]中，η爲1〜100之整數，式[5-37]中，η 爲1〜10之整數）。 此外，亦例如具有至少1種下述之式[5 - 3 8 ]〜式[5 -40]所示結構之聚矽氧烷等。 [化 42](In the formula [5-24], η is an integer of 1 to 5, and in the formula [5-25], η is an integer of 1 to 5, and in the formula [5-36], η is an integer of 1 to 100, and In [5-37], η is an integer of 1 to 10). Further, for example, it has at least one kind of polyoxoxane having a structure represented by the following formula [5 - 3 8 ] to formula [5 - 40]. [化42]

R2 一Si—0 r3 I —O—Si—0一 I r4R2 - Si - 0 r3 I - O - Si - 0 - I r4

Rs I _O—Si—O— I o [5-38] [5-39] [5-40] -89 201219451 (式[5·38]〜式[5-40]中 ’ Ri、R2、R3、R4 及 r5，分別獨立 爲式[5]所示之結構、氫原子、羥基、碳數1〜l〇之烷基、 烷氧基、脂肪族環或芳香族環’且至少1個爲式[5]所示之 結構）。 更具體而言，例如下述之式[5-41]或式[5_42]之化合 物等。 [化 43]Rs I _O—Si—O— I o [5-38] [5-39] [5-40] -89 201219451 (in the formula [5·38]~[5-40], 'Ri, R2, R3, R4 and r5 are each independently a structure represented by the formula [5], a hydrogen atom, a hydroxyl group, an alkyl group having 1 to 10 carbon atoms, an alkoxy group, an aliphatic ring or an aromatic ring ' and at least one of them is a formula [ 5] The structure shown). More specifically, for example, a compound of the following formula [5-41] or formula [5-42]. [化43]

[5-42] (式[5-42]中’ η爲1〜1〇之整數）。 具有至少1種由羥基或烷氧基所成群所選出之取代基 的交聯性化合物’例如’具有羥基或烷氧基之胺基樹脂， 例如’三聚氰胺樹脂、尿素樹脂、胍樹脂、乙炔脲-甲醛 樹脂、丁二醯基醯胺-甲醛樹脂、乙烯尿素-甲醛樹脂等。 具體而言’例如可使用胺基之氫原子被羥甲基或烷氧基甲 基或其二者所取代之三聚氰胺衍生物、苯胍胺 (benzoguanamine)衍生物’或乙炔脲。三聚氰胺衍生物或 苯胍胺衍生物，可以二聚物或三聚物形式存在。該些成份 -90- 201219451 以三嗪環作爲1個單位，以平均具有3〜6個羥甲基或烷 氧基甲基者爲佳。 該些三聚氰胺衍生物或苯胍胺衍生物之例如，每一個 市售物之三嗪環平均被3.7個甲氧甲基所取代之MX-750 、每一個三嗪環平均被5.8個甲氧甲基所取代之MW-30 ( 以上，三和化學公司製）、賽麥爾 300、301、303、350、 370、771、325、327、703、712等之甲氧甲基化三聚氰胺 、賽麥爾 235、236、238、212、253、254等之甲氧甲基 化丁氧甲基化三聚氰胺、賽麥爾5 06、5 08等之丁氧甲基 化三聚氰胺、賽麥爾1141等之含羧基之甲氧甲基化異丁 氧甲基化三聚氰胺、賽麥爾1123等之甲氧甲基化乙氧基 甲基化苯胍胺、賽麥爾1123-10等之甲氧甲基化丁氧甲基 化苯胍胺、賽麥爾1128等之丁氧甲基化苯胍胺、賽麥爾 1 1 25 -80等之含羧基之甲氧甲基化乙氧基甲基化苯胍胺（以 上’三井賽麥敏公司製）等。又，乙炔脲之例如，賽麥爾 1170等之丁氧甲基化乙炔脲、賽麥爾1172等之羥甲基化 乙炔脲、保達靈1174等之甲氧基羥甲基化乙炔脲等。 又如具有羥基或烷氧基之苯，或酚性化合物亦可作爲 交聯性化合物之例示。例如，1,3,5-三（甲氧甲基）苯、 1,2,4-三（異丙氧基甲基）苯、1,4-雙（sec-丁氧甲基）苯或 2,6-二羥甲基-p-tert-丁基酚等。 更具體而言，例如下述之式[6-1]〜式[6-48]所示之交 聯性化合物。 -91 - 201219451 [化 44][5-42] (In the formula [5-42], η is an integer of 1 to 1〇). a crosslinkable compound having at least one substituent selected from a group consisting of a hydroxyl group or an alkoxy group, such as an amine-based resin having a hydroxyl group or an alkoxy group, such as a 'melamine resin, a urea resin, an anthracene resin, an acetylene urea - Formaldehyde resin, butyl decyl amide-formaldehyde resin, ethylene urea-formaldehyde resin, and the like. Specifically, for example, a melamine derivative, a benzoguanamine derivative or acetylene urea in which a hydrogen atom of an amine group is substituted with a methylol group or an alkoxymethyl group or both can be used. A melamine derivative or a benzoguanamine derivative may be present in the form of a dimer or a trimer. These components -90-201219451 preferably have a triazine ring as one unit and an average of 3 to 6 methylol groups or alkoxymethyl groups. For example, each of the commercially available triazine rings is replaced by 3.7 methoxymethyl groups, MX-750, and each triazine ring is 5.8 methoxylated. Methoxymethylated melamine and maimai substituted by MW-30 (above, manufactured by Sanwa Chemical Co., Ltd.), Saimer 300, 301, 303, 350, 370, 771, 325, 327, 703, 712, etc. 235, 236, 238, 212, 253, 254, etc. of methoxymethylated butoxymethylated melamine, Semel 5 06, 5 08 and other butoxymethylated melamine, Semel 1141, etc. Carboxymethyloxymethylated isobutoxymethylated melamine, carbaryl 1123, etc., methoxymethylated ethoxymethylated benzoguanamine, cyral 1123-10, etc. Oxyxymethylated benzoylamine, carbaryl 1128, etc., butoxymethylated benzoguanamine, carbaryl 1 1 25-80, etc. (above 'Mitui Sai Mai Min Co., Ltd.) and so on. Further, examples of the acetylene urea include butyloxymethylated acetylene urea such as Semel 1170, methylolated acetylene urea such as Semel 1172, methoxymethylolated acetylene urea such as Paulalin 1174, and the like. . Further, benzene having a hydroxyl group or an alkoxy group or a phenolic compound can also be exemplified as a crosslinkable compound. For example, 1,3,5-tris(methoxymethyl)benzene, 1,2,4-tris(isopropoxymethyl)benzene, 1,4-bis(sec-butoxymethyl)benzene or 2 , 6-dimethylol-p-tert-butylphenol, and the like. More specifically, for example, a crosslinkable compound represented by the following formula [6-1] to formula [6-48]. -91 - 201219451 [Chem. 44]

[6 — 4][6 — 4]

•〇C2H5 [6 — 9] [6-10] [6-11] [6-12] OCH3 OH•〇C2H5 [6 — 9] [6-10] [6-11] [6-12] OCH3 OH

[6-13] Η〇-ν, /=T0H H3CO HO HO-/ ^OH H3CO [6-14][6-13] Η〇-ν, /=T0H H3CO HO HO-/ ^OH H3CO [6-14]

[6-15] 〇CH3 92 201219451 [化 45] H〇^ /=T0H HOy _TOH h3co^^ y-〇CHz Q h3c-^- h〇-ch3 a <} HO-/ ^-OH HO-^ ^OH h3c〇J V〇CH3 [6-16] [6-17] [6-18][6-15] 〇CH3 92 201219451 [化45] H〇^ /=T0H HOy _TOH h3co^^ y-〇CHz Q h3c-^- h〇-ch3 a <} HO-/ ^-OH HO-^ ^OH h3c〇JV〇CH3 [6-16] [6-17] [6-18]

-93- 201219451 [化 47]-93- 201219451 [Chem. 47]

[6 — 30] [6 - 31 ][6 — 30] [6 - 31 ]

[6 —32] [6-33][6 — 32] [6-33]

[化 48][化48]

-94- 201219451 [化 49]-94- 201219451 [化49]

具有聚合性不飽和鍵結之交聯性化合物，例如，分子 內具有3個三羥甲基丙烷三（甲基）丙烯酸酯、季戊四醇三（ 甲基）丙烯酸酯、二季戊四醇五（甲基）丙烯酸酯、三（甲基） 丙烯醯基氧代乙氧基三羥甲基丙烷或丙三醇聚縮水甘油醚 聚（甲基）丙烯酸酯等之聚合性不飽和基的交聯性化合物； 分子內具有2個乙二醇二（甲基）丙烯酸酯、二乙二醇二（甲 基）丙烯酸酯、四乙二醇二（甲基）丙烯酸酯、聚乙二醇二（ 甲基）丙烯酸酯、丙二醇二（甲基）丙烯酸酯、聚丙二醇二（ 甲基）丙烯酸酯、丁二醇二（甲基）丙烯酸酯、新戊基二醇二 (甲基）丙烯酸酯、環氧乙烯雙酚A型二（甲基）丙烯酸酯、 環氧丙烯雙酚型二（甲基）丙烯酸酯、1，6_己烷二醇二（甲基） 丙烯酸酯、丙三醇二（甲基）丙烯酸酯、季戊四醇二（甲基） IP !ial -95- 201219451 丙烯酸酯、乙二醇二縮水甘油醚二（甲基）丙烯酸酯、二乙 二醇二縮水甘油醚二（甲基）丙烯酸酯、苯甲酸二縮水甘油 酯二（甲基）丙烯酸酯或羥基三甲基乙酸新戊基二醇二（甲基 )丙烯酸酯等之聚合性不飽和基的交聯性化合物；分子內 具有1個2-羥基乙基（甲基）丙烯酸酯、2-羥基丙基（甲基） 丙烯酸酯、2 -羥基丁基（甲基）丙烯酸酯、2 -苯氧基-2-羥基 丙基（甲基）丙烯酸酯、2-(甲基）丙烯醯基氧代-2-羥基丙基 苯二甲酸酯、3-氯-2-羥基丙基（甲基）丙烯酸酯、丙三醇單 (甲基）丙烯酸酯、2-(甲基）丙烯醯基氧代乙基磷酸酯或N-羥甲基（甲基）丙烯酸基胺等之聚合性不飽和基的交聯性化 合物等。 此外’下述之式[7]所示之化合物亦可作爲交聯性化合 物之例示。 [it 49]A crosslinkable compound having a polymerizable unsaturated bond, for example, having three trimethylolpropane tri(meth)acrylates, pentaerythritol tris(meth)acrylate, dipentaerythritol penta(meth)acrylic acid in the molecule a crosslinkable compound of a polymerizable unsaturated group such as an ester, tris(meth)acryloyloxyethoxytrimethylolpropane or glycerol polyglycidyl ether poly(meth)acrylate; intramolecular; It has two ethylene glycol di(meth)acrylates, diethylene glycol di(meth)acrylate, tetraethylene glycol di(meth)acrylate, polyethylene glycol di(meth)acrylate, Propylene glycol di(meth)acrylate, polypropylene glycol di(meth)acrylate, butanediol di(meth)acrylate, neopentyl glycol di(meth)acrylate, ethylene oxide bisphenol A Di(meth)acrylate, propylene oxide bisphenol type di(meth)acrylate, 1,6-hexanediol di(meth)acrylate, glycerol di(meth)acrylate, pentaerythritol Di(methyl) IP !ial -95- 201219451 Acrylate, Glycol diglycidyl ether di(meth) acrylate, diethylene glycol diglycidyl ether di(meth) acrylate, diglycidyl diglycidyl di(meth) acrylate or hydroxytrimethyl acetic acid a crosslinkable compound of a polymerizable unsaturated group such as pentyl glycol di(meth)acrylate; having one 2-hydroxyethyl (meth) acrylate and 2-hydroxypropyl (methyl) in the molecule Acrylate, 2-hydroxybutyl (meth) acrylate, 2-phenoxy-2-hydroxypropyl (meth) acrylate, 2-(methyl) propylene decyl oxo-2-hydroxypropyl Phthalate, 3-chloro-2-hydroxypropyl (meth) acrylate, glycerol mono (meth) acrylate, 2-(meth) propylene decyl oxyethyl phosphate or N a crosslinkable compound of a polymerizable unsaturated group such as a hydroxymethyl (meth) acrylate amine. Further, the compound represented by the following formula [7] can also be exemplified as a crosslinkable compound. [it 49]

[7] (E1爲由環己烷環、二環己烷環、苯環、聯苯環、三苯環 、萘環、弗環、蒽環或菲環所形成之1價之基，]E2爲由下 述之式[7a]或式[7b]所形成之1價之基，11爲丨〜4之整數） -96- 201219451[7] (E1 is a monovalent group formed by a cyclohexane ring, a bicyclohexane ring, a benzene ring, a biphenyl ring, a triphenyl ring, a naphthalene ring, an anthracene ring, an anthracene ring or a phenanthrene ring),] E2 Is a monovalent group formed by the following formula [7a] or formula [7b], 11 is an integer of 丨~4) -96- 201219451

上述化合物爲交聯性化合物之一例，但並非限定於該 內容。又，本發明之液晶配向處理劑所含有之交聯性化合 物，可爲1種類亦可，或2種類以上之組合亦可。 本發明之液晶配向處理劑中，交聯性化合物之含量’ 相對於聚合物成分100質量份，以0.1〜150質量份爲佳 ，就進行交聯反應而可得到目的之效果，且不會降低液晶 配向性等觀點，更佳爲0.1〜100質量份，特佳爲1〜50 質量份。 可促進液晶配向膜中之電荷移動，測進去除使用該液 晶配向膜之液晶晶元的電荷之化合物，例如以添加下述之 式[Ml]〜[Ml 56]所示之含氮雜環胺化合物爲佳。該胺化合 物，可直接添加於特定聚合物之溶液，或使用適當之溶劑 調整至濃度爲〇· 1〜1 〇質量％，較佳爲1〜7質量％之溶液 後予以添加爲佳。該溶劑，只要爲可溶解上述特定聚合物 之有機溶劑時，並未有特別限定。 -97- 201219451The above compound is an example of a crosslinkable compound, but is not limited thereto. Further, the crosslinkable compound contained in the liquid crystal alignment agent of the present invention may be one type or a combination of two or more types. In the liquid crystal alignment treatment agent of the present invention, the content of the crosslinkable compound is preferably 0.1 to 150 parts by mass based on 100 parts by mass of the polymer component, and a crosslinking reaction is carried out to obtain the intended effect without lowering the effect. The viewpoint of liquid crystal alignment and the like is more preferably 0.1 to 100 parts by mass, particularly preferably 1 to 50 parts by mass. It is possible to promote the movement of charges in the liquid crystal alignment film, and to measure a compound which removes the charge of the liquid crystal cell using the liquid crystal alignment film, for example, by adding a nitrogen-containing heterocyclic amine represented by the following formula [Ml] to [Ml 56]. The compound is preferred. The amine compound may be added directly to a solution of a specific polymer or may be added to a solution having a concentration of 〇·1 to 1% by mass, preferably 1 to 7% by mass, using a suitable solvent. The solvent is not particularly limited as long as it is an organic solvent capable of dissolving the above specific polymer. -97- 201219451

-98- tT 201219451-98- tT 201219451

-99 201219451-99 201219451

M81 M82 M83 M84M81 M82 M83 M84

-100- 201219451 [化 54]-100- 201219451 [化54]

s、^、nh2 M105s, ^, nh2 M105

M109 -101 201219451 [化 55]M109 -101 201219451 [化55]

M123 M124 M125 M122M123 M124 M125 M122

M126 M127 M128 M129M126 M127 M128 M129

M130 M131 M132 M133M130 M131 M132 M133

M134 M135 M136 M137 M138 -102- 201219451 [化 56]M134 M135 M136 M137 M138 -102- 201219451 [化56]

^¾1 HO OH^3⁄41 HO OH

M153 M155 M156 本發明之液晶配向處理劑，於無損本發明效果之限度 ，就塗佈液晶配向處理劑之際，就提高聚合物被膜膜厚之 均勻性或表面平滑性等觀點，可含有有機溶劑（亦稱爲不 良溶劑）或化合物。此外，亦可含有提高液晶配向膜與基 板之密著性的化合物等。 可提高膜厚之均勻性或表面平滑性之不良溶劑的具體 例如以下所示成份等。 例如，異丙基醇、甲氧甲基戊醇、甲基賽珞蘇（Cellosolve) 、乙基賽络蘇（Cellosolve)、丁基賽络蘇（Cellosolve)、甲 基賽珞蘇（Cellosolve)乙酸鹽、乙基賽珞蘇（Cellosolve)乙 酸鹽、丁基卡必醇、乙基卡必醇、乙基卡必醇乙酸鹽、乙 -103- 201219451 二醇、乙二醇單乙酸鹽、乙二醇單異丙基醚、乙二醇 基醚、丙二醇、丙二醇單乙酸鹽、丙二醇單甲基醚、 醇-tert-丁基醚、二丙二醇單甲基醚、二乙二醇、二 醇單乙酸鹽、二乙二醇二甲基醚、二丙二醇單.乙酸鹽 基醚、二丙二醇單甲基醚、二丙二醇單乙基醚、二丙 單乙酸鹽單乙基醚、二丙二醇單丙基醚、二丙二醇單 鹽單丙基醚' 3-甲基-3-甲氧基丁基乙酸鹽、三丙二醇 醚、3-甲基-3-甲氧基丁醇、二異丙基醚、乙基異丁基 二異丁烯、戊基乙酸鹽、丁基丁酯、丁基醚、二異丁 、甲基環己烯、丙基醚、二己基醚、η-己烷、η-戊院 辛烷、二乙基醚、乳酸甲酯、乳酸乙酯、乙酸甲酯、 乙基、乙酸η-丁基、乙酸丙二醇單乙基醚、丙酮酸甲 丙酮酸乙基、3-甲氧基丙酸甲基、3-乙氧基丙酸甲基 、3-甲氧基丙酸乙基、3-乙氧基丙酸、3-甲氧基丙酸 甲氧基丙酸丙基、3-甲氧基丙酸丁基、1-甲氧基-2-丙 1-乙氧基-2-丙醇、1-丁氧-2-丙醇、1-苯氧基-2-丙醇 二醇單乙酸鹽、丙二醇二乙酸鹽、丙二醇-1-單甲基i 乙酸鹽、丙二醇-1-單乙基醚-2-乙酸鹽、二丙二醇、 乙氧基丙氧基）丙醇、乳酸甲酯、乳酸乙酯、乳酸n-酯、乳酸η-丁基酯、乳酸異戊基酯等之具有低表面張 有機溶劑等。 該些之不良溶劑可使用1種類或將多數種類混合 亦可。上述般，於使用不良溶劑之情形中，以液晶配 理劑所含有機溶劑全體之5〜80質量％爲佳，較佳爲 單丁 丙二 乙二 H ψ 二醇 乙酸 甲基 醚、 基酮 ' η - 乙酸 基、 乙基 、3-醇、 、丙 醚-2-2-(2-丙基 力之 使用 向處 20〜 -104- 201219451 6 0質量％。 提高膜厚之均勻性或表面平滑性之 界面活性劑' 聚矽氧系界面活性劑、非离 等。 更具體而言，例如，F-Top EF301 T0CHEM·公司製）、美格氟 F171、F173、 製）、氟拉朵FC430、FC431(住友3M公司製）、 、SAFUROS-382、SC101、SC102、SC103、 SC106(旭硝子公司製）等。該些之界面活 ，相對於液晶配向處理劑所含有之聚合物 ，較佳爲使用0.01〜2質量份，更佳爲〇. 可提高液晶配向膜與基板之密著性β ，例如以下所示含官能性矽烷之化合物窜 物等。 例如，3-胺基丙基三甲氧基矽烷、3 基矽烷、2-胺基丙基三甲氧基矽烷、2·肢 矽烷、Ν-(2-胺基乙基）-3-胺基丙基三甲氧 基乙基）-3-胺基丙基甲基二甲氧基矽烷、 氧基矽烷、3-脲基丙基三乙氧基矽烷、Ν. 基丙基三甲氧基矽烷、Ν-乙氧基羰基-3. 基矽烷、Ν-三乙氧基矽烷基丙基三乙烯三 矽烷基丙基三乙烯三胺、10-三甲氧基 雜癸烷、10-三乙氧基矽烷基-1，4,7-三氮 基矽烷基-3，_6_二氮雜壬基乙酸鹽、9-三 i合物，例如氟系 I子系界面活性劑 、EF303 、 EF352( R-30(大日本塗料 ASAHIGATOAG710 SC104 、 SC105 、 性劑之使用比例 成分100質量份 0 1〜1質量份。 J化合物之具體例 3含環氧基之化合 -胺基丙基三乙氧 :基丙基三乙氧基 基矽烷、N-(2-胺 3-脲基丙基三甲 乙氧基羰基-3-胺 胺基丙基三乙氧 :胺、N-三甲氧基 ’烷基-1，4,7-三氮 I癸烷、9-三甲氧 t氧基矽烷基-3,6- -105- 201219451 二氮雜壬基乙酸鹽、N-苄基-3-胺基丙基三甲氧基矽烷、 N-苄基-3-胺基丙基三乙氧基矽烷、N-苯基-3-胺基丙基三 甲氧基矽烷、N-苯基-3-胺基丙基三乙氧基矽烷、N-雙（氧 代乙烯）·3-胺基丙基三甲氧基矽烷、N-雙（氧代乙烯）-3·胺 基丙基三乙氧基矽烷、乙二醇二縮水甘油醚、聚乙二醇二 縮水甘油醚、丙二醇二縮水甘油醚' 三丙二醇二縮水甘油 醚、聚丙二醇二縮水甘油醚、新戊基二醇二縮水甘油醚、 1,6-己烷二醇二縮水甘油醚、丙三醇二縮水甘油醚、2,2-二溴新戊基二醇二縮水甘油醚、1，3,5,6-四縮水甘油基-2,4·己烷二醇、1^小氺’，1^’-四縮水甘油基-111-二甲苯二胺、 1，3-雙（Ν,Ν-二縮水甘油胺基甲基）環己烷、Ν，Ν,Ν’，Ν’-四縮 水甘油基-4,4’-二胺基二苯基甲烷等。 使用可提高與基板之密著性之化合物之情形，一般相 對於液晶配向處理劑所含有之聚合物成分1 0 0質量份，以 0.1〜30質量份爲佳，較佳爲1〜20質量份。未達0.1質 量份時，則無法期待其具有提高密著性之效果，多於3 0 質量份時，則液晶之配向性會有惡化之情形。 本發明之液晶配向處理劑，除添加上述交聯性化合物 、不良溶劑及提高密著性之化合物以外，於無損本發明效 果之範圍內，可添加以改變液晶配向膜之介電率或導電性 等電特性爲目的之介電體或導電物質。 <液晶配向膜·液晶顯示元件> 本發明之液晶配向處理劑，可於塗佈於基板上、燒焙 -106- 201219451 後，經由摩擦處理或光照射等配向處理，而可作爲液晶配 向膜使用。又，垂直配向用途等之情形，即使未進行配向 處理下亦可作爲液晶配向膜使用。此際所使用之基板，只 要爲具有高透明性之基板時，並未有特別限定，除玻璃基 板以外，亦可使用丙烯酸基板或聚碳酸酯基板等之塑膠基 板等。就製程簡單化之觀點，以使用形成有以進行液晶驅 動爲目的之ITO電極等之基板爲佳。又，反射型之液晶顯 示元件，若僅有單側之基板時，亦可使用矽晶圓等不透明 之基板，此時之電極亦可使用鋁等可反射光線之材料。 液晶配向處理劑之塗佈方法，並未有特別限定之方法 ，於工業上而言，一般爲使用旋轉印刷、平版印刷、凸版 印刷、噴墨法等方法進行。其他之塗佈方法例如浸漬法、 滾筒塗佈法、條狀塗佈法、旋轉塗佈法等，可配合目的使 用該些塗佈方法。 將液晶配向處理劑塗佈於基板上之後，再使用熱壓版 等之加熱手段，於50〜300°c，較佳爲80〜250°C下使溶劑 蒸發，而形成聚合物被膜。燒焙後之聚合物被膜之厚度， 過厚時就液晶顯示元件之消費電力之觀點而言爲不利，過 薄時，則會有降低液晶顯示元件信賴性之情形，故較佳爲 5〜300nm，更佳爲10〜lOOnm。欲使液晶形成水平配向或 傾斜配向之情形，其可對燒焙後之聚合物被膜施以摩擦或 偏光紫外線照射等處理。 本發明之液晶顯示元件爲使用上述手法，由本發明之 液晶配向處理劑製得附有液晶配向膜之基板後，再使用公 -107- 201219451 知之方法製作液晶晶元以形成液晶顯示元件者。 液晶晶兀之製作方法，例如準備一對形成有液晶配向 膜之基板，於單側之基板的液晶配向膜上散布調距器，並 以液晶配向膜面形成內側之方式，將另一側面之基板貼合 後’再將液晶減壓注入予以封閉之方法，或，於散佈有調 距器之液晶配向膜面滴下液晶後，再將基板貼合封閉之方 法等例示。 此外，本發明之液晶配向處理劑亦適合使用於由具備 有電極之一對基板之間具有液晶層所構成，且於一對基板 之間含有經由活性能量線及熱之至少一者所聚合之聚合性 化合物的液晶組成物，並經由對電極間施加電壓，使含有 可經活性能量線之照射及加熱中至少一者使聚合性化合物 聚合之步驟所製得之液晶顯示元件。其中，活性能量線以 使用紫外線爲佳。 上述液晶顯示元件爲使用PSA(P〇lYmer Sustained Alignment)之方式控制液晶分子之預傾角之元件。PSA方 式爲，於液晶材料中混入少量之光聚合性化合物，例如光 聚合性單體’組成液晶晶元後，於對液晶層施加特定電壓 之狀態下’對光聚合性化合物照射紫外線等，以生成之聚 合物控制液晶分子之預傾角。生成聚合物時之液晶分子之 配向狀態’即使去除電壓後亦呈現記憶狀態，故經由控制 形成於液晶層之電界等之方式，可調整液晶分子之預傾角 。又’ PSA方式中’因不需要進行摩擦處理，故適合使用 於不易經由摩擦處理控制預傾角之垂直配向型的液晶層之 -108- 201219451 形成。 即’本發明之液晶顯示元件爲，於依上述手法由本發 明之液晶配向處理劑製得附有液晶配向膜之基板後，製作 液晶晶元，再經由紫外線照射及加熱中至少一者使聚合性 化合物聚合，而可控制液晶分子之配向。 列舉液晶晶元製作之一例示如下，準備一對形成有液 晶配向膜之基板，於單側基板之液晶配向膜上散佈調距器 ，並使液晶配向膜面爲內側之方式，將另一單側之基板貼 合，再將液晶減壓注入並予以封閉之方法，或對散佈有調 距器之液晶配向膜面上，滴下液晶後，再將基板貼合，並 予封閉之方法等。 ##液晶中，可混合經由熱或紫外線照射而聚合之聚合 性化合物。聚合性化合物例如，分子內具有1個以上之丙 烯酸酯基或甲基丙烯酸酯基等之聚合性不飽和基之化合物 等。此時，聚合性化合物相對於液晶成分1 00質量份，以 0.01〜10質量份爲佳，較佳爲0.1〜5質量份。聚合性化 合物未達0.0 1質量份時，聚合性化合物將無法聚合而無 法控制液晶之配向，多於1 0質量份時，因未反應之聚合 性化合物過多，而會降低液晶顯示元件之燒付（殘影）特性 〇 製作液晶晶元後，於對液晶晶元施加交流或直流之電 壓中，可照射熱或紫外線使聚合性化合物聚合。如此，可 控制液晶分子之配向。 此外，本發明之液晶配向處理劑，亦適合使用於由具 -109- 201219451 備有電極之一對基板之間具有液晶層者所構成，且於前述 一對基板之間配置含有可經活性能量線及熱之至少一者而 聚合之聚合性基的液晶配向膜，經由對電極間施加電壓之 步驟所製得之液晶顯示元件。其中，活性能量線以紫外線 爲佳。 就欲製得含有可經活性能量線及熱之至少一者而聚合 之聚合性基的液晶配向膜之觀點，例如將含有該聚合性基 之化合物添加於液晶配向處理劑中之方法，或使用含有聚 合性基之聚合物成分之方法等。聚合性基例如丙烯酸基、 甲基丙烯酸基、乙烯基、馬來醯亞胺基等之聚合性不飽和 基等。 本發明之液晶配向處理劑，因含有具有可經熱或紫外 線之照射而反應之雙鍵部位的特定胺化合物，故可經由紫 外線之照射及加熱中至少一者以控制液晶分子之配向。 列舉製作液晶晶元之例示時，例如準備形成有液晶配 向膜之一對基板，於單側面之基板的液晶配向膜上散佈調 距器，使液晶配向膜面向內側之方式，與另一單側之基板 貼合，減壓注入液晶後予以封閉之方法，或將散佈有調距 器之液晶配向膜面滴下液晶後，將基板貼合予以封閉之方 法等。 製作液晶晶元後，於對液晶晶元施加交流或直流之電 壓中，經由照射熱或紫外線，而可控制液晶分子之配向。 如以上所述般，使用本發明之液晶配向處理劑所製作 之液晶顯示元件，爲具有優良信賴性之液晶元件，而極適 -110- 201219451 合使用於大畫面且具有高精細度之液晶電視等。 【實施方式】 [實施例] 以下將列舉實施例對本發明作更詳細之說明，但本發 明並非限定於該內容。 「特定二胺化合物之合成」 <合成例1 > 特定二胺化合物（4)之合成 [化 57]M153 M155 M156 The liquid crystal alignment agent of the present invention may contain an organic solvent in view of improving the uniformity of the film thickness of the polymer film or the surface smoothness when the liquid crystal alignment agent is applied, without impairing the effects of the present invention. (also known as poor solvent) or compound. Further, a compound or the like which improves the adhesion between the liquid crystal alignment film and the substrate may be contained. Specific examples of the poor solvent which can improve the uniformity of the film thickness or the surface smoothness are, for example, the components shown below. For example, isopropyl alcohol, methoxymethylpentanol, Cellosolve, Cellosolve, Cellosolve, Cellosolve acetate Salt, Cellosolve acetate, butyl carbitol, ethyl carbitol, ethyl carbitol acetate, B-103-201219451 diol, ethylene glycol monoacetate, ethylene Alcohol monoisopropyl ether, ethylene glycol ether, propylene glycol, propylene glycol monoacetate, propylene glycol monomethyl ether, alcohol-tert-butyl ether, dipropylene glycol monomethyl ether, diethylene glycol, glycol monoacetic acid Salt, diethylene glycol dimethyl ether, dipropylene glycol monoacetate ether, dipropylene glycol monomethyl ether, dipropylene glycol monoethyl ether, dipropyl monoacetate monoethyl ether, dipropylene glycol monopropyl ether , dipropylene glycol mono-salt monopropyl ether ' 3-methyl-3-methoxybutyl acetate, tripropylene glycol ether, 3-methyl-3-methoxybutanol, diisopropyl ether, ethyl Isobutyl diisobutylene, pentyl acetate, butyl butyl ester, butyl ether, diisobutyl, methylcyclohexene, propyl ether, dihexyl ether, η-hexane, η-pentyl Hospital octane, diethyl ether, methyl lactate, ethyl lactate, methyl acetate, ethyl, η-butyl acetate, propylene glycol monoethyl ether, ethyl pyruvate methyl acetate, 3-methoxy Propionic acid methyl, 3-ethoxypropionic acid methyl, 3-methoxypropionic acid ethyl, 3-ethoxypropionic acid, 3-methoxypropionic acid methoxypropionic acid propyl, 3- Butyl methoxypropionate, 1-methoxy-2-propan-1-ethoxy-2-propanol, 1-butoxy-2-propanol, 1-phenoxy-2-propanol diol Monoacetate, propylene glycol diacetate, propylene glycol-1-monomethyl i acetate, propylene glycol-1-monoethyl ether-2-acetate, dipropylene glycol, ethoxypropoxy)propanol, methyl lactate Ethyl lactate, n-ester of lactate, η-butyl lactate, isoamyl lactate or the like having a low surface organic solvent or the like. These poor solvents may be used in one type or in a plurality of types. In the case of using a poor solvent, it is preferably 5 to 80% by mass based on the total of the organic solvent contained in the liquid crystal compounding agent, preferably monobutylidene dihethanediol ethylene glycol methyl ether or ketone. ' η - Acetate, Ethyl, 3-Alcohol, Ethyl Ether-2-2-(2-propyl force is used 20~ -104- 201219451 60% by mass. Improve film thickness uniformity or surface A smooth interfacial surfactant 'polyoxygenated surfactant, non-isolated, etc. More specifically, for example, F-Top EF301 T0CHEM·Company), Megfried F171, F173, manufactured by Fluordo FC430 FC431 (manufactured by Sumitomo 3M Co., Ltd.), SAFUROS-382, SC101, SC102, SC103, SC106 (made by Asahi Glass Co., Ltd.). The interface activity of the liquid crystal alignment agent is preferably 0.01 to 2 parts by mass, more preferably 〇. The adhesion between the liquid crystal alignment film and the substrate can be improved, for example, as shown below. A compound containing a functional decane, such as a substance. For example, 3-aminopropyltrimethoxydecane, 3 decane, 2-aminopropyltrimethoxydecane, 2·limantane, Ν-(2-aminoethyl)-3-aminopropyl Trimethoxyethyl)-3-aminopropylmethyldimethoxydecane, oxydecane, 3-ureidopropyltriethoxydecane, decylpropyltrimethoxydecane, Ν-B Oxycarbonyl-3, decyl, decyl-triethoxydecylpropyltriethylenetridecylpropyltriethylenetriamine, 10-trimethoxyhydrononane, 10-triethoxydecyl-1 , 4,7-triazadecyl-3,_6-diazepine acetate, 9-trienide, such as fluorine-based I-based surfactant, EF303, EF352 (R-30) Coatings ASAHIGATOAG710 SC104, SC105, and the use ratio of the agent 100 parts by mass of 0 1 to 1 part by mass. Specific examples of the compound J include an epoxy group-aminopropyl triethoxy group: propyl triethoxy group Baseline, N-(2-amine 3-ureidopropyltrimethylethoxycarbonyl-3-amineaminopropyltriethoxy:amine, N-trimethoxy'alkyl-1,4,7-three Nitrogen I decane, 9-trimethoxy oxy oxoalkyl-3,6--105- 201219451 dinitrogen Heteromethoxyacetate, N-benzyl-3-aminopropyltrimethoxydecane, N-benzyl-3-aminopropyltriethoxydecane, N-phenyl-3-aminopropyl Trimethoxydecane, N-phenyl-3-aminopropyltriethoxydecane, N-bis(oxyethylene)-3-aminopropyltrimethoxydecane, N-bis(oxyethylene) -3·Aminopropyltriethoxydecane, ethylene glycol diglycidyl ether, polyethylene glycol diglycidyl ether, propylene glycol diglycidyl ether, tripropylene glycol diglycidyl ether, polypropylene glycol diglycidyl ether, Neopentyl glycol diglycidyl ether, 1,6-hexanediol diglycidyl ether, glycerol diglycidyl ether, 2,2-dibromoneopentyl glycol diglycidyl ether, 1,3 ,5,6-tetraglycidyl-2,4·hexanediol, 1^small', 1^'-tetraglycidyl-111-xylenediamine, 1,3-bis(Ν,Ν - diglycidylaminomethyl) cyclohexane, hydrazine, hydrazine, hydrazine, Ν'-tetraglycidyl-4,4'-diaminodiphenylmethane, etc. Use to improve adhesion to the substrate The case of a compound, generally relative to the polymer contained in the liquid crystal alignment treatment agent The component is preferably used in an amount of 0.1 to 30 parts by mass, preferably 1 to 20 parts by mass, and when it is less than 0.1 part by mass, the effect of improving the adhesion is not expected to be more than 30 parts by mass. In the case where the alignment property of the liquid crystal is deteriorated, the liquid crystal alignment treatment agent of the present invention may be used in addition to the above-mentioned crosslinkable compound, poor solvent, and adhesion-improving compound, without departing from the effects of the present invention. A dielectric or a conductive material for the purpose of changing the dielectric properties of the liquid crystal alignment film or electrical conductivity is added. <Liquid Crystal Alignment Film/Liquid Crystal Display Element> The liquid crystal alignment treatment agent of the present invention can be applied to a substrate, baked at -106 to 201219451, and subjected to alignment treatment such as rubbing treatment or light irradiation to obtain a liquid crystal alignment. Membrane use. Further, in the case of vertical alignment use or the like, it can be used as a liquid crystal alignment film even without alignment treatment. The substrate to be used in this case is not particularly limited as long as it has a substrate having high transparency, and a plastic substrate such as an acrylic substrate or a polycarbonate substrate may be used in addition to the glass substrate. From the viewpoint of simplification of the process, it is preferred to use a substrate on which an ITO electrode or the like for liquid crystal driving is formed. Further, in the case of a reflective liquid crystal display device, if only one substrate is used, an opaque substrate such as a germanium wafer may be used. In this case, a material such as aluminum which can reflect light may be used. The method of applying the liquid crystal alignment agent is not particularly limited, and industrially, it is generally carried out by a method such as rotary printing, lithography, letterpress printing, or inkjet method. Other coating methods such as a dipping method, a roll coating method, a strip coating method, a spin coating method, and the like can be used in combination with the purpose. After the liquid crystal alignment agent is applied onto the substrate, the solvent is evaporated at 50 to 300 ° C, preferably 80 to 250 ° C by a heating means such as a hot plate to form a polymer film. The thickness of the polymer film after baking is not favorable from the viewpoint of the power consumption of the liquid crystal display element when it is too thick, and when it is too thin, the reliability of the liquid crystal display element is lowered, so it is preferably 5 to 300 nm. More preferably, it is 10 to 100 nm. In order to form the liquid crystal in a horizontal alignment or an oblique alignment, it may be subjected to rubbing or polarized ultraviolet irradiation or the like to the baked polymer film. In the liquid crystal display device of the present invention, a substrate having a liquid crystal alignment film is obtained by using the liquid crystal alignment treatment agent of the present invention, and a liquid crystal cell is produced by a method known in the art to form a liquid crystal display element. For the method of fabricating a liquid crystal wafer, for example, a pair of substrates on which a liquid crystal alignment film is formed is prepared, and a distance aligner is spread on a liquid crystal alignment film of a substrate on one side, and the liquid crystal alignment film surface is formed inside, and the other side is After the substrate is bonded, the liquid crystal is injected under reduced pressure to be closed, or the liquid crystal is dispensed on the liquid crystal alignment film surface on which the distance adjuster is dispersed, and then the substrate is bonded and closed. Further, the liquid crystal alignment agent of the present invention is also suitably used in which a liquid crystal layer is provided between a pair of electrodes including a pair of electrodes, and a pair of substrates is polymerized via at least one of an active energy ray and heat. A liquid crystal display device obtained by a step of polymerizing a polymerizable compound by applying a voltage between the electrodes to a step of polymerizing the polymerizable compound by at least one of irradiation and heating of the active energy ray. Among them, the active energy ray is preferably ultraviolet light. The liquid crystal display element described above is an element for controlling the pretilt angle of liquid crystal molecules by means of PSA (P〇l Ymer Sustained Alignment). In the PSA method, a small amount of a photopolymerizable compound is mixed in a liquid crystal material, and for example, a photopolymerizable monomer 'is composed of a liquid crystal cell, and a photopolymerizable compound is irradiated with ultraviolet rays or the like while a specific voltage is applied to the liquid crystal layer. The resulting polymer controls the pretilt angle of the liquid crystal molecules. When the polymer is formed, the alignment state of the liquid crystal molecules is in a memory state even after the voltage is removed. Therefore, the pretilt angle of the liquid crystal molecules can be adjusted by controlling the formation of the liquid crystal layer or the like. Further, since the 'PSA method' is not required to be subjected to the rubbing treatment, it is preferably formed in -108 to 201219451 which is a liquid crystal layer of a vertical alignment type which is difficult to control the pretilt angle by the rubbing treatment. In other words, the liquid crystal display device of the present invention is obtained by preparing a liquid crystal alignment film by using the liquid crystal alignment film of the liquid crystal alignment treatment agent of the present invention in accordance with the above method, and then producing a liquid crystal cell by at least one of ultraviolet irradiation and heating. The compound is polymerized to control the alignment of the liquid crystal molecules. One example of the production of a liquid crystal cell is as follows. A pair of substrates on which a liquid crystal alignment film is formed is prepared, and a distance aligner is spread on a liquid crystal alignment film of a single-sided substrate, and the liquid crystal alignment film surface is inside. The substrate on the side is bonded, and the liquid crystal is injected under reduced pressure and sealed, or the liquid crystal alignment film surface on which the distance adjuster is dispersed, and the liquid crystal is dropped, and then the substrate is bonded and sealed. In the ## liquid crystal, a polymerizable compound polymerized by heat or ultraviolet irradiation may be mixed. The polymerizable compound is, for example, a compound having one or more polymerizable unsaturated groups such as an acrylate group or a methacrylate group in the molecule. In this case, the polymerizable compound is preferably 0.01 to 10 parts by mass, more preferably 0.1 to 5 parts by mass, per 100 parts by mass of the liquid crystal component. When the amount of the polymerizable compound is less than 0.01 part by mass, the polymerizable compound cannot be polymerized and the alignment of the liquid crystal cannot be controlled. When the amount is more than 10 parts by mass, the amount of the unreacted polymerizable compound is too large, and the burning of the liquid crystal display element is lowered. (Image Remaining) Characteristics After the liquid crystal cell is produced, a polymerizable compound can be polymerized by applying heat or ultraviolet rays to a voltage of alternating current or direct current applied to the liquid crystal cell. In this way, the alignment of the liquid crystal molecules can be controlled. Further, the liquid crystal alignment treatment agent of the present invention is also suitably used in the case where a liquid crystal layer is provided between one of the electrodes provided in the electrode of -109-201219451, and the active energy is disposed between the pair of substrates. A liquid crystal display element obtained by a step of applying a voltage between electrodes by a liquid crystal alignment film of a polymerizable group polymerized by at least one of a line and heat. Among them, the active energy ray is preferably ultraviolet ray. From the viewpoint of producing a liquid crystal alignment film containing a polymerizable group polymerizable by at least one of an active energy ray and heat, for example, a method of adding a compound containing the polymerizable group to a liquid crystal alignment treatment agent, or using A method of containing a polymer component of a polymerizable group or the like. The polymerizable group is, for example, a polymerizable unsaturated group such as an acryl group, a methacryl group, a vinyl group or a maleimine group. Since the liquid crystal alignment agent of the present invention contains a specific amine compound having a double bond site which can be reacted by irradiation with heat or ultraviolet rays, at least one of irradiation and heating of the ultraviolet rays can be used to control the alignment of the liquid crystal molecules. In the case of exemplifying the production of a liquid crystal cell, for example, one of the liquid crystal alignment films is formed, and the substrate is spread on the liquid crystal alignment film of the substrate on one side, so that the liquid crystal alignment film faces inward, and the other side The substrate is bonded, the liquid crystal is injected under reduced pressure, and the liquid crystal is placed on the liquid crystal alignment film surface on which the distance adjuster is dispersed, and the substrate is bonded and sealed. After the liquid crystal cell is produced, the alignment of the liquid crystal molecules can be controlled by applying heat or ultraviolet light to the liquid crystal cell by applying an alternating current or a direct current voltage. As described above, the liquid crystal display element produced by using the liquid crystal alignment treatment agent of the present invention is a liquid crystal element having excellent reliability, and the extremely suitable -110-201219451 is used for a large-screen LCD TV with high definition. Wait. [Embodiment] [Examples] Hereinafter, the present invention will be described in more detail by way of examples, but the present invention is not limited thereto. "Synthesis of a specific diamine compound" <Synthesis Example 1 > Synthesis of a specific diamine compound (4) [Chem. 57]

(1) h2n(1) h2n

(4)(4)

CNCN

(2) Ο 將化合物（2)(57.00g，45 5 mmol)及三乙基胺（46.0 8g， 455mmol)之四氫呋喃（l〇〇〇g)溶液冷卻至10〇c以下，將化 合物（l)(100.00g，434mmol)之四氫呋喃（500g)溶液於注意 發熱下滴入其中。滴下結束後，使反應溫度上升至23 t， 再1度進行反應。使用HPLC(高速液體色層分析儀）確認反 應結束後’將反應液注入蒸餾水（9L(公升））中之後，過濾 -111 - 201219451 析出之固體，經水洗後，使用2-丙醇（200g)分散洗淨’得 化合物（3)(產量：120.6g，產率：89%)。 j-NMRCH 核磁共振光譜）（400MHz ’ DMSO-d6， σ(ρριη)) : 9·21(1Η，t)，9.05(2H ’ d) ’ 8.97(1H ’ t) ’ 7.66(1H，s)，7.22(1H，s)，6.90(1H，s)，4.05(2H ’ t)， 3.3 1 (2H，q)，2.01 (2H，tt)。 隨後’將化合物（3)(l〇〇.〇〇g，3 13mmol)、5%鈀碳（含 水型，lO.OOg，10wt%)及N，N-二甲基甲醯胺（2000g)之混 合物，於氫存在下、23 °C下攪拌。反應結束後，以氮氣取 代後，加入活性碳（10.00g)，於23 °C下攪拌1小時。隨後 ，經由過濾去除觸媒及活性碳，餾除溶劑，得粗結晶。將 2-丙醇（300g)加入該粗結晶中，23 °C下攪拌30分鐘’進行 分散洗淨。將分散洗淨後之固體過滤、乾燥，得特定二胺 化合物（4)(產量：76.3g，產率：94%)。 !Η-ΝΜΚ(400ΜΗζ > DMSO-de ' a(ppm)) ： 8.05(1H，t) ，7·62(1Η，t)，7_16(1H，t)，6·85(1Η ’ t)，6·16(2Η，d) ，5.89(1H，t)，4.82(4H，broad)，3.94(2H，t)，3.43(2H ，q)，1 .85(2H，tt)。 <合成例2> 特定二胺化合物（7)之合成 -112- 201219451(2) 冷却 Compound (2) (57.00g, 45 5 mmol) and triethylamine (46.0 8g, 455mmol) in tetrahydrofuran (l〇〇〇g) solution are cooled to below 10〇c, compound (1) A solution of (100.00 g, 434 mmol) in tetrahydrofuran (500 g) was added dropwise under the influence of heat. After the completion of the dropwise addition, the reaction temperature was raised to 23 t, and the reaction was further carried out at 1 degree. After confirming the completion of the reaction by HPLC (high-speed liquid chromatography), the reaction liquid was poured into distilled water (9 L (liter)), and the solid precipitated from -111 - 201219451 was filtered, and after washing with water, 2-propanol (200 g) was used. The compound (3) was obtained by dispersion washing (yield: 120.6 g, yield: 89%). j-NMRCH nuclear magnetic resonance spectrum) (400MHz 'DMSO-d6, σ(ρριη)): 9·21(1Η,t), 9.05(2H 'd) ' 8.97(1H 't) ' 7.66(1H,s), 7.22 (1H, s), 6.90 (1H, s), 4.05 (2H 't), 3.3 1 (2H, q), 2.01 (2H, tt). Subsequently, 'Compound (3) (l〇〇.〇〇g, 3 13 mmol), 5% palladium on carbon (aqueous form, 1.00 g, 10 wt%) and N,N-dimethylformamide (2000 g) The mixture was stirred at 23 ° C in the presence of hydrogen. After completion of the reaction, after replacing with nitrogen, activated carbon (10.00 g) was added, and the mixture was stirred at 23 ° C for 1 hour. Subsequently, the catalyst and activated carbon were removed by filtration, and the solvent was distilled off to obtain a crude crystal. 2-propanol (300 g) was added to the crude crystals, and the mixture was stirred at 23 ° C for 30 minutes to carry out dispersion washing. The solid after dispersion washing was filtered and dried to give a specific diamine compound (4) (yield: 76.3 g, yield: 94%). !Η-ΝΜΚ(400ΜΗζ > DMSO-de ' a(ppm)) : 8.05(1H,t) ,7·62(1Η,t),7_16(1H,t),6·85(1Η't), 6.16 (2Η, d), 5.89 (1H, t), 4.82 (4H, broad), 3.94 (2H, t), 3.43 (2H, q), 1.85 (2H, tt). <Synthesis Example 2> Synthesis of specific diamine compound (7) -112- 201219451

將化合物（5)(24.00g，195mmol)及三乙基胺（19_7 2g， 195mm〇l)之四氫呋喃（500g)溶液冷卻至10°C以下，將化合 物（l)(42.8 0g、186mmol)之四氫呋喃（142g)溶液於注意發 熱下滴入其中。滴下結束後，使反應溫度上升至23t，再 度進行反應。以HPLC確認反應結束後，將反應液注入蒸 餾水（3.9L)中之後，過濾析出之固體，經水洗後，以2-丙 醇（240g)分散洗淨，得化合物（6)(產量：5 1 .3g，產率： 8 7%) » ]Η-ΝΜΚ(400ΜΗζ - DMSO-d6 > a(ppm)) ： 9.87(1H > broad) ’ 9.10(2H ’ d)，8.97(1H，t)，8·57(1Η，d)， 8.50(1H ’ t) ’ 4.65(2H，s)，2.84(3H，s)。 隨後’將化合物（6)(45.00g，142mmol)、碳（含水 物，4.5g ’ 10wt%)及 1，4-二噁烷（67 5 g)/DMF(200g)之混合 物’於氫存在下、70 °C下進行攪拌。反應結束後、以氮氣 取代後’加入活性碳（4.5g)，於7(TC下攪拌1小時。隨後 -113- 201219451 ，經由過濾去除觸媒及活性碳，餾除溶劑，得粗結晶。所 得粗結晶以2-丙醇（100g)分散洗淨結果’得特定二胺化合 物（7)(產量：33.7g，產率：92%)。 1 H-NMR(400MHz > DMSO-d6，a(ppm)) : 8·60(1Η，t) ，8.42(1H，m)，8.38(1H，d)，6·22(2Η，d)，5·92(1Η，t) ，4.84(4H，s)，4.43(2H，d)，2.43(3H，s)。 <合成例3> 特定二胺化合物（10)之合成A solution of the compound (5) (24.00 g, 195 mmol) and triethylamine (19_7 2 g, 195 mm) in tetrahydrofuran (500 g) was cooled to below 10 ° C to give the compound (1) (42.8 0 g, 186 mmol) of tetrahydrofuran. (142 g) The solution was dropped into it under the attention of fever. After the completion of the dropwise addition, the reaction temperature was raised to 23 t, and the reaction was again carried out. After confirming the completion of the reaction by HPLC, the reaction liquid was poured into distilled water (3.9 L), and the precipitated solid was filtered, washed with water, and then washed with 2-propanol (240 g) to obtain compound (6) (yield: 5 1) .3g, yield: 8 7%) » ]Η-ΝΜΚ(400ΜΗζ - DMSO-d6 > a(ppm)) : 9.87(1H > broad) ' 9.10(2H ' d),8.97(1H,t) , 8.57 (1Η, d), 8.50 (1H 't) ' 4.65 (2H, s), 2.84 (3H, s). Subsequent 'mixture of compound (6) (45.00 g, 142 mmol), carbon (hydrated, 4.5 g '10 wt%) and 1,4-dioxane (67 5 g) / DMF (200 g) in the presence of hydrogen Stir at 70 °C. After completion of the reaction, after replacing with nitrogen, 'activated carbon (4.5 g) was added, and the mixture was stirred at 7 (TC for 1 hour. Then -113-201219451, the catalyst and activated carbon were removed by filtration, and the solvent was distilled off to obtain crude crystals. The crude crystals were washed with 2-propanol (100 g) to give a specific diamine compound (7) (yield: 33.7 g, yield: 92%). 1 H-NMR (400 MHz > DMSO-d6, a ( Ppm)) : 8·60(1Η,t) , 8.42(1H,m),8.38(1H,d),6·22(2Η,d),5·92(1Η,t) ,4.84(4H,s ), 4.43 (2H, d), 2.43 (3H, s). <Synthesis Example 3> Synthesis of a specific diamine compound (10)

(8) 將化合物（8)(24.008，1461«111〇丨）及三乙基胺（14.79呂’ 146mm〇l)之四氫呋喃（3 3 2g)溶液冷卻至l〇°C以下，將化合 物（l)(32.10g、139mmol)之四氫咲喃（l〇〇g)溶液於注意發 熱下滴入其中。滴下結束後，使反應溫度上升至23 °c，再度 進行反應。以HPLC確認反應結束後，將反應液注入蒸餾水 (3.9L)中之後，過濾析出之固體，水洗後，以2_丙醇（2〇〇g) -114-(8) Cooling a compound (8) (24.008, 1461 «111〇丨) and a solution of triethylamine (14.79 Lu' 146mm〇l) in tetrahydrofuran (3 2 2g) to below 10 ° C, the compound (l) (32.10 g, 139 mmol) of tetrahydrofuran (l〇〇g) solution was dropped into it under the attention of heat. After the completion of the dropwise addition, the reaction temperature was raised to 23 ° C, and the reaction was again carried out. After confirming the completion of the reaction by HPLC, the reaction solution was poured into distilled water (3.9 L), and the precipitated solid was filtered, and washed with water to give 2-propanol (2 g) -114-

201219451 分散洗淨，得化合物（9)(產量：47.6g，產率：95%)。 1H-NMR(400MHz > DMSO-d6，a(ppm)) ： 8·88(1Η ’ t) ，8.70(2Η，d)，8·40(2Η，t)，6·68(1Η，t) ’ 3.90(2Η， broad)，3.75(4Η，broad)，3.42(2Η 1 broad) 〇 隨後，將化合物（9)(40.00g，112mmol)、5%把碳（含水 物，4.0g，10wt%)及DMF(800g)之混合物，於氫存在下、 7 0°C下進行攪拌。反應結束後，觸媒以沸石過濾後’使用蒸 發器餾除溶劑，得粗產物。所得粗產物使用2-丙醇（12g)分 散洗淨，得特定二胺化合物（1〇)(產量：1.7g，產率：68%)。 1H-NMR(400MHz - DMSO-d6，σ(ρριη)) ： 8.35(2Η，d) ，6.63(1Η，t)，5·82(1Η，t)，5·75(2Η , d)，4·86(4Η ’ s) ，3.70(4Η > broad)，3.49(4Η，broad) ° <合成例4> 二胺化合物（1 3 )之合成 [化 60]Dispersion washing with 201219451 gave compound (9) (yield: 47.6 g, yield: 95%). 1H-NMR (400 MHz > DMSO-d6, a (ppm)): 8·88 (1Η't), 8.70 (2Η, d), 8·40 (2Η, t), 6.68 (1Η, t) ' 3.90 (2Η, broad), 3.75 (4Η, broad), 3.42 (2Η 1 broad) 〇 Subsequently, compound (9) (40.00 g, 112 mmol), 5% carbon (aqueous, 4.0 g, 10 wt%) A mixture of DMF (800 g) was stirred at 70 ° C in the presence of hydrogen. After completion of the reaction, the catalyst was filtered with zeolite, and the solvent was distilled off using an evaporator to obtain a crude product. The obtained crude product was washed with 2-propanol (12 g) to give a specific diamine compound (1 〇) (yield: 1.7 g, yield: 68%). 1H-NMR (400MHz - DMSO-d6, σ(ρριη)): 8.35(2Η,d), 6.63(1Η,t),5·82(1Η,t),5·75(2Η, d),4· 86(4Η 's) , 3.70 (4Η > broad), 3.49 (4Η, broad) ° <Synthesis Example 4> Synthesis of diamine compound (13) [Chem. 60]

將化合物（ll)(l5.22g’ 142爪111〇1)及三乙基胺（15.098 -115- 201219451 ，：I49mmol)之四氫呋喃（150g)溶液冷卻至1 0 °C以下，將化 合物（1)(31.lg，135mm〇l)之四氫呋喃（50 g)溶液於注意發 熱下滴入其中。滴下結束後，.使反應溫度上升至23 °C ’再 度進行反應。使用HPLC確認反應結束後，將反應液注入 蒸餾水（1 L)中之後，過濾析出之固體，進行水洗。隨後， 將固體使用乙醇（3〇〇g)分散洗淨，得化合物（12)(產量： 3 6 · 9 2 g，產率· 9 0%)° 1 H-NMR(400MHz，DMSO-d6，o(ppm)) ： 9·75(1Η， broad)，9·10(2Η，s)，8.97-8·92(1Η，m)，7.40-7.22(5Η， m)，4.5 9-4· 52(2Η，m) 〇 隨後，將化合物（12)(36.00g，119mmol)、5%鈀碳（含 水型，3.6g ’ 1 Owt%)及1，4-二噁烷（300g)之混合物，於氫 存在下、60 °C下進行攪拌。反應結束後，觸媒以沸石過濾 後’使用蒸發器餾除溶劑，得粗產物。所得粗產物使用甲 醇（200g)再結晶，得二胺化合物（13)(產量：21.5g，產率： 7 2%) 〇 'H-NMR(400MHz > DMSO-d6 « σ(ρρπι)) ： 8.55(1Η > broad) ’ 7.37-7.17(5Η，m) ’ 6.28(2Η，s)，6.98-6.94( 1 Η， m) ’ 4.8 5-4.74(4Η ’ broad)，4.42-4.3 5(2Η，m)。 <合成例5> 二胺化合物（16)之合成 -116- 201219451 [化 61]Cooling a solution of the compound (11) (l5.22g '142 claw 111〇1) and triethylamine (15.098 -115-201219451,:I49mmol) in tetrahydrofuran (150g) to below 10 ° C, the compound (1) A solution of (31. lg, 135 mm 〇l) in tetrahydrofuran (50 g) was added dropwise under the influence of heat. After the completion of the dropwise addition, the reaction temperature was raised to 23 ° C' and the reaction was again carried out. After confirming the completion of the reaction by HPLC, the reaction solution was poured into distilled water (1 L), and the precipitated solid was filtered and washed with water. Subsequently, the solid was washed with ethanol (3 〇〇g) to obtain a compound (12) (yield: 3 6 · 9 2 g, yield: 90%) ° 1 H-NMR (400 MHz, DMSO-d6, o(ppm)): 9·75 (1Η, broad), 9·10 (2Η, s), 8.97-8·92 (1Η, m), 7.40-7.22 (5Η, m), 4.5 9-4· 52 (2Η,m) 〇 Subsequently, a mixture of compound (12) (36.00 g, 119 mmol), 5% palladium on carbon (aqueous form, 3.6 g '1 Owt%) and 1,4-dioxane (300 g) Stirring was carried out at 60 ° C in the presence of hydrogen. After completion of the reaction, the catalyst was filtered with zeolite, and the solvent was distilled off using an evaporator to obtain a crude product. The obtained crude product was recrystallized from methanol (200 g) to give the diamine compound (13) (yield: 21.5 g, yield: 7 2%) 〇 'H-NMR (400 MHz > DMSO-d6 « σ(ρρπι)): 8.55(1Η > broad) ' 7.37-7.17(5Η,m) ' 6.28(2Η,s),6.98-6.94( 1 Η, m) ' 4.8 5-4.74(4Η ' broad),4.42-4.3 5(2Η , m). <Synthesis Example 5> Synthesis of diamine compound (16) -116- 201219451 [Chem. 61]

將化合物（14)(23.45g ’ 190mmol)及三乙基胺（19.23g ，277mmol)之四氫呋喃（230g)溶液冷卻至l〇°C以下，將化 合物（1)(41.68g，180mmol)之四氫呋喃（ll〇g)溶液於注意 發熱下滴入其中。滴下結束後，使反應溫度上升至23 °C， 再度進行反應。使用HP LC確認反應結束後，將反應液注 入蒸餾水（1.5 L)中之後，過濾析出之固體，進行水洗。隨 後，將固體以乙醇（3 80g)分散洗淨，得化合物（15)(產量： 50.82g > 產率：89%)。 'H-NMR(400MHz > DMSO-d6 > a(ppm)) ： 9.76(1H > t) ，9.09-9.02(2H，m)， 8.99-8·93(1Η，m)，8·50(1Η ， broad) > 7.64-7.60(lH > m) * 7.3 6-7.32(lH - m) · 7.20- 7.14(1H，m)，4.57(2H，s)，3.35(2H，s)。 隨後，將化合物（ 1 5)(48.00g，151mmol)、5%鈀碳（含 水型’ 4.8g’ 10wt%)及1，4-二噁烷（490g)之混合物，於氫 存在下、60°C下進行攪拌。反應結束後，觸媒以沸石過濾 後，使用蒸發器餾除溶劑’得粗產物。所得粗產物使用乙 醇（300g)分散洗淨’得二胺化合物（16)(產量：27.20g，產 -117- 201219451 率：70%)。 1 H-NMR(400MHz，DMSO-d6 ’ a(ppm)) ： 8.64( 1Η * t) ，8·50(1Η ’ d)，8.44(1Η，d) ’ 7.67(1Η ’ d) ’ 7_34(1Η ’ q) ’ 6·23(2Η，d) ’ 5·94(1Η ’ s) ’ 4.87(4Η ’ s) ’ 4.39(2Η ’ d)。 「聚醯亞胺前趨物及聚醯亞胺之合成」 實施例中所使用之化合物之簡稱係如以下所示。 (四羧酸二酐） CBDA ： 1，2,3,4 -環丁烷四羧酸二酐 6〇〇八：二環[3,3,0]辛烷-2,4,6,8-四羧酸二酐 TCA :下述之式所示之四羧酸二酐 TDA:下述之式所示之四羧酸二酐 [化 62]A solution of the compound (14) (23.45 g '190 mmol) and triethylamine (19.23 g, 277 mmol) in tetrahydrofuran (230 g) was cooled to below 10 ° C to give the compound (1) (41.68 g, 180 mmol) of tetrahydrofuran ( Ll〇g) The solution was dropped into it under the attention of fever. After the completion of the dropwise addition, the reaction temperature was raised to 23 ° C, and the reaction was again carried out. After confirming the completion of the reaction using HP LC, the reaction solution was poured into distilled water (1.5 L), and the precipitated solid was filtered and washed with water. Subsequently, the solid was washed with ethanol (380 g) to give Compound (15) (yield: 50.82 g > yield: 89%). 'H-NMR (400 MHz > DMSO-d6 > a (ppm)): 9.76 (1H > t) , 9.09-9.02 (2H, m), 8.99-8·93 (1 Η, m), 8.50 (1Η , broad) > 7.64-7.60(lH > m) * 7.3 6-7.32(lH - m) · 7.20- 7.14(1H,m), 4.57(2H,s), 3.35(2H,s). Subsequently, a mixture of compound (15) (48.00 g, 151 mmol), 5% palladium on carbon (aqueous type '4.8 g' 10 wt%) and 1,4-dioxane (490 g) in the presence of hydrogen at 60° Stirring was carried out under C. After completion of the reaction, the catalyst was filtered with zeolite, and then the solvent was distilled off using an evaporator to obtain a crude product. The obtained crude product was washed with ethanol (300 g) to give a diamine compound (16) (yield: 27.20 g, yield -117 - 201219451: 70%). 1 H-NMR (400 MHz, DMSO-d6 ' a (ppm)): 8.64 (1 Η * t) , 8.50 (1 Η 'd), 8.44 (1 Η, d) ' 7.67 (1Η ' d) ' 7_34 (1Η ' q) ' 6·23(2Η,d) ' 5·94(1Η ' s) ' 4.87(4Η ' s) ' 4.39(2Η ' d). "Synthesis of Polyimine Precursor and Polyimine" The abbreviations of the compounds used in the examples are as follows. (tetracarboxylic dianhydride) CBDA: 1,2,3,4-cyclobutanetetracarboxylic dianhydride 6〇〇8:bicyclo[3,3,0]octane-2,4,6,8- Tetracarboxylic dianhydride TCA: tetracarboxylic dianhydride TDA represented by the following formula: tetracarboxylic dianhydride represented by the following formula [Chem. 62]

(特定二胺化合物） 特定二胺化合物（4):經由合成例1之合成路徑所得之 特定二胺化合物 特定二胺化合物（7):經由合成例2之合成路徑所得之 特定二胺化合物 特定一胺化合物（1 〇):經由合成例3之合成路徑所得 -118- 201219451 之特定二胺化合物 (特定側鏈型二胺化合物） PCH7DAB ： 1，3-二胺基-4-〔 4-(反- 4-n-庚基環己基）苯 氧基〕苯 PBCH5DAB ： 1, 3 -二胺基-4 - { 4 -〔反-4 -(反-4 - η-戊基環 己基）環己基〕苯氧基}苯 m-PBCH5DABz ： 1,3-二胺基- 5- {4-〔 4-(反- 4- n-戊基環 己基）苯基〕苯氧基甲基}苯(Specific diamine compound) Specific diamine compound (4): specific diamine compound obtained by the synthesis route of Synthesis Example 1 Specific diamine compound (7): specific one of the specific diamine compounds obtained by the synthesis route of Synthesis Example 2 Amine compound (1 〇): a specific diamine compound (specific side chain type diamine compound) obtained by the synthetic route of Synthesis Example 3 -118-201219451 PCH7DAB : 1,3-diamino-4-[4-(reverse - 4-n-heptylcyclohexyl)phenoxy]benzene PBCH5DAB : 1,3 -diamino-4 - { 4 -[trans-4 -(trans-4 - η-pentylcyclohexyl)cyclohexyl] Phenoxy}benzene m-PBCH5DABz : 1,3-diamino-5-{4-[4-(trans-4-n-pentylcyclohexyl)phenyl]phenoxymethyl}benzene

ColDAB-1 :下述之式所示之特定側鏈型二胺化合物 [化 63]ColDAB-1: a specific side chain type diamine compound represented by the following formula [Chem. 63]

(其他二胺化合物） p-PDA : p-伸苯二胺 m-PDA: m -伸苯二胺 DBA : 3,5-二胺基苯甲酸 AP18: 1,3-二胺基-4-十八烷基基羥苯 -119- 201219451 二胺化合物（1 3):經由合成例4之合成路徑所得之二 胺化合物 二胺化合物（1 6):經由合成例5之合成路徑所得之二 胺化合物 [化 64] h2n(Other diamine compounds) p-PDA : p-phenylenediamine m-PDA: m -phenylenediamine DBA: 3,5-diaminobenzoic acid AP18: 1,3-diamino-4- Octaylhydroxybenzene-119-201219451 Diamine compound (13): Diamine compound diamine compound (16) obtained by the synthesis route of Synthesis Example 4: Diamine compound obtained by the synthesis route of Synthesis Example 5 [化64] h2n

(交聯性化合物） 交聯性化合物（1) : YH-43 4L(東都化成公司製）（環氧系 交聯性化合物） 交聯性化合物（2) : 〇χτ-221(東亜合成公司製）（環氧丙 烷系交聯性化合物） 交聯性化合物（3):下述之式所示之交聯性化合物（羥 基酚系交聯性化合物） [化 65](Crosslinking compound) Crosslinkable compound (1) : YH-43 4L (manufactured by Tohto Kasei Co., Ltd.) (epoxy crosslinkable compound) Crosslinkable compound (2) : 〇χτ-221 (manufactured by Tosoh Corporation) (Polypropylene oxide-based crosslinkable compound) Crosslinkable compound (3): a crosslinkable compound represented by the following formula (hydroxyphenol-based crosslinkable compound) [Chem. 65]

交聯性化合物(1) 交聯性化合物(2) 交聯性化合物⑶ (有機溶劑） -120- 201219451 NMP : N-甲基-2-吡咯啶酮 BCS: 丁基賽络蘇（Cellosolve) (聚醯亞胺前趨物及聚醯亞胺之分子量測定） 合成例中之聚醯亞胺之分子量爲使用常溫凝膠浸透色 層分析儀（GPC)裝置（GPC-101)(昭和電工公司製）、管柱 (KD- 8 03、KD- 8 05)(ShodeX公司製），並依以下方式測定 〇Crosslinkable compound (1) Crosslinkable compound (2) Crosslinkable compound (3) (organic solvent) -120- 201219451 NMP : N-methyl-2-pyrrolidone BCS: butyl celecoxib (Cellosolve) Determination of the molecular weight of the polyimine precursor and the polyimine. The molecular weight of the polyimine in the synthesis example is a room temperature gel-impregnated color layer analyzer (GPC) device (GPC-101) (manufactured by Showa Denko Corporation). ), pipe column (KD- 8 03, KD- 8 05) (ShodeX company), and measured as follows

管柱溫度：5 0 °C 溶離液：N，N’-二甲基甲醯胺（添加劑爲溴化鋰-水和物 (LiBr‘H2〇)30mmol/L、磷酸.無水結晶（〇 -磷酸）30mmol/L 、四氫呋喃（THF)lOml(毫升）/L) 流速：1 .Oml/分 製作檢量線用標準樣品：TSK標準聚環氧乙烯（分子 量約 900,000、1 50,000、1 00,000、30,000)(東曹公司製）及 聚乙二醇（分子量約12,000、4，000、1,000)(聚合物拉伯特 公司製）。 (醯亞胺化率之測定）# # 合成例中之聚醯亞胺的醯亞胺化率爲依以下方式測定 。將聚醯亞胺粉末2〇mg置入NMR樣品管（NMR採樣標準 管、φ 5(草野科學公司製）），於重氫化二甲基亞颯（DMSO-d6中添加〇.〇5質量％ TMS(四甲基矽烷））（0.53 ml)，使用超 音波使其完全溶解。此溶液使用NMR測定機（JNW- -121 - 201219451 ECA500)(日本電子數據公司製）測定500MHz之質子NMR 。醯亞胺化率由醯亞胺化前後未產生變化之質子作爲基準 質子之方式決定，使用此質子之波峰積算値，與9.5〜 10.Oppm附近出現之醯胺酸的NH基所產生之質子波峰積 算値，依以下算式而求得。 醯亞胺化率（％) = U-a*x/y)x 100 上述式中，X爲醯胺酸之NH基所產生之質子波峰積 算値、y爲基準質子之波峰積算値、α爲聚醯胺酸（醯亞胺 化率爲0%)之情形中，相對於醯胺酸之1個ΝΗ基質子， 該基準質子之個數比例。 <合成例1> 將 BODA(5.87g，23.5mmol)、特定二胺化合物（4)( 0.76g，2 · 9 3 mm ο 1)、P C Η 7 D AB (5 _ 5 8 g，1 4 · 7 mm ο 1)，及 p-PDA(1.27g，11.7mmol)於 NMP(24.1g)中混合，80°C 下進行 4.5 小時反應。隨後’加入 CBDA(1.15g，5.86mmol)與 NMP (19.7g)，於40°C下反應6小時，得樹脂固體成份濃度爲 25.0質量％之聚醯胺酸溶液（A)。此聚醯胺酸之數平均分子 量爲27,400、重量平均分子量爲77,3 00。 <合成例2> 於合成例1所得之樹脂固體成份濃度爲25.0質量％之 -122- 201219451 聚醯胺酸溶液（A)(20.0g)中，加入NMP使其稀釋至6質量 %後，加入醯亞胺化觸媒之乙酸酐（2.45g)，及吡啶（1.80g) ，80°C下反應3.5小時。將此反應溶液投入甲醇（3 5 0ml)中 ，將所得沈澱物濾出。此沈澱物以甲醇洗淨，於100°C下 減壓乾燥，得聚醯亞胺粉末（B)。此聚醯亞胺之醯亞胺化 率爲55%，數平均分子量爲23,200、重量平均分子量爲 57,100 。 <合成例3>Column temperature: 50 °C Dissolution: N,N'-dimethylformamide (additive is lithium bromide-water and (LiBr'H2〇) 30 mmol/L, phosphoric acid. Anhydrous crystal (〇-phosphoric acid) 30 mmol /L, tetrahydrofuran (THF) 10 ml (ml) / L) Flow rate: 1.0 ml / min. Standard sample for the production of the calibration line: TSK standard polyethylene oxide (molecular weight of about 900,000, 1 50,000, 1 00,000, 30,000) (East Polyethylene glycol (molecular weight: about 12,000, 4,000, 1,000) (manufactured by Lambert Co., Ltd.). (Measurement of ruthenium imidation ratio) # # The ruthenium imidation ratio of the polyimine in the synthesis example was measured as follows. 2 〇mg of the polyimine powder was placed in an NMR sample tube (NMR sampling standard tube, φ 5 (manufactured by Kusano Scientific Co., Ltd.)), and dimethyl hydrazine was added (DMSO-d6). TMS (tetramethyl decane) (0.53 ml) was completely dissolved using ultrasonic waves. This solution was measured for proton NMR at 500 MHz using an NMR measuring machine (JNW-121 - 201219451 ECA500) (manufactured by JEOL Ltd.). The rate of ruthenium imidization is determined by the way in which the protons that have not changed before and after the imidization are used as the reference protons. The protons of this proton are used to calculate the enthalpy of protons and the protons produced by the NH group of proline under 9.5 to 10.Oppm. After the peak is calculated, it is obtained according to the following formula.醯imination rate (%) = Ua*x/y)x 100 In the above formula, X is the proton peak product 値 produced by the NH group of proline, y is the peak product of the reference proton, and α is the poly In the case of an amine acid (the imidization ratio is 0%), the ratio of the number of the reference protons is relative to one ruthenium matrix of lysine. <Synthesis Example 1> BODA (5.87 g, 23.5 mmol), a specific diamine compound (4) (0.76 g, 2 · 9 3 mm ο 1), PC Η 7 D AB (5 _ 5 8 g, 1 4 7 mm ο 1), and p-PDA (1.27 g, 11.7 mmol) were mixed in NMP (24.1 g) and reacted at 80 ° C for 4.5 hours. Subsequently, CBDA (1.15 g, 5.86 mmol) and NMP (19.7 g) were added and reacted at 40 ° C for 6 hours to obtain a polyamic acid solution (A) having a resin solid concentration of 25.0% by mass. The polyamine has a number average molecular weight of 27,400 and a weight average molecular weight of 77,300. <Synthesis Example 2> In the -122-201219451 polyglycine solution (A) (20.0 g) having a resin solid content concentration of 25.0% by mass obtained in Synthesis Example 1, NMP was added and diluted to 6 mass%, Acetic anhydride (2.45 g) of ruthenium catalyst was added, and pyridine (1.80 g) was reacted at 80 ° C for 3.5 hours. The reaction solution was poured into methanol (305 ml), and the obtained precipitate was filtered. This precipitate was washed with methanol, and dried under reduced pressure at 100 ° C to obtain a polyimine powder (B). The polyimine had a hydrazine imidation ratio of 55%, a number average molecular weight of 23,200, and a weight average molecular weight of 57,100. <Synthesis Example 3>

將 BODA(5.87g，23.5mmol)、特定二胺化合物（4)( 1. 5 2g · 5.8 6mmo 1)、PB C Η 5 D AB (3.8 1 g，8.8 Ommo 1)，及 p-PDA(1.59g，14.7mmol)於 NMP(23.0g)中混合，80°C 下進行 4.5 小時反應。隨後，加入 CBDA(1.15g，5.86mmol)與 NMP (18.8g)，於40 °C下反應6小時，得樹脂固體成份濃度爲 25.0質量％之聚醯胺酸溶液。 於所得之聚醯胺酸溶液（20.5g)中，加入NMP稀釋至 6質量％後，加入作爲醯亞胺化觸媒之乙酸酐（2.42g)，及 吡啶（1.81g)，於80 °C下反應3.5小時。將此反應溶液投入 甲醇（3 5 0ml)中，將所得沈澱物濾出。此沈澱物以甲醇洗 淨，於100°C下減壓乾燥，得聚醯亞胺粉末（C)。此聚醯亞 胺之醯亞胺化率爲52% ’數平均分子量爲2 1,600、重量平 均分子量爲5 1,700。 <合成例4> -123- 201219451 將 B〇DA(3_42g，13.7mmol)、特定二胺化合物（4)( l.Olg，3.91mmol)、m-PBCH5DABz(2.62g，5.86mmol)、 DBA(1.49g，9.77mmo〇於 NMP(16.0g)中混合，於 80°C 下 進行4.5小時反應後，加入CBDA(1 · 1 5g，5.86mmol)與NMP (1 3 . 1 g)，於4〇 °C下反應6小時’得樹脂固體成份濃度爲 25.0質量％之聚醯胺酸溶液。 於所得之聚醯胺酸溶液（20.0g)中，加入NMP稀釋至 6質量％後，加入作爲醯亞胺化觸媒之乙酸酐（4.5 5 g )、吡 啶（3.3 0g)，於90°C下反應3小時。將此反應溶液投入甲醇 (400ml)中，將所得沈澱物濾出。此沈澱物以甲醇洗淨， 於100eC下減壓乾燥，得聚醯亞胺粉末（D)。此聚醯亞胺之 醯亞胺化率爲81%’數平均分子量爲22,100、重量平均分 子量爲53,200 。 <合成例5> 將 BODA(5.72g，22.8mmol)、特定二胺化合物（7)( 0.73 g，2 · 86mm ο 1)、Cο 1D AB-1 (2 · 1 1 g，4.2 8mmο 1)，及 m-PDA(2.32g，21.4mmol)於 NMP(19.8g)中混合，於 80°C 下 進行4.5小時反應。隨後，加入CBDA(1.12g，5.71mmol) 與NMP (16.2g)，於40 °C下反應6小時，得樹脂固體成份 濃度爲25.0質量％之聚醯胺酸溶液。 於所得之聚醯胺酸溶液（20.5g)中，加入NMP稀釋至 6質量％後，加入作爲醯亞胺化觸媒之乙酸酐（2 · 5 5 g )，及 吡啶（1.95g)，於80°C下反應4小時。將此反應溶液投入甲 201219451 醇（3 5 0ml)中，將所得沈澱物濾出。此沈澱物以甲醇洗淨 ’於1〇〇 °C下減壓乾燥，得聚醯亞胺粉末（E)。此聚醯亞胺 之醯亞胺化率爲52%，數平均分子量爲20,800、重量平均 分子量爲53,100。 <合成例6> 將 TCA(3.51g，15.7mmol)、特定二胺化合物（4)(0.41g ，1 . 5 7mmo 1)、PC Η 7 D AB (2 · 3 8 g，6 · 2 6 mmo 1)，及 p-PDA( 0.85g，7.83mmol)於 NMP(28.6g)中混合，於 40°C 下反應 8 小時，得樹脂固體成份濃度爲25.0質量％之聚醯胺酸溶液 (F)。此醯胺酸之數平均分子量爲28,900、重量平均分子 量爲 75,3 00。 <合成例7 > 將 TCA(3.52g，15.7mmol)、特定二胺化合物（10)( 0.47g > 1.57mmol)、PBCH5DAB(1.80g，4_16mmol)，及 m-PDA(0.90g，8.32mmol)於 NMP(21.1g)中混合，於 40°C 下 反應8小時，得樹脂固體成份濃度爲25.0質量％之聚醯胺 酸溶液。 於所得之聚醯胺酸溶液（20.0g)中，加入NMP稀釋至 6質量％後，加入作爲醯亞胺化觸媒之乙酸酐（2.55 g)，及 吡啶（1.95g)，於80°C下進行4.5小時反應。將此反應溶液 投入甲醇（35 0ml)中，將所得沈澱物濾出。此沈澱物以甲 醇洗淨，於l〇〇°C下減壓乾燥，得聚醯亞胺粉末（G)。此聚 -125- 201219451 醯亞胺之醯亞胺化率爲52%，數平均分子量爲21，200、重 量平均分子量爲5 1,3 00。 <合成例8> 將 BODA(1.15g，4.60mmol)、特定二胺化合物（4)( 0.40g， 1 .53mmol)、PBCH5DAB( 1 .99g，4.70mmol)，及 DBA(1.40g，9. 19mmol)於 N Μ P (1 2.1 g)中混合，於 8 0 °C 下 反應3小時。隨後’加入TCA(2.40g，10.7mmol)與NMP( 9.9 1 g)，於40 °C下反應6小時，得樹脂固體成份濃度爲 2 5.0質量％之聚醯胺酸溶液。 於所得之聚醯胺酸溶液（20.1 g)中，加入NMP稀釋至 6質量％後，加入作爲醯亞胺化觸媒之乙酸酐（4.5 0g)，及 吡啶（3.3 5 g)，於90°C下反應3小時。將此反應溶液投入甲 醇（3 5 0ml)中，將所得沈澱物濾出。此沈澱物以甲醇洗淨 ，於100 °C下減壓乾燥，得聚醯亞胺粉末（H)。此聚醯亞胺 之醯亞胺化率爲82%，數平均分子量爲21，900、重量平均 分子量爲51，900 。 <合成例9> 將 BODA(1.15g ’ 4.60mmol)、特定二胺化合物（7)( 0.79g， 3.06mmol)、ColD AB -1 (1 · 5 1 g， 3.06mmol)，及 DBA(1.40g，9.19mmol)於 NMP(12.0g)中混合，於 80°C 下 反應3小時。隨後’加入TCA(2.40g，l〇.7mmol)與NMP (9.79g)，於40°C下反應6小時，得樹脂固體成份濃度爲 -126 - 201219451 25.0質量％之聚醯胺酸溶液。 於所得之聚醯胺酸溶液（20.0g)中，加入NMP稀釋至 6質量％後，加入作爲醯亞胺化觸媒之乙酸酐（2.50g)，及 吡啶（1.90g)’於80 °C下反應3.5小時。將此反應溶液投入 甲醇（3 5 0ml)中，將所得沈澱物濾出。此沈澱物以甲醇洗 淨，於100 °C下減壓乾燥，得聚醯亞胺粉末（I)。此聚醯亞 胺之醯亞胺化率爲56%，數平均分子量爲1 9,800、重量平 均分子量爲5 3,5 00。 <合成例1〇> 將 TDA(1.39g ’ 4_63mmol)、特定二胺化合物（1〇)( 0.46g， 1.54mmol)、PCH7DAB(2.35g，6.1 8 mm ο 1)，及 DBA(1.17g’7.72mmol)於 NMP(12.4g)中混合，於 80°C 下 反應3小時。隨後，加入CBDA(2.12g，l〇.8mmol)與NMP (lO.lg) ’於40°C下反應6小時，得樹脂固體成份濃度爲 2 5.0質量％之聚醯胺酸溶液。 於所得之聚醯胺酸溶液（20.0g)中，加入NMP稀釋至 6質量％後’加入作爲醯亞胺化觸媒之乙酸酐（4.5 0 g)，及 吡啶（3.3 5g)，於90°C下反應3小時。將此反應溶液投入甲 醇（40 0ml)中，將所得沈澱物濾出。此沈澱物以甲醇洗淨 ，於1〇〇 °C下減壓乾燥，得聚醯亞胺粉末（J)。此聚醯亞胺 之醯亞胺化率爲72%，數平均分子量爲20，200、重量平均 分子量爲49,800。 -127- 201219451 <合成例1 ι> 將 BODA(5.87g，23.5mmol)、AP18(5.52g， 14.7 mmol)，及 p-PDA(1.59g，14.7mmol)於 NMP(23.3g)中混合 ，於80°C下反應4小時。隨後，加入CBDA(1.15g，5.86 mmol)與NMP(19.1g)，於40°C下反應6小時，得樹脂固體 成份濃度爲2 5 · 0質量％之聚醯胺酸溶液（K)。此聚醯胺酸 之數平均分子量爲25,400、重量平均分子量爲70,900。 <合成例12> 於合成例1 1所得之樹脂固體成份濃度爲2 5.0質量。/。 之聚醯胺酸溶液（K)(20.1g)中，加入NMP稀釋至6質量％ 後’加入作爲醯亞胺化觸媒之乙酸酐（2.40g)，及吡啶（ 1.85g)’於80°C下反應4小時。將此反應溶液投入甲醇 (350ml)中，將所得沈澱物濾出。此沈澱物以甲醇洗淨， 於l〇〇°C下減壓乾燥，得聚醯亞胺粉末（L)。此聚醯亞胺之 醯亞胺化率爲56%，數平均分子量爲20,100、重量平均分 子量爲54,200。 <合成例13> 將 BODA(5.87g，23.5mmol)、PCH7DA(5.58g，14.7 mmol)’ 及 p-PDA(1.59g，14.7mmol)於 NMP(23.4g)中混合 ’於8〇C下反應4小時後’加入CBDA(1.15g，5.86mmol) 與Ν Μ P (1 9 . 1 g) ’於4 0 °C下反應6小時，得樹脂固體成份 濃度爲25.0質量％之聚醯胺酸溶液。BODA (5.87 g, 23.5 mmol), specific diamine compound (4) (1.52 g · 5.8 6 mmo 1), PB C Η 5 D AB (3.8 1 g, 8.8 Ommo 1), and p-PDA (1.59 g, 14.7 mmol) was mixed in NMP (23.0 g), and the reaction was carried out at 80 ° C for 4.5 hours. Subsequently, CBDA (1.15 g, 5.86 mmol) and NMP (18.8 g) were added and reacted at 40 ° C for 6 hours to obtain a polyamic acid solution having a resin solid concentration of 25.0% by mass. After adding NMP to 6% by mass, the obtained poly-proline solution (20.5 g) was added, and acetic anhydride (2.42 g) as a ruthenium catalyst was added, and pyridine (1.81 g) was added at 80 ° C. The reaction was carried out for 3.5 hours. The reaction solution was poured into methanol (305 ml), and the obtained precipitate was filtered. This precipitate was washed with methanol, and dried under reduced pressure at 100 ° C to obtain a polyimine powder (C). The polyimide imidization ratio of this polyimine was 52%', the number average molecular weight was 2,600, and the weight average molecular weight was 5,700. <Synthesis Example 4> -123- 201219451 B〇DA (3_42 g, 13.7 mmol), specific diamine compound (4) (1. Olg, 3.91 mmol), m-PBCH5DABz (2.62 g, 5.86 mmol), DBA ( 1.49 g, 9.77 mmo of hydrazine was mixed in NMP (16.0 g), and after reacting at 80 ° C for 4.5 hours, CBDA (1 · 15 g, 5.86 mmol) and NMP (1 3. 1 g) were added at 4 〇. The reaction was carried out at ° C for 6 hours to obtain a polyamic acid solution having a resin solid concentration of 25.0% by mass. In the obtained polyaminic acid solution (20.0 g), NMP was added and diluted to 6 mass%, and then added as a yam. Acetic anhydride (4.5 5 g) and pyridine (3.30 g) of the amination catalyst were reacted at 90 ° C for 3 hours. The reaction solution was poured into methanol (400 ml), and the resulting precipitate was filtered off. The mixture was washed with methanol and dried under reduced pressure at 100 ° C to obtain a polyimine powder (D). The polyamidimide had a ruthenium imidation ratio of 81% and a number average molecular weight of 22,100 and a weight average molecular weight of 53,200. Synthesis Example 5> BODA (5.72 g, 22.8 mmol), a specific diamine compound (7) (0.73 g, 2 · 86 mm ο 1), Cο 1D AB-1 (2 · 1 1 g, 4.2 8 mmο 1), and m-PDA (2.32g, 21.4 mmol) was mixed with NMP (19.8 g), and the reaction was carried out at 80 ° C for 4.5 hours. Subsequently, CBDA (1.12 g, 5.71 mmol) and NMP (16.2 g) were added and reacted at 40 ° C for 6 hours. A polyamic acid solution having a solid concentration of the resin of 25.0% by mass. In the obtained polyaminic acid solution (20.5 g), after adding NMP to 6% by mass, acetic anhydride as a ruthenium catalyst was added ( 2 · 5 5 g ), and pyridine (1.95 g), reacted at 80 ° C for 4 hours. The reaction solution was poured into a 201219451 alcohol (305 ml), and the resulting precipitate was filtered off. The washing was dried under reduced pressure at 1 ° C to obtain a polyimine powder (E). The polyamidimide had a hydrazine imidization ratio of 52%, a number average molecular weight of 20,800, and a weight average molecular weight of 53,100. <Synthesis Example 6> TCA (3.51 g, 15.7 mmol), a specific diamine compound (4) (0.41 g, 1.57 mmo 1), PC Η 7 D AB (2 · 3 8 g, 6 · 2 6 mmo 1), and p-PDA (0.85 g, 7.83 mmol) were mixed in NMP (28.6 g), and reacted at 40 ° C for 8 hours to obtain a polyglycine solution having a resin solid concentration of 25.0% by mass. F). The proline has a number average molecular weight of 28,900 and a weight average molecular weight of 75,300. <Synthesis Example 7 > TCA (3.52 g, 15.7 mmol), specific diamine compound (10) (0.47 g > 1.57 mmol), PBCH5DAB (1.80 g, 4-16 mmol), and m-PDA (0.90 g, 8.32) Methyl) was mixed in NMP (21.1 g) and reacted at 40 ° C for 8 hours to obtain a polyamine acid solution having a resin solid concentration of 25.0% by mass. After the NMP was diluted to 6% by mass in the obtained polyamic acid solution (20.0 g), acetic anhydride (2.55 g) as a ruthenium amide catalyst and pyridine (1.95 g) were added at 80 ° C. The reaction was carried out for 4.5 hours. The reaction solution was poured into methanol (35 ml), and the obtained precipitate was filtered. This precipitate was washed with methanol, and dried under reduced pressure at 10 ° C to obtain a polyimine powder (G). The poly-125-201219451 quinone imine has an imidization ratio of 52%, a number average molecular weight of 21,200, and a weight average molecular weight of 5,3,00. <Synthesis Example 8> BODA (1.15 g, 4.60 mmol), a specific diamine compound (4) (0.40 g, 1.53 mmol), PBCH5DAB (1.99 g, 4.70 mmol), and DBA (1.40 g, 9. 19 mmol) was mixed in N Μ P (1 2.1 g) and reacted at 80 ° C for 3 hours. Subsequently, TCA (2.40 g, 10.7 mmol) and NMP (9.9 1 g) were added and reacted at 40 ° C for 6 hours to obtain a polyamic acid solution having a resin solid concentration of 25.0% by mass. After adding NMP to 6 mass%, the obtained poly-proline solution (20.1 g) was added, and acetic anhydride (4.50 g) as a ruthenium-imiding catalyst, and pyridine (3.35 g) were added at 90°. The reaction was carried out for 3 hours at C. The reaction solution was poured into methanol (305 ml), and the resulting precipitate was filtered. This precipitate was washed with methanol and dried under reduced pressure at 100 ° C to obtain a polyimine powder (H). The polyimine had an oxime imidization ratio of 82%, a number average molecular weight of 21,900, and a weight average molecular weight of 51,900. <Synthesis Example 9> BODA (1.15 g ' 4.60 mmol), specific diamine compound (7) (0.79 g, 3.06 mmol), ColD AB -1 (1 · 5 1 g, 3.06 mmol), and DBA (1.40) g, 9.19 mmol) was mixed in NMP (12.0 g) and reacted at 80 ° C for 3 hours. Subsequently, TCA (2.40 g, 1 mmol. 7 mmol) and NMP (9.79 g) were added and reacted at 40 ° C for 6 hours to obtain a polyamic acid solution having a resin solid concentration of -126 - 201219451 25.0% by mass. After the NMP was diluted to 6% by mass in the obtained polyamic acid solution (20.0 g), acetic anhydride (2.50 g) as a ruthenium catalyst was added, and pyridine (1.90 g) was added at 80 °C. The reaction was carried out for 3.5 hours. The reaction solution was poured into methanol (305 ml), and the obtained precipitate was filtered. This precipitate was washed with methanol, and dried under reduced pressure at 100 ° C to obtain a polyimine powder (I). The polyamidiamine had a ruthenium iodide ratio of 56%, a number average molecular weight of 1,980, and an average weight molecular weight of 5 3,500. <Synthesis Example 1〇> TDA (1.39g '4_63mmol), a specific diamine compound (1〇) (0.46g, 1.54mmol), PCH7DAB (2.35g, 6.1 8 mm ο 1), and DBA (1.17g) '7.72 mmol) was mixed in NMP (12.4 g), and reacted at 80 ° C for 3 hours. Subsequently, CBDA (2.12 g, 10 mmol) was added and NMP (10.g) was reacted at 40 ° C for 6 hours to obtain a polyamic acid solution having a resin solid concentration of 25.0% by mass. To the obtained poly-proline solution (20.0 g), after adding NMP to 6% by mass, 'addition of acetic anhydride (4.50 g) as a ruthenium-imiding catalyst, and pyridine (3.35 g) at 90° The reaction was carried out for 3 hours at C. The reaction solution was poured into methanol (40 ml), and the resulting precipitate was filtered. This precipitate was washed with methanol and dried under reduced pressure at 1 ° C to obtain a polyimine powder (J). The polyimine had a hydrazine imidation ratio of 72%, a number average molecular weight of 20,200, and a weight average molecular weight of 49,800. -127-201219451 <Synthesis Example 1 ι> BODA (5.87 g, 23.5 mmol), AP18 (5.52 g, 14.7 mmol), and p-PDA (1.59 g, 14.7 mmol) were mixed in NMP (23.3 g). The reaction was carried out at 80 ° C for 4 hours. Subsequently, CBDA (1.15 g, 5.86 mmol) and NMP (19.1 g) were added and reacted at 40 ° C for 6 hours to obtain a polyamic acid solution (K) having a resin solid concentration of 25.0% by mass. The polyamine had a number average molecular weight of 25,400 and a weight average molecular weight of 70,900. <Synthesis Example 12> The resin solid content concentration obtained in Synthesis Example 1 1 was 25.0 mass. /. In the poly-proline solution (K) (20.1 g), after adding NMP to 6% by mass, 'addition of acetic anhydride (2.40 g) as a ruthenium catalyst, and pyridine (1.85 g)' at 80 ° The reaction was carried out for 4 hours at C. The reaction solution was poured into methanol (350 ml), and the obtained precipitate was filtered. This precipitate was washed with methanol, and dried under reduced pressure at 10 ° C to give a polyimine powder (L). The polyimine had a ruthenium iodide ratio of 56%, a number average molecular weight of 20,100, and a weight average molecular weight of 54,200. <Synthesis Example 13> BODA (5.87 g, 23.5 mmol), PCH7DA (5.58 g, 14.7 mmol)' and p-PDA (1.59 g, 14.7 mmol) were mixed in NMP (23.4 g) at 8 〇C After reacting for 4 hours, 'CBDA (1.15 g, 5.86 mmol) and ΝP (19.1 g) were reacted at 40 ° C for 6 hours to obtain a polyamic acid having a resin solid concentration of 25.0% by mass. Solution.

Q -128- 201219451 於所得之聚醯胺酸溶液（20.0g)中，加入NMP稀釋至 6質量％後，加入作爲醯亞胺化觸媒之乙酸酐（2.50g)，及 吡啶（1.9 0g)，於80 °C下反應4小時。將此反應溶液投入甲 醇（3 5 0ml)中，將所得沈澱物濾出。此沈澱物以甲醇洗淨 ，於l〇〇t下減壓乾燥，得聚醯亞胺粉末（M)。此聚醯亞胺 之醯亞胺化率爲55%，數平均分子量爲20,300、重量平均 分子量爲49,800。 <合成例14> 將 BODA(5.87g，23.5mmol)、PCH7DAB(5.58g，14.7 mmol)、二胺化合物（13)(0.71g，2.93mmol)，及 p-PDA(1.27g，11.7mmol)於 N Μ P ( 2 2 · 2 g)中混合，於 8 0 °C 下 反應4小時。隨後，加入CBDA(1.15g，5.86mmol)與NMP (1 8.2g)，於40 °C下反應6小時，得樹脂固體成份濃度爲 25.0質量％之聚醯胺酸溶液。 於所得之聚醯胺酸溶液（2 0.0 g)中，加入NMP稀釋至 6質量％後，加入作爲醯亞胺化觸媒之乙酸酐（2.50g)，及 吡啶（1.92g)，於80 °C下反應4小時。將此反應溶液投入甲 醇（3 5 0 m 1)中，將所得沈澱物濾出。此沈澱物以甲醇洗淨 ，於100°c下減壓乾燥’得聚醯亞胺粉末（N)。此聚醯亞胺 之醯亞胺化率爲55%，數平均分子量爲20,100、重量平均 分子量爲54,100。 <合成例15> -129- 201219451 將 BODA(5.87g，23.5mm〇l)、PCH7DAB(5.58g ’ 14.7 mmol)、二胺化合物（16)(0.75g’ 2.93mmol)，及 p-PDA (1.27g，11.7mmol)於 NMP(24.1g)中混合’於 80°C 下反應 4 小時。隨後’加入 CBDA(1.15g’ 5.86mmol)與 NMP 19.7 g)，於40 °C下反應8小時，得樹脂固體成份濃度爲25.0 質量％之聚醯胺酸溶液。 於所得之聚醯胺酸溶液（2〇.〇g)中’加入NMP稀釋至 6質量％後，加入作爲醯亞胺化觸媒之乙酸酐（2 · 4 5 g)’及 吡啶（1.85g)，於80°C下反應3.5小時。將此反應溶液投入 甲醇（3 5 Oml)中，將所得沈澱物濾出。此沈澱物以甲醇洗 淨，於1001下減壓乾燥，得聚醯亞胺粉末（〇)。此聚醯亞 胺之醯亞胺化率爲55%，數平均分子量爲21,2 00、重量平 均分子量爲5 2,1 00。 <合成例1 6 >Q-128-201219451 After adding NMP to 6% by mass in the obtained polyamidic acid solution (20.0 g), acetic anhydride (2.50 g) as a ruthenium-imiding catalyst, and pyridine (1.90 g) were added. , react at 80 ° C for 4 hours. The reaction solution was poured into methanol (305 ml), and the resulting precipitate was filtered. This precipitate was washed with methanol and dried under reduced pressure at 1 Torr to give a polyimine powder (M). The polyimine had a hydrazine imidation ratio of 55%, a number average molecular weight of 20,300, and a weight average molecular weight of 49,800. <Synthesis Example 14> BODA (5.87 g, 23.5 mmol), PCH7DAB (5.58 g, 14.7 mmol), diamine compound (13) (0.71 g, 2.93 mmol), and p-PDA (1.27 g, 11.7 mmol) Mix in N Μ P ( 2 2 · 2 g) and react at 80 ° C for 4 hours. Subsequently, CBDA (1.15 g, 5.86 mmol) and NMP (18.2 g) were added and reacted at 40 ° C for 6 hours to obtain a polyamic acid solution having a resin solid concentration of 25.0% by mass. After the NMP was diluted to 6% by mass in the obtained polyamic acid solution (20.0 g), acetic anhydride (2.50 g) as a ruthenium amide catalyst and pyridine (1.92 g) were added at 80 °. The reaction was carried out for 4 hours at C. This reaction solution was poured into methanol (3,500 ml), and the resulting precipitate was filtered. This precipitate was washed with methanol and dried under reduced pressure at 100 ° C to give a polyimine powder (N). The polyimine had a hydrazine imidation ratio of 55%, a number average molecular weight of 20,100, and a weight average molecular weight of 54,100. <Synthesis Example 15> -129- 201219451 BODA (5.87 g, 23.5 mm 〇l), PCH7DAB (5.58 g '14.7 mmol), diamine compound (16) (0.75 g ' 2.93 mmol), and p-PDA ( 1.27 g, 11.7 mmol) was mixed in NMP (24.1 g) to react at 80 ° C for 4 hours. Subsequently, CBDA (1.15 g' 5.86 mmol) and NMP 19.7 g) were added and reacted at 40 ° C for 8 hours to obtain a polyamic acid solution having a resin solid concentration of 25.0% by mass. After the NMP was diluted to 6% by mass in the obtained polyamic acid solution (2 〇.〇g), acetic anhydride (2·45 g) and pyridine (1.85 g) as a ruthenium catalyst were added. ), reacted at 80 ° C for 3.5 hours. The reaction solution was poured into methanol (3 5 ml), and the obtained precipitate was filtered. This precipitate was washed with methanol, and dried under reduced pressure at 1001 to give a polyimine powder. The polyamidiamine had a hydrazine imidation ratio of 55%, a number average molecular weight of 21,200, and an average weight molecular weight of 5 2,100. <Synthesis Example 1 6 >

將 BODA(5.77g，23.0mmol)、特定二胺化合物（4)( 0.75g，2.88mmol)、AP18(5.43g ’ 14.4mmol) ’ 及 p-PDA (1.27g，1 1.5mmol)於 NMP(23.6g)中混合，於 8 0 °C 下反應 4 小時。隨後，加入 CBDA(l_13g’ 5.76mmol)與 NMP( 19.3g)，於40°C下反應8小時’得樹脂固體成份濃度爲 2 5.0質量％之聚醯胺酸溶液。 於所得之聚醯胺酸溶液（20.5g)中’加入NMP稀釋至 6質量％後，加入作爲醯亞胺化觸媒之乙酸酐（2.50g) ’及 吡啶（1 . 9 0 g )，於8 0 °C下反應4小時。將此反應溶液投入甲 -130- 201219451 醇（3 5 0ml)中，將所得沈澱物濾出。此沈澱物以甲醇洗淨 ，於l〇〇°C下減壓乾燥，得聚醯亞胺粉末（P)。此聚醯亞胺 之醯亞胺化率爲54%，數平均分子量爲21，900'重量平均 分子量爲51,400。 本發明之聚醯胺酸及聚醯亞胺係如表45所示。 [表 45]BODA (5.77 g, 23.0 mmol), specific diamine compound (4) (0.75 g, 2.88 mmol), AP18 (5.43 g ' 14.4 mmol) ' and p-PDA (1.27 g, 1 1.5 mmol) in NMP (23.6) g) Mix in and react at 80 ° C for 4 hours. Subsequently, CBDA (l_13g' 5.76 mmol) and NMP (19. 3 g) were added and reacted at 40 ° C for 8 hours to obtain a polyaminic acid solution having a resin solid concentration of 25.0% by mass. After the NMP was added to the obtained poly-proline solution (20.5 g) and diluted to 6 mass%, acetic anhydride (2.50 g) as a ruthenium-imiding catalyst and pyridine (1.90 g) were added thereto. The reaction was carried out at 80 ° C for 4 hours. This reaction solution was poured into a methyl-130-201219451 alcohol (305 ml), and the resulting precipitate was filtered. This precipitate was washed with methanol and dried under reduced pressure at 10 ° C to obtain a polyimine powder (P). The polyimine had a ruthenium iodide ratio of 54% and a number average molecular weight of 21,900' weight average molecular weight of 51,400. The poly-proline and polyimine of the present invention are shown in Table 45. [Table 45]

樹脂成分 四羧酸二酐 二胺成分 βΏ眩 特定二胺化雜 特足茭卿 -胺化細 其他二胺化潍 化率W 合成例1 聚醯胺酸溶MA) CBDA (M5g. 5.86mmol) BODA (5.87g.23,5mmol) ⑷ C〇 76g 2.93mmol) PCH7DAB 14.7mmoI) (r-PDA (l.27g. 11.7rmio() 合成例2 聚姬胺粉細 CBDA (I.15g. 5.86mmol) BODA (5.87g. 23.5mmol) ⑷ (〇.76g 2.93 mmol) PCH7DAB (5.58g, 14.7mmDl) p-PDA (l.27g, n.7mmol) £5 合成例3 聚醸亞胺粉未C。） CBDA (U5g. 5.86mmol) BODA (5.87g, 23,5mmol) ⑷ (l.52g 5.86mmol) FBCH5DAB (3.81g, 8.80mrrol) p-PDA (1.59ft 14.7mmal) 52 合成例4 聚醯亞胺粉末D) CBDA Cl.15g, 5.86mmol) BODA (3.42g,13.7mmol) ⑷ (l.Olg 3.91 mmol) m-PBCH5DAB2 (2.62g. 5.86mmol) DBA (1.A9& 9.77mm〇l) 81 合成例5 聚醢亞胺粉細 CBDA (l.12g. 5.71 mmol) BODA (5 72g, 22.8hTmol) (7) (〇73g 2.86mmol) CoDAB-T C2.11g.4.28mrrol) m-POA (232g,21.4nm〇l) S3 合成例6 聚挪酸溶液(F) TCA (3.51 g, T5,7mm〇}) ⑷ (0.41 g 1,57 mmol) PCH7DAB (238g,626mrrOl) p-PDA (0.85g, 7.83mmol) 合成例7 聚软亞胺粉細 TCA (3.52g.15.7mmol) (10) (〇L47g 1.57mmol) FBCH50AB (l.80g. 4.16mrrol) rrrPOA (a90g, 8.32nmol) £2 合成例8 聚醯亞胺粉細） BODA (U5g. 4.6Crrtfnol) TCA C2.40g.107mmd) (4) (0.40¾ 1.53mmol) FBCH5DAB (l.99g.4.70mmDl) OBA (l.40g, 9.19mmol) 82 合成例9 BODA (l.15g. 4.60mmol) TCA (2.4〇g> 10.7mmol) (7) (Q79g aC6mmol) CoOAB-1 (I.51g.3.06mm3l) DBA (l.40g, 9.19mmcl) S6 合成例10 mmssmm) CBDA (212g.l0.8mmol) TOA 0.39g. 4.63mmoi) (10) (0,46g 1.54mmol) PCH7DAB (2.35g. 6.1 8mm〇l) DBA (U7g. 7.72mmol) 12 合成例11 聚醯胺酸溶液(κ) CBDA (l.15g, 5.86mm(M) BODA (5.87g. 23.5mmo0 API 8 (5.52¾ l4,7mmol). p-PDA (Ί 14.7irmol) 合成例12 聚酶亞胺粉葙D CBOA (V15g. 5.86cwol) BODA (5.e7g.23.5mmol) API 8 (5.52g. l4.7mmol). p-P〇A(V59a 14 7mrrol) 56 合成例13 CBOA 0.15g, 5.86mmoJ) BODA (5.87g. 23.5mmol) PCH70AB (5.58g. 14.7mnx>l) prPDA (l.59g, 14.7rrmol) ii5 合成例14 聚末⑽ CBDA (1.15g. 5.86mmol) BODA (5.87¾ 23.5mmol) PCH7DAB (5.58g, 14.7mmol) (13) (Q71g 2.93mmol). p-PDA (l.27g, n.7mmol) ；i5 合成例15 聚酸亞胺粉末0) CBDA (1.15g. 5.86mmol) BODA (5.87g,23.5mmo!) PCH7DAB (5.58g. 14.7mmrl) ¢16) (0.75 g. 2.93 mmol). p-POA (l.27g, I1.7rrmd) 55 合成例16 聚酿亞胺粉菊吒 CBDA (l.l3g, 5.76mmol) ΘΟΟΑ (5.77g. 23.0rtimol) ⑷ C〇.75g Z88mmol) AR8 (543ct 14.4mmo0. prPOA il ?fte. 11.5frm〇l) M *1:聚醯胺酸· -131 - 201219451 「液晶配向處理劑之製造」 實施例1〜1 3及比較例1〜6爲記載液晶配向 之製造例。所製造之液晶配向處理劑的組成係如表 表47所示。 「液晶晶元之製作」及「電特性之評估」係如 容。 使用實施例1〜1 3及比較例1〜6所得之各液 處理劑，製作液晶晶元，並對所製得之液晶晶元評 特性。 「液晶晶元之製作」 將液晶配向處理劑旋轉塗佈於附有3 0 x40mm 電極的基板之ITO面上，於熱壓版上以80°C、5分 循環型清淨烘箱中進行23 0 °C、30分鐘加熱處理， 膜厚1 OOnm之聚醯亞胺液晶配向膜之基板。 準備2片附有液晶配向膜之基板，以液晶配向 內側之方式挾夾6μιη之調距器，並予組合，使用密 著周邊以製作空晶元。對該空晶元以減壓注入法 MLC-6608(MERCK-JAPAN公司製），將注入口封閉 向列型液晶（Nematic Liquid)晶元。 使用偏光顯微鏡觀察此液晶晶元結果，確認液 均勻配向，並未發現配向瑕疵。 處理劑 46及 下述內 晶配向 估其電 之 ITO 鐘，熱 得附有 膜面向 封劑黏 ，注入 ，製得 晶呈現 -132- 201219451 「電特性之評估」 對依上述「液晶晶元之製作」所製得之液晶晶元於 8〇°C之溫度下以60μηι施加IV之電壓，並分別測定 16.67ms後，及50ms後之電壓，以電壓可如何至何種程 度之方式作爲電壓保持率之計算。又，測定爲使用VHR-1 電壓保持率測定裝置（東陽科技公司製），並進行 Voltage :±1V、Pulse Width : 60ps、Flame Period : 16.67ms 或 5 0ms之設定。 對於測定電壓保持率後之液晶晶元，以3 0分鐘施加 直流電壓1 0 V，使其形成1秒鐘短路後，測定於1 8 0 0秒 間於液晶晶元內所發生之電位。隨後，測定5 0秒後及 1 000秒後之殘留電荷。又，測定爲使用東陽科技公司製之 液晶物性評估裝置（6254型）。 電壓保持率及殘留電荷之測定爲，對於結束後之液晶晶 元，照射於365nm換算下爲50J/cm2之紫外線之後，並依與 上述相同之條件，進行電壓保持率及殘留電荷之測定。又， 紫外線照射爲使用桌上型UV硬化裝置（HCT3B28HEX-1)(先 萊特公司製（SEN LIGHT CORPORATION))。 <實施例1> 將合成例1所得之樹脂固體成份濃度24.9質量％之聚 醯胺酸溶液（A)(10.5g)、NMP(8.50g)及 BCS(24.6g)於 25t 下混合6小時，得液晶配向處理劑（1)。該液晶配向處理劑 中，未發現混濁或結晶等異常現象，確認得到均勻之溶液 -133- 201219451 使用所得液晶配向處理劑（1)，依上述之條件，進行液 晶晶兀之製作及電特性之評估。 對於實施例2〜13，及比較例1〜6，爲使用與實施例 1相同方法製造之各液晶配向處理劑，進行液晶晶元之製 作及電特性之評估。其結果係如表48〜5 1所示。 <實施例2> 將合成例2所得之聚醯亞胺粉末（B)(2.52g)、NMP( 22.3g)及BCS(19.7g)於25t下混合8小時，得液晶配向處 理劑（2)。該液晶配向處理劑中，未發現混濁或結晶等異常 現象’確認得到均句之溶液。 <實施例3> 將合成例3所得之聚醯亞胺粉末（c)(2.50g)、NMP( 24.0g)及BCS(17.6g)於25°C下混合8小時，得液晶配向處 理劑（3)。該液晶配向處理劑中，未發現混濁或結晶等異常 現象’確認得到均句之溶液。 <實施例4> 將合成例4所得之聚醯亞胺粉末（D)(2.51g)、NMP( 26.1g)及BCS(15.7g)於25°C下混合8小時，得液晶配向處 理劑（4)。該液晶配向處理劑中，未發現混濁或結晶等異常 現象，確認得到均勻之溶液。 -134- 201219451 <實施例5> 將合成例5所得之聚醯亞胺粉末（E)(2.50g)、NMP( 29.9g)及BCS(11.8g)於25°C下混合8小時，得液晶配向處 理劑（5)。該液晶配向處理劑中，未發現混濁或結晶等異常 現象，確認得到均勻之溶液。 <實施例6 > 將合成例6所得之樹脂固體成份濃度25.0質量％之聚 醯胺酸溶液（F)(11.0g)、NMP(ll.lg)及BCS(23.7g)於25。C 下混合6小時，得液晶配向處理劑（6)。該液晶配向處理劑 中’未發現混濁或結晶等異常現象，確認得到均勻之溶液 <實施例7> 將合成例7所得之聚醯亞胺粉末（G)(2.51g)、NMP( 3〇.〇g)及BCS(11.8g)於25°C下混合8小時，得液晶配向處 理劑（7)。該液晶配向處理劑中，未發現混濁或結晶等異常 現象，確認得到均勻之溶液。 <實施例8> 將合成例8所得之聚醯亞胺粉末（H)(2.50g)、NMP( 26』g)及BCS(15.7g)於25°C下混合8小時，得液晶配向處 理劑（8)。該液晶配向處理劑中，未發現混濁或結晶等異常 -135- 201219451 現象，確認得到均勻之溶液。 <實施例9> 將合成例9所得之聚醯亞胺粉末（I)(2.50g)、NMP( 3 1.9g)及BCS(9.80g)於25°C下混合8小時，得液晶配向處 理劑（9) »該液晶配向處理劑中，未發現混濁或結晶等異常 現象，確認得到均勻之溶液。 <實施例1 〇 > 將合成例10所得之聚醯亞胺粉末（J)(2.53g)、NMP( 3〇.3g)及BCS(11.9g)於25°C下混合8小時，得液晶配向處 理劑（1 〇)。該液晶配向處理劑中，未發現混濁或結晶等異 常現象，確認得到均勻之溶液。 <實施例1 1> 將合成例2所得之聚醯亞胺粉末（B)(2.50g)、NMP( 22.1g)、BCS(19.6g)及交聯性化合物（l)(0.25g)於 25°C 下混 合1 2小時，得液晶配向處理劑（丨丨）。該液晶配向處理劑中 ’未發現混濁或結晶等異常現象，確認得到均勻之溶液。 <實施例1 2 > 將合成例3所得之聚醯亞胺粉末（C)(2.50g)、NMP( 24.0g)、BCS(17.6g)及交聯性化合物（2)(0.50g)於 25°C 下混 合1 2小時’得液晶配向處理劑（丨2)。該液晶配向處理劑中 -136- 201219451 ，未發現混濁或結晶等異常現象，確認得到均勻之溶液。 <實施例13> 將合成例3所得之聚醯亞胺粉末（C)(2.51g)、NMP( 24.1g)、BCS(17.7g)及交聯性化合物（3)(0.25g)於 25°C 下混 合1 2小時，得液晶配向處理劑（1 3 )。該液晶配向處理劑中 ，未發現混濁或結晶等異常現象，確認得到均勻之溶液。 <比較例1 > 將合成例11所得之樹脂固體成份濃度25 ·4質量％之 聚醯胺酸溶液（K)(10.0g)、NMP(8.50g)及 BCS(23.9g)於 2 5 °C下混合6小時，得液晶配向處理劑（14)。該液晶配向 處理劑中，未發現混濁或結晶等異常現象，確認得到均勻 之溶液。 <比較例2 > 將合成例12所得之聚醯亞胺粉末（L)(2.50g)、NMP( 22.1g)及BCS(19.6g)於25°C下混合8小時，得液晶配向處 理劑（1 5)。該液晶配向處理劑中，未發現混濁或結晶等異 常現象，確認得到均勻之溶液。 <比較例3 > 將合成例13所得之聚醯亞胺粉末（M)(2.5 1g)、NMPC 2 4.1 g)及B C S (1 7 _ 7 g)於2 5 °C下混合8小時，得液晶配向處 -137- 201219451 理劑（1 6)。該液晶配向處理劑中，未發現混濁或結晶等異 常現象，確認得到均勻之溶液。 <比較例4 > 將合成例14所得之聚醯亞胺粉末（N)(2.50g)、NMP( 22.1g)及BCS(19.6g)於25°C下混合8小時，得液晶配向處 理劑（1 7)。該液晶配向處理劑中，未發現混濁或結晶等異 常現象，確認得到均勻之溶液。 <比較例5 > 將合成例15所得之聚醯亞胺粉末（〇)(2· 5 0g)、NMP( 29.9g)及BCS(11.8g)於25°C下混合8小時，得液晶配向處 理劑（1 8)。該液晶配向處理劑中，未發現混濁或結晶等異 常現象，確認得到均勻之溶液。 <比較例6 > 將合成例16所得之聚醯亞胺粉末（P)(2.51g)、NMP( 28.1g)及BCS(13.8g)於25°C下混合8小時，得液晶配向處 理劑（1 9)。該液晶配向處理劑中，未發現混濁或結晶等異 常現象，確認得到均勻之溶液。 -138- 201219451 [表 46] 液晶配向處理劑 樹脂成分 特定二胺化合物 特定支_二胺化合物 交聯性化合物 實施例1 液晶配向處理劑(1) 聚賺酸溶液(A) ⑷ PCH70AB 實施例2 液晶配向處理劑(2> 聚面亞胺粉末(B) ⑷ PCH7DAB 貿施例3 液晶配向處理劑(3) 聚姬胺粉末(Q ⑷ PBCH5DAB 貪施例4 液晶配向處理劑(4> 聚醯亞膨份末ω) ⑷ m-PBCH5DABr 實施例5 液晶配向處理劑(5> 聚醒亞胺粉未(Ε) (7) ColDAB-1 實施例6 液晶配向處理劑(6) 聚—肢溶液(F) (4) PCH7DAB 貢施例7 液晶配向處理劑(7) 聚麵胺粉末(G) (10) PBCH5DAB 實施例8 液晶配向處理劑⑻ 聚睡亞胺粉末(Η) (4) PBCH5DAB 實施例9 液晶配向處理劑(9) 聚醯亞祕末ω (7) GolDAB-1 實施例10 液晶配向處理劑；10) 聚姬胺粉末(η 00) PCH7DAB 會施例11 液晶配向處理覿11) 聚醯亞夫rm ⑷ PCH7DAB 女#性化会物(υ 貪施例12 液晶配向處理劑：12) 聚末ra (4) PBCH5DAB 交聯性化雜(2) 實施例13 鹏配向處理敵13) 聚酿亞胺粉末(〇 (4) PBCH5DAB 交聯性化合物(3> [表 47] 液晶配向處理劑 樹脂成分 特定二胺化合物 特定支醒二胺化合物 其他二胺化合物 比較例1 液晶配向處理挪14) 聚醯胺麟液(K) AP18 比較例2 液晶配向處理»Π5) 聚醣亞贿末(L) AP18 比較例3 液晶配向處理劑：1β) 聚姬腿末(M) PCH7DAB 比較例4 液晶配向處理剤C17> 聚 末(N) PCH7DAB (13) 比較例5 液晶配向處理劑：18) 聚胺粉未(0) PCH7DAB (16) 比較例6 液晶配向處理觫怕） 聚触胺扮来(P) ⑷ AP18 [表 48] 液晶配向處理劑 鬣厭保持率(％) 液晶晶元製造後即時 紫外線照射後 16.67ms 50 ms 16.67ms 50ms 實施例1 液晶配向處理劑（1) 97.1 94.1 85.7 80.1 實施例2 液晶配向處理劑(2) 97.4 95.3 922 89.6 實施例3 液晶配向處理劑(3) 97.4 95.4 92.3 89.8 啻施例4 液晶配向處理劑(4) 97.6 95.5 92.8 90.5 眚施俐<5 液晶配向處理劑(5) 97.3 95.3 92.2 89.5 會施例6 液晶配向處理劑(6) 97.0 94.0 852 79.5 實施例7 液晶配向處理劑⑺ 97.3 95.3 92.1 89.7 實施例8 液晶配向處理劑(8) 97.5 95.4 92.7 90.3 實施例9 液晶配向處理劑(9) 97.3 952 92.0 89.5 實施例10 液晶配向處理劑：1〇〉 97.4 95.4 922 90.0 實施例11 液晶配向處理劑(11) 97.5 95.5 92.6 90.4 實施例12 液晶配向處理劑(12) 97.6 95.7 92.7 90.6 實施例13 液晶配向處理劑(13) 97.5 95.7 92.6 90.5 -139- 201219451 康49] 液晶配向處理劑 電壓保持率㈤ 液晶晶兀嬰 造後即時 紫外線照射後 16.67ms 50 ms 16.67ms 50ms 比較例1 液晶配向處理劑(14) 96.8 93.6 79.3 64.4 比較例2 液晶配向處理劑(15) 97.0 94.0 84.4 79.8 比較例3 液晶配向處理劑:16) 97.1 947 87.4 82.2 比較例4 液晶配向處理劑C17) 97.0 94.6 87.3 82.0 比較例5 液晶配向處理劑(18) 97.1 94.4 872 82.1 比較例6 液晶配向處理劑>9) 97.2 94.5 88.9 837 [表 50] 液晶配向處理劑 殘留電荷之緩和(V) 液晶晶元! 雜造後即時 紫外線照射後 50秒後 1000秒後 50秒後 1000秒後 實施例1 液晶配向處理劑（1) 0.64 0.12 0.98 0.23 晳施例2 液晶配向處理劑(2) U3 0.17 143 0.22 實施例3 液晶配向處理劑(3) 1.15 0.18 1.41 0.21 實施例4 液晶配向處理劑(4) 1.35 0.31 1.55 0.34 實施例5 液晶配向處理劑(5> 1.12 0.16 140 0.22 實施例6 液晶配向處理劑(6) 0.61 0.11 1.01 0.25 實施例7 液晶配向處理劑（7) 1.15 0.16 1.44 0.22 實施例8 液晶配向處理劑(8) 1.21 0.24 U3 0.28 哲施例9 液晶配向處理劑(9) 1.11 0.13 1.42 0.24 窗施例10 液晶配向處理劑1〇) 1.18 0.20 1.40 0.27 官施例11 液晶配向處理劑(11) 1.20 0.22 1.34 0.25 實施例12 液晶配向處理劑(12) 1.22 0.21 1.38 0.24 實施例13 液晶配向處理劑：13) 1.20 0.21 135 0.25 [表 51] 液晶配向處理劑 殘留電荷之緩和(V) 液晶晶元! 络造後即時 紫外線照射後 50秒後 1000秒後 50秒後 1000秒後 比較例1 液晶配向處理劑(14> 0.61 0.11 2.12 0.56 比較例2 液晶配向處理劑(15) 1.18 0.17 1.93 0.45 比較例3 液晶配向處理劑（16) 1.15 0.15 1S7 0.43 比較例4 液晶配向處理劑(17) 1.14 0.17 1B5 0.44 比較例5 液晶配向處理劑(18) 1.15 0.16 1B4 0.42 比較例6 液晶配向處理劑(19) 1.17 0.18 1B8 0.44 由上述結果得知，由實施例1〜1 3之液晶配向處理劑 所得之液晶配向膜，與由比較例1〜6之液晶配向劑所得 之液晶配向膜相比較時，得知即使暴露於紫外線之後，仍 具有較小之電壓保持率之下降，且可快速地緩和因直流電 -140- 201219451 壓所蓄積之殘留電荷。 不含特定二胺化合物之比較例1〜5中’其於暴露於 紫外線之後，爲具有較大之電壓保持率之下降’此外’因 直流電壓所蓄積之殘留電荷之緩和亦較爲遲緩。又’不含 特定側鏈型二胺化合物之比較例6，亦得到相同之結果。 [產業上之利用性] 本發明之液晶配向處理劑，可得到一種即使長時間暴 露於光照射下，可抑制電壓保持率之降低，且可快速地緩 和因直流電壓而蓄積之電荷液晶配向膜。具有本發明之液 晶配向膜之液晶顯示元件，爲具有優良信賴性之顯示元件 ，而適合使用大畫面且具有高精細度之液晶電視等，又， 其適用於TN元件、STN元件、TFT液晶元件，特別是適 合用於垂直配向型液晶顯示元件。 此外，由本發明之液晶配向處理劑所得之液晶配向膜 ’可使用於具有於電極間施加電壓中，照射紫外線之步驟 的液晶顯示元件之製造中。 又’本說明中爲引用2010年7月26日所申請之曰本 專利出願2 0 1 0 - 1 6 7 3 7 1號之說明書、申請專利範圍，及摘 要等全部內容，其係作爲本發明說明書之揭示內容而擷取 置入說明書內。 -141 -Resin component tetracarboxylic dianhydride diamine component β Ώ 特定 特定 特定 特定 特定 特定 特定 - - - - - - - - - - - - - - - - - - - - - 合成 合成 合成 合成 合成 合成 合成 合成 合成 合成 合成 合成 合成 合成 合成 合成 合成 合成 合成 合成BODA (5.87g.23, 5mmol) (4) C〇76g 2.93mmol) PCH7DAB 14.7mmoI) (r-PDA (1.27g. 11.7rmio() Synthetic Example 2 Polyamineamine fine CBDA (I.15g. 5.86mmol) BODA (5.87g. 23.5mmol) (4) (〇.76g 2.93 mmol) PCH7DAB (5.58g, 14.7mmDl) p-PDA (1.27g, n.7mmol) £5 Synthesis Example 3 Polyimine powder No C.) CBDA (U5g. 5.86mmol) BODA (5.87g, 23,5mmol) (4) (l.52g 5.86mmol) FBCH5DAB (3.81g, 8.80mrrol) p-PDA (1.59ft 14.7mmal) 52 Synthesis Example 4 Polyimine powder D) CBDA Cl.15g, 5.86mmol) BODA (3.42g, 13.7mmol) (4) (l.Olg 3.91 mmol) m-PBCH5DAB2 (2.62g. 5.86mmol) DBA (1.A9& 9.77mm〇l) 81 Synthesis Example 5 Polyimine powder fine CBDA (l.12g. 5.71 mmol) BODA (5 72g, 22.8hTmol) (7) (〇73g 2.86mmol) CoDAB-T C2.11g.4.28mrrol) m-POA (232g, 21.4 Nm〇l) S3 Synthesis Example 6 Poly (or acid) solution (F) TCA (3.51 g, T5, 7 mm〇}) (4) (0.41 g 1,57 mmol) PCH7DAB (238 g, 626 mrrOl) p-PDA (0.8 5g, 7.83mmol) Synthesis Example 7 Poly soft imine powder fine TCA (3.52g.15.7mmol) (10) (〇L47g 1.57mmol) FBCH50AB (l.80g. 4.16mrrol) rrrPOA (a90g, 8.32nmol) £2 Synthesis Example 8 Polyimine powder fine) BODA (U5g. 4.6Crrtfnol) TCA C2.40g.107mmd) (4) (0.403⁄4 1.53mmol) FBCH5DAB (l.99g.4.70mmDl) OBA (l.40g, 9.19mmol) 82 Synthesis Example 9 BODA (l.15g. 4.60mmol) TCA (2.4〇g> 10.7mmol) (7) (Q79g aC6mmol) CoOAB-1 (I.51g.3.06mm3l) DBA (l.40g, 9.19mmcl) S6 Synthesis Example 10 mmssmm) CBDA (212 g.l0.8 mmol) TOA 0.39 g. 4.63 mmoi) (10) (0,46 g 1.54 mmol) PCH7DAB (2.35 g. 6.1 8 mm 〇l) DBA (U7g. 7.72 mmol) 12 Synthesis Example 11 Polyproline solution (κ) CBDA (l.15g, 5.86mm(M) BODA (5.87g. 23.5mmo0 API 8 (5.523⁄4 l4,7mmol). p-PDA (Ί 14.7irmol) Synthesis Example 12 Polymerase Imine powder 葙D CBOA (V15g. 5.86cwol) BODA (5.e7g.23.5mmol) API 8 (5.52g. l4.7mmol). pP〇A(V59a 14 7mrrol) 56 Synthesis Example 13 CBOA 0.15g, 5.86mmoJ BODA (5.87g. 23.5mmol) PCH70AB (5.58g. 14.7mnx>l) prPDA (l.59g, 14.7rrmol) ii5 Synthesis Example 14 Poly(10) CBDA (1.15g. 5.86mmol) BODA (5 .873⁄4 23.5mmol) PCH7DAB (5.58g, 14.7mmol) (13) (Q71g 2.93mmol). p-PDA (1.27g, n.7mmol); i5 Synthesis Example 15 Polyimine powder 0) CBDA (1.15g 5.86mmol) BODA (5.87g, 23.5mmo!) PCH7DAB (5.58g. 14.7mmrl) ¢16) (0.75 g. 2.93 mmol). p-POA (l.27g, I1.7rrmd) 55 Synthesis Example 16 Imine powder Jerusalem artichoke CBDA (l.l3g, 5.76mmol) ΘΟΟΑ (5.77g. 23.0rtimol) (4) C〇.75g Z88mmol) AR8 (543ct 14.4mmo0. prPOA il ?fte. 11.5frm〇l) M *1:醯 酸 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - The composition of the liquid crystal alignment treatment agent produced is shown in Table 47. The "production of liquid crystal wafers" and "assessment of electrical characteristics" are as follows. Using the respective liquid treating agents obtained in Examples 1 to 13 and Comparative Examples 1 to 6, liquid crystal crystal cells were produced, and the obtained liquid crystal crystal cells were evaluated for characteristics. "Production of Liquid Crystal Cell" The liquid crystal alignment agent was spin-coated on the ITO surface of a substrate with a 30 x 40 mm electrode, and subjected to a hot press plate at 80 ° C in a 5-minute cycle type cleaning oven. C. The substrate of the polyimine liquid crystal alignment film having a film thickness of 100 nm was heat-treated for 30 minutes. Two substrates with a liquid crystal alignment film were prepared, and a 6 μm pitch adjuster was sandwiched so that the liquid crystal alignment was inside, and the periphery was used to make an empty crystal cell. This empty crystal cell was subjected to a reduced pressure injection method MLC-6608 (manufactured by MERCK-JAPAN Co., Ltd.), and the injection port was sealed with a Nematic Liquid crystal cell. The liquid crystal cell results were observed using a polarizing microscope, and it was confirmed that the liquid was uniformly aligned, and no alignment enthalpy was observed. The treatment agent 46 and the following internal crystal are used to estimate the electric ITO clock, and the heat is attached with a film facing the sealant to be adhered and injected to obtain a crystal. -132-201219451 "Evaluation of Electrical Characteristics" The liquid crystal cell produced by the method produces a voltage of IV at 60 °N at a temperature of 8 ° C, and measures the voltage after 16.67 ms and after 50 ms, respectively, as the voltage can be maintained as a voltage. Calculation of the rate. Further, it was measured to use a VHR-1 voltage retention rate measuring device (manufactured by Toyo Corporation) and set the voltage: ±1V, Pulse Width: 60ps, Flame Period: 16.67ms or 50ms. For the liquid crystal cell in which the voltage holding ratio was measured, a direct current voltage of 10 V was applied for 30 minutes to form a short circuit for one second, and then the potential generated in the liquid crystal cell was measured at 180 seconds. Subsequently, the residual charge after 50 seconds and after 1 000 seconds was measured. Further, it was measured to use a liquid crystal physical property evaluation device (Model 6254) manufactured by Dongyang Technology Co., Ltd. The voltage holding ratio and the residual electric charge were measured by irradiating ultraviolet rays of 50 J/cm 2 in terms of 365 nm in the liquid crystal cell after completion, and measuring the voltage holding ratio and residual electric charge under the same conditions as above. Further, the ultraviolet irradiation was performed using a desktop type UV curing device (HCT3B28HEX-1) (SEN LIGHT CORPORATION). <Example 1> Polyamic acid solution (A) (10.5 g), NMP (8.50 g), and BCS (24.6 g) obtained by synthesizing the resin having a solid concentration of 24.9% by mass were mixed at 25 t for 6 hours. A liquid crystal alignment treatment agent (1) is obtained. In the liquid crystal alignment treatment agent, no abnormality such as turbidity or crystallization was observed, and it was confirmed that the liquid crystal alignment treatment agent (1) obtained by using the uniform solution-133-201219451 was used, and the production of the liquid crystal wafer and the electrical characteristics were carried out under the above conditions. Evaluation. In Examples 2 to 13 and Comparative Examples 1 to 6, each of the liquid crystal alignment treatment agents produced in the same manner as in Example 1 was used to carry out liquid crystal wafer production and evaluation of electrical characteristics. The results are shown in Tables 48 to 51. <Example 2> The polyimine powder (B) (2.52 g) obtained in Synthesis Example 2, NMP (22.3 g) and BCS (19.7 g) were mixed at 25 t for 8 hours to obtain a liquid crystal alignment treatment agent (2). ). In the liquid crystal alignment treatment agent, no abnormality such as turbidity or crystallization was observed, and a solution of the uniform sentence was confirmed. <Example 3> The polyimine powder (c) (2.50 g) obtained in Synthesis Example 3, NMP (24.0 g) and BCS (17.6 g) were mixed at 25 ° C for 8 hours to obtain a liquid crystal alignment treatment agent. (3). In the liquid crystal alignment treatment agent, no abnormality such as turbidity or crystallization was observed, and a solution of the uniform sentence was confirmed. <Example 4> The polyimine powder (D) (2.51 g) obtained in Synthesis Example 4, NMP (26. 1 g), and BCS (15.7 g) were mixed at 25 ° C for 8 hours to obtain a liquid crystal alignment treatment agent. (4). In the liquid crystal alignment treatment agent, no abnormality such as turbidity or crystallization was observed, and it was confirmed that a uniform solution was obtained. -134-201219451 <Example 5> The polyimine powder (E) (2.50 g) obtained in Synthesis Example 5, NMP (29.9 g) and BCS (11.8 g) were mixed at 25 ° C for 8 hours to obtain Liquid crystal alignment treatment agent (5). In the liquid crystal alignment treatment agent, no abnormality such as turbidity or crystallization was observed, and it was confirmed that a uniform solution was obtained. <Example 6> The polyamic acid solution (F) (11.0 g), NMP (ll.lg), and BCS (23.7 g) of the resin solid content concentration of 25.0% by mass obtained in Synthesis Example 6 were at 25. The mixture was mixed under C for 6 hours to obtain a liquid crystal alignment treatment agent (6). In the liquid crystal alignment agent, "no abnormality such as turbidity or crystals was observed, and it was confirmed that a uniform solution was obtained." Example 7> The polyimine powder (G) (2.51 g) obtained in Synthesis Example 7 and NMP (3 〇) .〇g) and BCS (11.8g) were mixed at 25 ° C for 8 hours to obtain a liquid crystal alignment treatment agent (7). In the liquid crystal alignment treatment agent, no abnormality such as turbidity or crystallization was observed, and it was confirmed that a uniform solution was obtained. <Example 8> The polyimine powder (H) (2.50 g), NMP (26 μg), and BCS (15.7 g) obtained in Synthesis Example 8 were mixed at 25 ° C for 8 hours to obtain a liquid crystal alignment treatment. Agent (8). In the liquid crystal alignment treatment agent, no abnormality such as turbidity or crystallization was observed, and it was confirmed that a uniform solution was obtained. <Example 9> The polyimine powder (I) (2.50 g) obtained in Synthesis Example 9 and NMP (3 1.9 g) and BCS (9.80 g) were mixed at 25 ° C for 8 hours to obtain a liquid crystal alignment treatment. (9) » In the liquid crystal alignment treatment agent, no abnormality such as turbidity or crystallization was observed, and it was confirmed that a uniform solution was obtained. <Example 1 〇> The polyimine powder (J) (2.53 g) obtained in Synthesis Example 10, NMP (3 〇.3 g), and BCS (11.9 g) were mixed at 25 ° C for 8 hours to obtain Liquid crystal alignment agent (1 〇). In the liquid crystal alignment treatment agent, no abnormality such as turbidity or crystallization was observed, and it was confirmed that a homogeneous solution was obtained. <Example 1 1> The polyimine powder (B) (2.50 g) obtained in Synthesis Example 2, NMP (22. 1 g), BCS (19.6 g), and a crosslinkable compound (1) (0.25 g) were The mixture was mixed at 25 ° C for 12 hours to obtain a liquid crystal alignment treatment agent (丨丨). In the liquid crystal alignment agent, no abnormality such as turbidity or crystallization was observed, and it was confirmed that a uniform solution was obtained. <Example 1 2 > Polyimine powder (C) (2.50 g) obtained in Synthesis Example 3, NMP (24.0 g), BCS (17.6 g), and crosslinkable compound (2) (0.50 g) The liquid crystal alignment treatment agent (丨2) was obtained by mixing at 25 ° C for 12 hours. In the liquid crystal alignment agent -136-201219451, no abnormality such as turbidity or crystallization was observed, and it was confirmed that a uniform solution was obtained. <Example 13> The polyimine powder (C) (2.51 g), NMP (24.1 g), BCS (17.7 g) and crosslinkable compound (3) (0.25 g) obtained in Synthesis Example 3 were used in 25 The mixture was mixed at ° C for 12 hours to obtain a liquid crystal alignment treatment agent (1 3 ). In the liquid crystal alignment treatment agent, no abnormality such as turbidity or crystallization was observed, and it was confirmed that a uniform solution was obtained. <Comparative Example 1 > Polyamic acid solution (K) (10.0 g), NMP (8.50 g), and BCS (23.9 g) obtained in Synthesis Example 11 and having a resin solid content concentration of 24.0% by mass were used in 2 5 The mixture was mixed at ° C for 6 hours to obtain a liquid crystal alignment treatment agent (14). In the liquid crystal alignment treatment agent, no abnormality such as turbidity or crystallization was observed, and it was confirmed that a uniform solution was obtained. <Comparative Example 2 > Polyimine powder (L) (2.50 g) obtained in Synthesis Example 12, NMP (22. 1 g) and BCS (19.6 g) were mixed at 25 ° C for 8 hours to obtain a liquid crystal alignment treatment. Agent (1 5). In the liquid crystal alignment treatment agent, no abnormality such as turbidity or crystallization was observed, and it was confirmed that a homogeneous solution was obtained. <Comparative Example 3 > The polyimine powder (M) (2.5 1 g) obtained in Synthesis Example 13, NMPC 2 4.1 g), and BCS (1 7 -7 g) were mixed at 25 ° C for 8 hours. The liquid crystal alignment is -137- 201219451 (1 6). In the liquid crystal alignment treatment agent, no abnormality such as turbidity or crystallization was observed, and it was confirmed that a homogeneous solution was obtained. <Comparative Example 4 > Polyimine powder (N) (2.50 g) obtained in Synthesis Example 14, NMP (22. 1 g) and BCS (19.6 g) were mixed at 25 ° C for 8 hours to obtain a liquid crystal alignment treatment. Agent (1 7). In the liquid crystal alignment treatment agent, no abnormality such as turbidity or crystallization was observed, and it was confirmed that a homogeneous solution was obtained. <Comparative Example 5 > Polyimine powder (〇) (2.50 g) obtained in Synthesis Example 15, NMP (29.9 g), and BCS (11.8 g) were mixed at 25 ° C for 8 hours to obtain a liquid crystal. Orientation treatment agent (18). In the liquid crystal alignment treatment agent, no abnormality such as turbidity or crystallization was observed, and it was confirmed that a homogeneous solution was obtained. <Comparative Example 6 > The polyimine powder (P) (2.51 g) obtained in Synthesis Example 16 and NMP (8.21 g) and BCS (13.8 g) were mixed at 25 ° C for 8 hours to obtain a liquid crystal alignment treatment. Agent (1 9). In the liquid crystal alignment treatment agent, no abnormality such as turbidity or crystallization was observed, and it was confirmed that a homogeneous solution was obtained. -138-201219451 [Table 46] Liquid Crystal Alignment Treatment Resin Component Specific Diamine Compound Specific Branch-Diamine Compound Crosslinkable Compound Example 1 Liquid Crystal Alignment Treatment Agent (1) Polyacid Solution (A) (4) PCH70AB Example 2 Liquid crystal alignment treatment agent (2) Polyimide imine powder (B) (4) PCH7DAB Trade example 3 Liquid crystal alignment treatment agent (3) Polyamide powder (Q (4) PBCH5DAB Grease example 4 Liquid crystal alignment treatment agent (4 > Poly" Extruded ω) (4) m-PBCH5DABr Example 5 Liquid crystal alignment treatment agent (5) Resveratide powder (Ε) (7) ColDAB-1 Example 6 Liquid crystal alignment treatment agent (6) Poly-limb solution (F) (4) PCH7DAB Example 7 Liquid crystal alignment treatment agent (7) Polyhedral powder (G) (10) PBCH5DAB Example 8 Liquid crystal alignment treatment agent (8) Polyimine powder (Η) (4) PBCH5DAB Example 9 Liquid crystal alignment treatment agent (9) Polymerization end point ω (7) GolDAB-1 Example 10 Liquid crystal alignment treatment agent; 10) Polyamide powder (η 00) PCH7DAB Example 11 Liquid crystal alignment treatment 觌 11) Polyfluorene Yafu rm (4) PCH7DAB Female #性化会物(υ 贪例12 Liquid crystal alignment agent: 12) Poly-ra (4) PBCH5DAB Crosslinking hybrid (2) Example 13 Peptide alignment treatment 13) Polyanilin powder (〇(4) PBCH5DAB crosslinkable compound (3) [Table 47] Liquid crystal alignment treatment resin component specific diamine compound specific Asymmetric diamine compound other diamine compound Comparative Example 1 Liquid crystal alignment treatment 14) Polyamidamine liquid (K) AP18 Comparative Example 2 Liquid crystal alignment treatment »Π5) Glycan brittle (L) AP18 Comparative Example 3 Liquid crystal alignment Treatment agent: 1β) Polypigmental leg (M) PCH7DAB Comparative Example 4 Liquid crystal alignment treatment 剤C17> Poly(N) PCH7DAB (13) Comparative Example 5 Liquid crystal alignment treatment agent: 18) Polyamine powder (0) PCH7DAB ( 16) Comparative Example 6 Liquid crystal alignment treatment 觫 fear) Polyamines (P) (4) AP18 [Table 48] Liquid crystal alignment agent 鬣 保持 retention rate (%) Immediately after UV ray treatment, liquid crystal wafers are 16.67 ms 50 ms 16.67 Ms 50ms Example 1 Liquid crystal alignment treatment agent (1) 97.1 94.1 85.7 80.1 Example 2 Liquid crystal alignment treatment agent (2) 97.4 95.3 922 89.6 Example 3 Liquid crystal alignment treatment agent (3) 97.4 95.4 92.3 89.8 啻 Example 4 Liquid crystal alignment Treatment agent (4) 97.6 95.5 92.8 90.5 俐 application 俐 < 5 Liquid crystal alignment treatment agent (5) 97.3 95.3 92.2 89.5 Application example 6 Liquid crystal alignment treatment agent (6) 97.0 94.0 852 79.5 Example 7 Liquid crystal alignment treatment agent (7) 97.3 95.3 92.1 89.7 Example 8 Liquid crystal alignment treatment agent (8) 97.5 95.4 92.7 90.3 Example 9 Liquid crystal alignment treatment agent (9) 97.3 952 92.0 89.5 Example 10 Liquid crystal alignment treatment agent: 1〇> 97.4 95.4 922 90.0 Example 11 Liquid crystal alignment treatment agent (11) 97.5 95.5 92.6 90.4 Example 12 Liquid crystal Directional treatment agent (12) 97.6 95.7 92.7 90.6 Example 13 Liquid crystal alignment treatment agent (13) 97.5 95.7 92.6 90.5 -139- 201219451 Kang 49] Liquid crystal alignment treatment agent voltage retention rate (5) Liquid crystal wafer after instant UV irradiation 16.67 Ms 50 ms 16.67ms 50ms Comparative Example 1 Liquid crystal alignment treatment agent (14) 96.8 93.6 79.3 64.4 Comparative Example 2 Liquid crystal alignment treatment agent (15) 97.0 94.0 84.4 79.8 Comparative Example 3 Liquid crystal alignment treatment agent: 16) 97.1 947 87.4 82.2 Comparative example 4 Liquid crystal alignment treatment agent C17) 97.0 94.6 87.3 82.0 Comparative Example 5 Liquid crystal alignment treatment agent (18) 97.1 94.4 872 82.1 Comparative Example 6 Liquid crystal alignment treatment agent > 9) 97.2 94.5 88.9 83 7 [Table 50] Releasing the residual charge of the liquid crystal alignment agent (V) Liquid crystal cell! Immediately after the hybridization, 50 seconds after the ultraviolet irradiation, 1000 seconds, 50 seconds, and 1000 seconds later, Example 1 Liquid crystal alignment treatment agent (1) 0.64 0.12 0.98 0.23 Example 2 Liquid crystal alignment treatment agent (2) U3 0.17 143 0.22 Example 3 Liquid crystal alignment treatment agent (3) 1.15 0.18 1.41 0.21 Example 4 Liquid crystal alignment treatment agent (4) 1.35 0.31 1.55 0.34 Example 5 Liquid crystal Orientation treatment agent (5 > 1.12 0.16 140 0.22 Example 6 Liquid crystal alignment treatment agent (6) 0.61 0.11 1.01 0.25 Example 7 Liquid crystal alignment treatment agent (7) 1.15 0.16 1.44 0.22 Example 8 Liquid crystal alignment treatment agent (8) 1.21 0.24 U3 0.28 哲例例 9 Liquid crystal alignment treatment agent (9) 1.11 0.13 1.42 0.24 Window application example 10 Liquid crystal alignment treatment agent 1〇) 1.18 0.20 1.40 0.27 Example 11 Liquid crystal alignment treatment agent (11) 1.20 0.22 1.34 0.25 Example 12 Liquid crystal alignment treatment agent (12) 1.22 0.21 1.38 0.24 Example 13 Liquid crystal alignment treatment agent: 13) 1.20 0.21 135 0.25 [Table 51] Releasing the residual charge of the liquid crystal alignment treatment agent (V) Liquid crystal cell! Immediate ultraviolet light after the formation After 50 seconds, after 1000 seconds, after 50 seconds, and after 1000 seconds, Comparative Example 1 Liquid crystal alignment treatment agent (14) 0.61 0.11 2.12 0.56 Comparative Example 2 Liquid crystal alignment treatment agent (15) 1.18 0.17 1.93 0.45 Comparative Example 3 Liquid crystal alignment treatment agent ( 16) 1.15 0.15 1S7 0.43 Comparative Example 4 Liquid crystal alignment treatment agent (17) 1.14 0.17 1B5 0.44 Comparative Example 5 Liquid crystal alignment treatment agent (18) 1.15 0.16 1B4 0.42 Comparative Example 6 Liquid crystal alignment treatment agent (19) 1.17 0.18 1B8 0.44 As a result, it was found that the liquid crystal alignment films obtained from the liquid crystal alignment treatment agents of Examples 1 to 13 were compared with the liquid crystal alignment films obtained from the liquid crystal alignment agents of Comparative Examples 1 to 6, and it was found that even after exposure to ultraviolet rays, It still has a small drop in voltage retention and can quickly alleviate the residual charge accumulated by DC-140-201219451. In Comparative Examples 1 to 5, which did not contain a specific diamine compound, it was a decrease in the voltage holding ratio after exposure to ultraviolet rays, and the relaxation of the residual charge accumulated by the DC voltage was also sluggish. Further, Comparative Example 6 containing no specific side chain type diamine compound gave the same result. [Industrial Applicability] The liquid crystal alignment treatment agent of the present invention can provide a charge liquid crystal alignment film which can suppress the decrease in the voltage holding ratio even when exposed to light for a long period of time and can be quickly accumulated by the DC voltage. . The liquid crystal display element having the liquid crystal alignment film of the present invention is a display element having excellent reliability, and is suitable for a liquid crystal television having a large screen and high definition, and is suitable for a TN element, an STN element, and a TFT liquid crystal element. In particular, it is suitable for use in a vertical alignment type liquid crystal display element. Further, the liquid crystal alignment film obtained by the liquid crystal alignment treatment agent of the present invention can be used in the production of a liquid crystal display element having a step of applying a voltage between electrodes and irradiating ultraviolet rays. In the present specification, the specification, the scope of application, and the abstract of the patent application No. 2 0 1 0 - 1 6 7 3 7 1, which is filed on July 26, 2010, is incorporated herein by reference. The disclosure of the specification is taken into the specification. -141 -

Claims (1)

201219451 七、申請專利範圍： 1. 一種液晶配向處理劑，其特徵爲含有’由含有下述 之式Π]所示之二胺化合物及下述之式[2]所示之二胺化合 物的二胺成分，與四羧酸二酐成分反應所得之聚醯亞胺前 趨物及聚醯亞胺所成群所選出之至少1種之聚合物， [化1]201219451 VII. Patent application scope: 1. A liquid crystal alignment treatment agent characterized by containing a diamine compound represented by the following formula 及 and a diamine compound represented by the following formula [2] At least one polymer selected from the group consisting of a polyamine imine precursor obtained by reacting an amine component with a tetracarboxylic dianhydride component and a polyimine group, [Chemical Formula 1] (式[1]中 ’ X1 g-〇-、-CO-、-NH-、-N(CH3)-、-CONH-、-NHCO-、-CH2O-、-OCO-、-CON(CH3)-或 N(CH3)CO-， X2爲碳數1〜5之烷基或含有氮原子之非芳香族雜環’X3 爲可被碳數1〜5之烷基所取代之含有2個氮原子之5員 環或6員環之芳香族雜環）(In the formula [1] 'X1 g-〇-, -CO-, -NH-, -N(CH3)-, -CONH-, -NHCO-, -CH2O-, -OCO-, -CON(CH3)- Or N(CH3)CO-, X2 is an alkyl group having 1 to 5 carbon atoms or a non-aromatic heterocyclic ring 'X3 containing a nitrogen atom, which is substituted by an alkyl group having 1 to 5 carbon atoms and contains 2 nitrogen atoms. 5-membered ring or 6-membered ring aromatic ring) (式[2]中’ Y1爲單鍵、-(CH2)a-(a爲1〜15之整數）、-〇- 、-CH20-、-COO-或 OCO-，γ2 爲單鍵或（CH2)b-(b 爲 1 〜 15之整數），Y3爲單鍵、-(CDHc爲1〜15之整數）、-〇- -142- 201219451 、-CH20-、-COO-或OCO-; Y4爲由苯環、環己烷環及雜 環所成群所選出之環狀基（該些之環狀基上之任意的氫原 子可被碳數1〜3之烷基、碳數1〜3之烷氧基、碳數1〜3 之含氟烷基、碳數1〜3之含氟烷氧基或氟原子所取代）， 或具有固醇骨架之碳數12〜25之有機基所選出之2價之 有機基，Υ5爲由苯環、環己烷環及雜環所成群所選出之2 價之環狀基（該些之環狀基上之任意的氫原子可被碳數1〜 3之烷基、碳數1〜3之烷氧基、碳數1〜3之含氟烷基、 碳數1〜3之含氟烷氧基或氟原子所取代），η爲0〜4之整 數；Υ6爲碳數1〜18之烷基、碳數1〜18之含氟烷基 '碳 數1〜18之烷氧基或碳數1〜18之含氟烷氧基，m爲1〜4 之整數）。 2 .如申請專利範圍第1項之液晶配向處理劑，其式[1 ] 中，χΐ 爲-0-、-CO.、-NH-、-CONH-、-NHCO-、_CON(CH3)_ 或 CH2〇-。 3 ·如申請專利範圍第1或2項之液晶配向處理劑，其 式[1]中，X2爲哌嗪環。 4.如申請專利範圍第1〜3項中任一項之液晶配向處 理劑，其式[1]中’ X3爲咪唑環、吡嗪環或嘧啶環。 5 .如申請專利範圍第1〜4項中任一項之液晶配向處 理劑，其中，前述聚合物爲使用下述之式[3]所示之四羧酸 二酐之聚合物’ -143- 201219451 [化3](In the formula [2], Y1 is a single bond, -(CH2)a- (a is an integer of 1 to 15), -〇-, -CH20-, -COO- or OCO-, and γ2 is a single bond or (CH2) B-(b is an integer from 1 to 15), Y3 is a single bond, -(CDHc is an integer from 1 to 15), -〇- -142- 201219451, -CH20-, -COO- or OCO-; Y4 is a cyclic group selected from the group consisting of a benzene ring, a cyclohexane ring, and a heterocyclic ring (any hydrogen atom on the cyclic group may be an alkyl group having 1 to 3 carbon atoms, and a carbon number of 1 to 3) An alkoxy group, a fluorine-containing alkyl group having 1 to 3 carbon atoms, a fluorine-containing alkoxy group having 1 to 3 carbon atoms or a fluorine atom, or an organic group having a sterol skeleton having 12 to 25 carbon atoms selected a divalent organic group, Υ5 is a bivalent cyclic group selected from the group consisting of a benzene ring, a cyclohexane ring and a heterocyclic ring (any hydrogen atom on the cyclic group may be carbon number 1~ An alkyl group of 3, an alkoxy group having 1 to 3 carbon atoms, a fluorine-containing alkyl group having 1 to 3 carbon atoms, a fluorine-containing alkoxy group having 1 to 3 carbon atoms or a fluorine atom, and η of 0 to 4;整数6 is an alkyl group having 1 to 18 carbon atoms, a fluorine-containing alkyl group having 1 to 18 carbon atoms, an alkoxy group having 1 to 18 carbon atoms or a fluorine-containing alkoxy group having 1 to 18 carbon atoms, and m is 1 4 of the integer). 2. In the liquid crystal alignment treatment agent of claim 1, in the formula [1], χΐ is -0-, -CO., -NH-, -CONH-, -NHCO-, _CON(CH3)_ or CH2〇-. 3. The liquid crystal alignment treatment agent according to claim 1 or 2, wherein in the formula [1], X2 is a piperazine ring. 4. The liquid crystal alignment treatment agent according to any one of claims 1 to 3, wherein in the formula [1], X3 is an imidazole ring, a pyrazine ring or a pyrimidine ring. The liquid crystal alignment treatment agent according to any one of claims 1 to 4, wherein the polymer is a polymer of tetracarboxylic dianhydride represented by the following formula [3] -143- 201219451 [化3] (式[3]中’ Z1爲碳數4〜13之4價之有機基，且含有碳數 4〜1 0之非芳香族環狀烴基）。 6.如申請專利範圍第5項之液晶配向處理劑，其中’ Z1爲下述之式[3a]〜[3j]所示結構之基， [化4] ?2 ?4(In the formula [3], Z1 is a tetravalent organic group having 4 to 13 carbon atoms and a non-aromatic cyclic hydrocarbon group having 4 to 10 carbon atoms). 6. The liquid crystal alignment treatment agent of claim 5, wherein 'Z1 is a group of the structures represented by the following formulas [3a] to [3j], [Chem. 4] ? 2 ? Z3 2s [3a]Z3 2s [3a] [3b] [3c] [3d] [3e] [3f ][3b] [3c] [3d] [3e] [3f ] (式[3 a]中，Z2〜Z5爲氫原子、甲基、氯原子或苯環，其可 分別爲相同或相異皆可；式[3 g]中，Z6及Z7爲氫原子或 甲基，其可分別爲相同或相異皆可）。 7.如申請專利範圍第1〜6項中任一項之液晶配向處 -144- 201219451 理劑’其中’前述聚合物爲由二胺成分與四羧酸二 反應所得之聚醯胺酸及該聚醯胺酸經脫水閉環所得 亞胺所成群所.選出之至少1種之聚合物。 8 _如申請專利範圍第1〜6項中任一項之液晶 理劑’其中，前述聚合物爲聚醯胺酸經脫水閉環所 醯亞胺。 9·如申請專利範圍第1〜8項中任一項之液晶 理劑’其液晶配向處理劑中爲具有，具有環氧基、 院基、環碳酸醋基或異氰酸酯基之交聯性化合物、 羥基及烷氧基所成群所選出之至少1種之取代基的 化合物，或具有聚合性不飽和鍵結之交聯性化合物 1 0.如申請專利範圍第1〜9項中任一項之液晶 理劑，其中，液晶配向處理劑中含有有機溶劑，有 之全體中含有5〜80質量％之不良溶劑。 1 1 · 一種液晶配向膜，其特徵爲，使用由申請 圍第1〜1 0項中任一項之液晶配向處理劑所得。 12.—種液晶顯示元件，其特徵爲，具有申請 圍第11項之液晶配向膜。 1 3 .如申請專利範圍第1 1項之液晶配向膜，其 於由具備有電極之一對基板之間具有液晶層所構成 前述一對基板之間配置含有可經活性能量線及熱之 者而聚合之聚合性化合物的液晶組成物，並經由對 極間施加電壓，使前述聚合性化合物聚合之步驟所 液晶顯示元件。 ’ 酐成分 之聚醯 配向處 得之聚 配向處 環氧丙 具有由 交聯性 〇 配向處 機溶劑 專利範 專利範 爲使用 ，且於 至少一 前述電 製得之 -145- 201219451 14.一種液晶顯示元件，其特徵爲，由具備有申請專 利範圍第11項之液晶配向膜與電極之一對基板間具有液 晶層所構成，並經由於前述一對基板之間配置含有經活性 能量線及熱之至少一者而聚合之聚合性化合物的液晶組成 物，並對前述電極間施加電壓，使前述聚合性化合物聚合 之步驟所製得之液晶顯示元件。 1 5 ·如申請專利範圍第1 1項之液晶配向膜，其爲使用 於由具備有電極之一對基板之間具有液晶層者所構成，且 於前述一對基板之間配置含有可經活性能量線及熱之至少 —者而聚合之聚合性基的液晶配向膜，並經由對前述電極 間施加電壓，使前述聚合性基聚合之步驟所製得之液晶顯 示元件。 16· —種液晶顯示元件，其特徵爲，由對具備有電極 之一對基板之間具有液晶層所構成，且於前述一對基板之 間配置含有可經活性能量線及熱之至少一者而聚合之聚合 性基的申請專利範圍第1 1項之液晶配向膜，並經由對前述 電極間施加電壓，使前述聚合性基聚合之步驟所製得。 -146- 201219451 四 指定代表圖： (一） 本案指定代表圖為：無 (二） 本代表圖之元件符號簡單說明：無 201219451 五、本案若有化學式時，請揭示最能顯示發明特徵的化學 式：(In the formula [3 a], Z2 to Z5 are a hydrogen atom, a methyl group, a chlorine atom or a benzene ring, which may be the same or different, respectively; in the formula [3 g], Z6 and Z7 are a hydrogen atom or a Base, which can be the same or different, respectively). 7. The liquid crystal alignment of any one of the first to sixth aspects of the invention, wherein the polymer is a polyamic acid obtained by reacting a diamine component with a tetracarboxylic acid and At least one polymer selected from the group consisting of imines obtained by dehydration ring closure. The liquid crystal agent according to any one of claims 1 to 6, wherein the polymer is a polyamine acid which is subjected to dehydration ring closure. 9. The liquid crystal remedy according to any one of the first to eighth aspects of the invention, wherein the liquid crystal alignment treatment agent has a crosslinkable compound having an epoxy group, a hospital group, a cyclic carbonate group or an isocyanate group, a compound having at least one substituent selected from the group consisting of a hydroxyl group and an alkoxy group, or a crosslinkable compound having a polymerizable unsaturated bond. 10. The method according to any one of claims 1 to 9 In the liquid crystal physicochemical agent, the liquid crystal alignment agent contains an organic solvent, and all of them contain 5 to 80% by mass of a poor solvent. 1 1 A liquid crystal alignment film obtained by using the liquid crystal alignment treatment agent according to any one of the above items 1 to 10. A liquid crystal display element comprising the liquid crystal alignment film of the eleventh application. The liquid crystal alignment film according to the first aspect of the invention, wherein the active energy ray and the heat are disposed between the pair of substrates including the liquid crystal layer between the one of the electrodes and the substrate; The liquid crystal composition of the polymerizable compound to be polymerized, and a liquid crystal display element in which the polymerizable compound is polymerized by applying a voltage between the electrodes. The polyglycol alignment of the anhydride component is obtained by using a cross-linking 〇 处 溶剂 溶剂 专利 专利 专利 专利 专利 专利 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - A display element comprising a liquid crystal layer between one of a liquid crystal alignment film and an electrode having the eleventh aspect of the patent application scope, and comprising an active energy ray and heat disposed between the pair of substrates A liquid crystal display device obtained by the step of polymerizing the polymerizable compound by applying a voltage between the electrodes and polymerizing the liquid crystal composition of the polymerizable compound. The liquid crystal alignment film according to the first aspect of the invention, which is configured to be provided with a liquid crystal layer between the substrates provided with one of the electrodes, and is disposed between the pair of substrates to be active. A liquid crystal display element produced by the step of polymerizing the polymerizable group by applying a voltage between the electrodes, at least a polymerizable group-based liquid crystal alignment film in which energy rays and heat are polymerized. A liquid crystal display device comprising: a liquid crystal layer formed between a pair of electrodes including a pair of electrodes; and at least one of an active energy ray and heat disposed between the pair of substrates Further, the liquid crystal alignment film of the polymerized group of the polymerized group of the polymerization is obtained by a step of polymerizing the polymerizable group by applying a voltage between the electrodes. -146- 201219451 Four designated representatives: (1) The representative representative of the case is: None (2) The symbol of the representative figure is simple: No 201219451 5. If there is a chemical formula in this case, please disclose the chemical formula that best shows the characteristics of the invention. : -4--4-
TW100126353A 2010-07-26 2011-07-26 Liquid crystal alignment agent, liquid crystal alignment film and liquid crystal display element TWI522391B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2010167371 2010-07-26

Publications (2)

Publication Number Publication Date
TW201219451A true TW201219451A (en) 2012-05-16
TWI522391B TWI522391B (en) 2016-02-21

Family

ID=45530104

Family Applications (1)

Application Number Title Priority Date Filing Date
TW100126353A TWI522391B (en) 2010-07-26 2011-07-26 Liquid crystal alignment agent, liquid crystal alignment film and liquid crystal display element

Country Status (5)

Country Link
JP (1) JP5904121B2 (en)
KR (1) KR101826380B1 (en)
CN (1) CN103119509B (en)
TW (1) TWI522391B (en)
WO (1) WO2012014898A1 (en)

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104059675A (en) * 2013-03-19 2014-09-24 Jsr株式会社 Liquid Crystal Aligning Agent, Liquid Crystal Alignment Film, Liquid Crystal Display Device, Polymer And Compound
TWI485201B (en) * 2012-08-10 2015-05-21 Nissan Chemical Ind Ltd Liquid crystal aligning agent, liquid crystal alignment film and liquid crystal display element
CN105122128A (en) * 2013-02-13 2015-12-02 日产化学工业株式会社 Production method for liquid-crystal alignment film, liquid-crystal alignment film, liquid-crystal display element, and liquid-crystal alignment agent
TWI513753B (en) * 2012-12-12 2015-12-21 Nissan Chemical Ind Ltd A liquid crystal alignment agent, a liquid crystal alignment film, and a liquid crystal display device
TWI626266B (en) * 2013-05-13 2018-06-11 日產化學工業股份有限公司 Manufacturing method of substrate with liquid crystal alignment film for lateral electric field drive type liquid crystal display element
TWI628219B (en) * 2013-05-13 2018-07-01 日產化學工業股份有限公司 Manufacturing method of substrate with liquid crystal alignment film for lateral electric field drive type liquid crystal display element
TWI678385B (en) * 2014-12-25 2019-12-01 日商日產化學工業股份有限公司 Liquid crystal alignment treatment agent, liquid crystal alignment film and liquid crystal display element

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103492462B (en) * 2011-03-07 2016-01-20 日产化学工业株式会社 Composition, aligning agent for liquid crystal, liquid crystal orientation film and liquid crystal display device
KR101842740B1 (en) * 2011-03-07 2018-05-14 닛산 가가쿠 고교 가부시키 가이샤 Composition, liquid crystal aligning agent, liquid crystal alignment film, and liquid crystal display element
JP6127982B2 (en) * 2012-01-12 2017-05-17 和光純薬工業株式会社 Liquid crystal alignment agent
WO2013125595A1 (en) * 2012-02-22 2013-08-29 日産化学工業株式会社 Composition, liquid crystal aligninig agent, liquid crystal alighment film, and liquid crystal display element
CN105164579B (en) * 2013-02-28 2018-03-09 日产化学工业株式会社 Polymer, aligning agent for liquid crystal, liquid crystal orientation film and liquid crystal represent element
JP6264577B2 (en) * 2013-02-28 2018-01-24 日産化学工業株式会社 Liquid crystal aligning agent, liquid crystal alignment film, and liquid crystal display element
KR102196272B1 (en) * 2013-03-01 2020-12-29 닛산 가가쿠 가부시키가이샤 Liquid crystal display element, liquid crystal alignment film, and liquid crystal alignment treatment agent
JP6497520B2 (en) * 2013-05-23 2019-04-10 日産化学株式会社 Liquid crystal aligning agent, liquid crystal alignment film, and liquid crystal display element
WO2015022980A1 (en) * 2013-08-14 2015-02-19 日産化学工業株式会社 Liquid crystal display element
TWI487731B (en) * 2013-09-04 2015-06-11 Daxin Materials Corp Liquid crystal alignment agent, liquid crystal alignment film, and liquid crystal display device having the same
KR101944638B1 (en) * 2014-06-25 2019-01-31 닛산 가가쿠 가부시키가이샤 Liquid crystal display element
KR102478707B1 (en) * 2014-12-25 2022-12-16 닛산 가가쿠 가부시키가이샤 Liquid crystal aligning agent, liquid crystal alignment film, and liquid crystal display element
KR102667493B1 (en) * 2015-08-28 2024-05-20 닛산 가가쿠 가부시키가이샤 A novel diamine compound with radical-generating ability and base-generating ability and a new imide-based polymer using it as a raw material
CN105199387B (en) * 2015-10-12 2018-03-27 深圳市华星光电技术有限公司 The manufacture method of alignment film material and alignment film
CN110546176B (en) * 2017-02-28 2022-03-18 日产化学株式会社 Compound, liquid crystal composition and liquid crystal display element
CN113396359B (en) * 2019-02-05 2024-12-17 日产化学株式会社 Liquid crystal aligning agent, liquid crystal alignment film, and liquid crystal display element using same
CN114207086A (en) * 2019-08-08 2022-03-18 日产化学株式会社 Liquid crystal aligning agent, liquid crystal alignment film, and liquid crystal display element using same
EP4043948A4 (en) 2019-10-02 2023-11-01 Nissan Chemical Corporation LIQUID CRYSTAL LIGHT CONTROL ELEMENT

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH05216046A (en) * 1992-02-06 1993-08-27 Fuji Photo Film Co Ltd Oriented film
US6900271B2 (en) 2002-05-31 2005-05-31 Elsicon, Inc Hybrid polymer materials for liquid crystal alignment layers
JP4645823B2 (en) 2004-06-18 2011-03-09 Ｊｓｒ株式会社 Vertical liquid crystal aligning agent and vertical liquid crystal display element
JP5077048B2 (en) 2007-05-02 2012-11-21 Ｊｓｒ株式会社 Vertical alignment type liquid crystal alignment agent
WO2009154208A1 (en) 2008-06-17 2009-12-23 日産化学工業株式会社 Liquid-crystal alignment material, liquid-crystal display element employing same, and novel diamine
JP5614284B2 (en) 2008-10-29 2014-10-29 日産化学工業株式会社 Diamine, polyimide, liquid crystal aligning agent and liquid crystal aligning film
JP5304174B2 (en) 2008-10-29 2013-10-02 Ｊｎｃ株式会社 Liquid crystal alignment agent, liquid crystal alignment film, and liquid crystal display element
KR102073458B1 (en) * 2009-07-21 2020-02-04 닛산 가가쿠 가부시키가이샤 Diamine compound, polyamic acid, polyimide, and liquid crystal aligning agent

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI485201B (en) * 2012-08-10 2015-05-21 Nissan Chemical Ind Ltd Liquid crystal aligning agent, liquid crystal alignment film and liquid crystal display element
TWI513753B (en) * 2012-12-12 2015-12-21 Nissan Chemical Ind Ltd A liquid crystal alignment agent, a liquid crystal alignment film, and a liquid crystal display device
CN105122128A (en) * 2013-02-13 2015-12-02 日产化学工业株式会社 Production method for liquid-crystal alignment film, liquid-crystal alignment film, liquid-crystal display element, and liquid-crystal alignment agent
CN105122128B (en) * 2013-02-13 2017-11-28 日产化学工业株式会社 The manufacture method of liquid crystal orientation film, liquid crystal orientation film, liquid crystal represent element and aligning agent for liquid crystal
CN104059675A (en) * 2013-03-19 2014-09-24 Jsr株式会社 Liquid Crystal Aligning Agent, Liquid Crystal Alignment Film, Liquid Crystal Display Device, Polymer And Compound
TWI626266B (en) * 2013-05-13 2018-06-11 日產化學工業股份有限公司 Manufacturing method of substrate with liquid crystal alignment film for lateral electric field drive type liquid crystal display element
TWI628219B (en) * 2013-05-13 2018-07-01 日產化學工業股份有限公司 Manufacturing method of substrate with liquid crystal alignment film for lateral electric field drive type liquid crystal display element
TWI678385B (en) * 2014-12-25 2019-12-01 日商日產化學工業股份有限公司 Liquid crystal alignment treatment agent, liquid crystal alignment film and liquid crystal display element

Also Published As

Publication number Publication date
KR101826380B1 (en) 2018-02-06
WO2012014898A1 (en) 2012-02-02
CN103119509A (en) 2013-05-22
TWI522391B (en) 2016-02-21
JP5904121B2 (en) 2016-04-13
JPWO2012014898A1 (en) 2013-09-12
CN103119509B (en) 2015-08-19
KR20130094804A (en) 2013-08-26

Similar Documents

Publication Publication Date Title
TW201219451A (en) Liquid crystal aligning agent, liquid crystal alignment film, and liquid crystal display element
TWI447146B (en) Liquid crystal alignment agent, liquid crystal alignment film and liquid crystal display element
TWI449727B (en) A liquid crystal alignment agent, and a liquid crystal display device using the liquid crystal display device
TWI471655B (en) Liquid crystal alignment agent, liquid crystal alignment film and liquid crystal display element
TWI490207B (en) A diamine compound, a liquid crystal alignment treatment agent, and a liquid crystal display device using the same
TWI457368B (en) Using the same liquid crystal alignment treating agent to the liquid crystal display element
TWI477478B (en) Diamine compounds, polyamic acid, polyimide and liquid crystal alignment treatment agent
TWI480647B (en) A liquid crystal alignment agent, and a liquid crystal display device using the liquid crystal display device
TW201141912A (en) Liquid crystal display element and liquid crystal aligning agent
TW200948860A (en) Liquid-crystal alignment material, liquid-crystal alignment film, and liquid-crystal display element
TW201217433A (en) Liquid crystal aligning agent, liquid crystal alignment film, and liquid crystal display element
TW200944553A (en) Liquid-crystal alignment material and liquid-crystal display element
TW200906768A (en) Diamine compound, polyamic acid, polyimide and liquid crystal aligning agent
TW201326261A (en) Liquid crystal alignment agent, liquid crystal alignment film, liquid crystal display device, polymer and compound
JP6183616B2 (en) Liquid crystal alignment agent, liquid crystal alignment film, and liquid crystal display element
TW201509998A (en) Treatment agent for liquid crystal orientation, liquid crystal orientation film, and liquid crystal display device
TW201348293A (en) Liquid crystal alignment agent, liquid crystal alignment film, and liquid crystal display element
TWI633128B (en) Composition, liquid crystal alignment treatment agent, liquid crystal alignment film, and liquid crystal display element
TW201242991A (en) Liquid crystal aligning agent, liquid crystal alignment film and liquid crystal display element
TW201219380A (en) Liquid crystal alignment treatment agent, liquid crystal alignment film, and liquid crystal display element
TW200914953A (en) Alignment material for liquid crystal display device and a preparing method of the same
TW201120099A (en) Liquid crystal alignment agent, liquid crystal alignment film, liquid crystal display device, polyamic acid and compound
TWI624494B (en) Composition, liquid crystal alignment treatment agent, liquid crystal alignment film, and liquid crystal display element
TWI575022B (en) Liquid crystal alignment agent, liquid crystal alignment film and liquid crystal display element
TW201430054A (en) Composition, liquid crystal aligning agent, liquid crystal alignment film, and liquid crystal display element